<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <title>Parkinson's Guide</title>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3">
    <meta name="color-scheme" content="light dark">

<style>
:root {
    --body-background-color: #E2D8D6;
    --body-color: #111111cc;
    --body-border-color: #DDDDDDcc;

    --section-figure-border-color: #333333;
    --section-figure-bg-color: #FFFFFF33;
    
    --psuedo-target-bg-color: #FFFFFFCC;

    --treatment-legend-h3-bg-color: #FFFFFFCC;

    --tooltip-color: #444;
    --tooltip-bg-color: #EEE;
    --tooltip-border-color: #5555;
    --tooltip-shadow-color: #3333;
    --abbr-text-decoraction-color: hsl(0deg 3% 25% / 50%);
    --abbr-hover-bg-color: hsl(10deg 17% 96% / 73%);
    
    --dd-solution: rgb(0, 77, 0);

    color-scheme: light dark;
}

@media (prefers-color-scheme: dark) {
    :root {
        --body-background-color: #331F1B;
        --body-color: #ffffffc2;
        --body-border-color: #330500cc;
    
        --section-figure-border-color: #333333;
        --section-figure-bg-color: #FFFFFF33;
        
        --psuedo-target-bg-color:  #5555;

        --treatment-legend-h3-bg-color: #401C16EE;

        --tooltip-color: #EEE;
        --tooltip-bg-color: #555;
        --abbr-text-decoraction-color: hsl(12deg 5% 80% / 50%);
        --abbr-hover-bg-color: hsl(10 31% 11% / 1);
        
        --dd-solution: rgb(0, 111, 0);
    }
}

html {
    margin: 0;
    padding: 0;
    height: 100%;
    width: 100%;
    overflow-x: hidden;
    color-scheme: light dark;
}

body {
    background-color: var(--body-background-color);
    color: var(--body-color);
    border-color: var(--body-border-color);
    font-family: georgia, "Open Sans", Helvetica;
    position: relative;
    font-size: clamp(calc(12px + 0.8vi), 3vi, 32px);
    margin: 0;
    padding-left: 4vi;
    border-style: solid;
    border-width: 1px;
    min-height: 100%;
    overflow-x: hidden;
    position: relative;
    background-size: cover;
}

body > #metadata {
    font-size: smaller;
    margin: 0;
}

body > #metadata p {
    margin-top 0;
}

address.author {
    display: inline;
}

address.author strong {
    font-style: normal;
}

abbr[title], dfn[title] {
    position: relative;
    text-decoration: underline;
    text-decoration-style: dotted;
    border-radius: 0.5vi;
    padding:  0.3vi;
    margin: -0.3vi;
    text-decoration-color: var(--abbr-text-decoraction-color);
    cursor: text;
    transition: background-color 0.6s ease-out;
}

abbr[title]:hover, dfn[title]:hover {
    cursor: default;
    background-color: var(--abbr-hover-bg-color);
    transition: opacity 0.001s;
}

abbr[title]::after, dfn[title]::after {
    position: absolute;
    left: 0;
    bottom: 100%;
    right: unset;
    top: unset;
    padding: .5em .46em .5em .5em;
    background-color: var(--tooltip-bg-color);
    color: var(--tooltip-color);
    font-size: smaller;
    border-radius: .4em;
    transition: all 0.3s;
    content: attr(title);
    opacity: 0;
    z-index: 1;
    pointer-events: none;
    display: block;
    box-sizing: border-box;
    width: fit-content;
    block-size: fit-content;
    filter: drop-shadow(.1vi .1vi var(--tooltip-shadow-color));
    border: 1px solid  var(--tooltip-border-color);
}

abbr[title]:hover::after, dfn[title]:hover::after, 
    dfn[data-tip-r], dfn[data-tip-t],
    abbr[data-tip-r], abbr[data-tip-t]  {
    opacity: 0.9999999;
    transition: all 0.3s ease-out;
}

a:link, a:visited {
    color: inherit;
    text-decoration: underline;
    font-weight: bold;
    font-size: 90%;
}

cite.reflink {
    font-size: 60%;
}

cite.reflink::before {
    content: "(";
    padding-right: 0.15vi;
}

cite.reflink::after {
    content: ")";
    padding-left: 0.15vi;
}

a:visited {
    color: lighten;
    font-style: italic;
}

dl {
    font-family: cormorant, "Latin Modern Roman";
}
dt {
    font-style: italic;
}

#problems-list > dt {
    font-weight: 550;
    float: left;
    margin-right: 1ex;
}

dd.es {
    margin: 0.5ex 0.5ex 1.5ex 0.5ex;
    color: var(--dd-solution);
}

dd.es::before {
    content: "Solutions: ";
    font-style: italic;
}

.compact-inline-list, .compact-inline-list > * {
    display: inline;
    margin: 0;
}

.compact-inline-list > dt {
    display: inline; 
    margin-right: .8ex;
    font-weight: 600;
}

section > figure {
    border-width: 0.1vh;
    border-style: solid;
    border-color: var(--section-figure-border-color);
    background-color: var(--section-figure-bg-color);
    padding: 2vi 3vi;
}

figure > img.block-image {
    max-width: 100%;
    display: block;
    margin: auto;
}


img#choroid-plexus {
    max-width: 30vi;
}

figure > img#choroid-plexus.zoomable:focus {
     transform: scale(1);
    max-width: initial;
}


figure.flex-row {
    display: flex;
    flex-direction: row;
}

figure.flex-row img {
    border-width: 1px;
    border-style: solid;
    padding: 0.5px;
}

ol.reference-list > li {
    margin-top: 1ex;
}

ol.reference-list > li[id]::before {
    font-size: 60%;
    font-style: italic;
    margin: .1em;
    content: "[" attr(id) "]"
}

body > section, body > header {
    padding-left: 1.2vw;
    padding-right: 1.2vw;
}

section, header {
    background-color: light-dark(lighten, darken);
    margin: 0;
    padding: 0.1vi 1.3vi;
    border: 2px solid transparent;
}

*:target {
    background-color: var(--psuedo-target-bg-color);
    animation: highlightFade 4s ease forwards; /* Play the animation */
}

section section {
    background-color: inherit;
}

@scope(.product-list) {
    figure, p {
        margin-bottom: 0;
    }
}
/* Animation for highlighting and fading out on in-page links */
@keyframes highlightFade {
    0% {
        border-color: #e635;
    }
    50% {
        border-color: light-dark(lighten, darken);
    } 
    100% {
        background-color: initial;
    }  
} 

.answer {
    float: left;
    margin: 0 0.5em 0 0;
}
.good-answers, .bad-answers, .baseline-answers {
    list-style: none;
}
.good-answers li::before {
    content: "âœ…";
}
.bad-answers li::before {
    content: "âŒ";
}

.baseline-answers li::before {
    content: "âœ”ï¸";
}

.supplement-table > tbody > tr:nth-child(odd) {
    background: #eee1;
}

.supplement-table > tbody td:nth-child(2) {
    text-align: right;
}

.supplement-table td {
    padding: 0.2ex 0.4em;
}

.recipe-list {
    list-style: none;
}

.product-list {
    list-style: none;
    display: flex;
    flex-direction: row;
    flex-wrap: wrap;
    align-items: flex-end;
}

.product-list li {
    max-width: 30vw;
    height: auto;
    flex-grow: 1;
    flex-shrink: 3; /* default 1 */
}

.product-list img {
    width: auto;
    max-width: 28vw;
    min-width: 0;
    object-fit: cover;
    vertical-align: bottom;
}

#treatment-legend {
    margin-top: 1.2em;
    border: 1px solid #9999;
    position: relative;
}

#treatment-legend > h3:first-child {
    background-color: var(--treatment-legend-h3-bg-color);
    border-color: #777;
    border-width: 1px;
    border-style: solid;
    position: absolute;
    top: -1.4ex;
    display: inline-block;
    font-size: smaller;
    z-index: 10;
    margin-top: 0;
    margin-bottom: -1em;
    padding: 0.05em 0.3em;
}

#legend-legend {
    list-style: none;
    font-size: smaller;
}

</style>
    <link rel="stylesheet" href="css/nav.css">
    <link rel="stylesheet" href="css/diagrams.css">
    <link rel="stylesheet" href="css/nutrition-facts.css">
    <link rel="stylesheet" href="css/treatment-legend.css">

<style id="tipsheet">
abbr[title][itemprop^=r]::after, dfn[title][itemprop^=r]::after {
    left: unset;
    right: -.22em;
    transition: all .3s ease-in;
}
abbr[title][itemprop$=t]::after, dfn[title][itemprop$=t]::after {
    bottom: unset;
    transition: all .3s ease-in;
    top: 3ex;
}
</style>
    <script type="module">
const documentElement = document.documentElement;

const clickHandler = event => {
    const target = event.target;
    if (!target) return;
    const nav = document.getElementById("nav");
    const isNotNav = !nav.contains(target);
    const isNavHeader = target.matches("#nav-heading");
    
    if (isNavHeader) {
        nav.classList.toggle("open");
        return;
    } else if (isNotNav) {
        nav.classList.remove("open");
    }
};
documentElement.addEventListener("click", clickHandler);
documentElement.addEventListener("touchstart", clickHandler); 

addEventListener("hashchange", (ev) => {
    const navRight = nav.getBoundingClientRect().right;
    const rightPageMargin = innerWidth - navRight;
    if (rightPageMargin < 50) {
        nav.classList.remove("open");
    }
});
</script>

<script type="module">
document.addEventListener("mouseover", tooltipPositionFixer);
document.addEventListener("transitionend", tooltipPositionResetter);
window.addEventListener("resize", windowChanged);
window.addEventListener("scroll", windowChanged);
window.addEventListener("orientationchange", windowChanged);

let isWindowChanged = false;
function windowChanged(ev) {
    isWindowChanged = true;
}

const TOOLTIP_ACTUATOR_SELECTOR = "dfn[title], abbr[title]";

const tipActuatorMouseLeave = (ev) => {
    ev.target.removeAttribute("itemprop");
};

function tooltipPositionFixer(ev) {
    const target = ev.target;
    
    if(target.hasAttribute("itemprop") && !isWindowChanged) return;
    if (isWindowChanged) {
        target.removeAttribute("itemprop");
        isWindowChanged = false;
    }
    if (target.matches(TOOLTIP_ACTUATOR_SELECTOR)) {
        const targetBox = target.getBoundingClientRect();
        const afterStyle = window.getComputedStyle(target, '::after');
    
        const wasClippedRight = isClippedRight(targetBox, afterStyle);
        const wasClippedTop = isClippedTop(targetBox, afterStyle);
        
        target.removeAttribute("itemprop");
        if (wasClippedRight) {
        // Cannot use "data-" prop here ,as it causes transitionend to not fire
        // on the ABBR and DFN elements. So, use itemprop.
            target.setAttribute("itemprop", 'r');
        }
        if (wasClippedTop) {
            target.setAttribute("itemprop", target.getAttribute("itemprop")+"t");
        }
    }
    ev.preventDefault();
}

function isClippedRight(targetBox, afterStyle) {
    const targetRight = targetBox.right;
    const tooltipRight = targetRight + parseInt(afterStyle.width, 10);
    const bodyRight = window.innerWidth;
    return tooltipRight + 3.5 >  bodyRight;
}

function isClippedTop(targetBox, afterStyle) {
    const targetTop = targetBox.top;
    const pseudoEltTop = parseInt(afterStyle.top, 10);
    return targetTop + pseudoEltTop <  0;
}

/** FIXME:
    In theory, this actuator hover-off post-transition 
    should prevent the tooltip from flickering back into place.
*/
const tooltipOffCriteria = (ev) => {
    const target = ev.target;
    const matchesCriteria = false === target.matches(":hover") 
                && "text" === getComputedStyle(target).cursor
                && .6 === ev.elapsedTime;

    return matchesCriteria;
};
function tooltipPositionResetter(ev) {
    const target = ev.target;
    if (tooltipOffCriteria(ev)) resetDefaultPosition(target);
}
function resetDefaultPosition(target) {
    target.removeAttribute("itemprop");
}

    </script>
</head>
<body>
    <header id="metadata">
        <h1>Parkinson's Disease Guide</h1>
        <h2>A Health Optimization Approach</h2>
        <p>
            <strong>Working Draft</strong>, 
            <time datetime="2024-12-01">2024-12-01</time>
        <p>
        <address class="author">
            <strong>Editor:</strong> Garrett Smith
        </address>
    </header>
    <nav id="nav">
        <div><h3 tabindex="0" id="nav-heading">Menu</h3></div>
        <ul>
            <li><a href="#purpose">The Purpose of This Guide</a></li>
            <li><a href="#how-to-use-this-guide">How to Use This Guide</a></li>
            <li><a href="#introduction-to-pd">Introduction to Parkinson's Disease</a>
                <ul>
                    <li><a href="#causes-of-pd">Causes and Risk Factors</a>
                        <ul>
                            <li><a href="#alpha-synuclein-pathology">Alpha-Synuclein Pathology</a></li>
                            <li><a href="#calcium-dysregulation">Calcium Dysregulation</a></li>
                             <li><a href="#multiple-neurotransmitter-systems-damage">Multiple Neurotransmitter Systems Damage</a></li>
                            <li><a href="#environmental-factors">Environmental Factors</a></li>
                            <li><a href="#genetic-factors">Genetic and Epigenetic Influences</a></li>
                            <li><a href="#hormonal-loss">Hormonal Loss</a></li>
                        
                            <li><a href="#mechanisms-of-spread">Mechanisms of Spread</a>
                                <ul>
                                    <li><a href="#gut-brain-axis">Gut-Brain Axis and Alpha-Synuclein Propagation</a></li>
                                    <li><a href="#brain-waste-management-systems">Brain Waste Management Systems (BWMS)</a></li>
                                    <li><a href="#mitochondrial-dysfunction">Mitochondrial Dysfunction</a></li>
                                </ul>
                            </li>       
                        </ul>
                    </li>
                    <li><a href="#testing-for-pd">Testing for PD</a>
                        <ul>
                            <li>
                                <a href="#genetic-testing">Genetic Testing</a>
                            </li>
                        </ul>
                    </li> 
                </ul>           
            </li>
            <li><a href="#etiological-solutions">Etiological Solutions</a></li>
            <li><a href="#how-to-build-a-supplement-plan">How to Build a Supplement Plan</a></li>
            <li><a href="#food">Food</a></li>

            <li><a href="#treatment-approaches">Treatment Approaches</a>
                <ul>
                    <li><a href="#treatment-approaches-overview">Overview</a></li>
                    <li><a href="#symptomatic-approach">Symptomatic</a></li>
                    <li><a href="#disease-progression-approach">Disease-progression</a></li>
                    <li><a href="#etiological-approach">Etiological</a></li>
                    <li><a href="#holistic-approach">Holistic</a></li>
                </ul>
            </li>
            <li><a href="#treatments">Detailed Treatments</a>
                <ul>
                    <li>
                        <a href="#medications">Medications</a>
                        <ul>
                           <li><a href="#dopamine-agonists">Dopamine Replacement Therapy (DRT)</a>
                                <ul>
                                    <li><a href="#drt-introduction">Introduction to DRT</a></li>
                                    <li><a href="#impact-dopamine-agonists">Impact of DRT</a></li>
                                    <li><a href="#neurochemical-imbalances">Neurochemical and Vitamin Imbalances</a></li>
                                    <li><a href="#produodopa">Produodopa â€” Improved DRT</a></li>
                                    <li><a href="#drt-summary">DRT â€” Summary</a></li>
                                </ul>
                            </li>
                            <li><a href="#comt-inhibitors">COMT Inhibitors</a></li>
                            <li><a href="#mao-b-inhibitors">MAO-B Inhibitors</a></li>
                            <li><a href="#synuclean-d-and-minzasolmin">SynuClean-D and Minzasolmin</a> ðŸ§ª</li>
                        </ul>
                    </li>
                    <li>
                        <a href="#hormonal-interventions">Hormonal Interventions</a>
                        <ul>
                            <li><a href="#hrt">HRT for Women</a></li>
                            <li><a href="#hrt">HRT for Men</a></li>
                            <li><a href="#dhea">DHEA</a></li>
                            <li><a href="#pregnenolone">Pregnenolone</a></li>
                            <li><a href="#gh">Growth Hormone</a></li>
                            <li><a href="#peptides">Other Peptides</a></li>
                        </ul>
                    </li>
                    <li><a href="#dbs">Deep Brain Stimulation (DBS)</a></li>
                    <li><a href="#gene-therapy">Gene Therapy</a></li>
                    <li><a href="#stem-cell">Stem Cells (MSC, iPSC)</a></li>
                    <li><a href="#exercise"
                        >Exercise</a></li>
                    <li><a href="#pbm">Photobiomodulation</a></li>
                </ul>
            </li>
            <li><a href="#care-team">How to Build a Care Team</a>
                <ul>
                    <li><a href="#care-team-introduction">Introduction</a></li>
                    <li><a href="#hypothetical-care-team">Hypothetical Care Team</a></li>
                    <li><a href="#tips-for-selecting-providers">Tips for Selecting Providers</a></li>
                </ul>
            </li>
            <li><a href="#health-diagnostics">Health Diagnostics</a></li>
            <li><a href="#supplements">Supplements</a>
                <ul>
                    <li><a href="#glynac">GlyNAC (Glycine n-acetylcysteine)</a></li>
                    <li><a href="#collagen-peptides">Collagen Peptides</a></li>
                    <li><a href="#creatine">Creatine Monohydrate</a></li>
                    <li><a href="#taurine">Taurine</a></li>
                    <li><a href="#citrulline">Citrulline Malate</a></li>
                    <li><a href="#cinnamon">Cinnamon</a></li>
                    <li><a href="#cacao">Cacao</a></li>
                    <li>Carvacrol - TODO</li>
                    <li><a href="#lions-mane">Lion's Mane</a></li>
                    <li><a href="#cordyceps">Cordyceps</a></li>
                    
                    <li class="neuroprotective anti-aggregant"><a href="#turmeric">Turmeric</a></li>
                    <li class="neuroprotective antifibrillogenic"><a href="#saffron">Saffron</a></li>
                    <li><a href="#coconut-oil">Coconut Oil</a></li>
                    <li><a href="#ginger">Ginger</a></li>
                    <li><a href="#egcg">Matcha</a></li>
                    <li><a href="#ginsenoside">Ginseng</a></li>
                    <li><a href="#acetyl-l-carnitine">Acetyl-L-Carnitine (ALCAR)</a></li>
                    <li><a href="#r-ala">Alpha-Lipoic Acid (ALA)</a></li>
                    <li>
                        <a href="#gaba-5-htp-melatonin">GABA, 5-HTP, and Melatonin</a>
                        <ul>
                            <li><a href="#gaba">GABA</a></li>
                            <li><a href="#5-htp">5-HTP</a></li>
                            <li><a href="#melatonin">Melatonin</a></li>
                        </ul>
                    </li>
                    <li><a href="#theanine">Theanine</a></li>
                    <li>
                        <a href="#quinones">Mitochondrial Quinones (PQQ, CoQ10) and Vitamin K2</a>
                        <ul>
                            <li><a href="#pqq">PQQ Pyrroloquinoline Quinone</a></li>
                            <li><a href="#k2">Menaquinone (Vitamin K2)</a></li>
                            <li><a href="#ubiquinol">Ubiquinol (Reduced Coenzyme Q-10)</a></li>
                        </ul>
                    </li>
                    <li><a href="#gg">Geranylgeraniol (GG)</a></li>
                    <li><a href="#nattokinase">Nattokinase</a></li>
                    <li><a href="#dha">Docosahexaenoic Acid (DHA)</a></li>
                    <li><a href="#cholinergics">Cholinergics and Membrane Support</a>
                        <ul>
                            <li><a href="#uridine">Uridine Monophosphate</a></li>
                            <li><a href="#citicoline">CDP-Choline</a></li>
                            <li><a href="#alpha-gpc">Alpha-GPC</a></li>
                            <li><a href="#phosphatidylserine">Phosphatidylserine</a></li>
                        </ul>
                    </li>
                    <li><a href="#magnesium-threonate">Magnesium Threonate</a></li>
                    <li><a href="#vitamin-d">Vitamin D</a></li>
                    <li><a href="#vitamin-b1">Vitamin B-1 (Thiamine)</a></li>
                    <li><a href="#vitamin-b6">Vitamin B-6 (Pyridoxine)</a></li>
                    <li><a href="#vitamin-b12">Vitamin B-12 (Cobalamin)</a></li>
                    <li><a href="#tocotrienols">Tocotrienols and Tocopherols</a></li>
                    <li>
                        <a href="#nicotinamides">NAD+, NMN, Niacin, and NR</a>
                        <ul>
                            <li><a href="#nmn">NMN (Nicotinamide Mononucleotide)</a></li>
                            <li><a href="#nr">NR (Nicotinamide Riboside)</a></li>
                            <li><a href="#niacin">Niacin</a></li>
                            <li><a href="#nad-injection">Injectable NAD+</a></li>
                        </ul>
                    </li>
                    <li>
                        <a href="#blueberry">Blueberry</a>
                    </li>
                    <li>
                        <a href="#senolytics">Senolytics</a>
                        <ul>
                            <li><a href="#urolithin-a">Urolithin-A</a></li>
                            <li><a href="#resveratrol">Resveratrol (TODO)</a></li>
                            <li><a href="#fisetin">Fisetin (TODO)</a></li>
                            <li><a href="#quercetin">Quercetin (TODO)</a></li>
                            <li><a href="#spermidine">Spermidine</a> (TODO)</li>
                            <li><a href="#sulforaphane">Sulforaphane</a></li>
                            <li><a href="#trehalose">Trehalose</a> (TODO)</li>
                            <li><a href="#apigenin">Apigenin</a> (TODO)</li>
                            <li><a href="#piperlongumin">Piperlongumin (TODO)</a></li>
                            <li><a href="#theaflavin">Theaflavin</a> (TODO)</li>
                        </ul>
                    </li>
                </ul>
            </li>

            <li><a href="#summary">Summary</a></li>
        </ul>
    </nav>
    <header id="purpose">
        <h2>The Purpose of This Guide</h2>

        <p>
            This guide is crafted to empower individuals with Parkinson's Disease (PD) to optimize their health using the latest scientific evidence. It covers disease etiology, medication, exercise performance, diet and supplementation, care providers, photobiomodulation, and more, offering practical strategies for effective management and enhanced well-being.
        </p>
        <p>
            Started in 2021, this guide was inspired by a relative with PD who chose to eschew evidence-based strategies rather than investigate their veracity and incorporate them into her program. Her condition deteriorated due to complications of autonomic nervous system (ANS) failure, with gastrointestinal and heart problems. This guide reflects core principles of volition, self-ownership, evidence-based practice, informed decision-making, first principles, and critical thinking, aimed at helping others make proactive, informed choices to improve their health outcomes.
        </p>
    </header>
    <section id="how-to-use-this-guide">
        <h2>How to Use This Guide</h2>
        <p>
            This guide is meant to be explored at an individual pace. Parkinson's Disease is complex, and oversimplifying it would leave many questions unanswered. Understanding the disease is a fundamental step toward improvement; however, it isn't necessary to grasp every technical detail immediately. Solutions, such as those in <a href="#how-to-build-a-supplement-plan">How to Build a Supplement Plan</a>, can be applied right away, with gaps in understanding revisited later through sections like <a href="#causes-of-pd">Causes</a>, which covers the deep biological mechanisms and etiology necessary for comprehending PD.
        </p>
        <p>
            The guide is designed as a resource that can be revisited as the reader's knowledge grows, supporting gradual understanding and informed decision-making. If the material becomes overwhelming, focus on actionable sections like supplements or diet, and return to other parts when ready. Taking breaks or breaking the information into smaller steps can also aid comprehension.
        </p>
    </section>
    <section id="introduction-to-pd">
        <h2>Introduction to Parkinson's Disease</h2>

        <p>
            Parkinsonâ€™s Disease (PD) is a neurological condition characterized by tremor, muscle stiffness, impaired balance, and coordination. These symptoms are driven by the aggregation of the pre-synaptic protein Î±-synuclein, which disrupts multiple neurotransmitter systems. This disruption leads to damage in the dopaminergic system, oxidative stress, mitochondrial dysfunction, and weakening of protective brain barriers, all of which broaden the range and severity of symptoms.
        </p>

        <p>
            PD primarily affects the central nervous system (CNS), with overlapping symptoms haphazardly categorized by mainstream medicine into "motor" and "non-motor" symptoms. Neurological problems may spread to the autonomic nervous system (ANS), parasympathetic nervous system (PNS), and enteric nervous system (ENS), contributing to <abbr title="Gastrointestinal">GI</abbr> issues, low blood pressure, urinary dysfunction, renal issues, and orthostatic hypotension. 
        </p>
        
        <p>
            Mitochondrial dysfunction is a fundamental problem in PD, impairing cellular energy production, promoting oxidative damage, and disrupting calcium regulation. These dysfunctions create harmful feedback loops that exacerbate Î±-synuclein aggregation and neuronal damage.
        </p>
        
        <p>
            Although dopamine loss remains a central focus in conventional PD treatment, GABAergic dysfunction is a more fundamental causative factor, as has been well-documented since the 1980s, with research showing alterations in receptor binding and transmission (Rinne et al.). Despite this established evidence, there is no standard treatment specifically targeting GABA or mitochondrial dysfunction in PD. Instead, mainstream treatments focus predominantly on dopamine replacement, overlooking the problem of GABA system failure.
        </p>

        <p>
            Comprehensively addressing the multiple cellular problems of PD predicts better outcomes than the standard of care, and that is the approach taken in this guide.
        </p>
        <section id="causes-of-pd">
            <h3>Causes and Risk Factors</h3>
            <p>
                PD involves abnormal clumping of Î±-synuclein, a protein that regulates neurotransmitter release to help neurons communicate. In PD, Î±-synuclein misfolds, disrupting brain function.
			</p>
            <p>
                Alpha-synuclein is abundant in the brain, but also exists in small amounts in the heart and muscles. It moves between the brain and body via the blood-brain and cerebrospinal fluid barriers, both affected in PD. <cite class="reflink"><a href="#yu-ting-sui">Y. Sui</a></cite>
            </p>
            			
			<p> 
                In PD, Î±-synuclein misfolds, forming clumps called oligomers. Oligomers can grow into fibrils, larger, more harmful aggregates, eventually forming Lewy bodies, driving senescence. Similar Î±-synuclein misfolding occurs in related disorders, such as dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), whose research on Î±-synuclein misfolding is relevant. 
            </p>            
            <p>
                Aging, environmental hazards, and genetics interact pathologically, leading to neuronal death and neurotransmitter imbalances, Î±-synuclein aggregation, and mitochondrial dysfunctionâ€”another major factor in disease progression, causing oxidative damage, apoptosis, and neuroinï¬‚ammation, driving disease progression. <cite class="reflink"><a href="#k-burton">K. Burton</a></cite>
            </p>
            
            <section id="alpha-synuclein-pathology">    
                <h4>Alpha-Synuclein Pathology</h4>
                <p>
                    Mutations in Î±-synuclein increase its tendency to clump, particularly in familial PD cases <cite class="reflink"><a href="#v-c-ruf">V. Ruf</a>, <a href="#jie-li">J. Li</a></cite>. Misfolded or mutant forms resist breakdown, leading to toxic buildup, cellular stress, inflammation, waste accumulation, and Lewy body formation. Over time, these damaged cells become senescent, releasing toxic compounds that fuel neurodegeneration.
                </p>

                <h4>Alpha-Synuclein Aggregation</h4>
                <p>
                    Î±-synuclein aggregation leads to formation of oligomers, which can then form fibrils (see figure below). As oligomers and fibrils accumulate, they create Lewy bodiesâ€”dense, toxic protein clusters in nerve cells.
                </p>
                <figure>
                    <img src="img/alpha-synuclein.jpeg" alt="Î±-synuclein monomer, fibril, and oligomer." class="block-image">
                    <figcaption>
                        <p>
                            Depiction of Î±-synuclein monomer, fibril, and oligomer. Î±-synuclein fibrils are long, insoluble fibers made of smaller protein units (monomers and oligomers).
                        </p>
                    </figcaption>
                </figure>
                
                <h5 id="alpha-synuclein-clearance">Alpha-Synuclein Clearance Mechanisms</h5>
                <p>
                    Healthy cells clear small misfolded proteins with the ubiquitin-proteasome system (UPS) and larger aggregates with the autophagy-lysosome pathway (ALP).
                </p>
                
                <p>
                    In PD, the structure of misfolded Î±-synuclein and its sheer volume hinder its degradation and clearance. Misfolded Î±-synuclein aggregates are not efficiently broken down by the proteasome, leading to their buildup and overwhelming the <abbr title="ubiquitin proteasome system">UPS</abbr>. When the proteasome fails to degrade these aggregates, they are directed to the <abbr title="autophagy-lysosomal pathway">ALP</abbr>, where Î±-synuclein fibrils further resist lysosomal breakdown. This resistance disrupts both clearance pathways, contributing to extracellular waste and increasing neuronal stress. While these processes are explored further in this guide, they remain outside conventional treatment approaches.
                </p>
          
                <h6>Intracellular Î±-Synuclein Accumulation Diagram</h6>
                <div id="ups-alp-diagram" class="flow-diagram diagram">
                    <div class="concept step">
                        <h6>Î±-synuclein Misfolds</h6>
                        <p>Î±-synuclein misfolds, forming toxic oligomers.</p>
                        <div class="arrow"></div>
                    </div>
                
                    <div class="concept">
                        <h6><abbr title="ubiquitin proteasome system">UPS</abbr> Overload</h6>
                        <p><abbr title="ubiquitin proteasome system">UPS</abbr> overwhelmed by excess misfolded Î±-synuclein. Larger oligomers block the proteasome or inhibit its activity, preventing efficient degradation.</p>
                        <div class="arrow"></div>
                    </div>
                                          
                    <div class="concept">
                        <h6>Cellular Stress</h6>
                        <p>Cellular stress from protein buildup triggers autophagy.</p>
                        <div class="arrow"></div>
                    </div>     
                                                  
                    <div class="concept">
                        <h6>Autophagy Overload</h6>
                        <p>Autophagy overwhelmed as misfolded Î±-synuclein aggregates block autophagosomes formation and impair fusion with lysosomes.</p>
                        <div class="arrow"></div>
                    </div>
                                          
                    <div class="concept">
                        <h6>Cellular Damage</h6>
                        <p>Mitochondrial stress, oxidative damage, and inflammation from misfolded Î±-synuclein aggregates further impair <abbr title="ubiquitin proteasome system">UPS</abbr> and <abbr title="autophagy-lysosomal pathway">ALP</abbr> function, creating a vicious cycle.</p>
                        <div class="arrow"></div>
                    </div>
                    <div class="concept">
                        <h6>Î±-synuclein Misfolds</h6>
                        <p>A toxic cellular environment perpetuates Î±-synuclein misfolding, ER stress, and glial activation, causing formation of toxic Î±-synuclein oligomers.</p>
                    </div>
                </div>


				<h5>Alpha-Synuclein Clearance Mechanisms</h5>
				<p>
					As shown in the diagram above, small misfolded proteins like Î±-synuclein are cleared by the ubiquitin-proteasome system (UPS), which tags unwanted proteins for degradation. Larger aggregates are managed by the autophagy-lysosome pathway (ALP), which transports them to lysosomes for breakdown.
				</p>
				<p>
					In PD, autophagosomes (structures that deliver cellular waste to lysosomes) try to clear away Î±-synuclein aggregates but become overwhelmed, leading to buildup of these aggregates that worsens cellular dysfunction.
				</p>
				<p>
					In PD, misfolded Î±-synuclein overwhelms both systems, resisting degradation and leading to toxic buildup. These and other waste clearance mechanisms of the brain are explored in greater detail in the section  <a href="#brain-waste-management-systems">Brain Waste Management Systems (BWMS)</a>.
				</p>

				
				<h5>What Causes Alpha-Synuclein Misfolding?</h5>
				<p>
					This raises a natural question: <em>What causes Î±-synuclein misfolding in the first place?</em>
				</p>
				<p>
					Aside from genetic mutations, multiple things can contribute to alpha-synuclein misfolding, including a toxic cellular environment caused by problems resulting from the misfolding Î±-synuclein itself â€” a recursive chicken-and-egg quandary. 
				</p>

				<h5>Propagation from Gut to Brain: The Braak Hypothesis</h5>
				<p>
					Misfolded Î±-synuclein propagating from the enteric nervous system (ENS), aka "the gut", to the brain, known as the Braak hypothesis, explained later, is one such causal pathway. This dysfunction is exacerbated by excess calcium in dopaminergic neurons, which rely on precise calcium signaling to maintain normal firing patterns. The hypothesis holds that the misfolding begins in the gut. However, PD is more complex, and as mentioned throughout, it is induced in rodents through rotenone and paraquat administration, which indicates that this phenomenological condition may come about in different ways.
				</p>
			</section>
			<section id="calcium-dysregulation">
				<h4>Calcium Dysregulation</h4>
				<p>
					Calcium dysregulation is a fundamental problem that contributes to Î±-synuclein misfolding. This can result from elevated parathyroid hormone (PTH), menopause, deficiencies in vitamin D, or magnesium imbalance. <cite class="reflink"><a href="#emmanouilidou">Emmanouilidou</a></cite>
				</p>

				<p>
					Calcium dysregulation may promote the spread of misfolded Î±-synuclein along the gut-brain axis via the vagus nerve, providing a mechanistic link to Braakâ€™s hypothesis, which would implicate calcium dysregulation as a driver of PD.
				</p>

				<p>
					While elevated <abbr title="parathyroid hormones">PTH</abbr> can contribute to calcium dysregulation, addressing nutrient deficiencies and hormonal imbalances may better support neuronal health than pharmacological suppression of PTH, as drugs like cinacalcet, alendronate, and calcitriol carry significant side effects.
				</p>
				
				<h5>Intracellular Calcium Dysregulation: Pathway Overview</h5>
				<p>
					When a nerve impulse (or "action potential") reaches the presynaptic terminal (the end of the neuron), it triggers calcium channels (<abbr title="voltage-gated calcium channels">VGCCs</abbr>) to open, letting calcium into the neuron. Synaptic vesicles, specialized organelles responsible for storing and releasing neurotransmitters at chemical synapses, fuse with the presynaptic membrane, releasing their neurotransmitter contents into the synapse through a process called <dfn>exocytosis</dfn>, a form of active transport whereby neurons transport neurotransmitters out of the cell (<em>exo</em> â€” "outside" + <em>cytosis</em> â€” "cell").
				</p>

				<p>
					In healthy neurons, <abbr title="voltage-gated calcium channels">VGCCs</abbr> precisely regulate calcium influx, triggering neurotransmitter release only when a signal arrives. In PD, this regulation is disrupted, particularly in dopaminergic and GABAergic neurons, which depend on tight calcium control. These imbalances create an excitatory bias in neural networks, increasing neural stress.
				</p>
				
				<h5>Impact on Cellular Functions</h5>
				<p>
					Elevated calcium levels stress neurons, disrupt mitochondrial function, increase endoplasmic reticulum (ER) stress, and impair the clearance of misfolded proteins. Together, these disruptions heighten neuronal vulnerability, exacerbate Î±-synuclein aggregation, and contribute to PD pathology.
				</p>            
                
				<h5>Testing Calcium Dysregulation</h5>				
				<p>
					Standard blood tests measure total and ionized calcium, along with other electrolytes like magnesium and phosphate, but these donâ€™t reveal intracellular calcium levels. 
				</p>
				<p>
					Flow cytometry with calcium-sensitive dyes can assess intracellular calcium levels. Although calcium dysregulation is common, testing is expensive and rare. Patients can ask their providers; it might be available through a specialist or in research settings.
				</p>

				<p>
					 Medical systems tend to focus more on symptom management than on detecting fundamental issues like calcium dysregulation, as preventive care doesn't align with the predominant healthcare focus on symptomatic treatment. This approach can leave patients without access to meaningful insights on calcium imbalances, complicating targeted intervention.
				</p>
				
				<p>
					Most patients lack direct information about their intracellular calcium levels, and this complicates targeted intervention. The supplement guide includes several categories of compounds that, while often safe when used appropriately, require careful attention to dosage, interactions, and individual health profiles to avoid unintended effects on calcium homeostasis. See: <a href="#solution-calcium-dysregulation">Solution: Calcium Dysregulation</a> and consult your provider about these interventions.
				</p>
				
                <h5>References</h5>
                <ol class="reference-list">
					<li id="emmanouilidou">
						<a href="https://www.jneurosci.org/content/30/20/6838"
						title="Cell-Produced Î±-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival"
						target="_blank"
						>Cell-Produced Î±-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival</a>, Evangelia Emmanouilidou, et al.
					</li>
				</ol>
            </section>
            
            <section id="senescence">
                <h4>Cellular Senescence</h4>
                <p>
                    Senescent cells stop dividing but release harmful, pro-inflammatory molecules called <dfn>senescence-associated secretory phenotypes</dfn> (SASPs). These secretions damage neighboring cells, promoting their dysfunction and driving them into a senescent state.
                </p>
                <p>
                    Senescent cells contribute to mitochondrial dysfunction, neuroinflammation, and the spread of Î±-synuclein aggregates. By impairing autophagy, increasing oxidative stress, and perpetuating inflammation, they create a cycle disrupts calcium homeostasis, and accelerates disease progression across neurotransmitter systems.
                </p>
            </section> 
            <section id="multiple-neurotransmitter-systems-damage">
                <h4>Multiple Neurotransmitter Systems Damage</h4>
                
                <p>
                    In 2016, Janusz W. BÅ‚aszczyk challenged established beliefs, proposing that PD is a multisystem disorder, where GABAergic decline contributes to dopaminergic depletion in the progression of motor and non-motor symptoms. Numerous studies have since expanded on his claims. <cite class="reflink"><a href="#blaszczyk">BÅ‚aszczyk</a></cite>
                </p>
                <p>
                    PD affects multiple neurotransmitter systems beyond dopamine. Dysfunctions in the GABAergic, serotonergic, noradrenergic, and cholinergic systems leads to non-motor symptoms such as depression, anxiety, and cognitive decline. Standard care fails to address this multisystem damage, resulting in poor management of both motor and non-motor symptoms. Instead, a holistic approach that targets all these systems is necessary.
                </p>
                
                <p>
                    A comprehensive metastudy published in 2024 confirmed that GABAergic dysfunction disrupts calcium homeostasis, leading to mitochondrial dysfunction and oxidative stress. Restoring GABA activity may preserve mitochondrial health and protect dopaminergic neurons, alleviating both motor and non-motor symptoms in PD. <cite class="reflink"><a href="#alharbi">Alharbi</a></cite>
                </p>
                
                <p>
                    BÅ‚aszczyk observed nearly a decade prior that calcium/GABA dysregulation lead directly to dopaminergic neuron loss and neuroinflammation, weakening the BBB. Subsequent research strengthens this assertion, showing this neuroinflammation extends to the glymphatic system and <abbr title="cerebrospinal fluid">CSF</abbr> circulation, furthering PD progression.
                </p>
                
                <h5>GABAergic Dysfunction and Calcium Dysregulation</h5>
                <p>
                    GABAergic dysfunction disrupts motor control, exacerbating calcium dysregulation, leading to prolonged excitatory states in neurons. Excessive calcium influx overwhelms mitochondria, which absorb this excess into the mitochondrial matrix, impairing energy production and triggering oxidative stress. Dopaminergic neurons are highly sensitive to calcium fluctuations and vulnerable to this excitotoxic damage, accelerating degeneration. 
                </p>
                
                <h4>DRT Impact</h4>
                <p>
                     Dopamine Replacement Therapy (DRT) provides temporary symptomatic relief but contributes to long-term neurodegenerative damage by worsening calcium dysregulation. This calcium overload stresses mitochondria, leading to accelerated neurodegeneration. Additionally, DRT depletes vitamin B6, essential for GABA and serotonin production, compounding neurotransmitter imbalances. DRT aloneâ€”without addressing the underlying GABA imbalanceâ€”overstimulates excitatory pathways, leading to excessive calcium influx into neurons, perpetuating a harmful feedback cycle.
                </p>
                
                <h4>Solutions</h4>
                <p>
                     To reduce reliance on DRT, treatments should aim to address GABAergic collapse and calcium dysregulation. High-dose K2 (5,000 mcg daily) can aid in calcium regulation. Supplementation with GABA and theanine can help restore GABAergic function, with theanine potentially replenishing the neurotransmitter pool of GABA in GABAergic neurons. Cacao, which contains anandamide (an NMDA receptor antagonist reduced in PD), may help mitigate excitotoxicity. Cholinergics can stabilize the plasma membrane and reduce excessive calcium influx, while mitochondrial enhancers like CoQ10, PQQ, and NAD+ boosters restore mitochondrial health and energy balance, alleviating the effects of calcium overload. For more details on DRT pitfalls, see <a href="#neurochemical-imbalances">DRT: Neurochemical and Vitamin Imbalances</a>. 
                </p>
                <ol class="reference-list">
                    <li id="blaszczyk">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899466/"
                        title="Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis"
                        target="_blank"
                        >Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis</a>, Janusz W. BÅ‚aszczyk.
                    </li>
                    
                    <li id="alharbi">
                        <a href="https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-024-01779-7?Murueta-Goyena"
                        title="Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit"
                        target="_blank"
                        >Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit</a>, Bandar Alharbi, et al.
                    </li>
                </ol>
            </section>
            
            <section id="environmental-factors">
                <h4>Environmental Factors</h4>
                <p>
                    Individuals with a history of exposure to certain chemicals are at higher risk and may want to consider testing.
                </p>
                
                <h5>Pesticides and Herbicides</h5>
                <p>
                    Pesticide and herbicide exposure causes mitochondrial dysfunction and, in certain individuals, &alpha;-synuclein overexpression. Herbicide rotenone and pesticide paraquat so reliably induce PD that they are used to induce PD in rodent model experiments <cite class="reflink"><a href="#jae-hyeon-park">Park</a>, <a href="#f-pan-montojo">Pan-Montojo</a></cite>. Rotenone impairs the ubiquitin-proteasome system, leading to accumulation of misfolded proteins, including Î±-synuclein. <cite class="reflink"><a href="#betarbet">Betarbet</a></cite>
                </p>
                <h5>Drug Use</h5>
                <p>
                    Chronic use of cocaine and amphetamines weakens the brainâ€™s waste management systems, making it more susceptible to damage that can lead to PD. These drugs damage the brain differently, but both create oxidative stress and damage dopaminergic neurons. 
                </p>
            </section>
            
            <section id="genetic-factors">
                <h4>Genetic and Epigenetic Influences</h4>
                <p>
                   Gene mutations of <abbr title="Parkinsonism-Associated Deglycase 1 or Park7">DJ-1</abbr>, <abbr title="PTEN-induced Kinase 1">PINK1</abbr>, parkin, <abbr title="Leucine-Rich Repeat Kinase 2 gene">LRRK2</abbr>, and <abbr title="Synuclein Alpha Gene">SNCA</abbr> genes contribute to several cellular issues. These mutations disrupt mitochondrial function, protein degradation, and cellular stress responses, leading to increased oxidative stress, impaired autophagy, and disease progression. <cite class="reflink"><a href="#m-vlag">M. Vlag</a></cite>
                </p>
                
                <h4>Epigenetic Influences</h4>
                <p>
                    Epigenetic factors can influence the expression of genes like the <abbr title='Leucine-Rich Repeat Kinase 2 gene'>LRRK2</abbr> gene (<abbr title='Leucine-Rich Repeat Kinase 2 gene with a glycine to serine substitution at position 2019'>LRRK2-G2019S</abbr>) and <abbr title='Synuclein Alpha Gene'>SNCA</abbr>, affecting the production and pathogenicity of mutant Î±-synuclein. <cite class="reflink"><a href="#christine-klein">Klein</a>, <a href="#alpha-synuclein-net">alpha-synuclein-net</a></cite>
                </p>
                <p>
                    Vitamin B12, for example, is an external factor that prevents LRRK2-G2019S-potentiated &alpha;-synuclein accumulation in dopaminergic neurons. <cite class="reflink"><a href="#a-schaffner">Schaffner</a></cite>
                </p>
            </section>
            <section id="#hormonal-loss">
                <h4>Hormonal Loss</h4>
                <p>
                    The risk of developing PD is higher in men and in women with early menopause. Sex hormones are neuroprotective, and their loss is a risk factor in various neurodegenerative diseases, including PD. Hormonal therapies such as HRT, DHEA, and pregnenolone have shown beneficial effects in men and women. For more, see the section on <a href="#hormonal-interventions">HRT</a>.
            </p>

            </section>
            <section id="mechanisms-of-spread">
                <h4>Mechanisms of Spread</h4>
                <p>
                    Once aggregated, misfolded Î±-synuclein spreads between neurons and neural networks, leading to abnormalities in synaptic structure and function before neuronal loss occurs. This process contributes to the progressive spread of the disease from initially affected brain regions to others.  <cite class="reflink"><a href="#daley">Daley</a>, <a href="#perez-acuna">PÃ©rez-AcuÃ±a</a></cite>
                </p>
                
                <h4>Senescent Spread</h4>
                <p>
                    As senescent cells accumulate, their inflammatory response accelerate the spread of alpha-synuclein aggregates, enhancing cellular dysfunction across interconnected brain regions, in a <dfn>senescence-associated secretory phenotype</dfn> (SASP). <cite class="reflink"><a href="#verma">Verma</a></cite>
                </p>
                <p>
                    Strategies to address Î±-synuclein include preventing its mutation, inhibiting aggregation, improving its clearance from the brain, promoting proper refolding with chaperones, and using senolytics to remove senescent cells. A comprehensive approach to address each etiological problem is more likely to improve outcomes, steering away from <abbr title="progressive neurodegeneration">PN</abbr>.
                </p>
                
                <section id="gut-brain-axis">
                    <h5>Gut-Brain Axis and Alpha-Synuclein Propagation</h5>
                    
                    <p>
                        Alpha-synuclein aggregation in the GI tract may precede motor symptoms. Misfolded Î±-synuclein can propagate from the enteric nervous system (ENS) in the gut to the brain via the vagus nerve, creating a direct link between the gut and the central nervous system (CNS). This pathway, part of the Braak hypothesis, suggests that Î±-synuclein pathology may start in the gut before reaching the brain. <cite class="reflink"><a href="#h-braak">Braak</a>, <a href="#y-chao">Chao</a></cite>
                    </p>
                    <p>
                        Braak's seminal discovery led to imaging studies showing that Î±-synuclein pathology affects large parts of the peripheral nervous system which may further implicate the gut-brain pathway in PD progression, and sonographic studies have confirmed vagal nerve atrophy, supporting gut-brain pathway in PD progression. <cite class="reflink"><a href="#schaeffer">schaeffer</a></cite>
                    </p>
                    
                    <p>
                        Neurotransmitters, including dopamine, serotonin, and GABA, are also produced in the gut, affecting mood, sleep, and GI health. Impaired gut health reduces neurotransmitter production, worsening PD symptoms. Rstoring gut health may improve upon these symptoms. A preliminary 2020 study out of Nanjing Medical University found that colonic fecal (<abbr title="fecal microbiota transplantation">FMT</abbr>) improved sleep, anxiety, and depression, showing that improving gut health can lead to improved health and symptoms in PD.
<cite class="reflink"><a href="#xue">Xue</a></cite>
                    </p>
                    
                    <p>
                        Alpha-synuclein pathology can propagate bidirectionally between the gut and brain, via the vagus nerve or the bloodstream, depending on individual factors. GI symptoms, such as constipation, often precede motor symptoms by years, indicating that the gut may be an early site of PD pathology. <cite class="reflink"><a href="#klann">Klann</a>, <a href="#arotcarena">Arotcarena</a></cite>
                    </p>
                    
                    <p>
                        Gut dysbiosis can exacerbate Î±-synuclein misfolding and accelerate PD progression. Conversely, DRT may worse gut dysbiosis, further compounding the issue. This insight into gut dysbiosis and the mutually destructive interdependent effects of poor gut health and DRT usage provides yet another reason to minimize and avoid DRT overreliance in favor of a more comprehensive program to improve gut health. <cite class="reflink"><a href="#klann">Klann</a>, <a href="#breen">Breen</a>, <a href="#mulak">Mulak</a></cite>
                    </p>
                    
                    <h6>Solutions</h6>
                    <p>
						Strategies to support gut health include reducing sugar intake, increasing fiber, and consuming probiotic foods (e.g., yogurt, kimchi, natto). Such changes may help balance the microbiome and reduce GI-related symptoms in PD. Additionally, <abbr title="fecal microbiota transplantation">FMT</abbr> has shown promise in preliminary studies, potentially reducing inflammation and oxidative stress to improve both motor and non-motor symptoms.
                    </p>
                    <p>
                        Strategies to support gut health include reducing sugar intake, increasing fiber, and consuming probiotic foods (e.g., yogurt, kimchi, natto). Such changes may help balance the microbiome and reduce GI-related symptoms, improve gut health, and may help mitigate the progression of PD and improve patient outcomes. Additionally, <abbr title="fecal microbiota transplantation">FMT</abbr> has shown promise in preliminary studies, potentially reducing inflammation and oxidative stress to improve both motor and non-motor symptoms.
                    </p>
                    
                    <p>
                        The gut lining can be strengthened by first eliminating things that weaken it, including NSAIDs, gluten, alcohol, and fluoride. Consuming collagen peptides and hyaluronic acid can help strengthen the gut lining.
                    </p>
                    
                    <p>
                        The vagus nerve is involved in digestion and cardiovascular function. Transcutaneous vagus nerve stimulation (VNS) is a non-invasive procedure that has shown improvement in movement in PD patients. A 2022 doubleâ€blind randomized crossover on transcutaneous cervical vagus nerve stimulation (VNS) showed improvements in stride length, swing amplitude, gait speed, and gait time showed significant changes following treatment. <cite class="reflink"><a href="#marano">Marano</a></cite>
                    </p>
                    
                    <h6>References</h6>
                    <ol class="reference-list">
                        <li id="h-braak">
                            <a href="https://pubmed.ncbi.nlm.nih.gov/12721813/"
                            title="Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen"
                            target="_blank"
                            >Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen</a>, H. Braak, et al.
                        </li>
                        
                        <li id="y-chao">
                            <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477379/"
                            title="Gutâ€“Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease"
                            target="_blank"
                            >Gutâ€“Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease</a>, Yin-Xia Chao, et al.
                        </li>
                        <li id="klann">
                            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8776990/"
                            title="The Gutâ€“Brain Axis and Its Relation to Parkinsonâ€™s Disease: A Review"
                            target="_blank"
                            >The Gutâ€“Brain Axis and Its Relation to Parkinsonâ€™s Disease: A Review</a>, Emily M Klann, et al.
                        </li>
                        <li id="arotcarena">
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32380543/"
                            title="Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates"
                            target="_blank"
                            >Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates</a>, Marie-Laure Arotcarena, et al.
                        </li>
                        <li id="breen">
                            <a href="https://pubmed.ncbi.nlm.nih.gov/30653258/"
                            title="Gut-brain axis and the spread of Î±-synuclein pathology: Vagal highway or dead end?"
                            target="_blank"
                            >Gut-brain axis and the spread of Î±-synuclein pathology: Vagal highway or dead end?</a>, David P Breen, et al.
                        </li>
                        <li id="mulak">
                            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4588083/"
                            title="Brain-gut-microbiota axis in Parkinson's disease"
                            target="_blank"
                            >Brain-gut-microbiota axis in Parkinson's disease</a>, Agata Mulak and Bruno Bonaz.
                        </li>
                        
                        <li id="schaeffer">
                            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7509446/"
                            title="Alpha Synuclein Connects the Gut-Brain Axis in Parkinsonâ€™s Disease Patients â€“ A View on Clinical Aspects, Cellular Pathology and Analytical Methodology"
                            target="_blank"
                            >Alpha Synuclein Connects the Gut-Brain Axis in Parkinsonâ€™s Disease Patients â€“ A View on Clinical Aspects, Cellular Pathology and Analytical Methodology</a>, Eva Schaeffer, et al.
                        </li>
                        
                        <li id="xue">
                            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7458210/"
                            title="Fecal microbiota transplantation therapy for Parkinson's disease"
                            target="_blank"
                            >Fecal microbiota transplantation therapy for Parkinson's disease</a>, Liu-Jun Xue, et al.
                        </li>
                        <li id="marano">
                            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9796229/"
                            title="Transcutaneous Auricular Vagus Stimulation Improves Gait and Reaction Time in Parkinson's Disease"
                            target="_blank"
                            >Transcutaneous Auricular Vagus Stimulation Improves Gait and Reaction Time in Parkinson's Disease</a>, Massimo Marano, et al.
                        </li>
                    </ol>
                </section>
                
                <section id="brain-waste-management-systems">
                    <h5>Brain Waste Management Systems (BWMS)</h5>
                    <p>
                        The brain's waste management systems (BWMS) defined herein describes the coordinated systems of interdependent intracellular and extracellular components that protect the brain from harmful substances, clear waste, and maintain homeostasis. 
                    </p>
                    
                    <h6>Intracellular Clearance: UPS and ALP</h6>
                    <p>
                        Intracellular clearance mechanisms include the ubiquitin-proteasome system (UPS) and autophagy-lysosomal pathway (ALP) introduced previously. 
                    </p>
                    <h6>Extracellular Clearance</h6>
                    <p>
                        Extracellular clearance mechanisms include brain phagocytes, the blood-brain barrier (BBB), choroid plexus, CSF, glymphatic system, perivascular spaces, extracellular matrix (ECM), basement membrane. Dysfunction in any of these subsystems leads to Î±-synuclein aggregation, inflammation, and mitochondrial damage, which impacts other interdependent subsystems, leading to the accumulation of junk proteins and Lewy bodies. Various interventions can improve the integrity and function of these components, with measurable effects. <cite class="reflink"><a href="#solar">SolÃ¡r</a></cite>
                    </p>
                    
                    <h5>Impact of Dysfunction</h5>
                    <p>
                         When these systems are overwhelmed, their impairment leads to neuronal damage and overburdens interconnected systems, resulting in further dysfunction. For example, Î±-synuclein fibrils resist breakdown, overloading the <abbr title="ubiquitin proteasome system">UPS</abbr> and <abbr title="autophagy-lysosomal pathway">ALP</abbr>. This results in extracellular waste accumulation, which strains brain phagocytes and other clearance mechanisms.
                    </p>
					<p>
						Normally, smaller misfolded proteins (like Î±-synuclein) are cleared by the <abbr title="ubiquitin proteasome system"><abbr title="ubiquitin proteasome system">UPS</abbr></abbr>. However, the proteasomes in the UPS can't digest larger, insoluble aggregates that Î±-synuclein forms over time. In PD, mutant or aggregated Î±-synuclein resists lysosomal degradation, disrupting autophagy and causing the toxic accumulation of cellular waste. As autophagy fails, oxidative stress and inflammation increase, leading to mitochondrial damage and cell death.
					</p>
                    <p>
                         Microglia and astrocytes clear extracellular Î±-synuclein aggregates through phagocytosis. In PD, chronic neuroinflammation impairs this process, worsening protein clearance deficits. Increased BBB permeability compounds the problem, allowing contaminants and inflammatory substances to enter and harm the brain. These substances can accumulate in the CSF, further damaging the choroid plexus and disrupting CSF homeostasis, amplifying the strain on all of these interdependent clearance systems.
                    </p>    
                    
                    <h5>The Bloodâ€“Brain Barrier (BBB)</h5>
                    <p>
                        The BBB is a protective layer of specialized cells that line the blood vessels of the central nervous system (CNS) in the brain, controlling what enters and exits the <abbr title="central nervous system">CNS</abbr> to maintain homeostasis, allowing necessary nutrients and oxygen to pass through while blocking toxins, pathogens, and other harmful substances.
                    </p>
        
                    <h5>Choroid Plexus and CSF</h5>
                    <p>
                        The choroid plexus is a plexus of cells, a self-contained, functional unit located within the ventricles responsible for secreting <abbr title="cerebrospinal fluid">in the </abbr> and forming a blood-CSF barrier. It consists of a layer of epithelial cells surrounding a core of capillaries and loose connective tissue. As CSF circulates through the brain, it transports essential substances such as nutrients, growth factors, hormones, proteins, electrolytes, and neurotransmitters, while also collecting waste products, including misfolded proteins like Î±-synuclein. The waste-laden CSF is then drained through specialized pathways, including the ventricles and the glymphatic system, before being filtered out by the liver and kidneys. Damage to the choroid plexus can impair CSF production, disrupt waste clearance, and reduce the transport of essential substances, potentially contributing to cognitive decline.
                    </p>
                    <p>
                        Damage to the choroid plexus impairs CSF production and disrupts waste clearance, allowing Î±-synuclein to accumulate, clog, and damage its epithelial cells. This accumulation hinders the brain's ability to clear waste and deliver essential nutrients and growth factors, exacerbating neuroinflammation. <cite class="reflink"><a href="#albachari">Al-Bachari</a>, <a href="#saunders">Saunders</a>, <a href="#tadayon">Tadayon</a></cite>
                    </p>    

                    <figure>
                        <img alt="Choroid Plexus" src="img/choroid-plexus.jpg" 
                        id="choroid-plexus" class="block-image zoomable" tabindex="-1">
                        <figcaption>
                            <p>
                                Choroid Plexus â€”Â a highly vascularized tissue located in each ventricle of the brain that secretes CSF.
                            </p>
                        </figcaption>
                    </figure>
                    
                    <h5>Ventricles</h5>
                    <p>
                        The ventricles are interconnected cavities within the brain filled with CSF. This fluid eventually moves into small structures called arachnoid granulations, tiny, finger-like extensions of the brainâ€™s protective membrane. These granulations help reabsorb CSF into the bloodstream through the dural venous sinuses surrounding the brain, from where it is carried away by the internal jugular veins. 
                    </p>
                    <p>
                        The ventricles circulate and hold CSF and passively drain waste-laden CSF. However, the glymphatic system actively extends <em>through</em> brain tissue to clear waste directly from within the brain and distribute nutrients and neurotransmitters throughout the brain.
                    </p>
                    
                    <h5>The Glymphatic System</h5>
                    <p>
                        The glymphatic system is a dual-purpose pathway that transports nutrients and growth factors and also performs brain-specific waste clearance.
                    </p>
                       
                    <p>
                    	These glial cells remove metabolic waste and toxins, including misfolded proteins like Î±-synuclein, using CSF to flush out waste from the brain along perivascular spaces (areas surrounding arteries and veins), similar to the body's lymphatic system, hence the term "glymphatic" (glial + lymphatic). Its essential function is compromised in neurodegenerative diseases, including PD.
                    </p>
                    <h6>How it Works</h6>
                    <p>
                        The glymphatic system moves CSF from the space around the brain into brain tissue, where it mixes with interstitial fluid (fluid between brain cells) to clear waste like misfolded proteins. This waste is then carried along the spaces surrounding blood vessels and drained into the deep cervical lymph nodes in the neck for filtration and removal by the body's lymphatic system.
                    </p>
                    
                    <h5 id="protein-clearance-pathway-dysfunction">Protein Clearance Pathway Dysfunction</h5>

                    <h6>Ubiquitin-Proteasome System (UPS) Dysfunction</h6>
                    <p>
                        The UPS degrades smaller, soluble misfolded or damaged proteins by tagging them with ubiquitin and directing them to proteasomes for breakdown. In PD, UPS dysfunction leads to Î±-synuclein accumulation, which overwhelms other waste clearance pathways and triggers oxidative stress, mitochondrial dysfunction, and neurodegeneration.
                    </p>

                    <h6>Autophagy-Lysosomal Pathway</h6>

                    <p>
                        When Î±-synuclein aggregates are too large for the UPS, they are targeted for autophagic degradation. As noted earlier in the <a href="#alpha-synuclein-clearance">Alpha-Synuclein Clearance Mechanisms</a> section, autophagosomes form around these aggregates, isolating them from the rest of the cellular environment. The autophagosome then fuses with a lysosome, forming an autolysosome that degrades the aggregated proteins within the autophagosome.
                    </p>
                    
					<p>
						<dfn>autophagosome</dfn> â€”Â (<dfn>auto</dfn> â€” "self" + <dfn>phago</dfn> â€” "eat; consume" + <dfn>some</dfn> â€”Â "body") â€” temporary intracellular structure that engulfs damaged components and delivers them to lysosomes, which act as the cell's recycling centers.
					</p>
                    <p>
                        However, in PD, lysosomal degradation becomes impacted, disrupting autophagy and causing the toxic accumulation of cellular waste. As autophagy fails, oxidative stress and inflammation increase, leading to mitochondrial damage and cell death. This accumulation contributes to extracellular waste, overburdening phagocytes and the glymphatic system, worsening neurodegeneration.
                    </p>

                    <h6>Brain Phagocytes</h6>
                    <p>
                        As mentioned earlier, the lysosomal system in autophagy helps neurons degrade internal misfolded proteins like Î±-synuclein. Lysosomes also assist phagocytes in clearing extracellular waste. While neurons use autophagy to clear intracellular waste, brain phagocytes, such as microglia and astrocytes, use lysosomal phagocytosis to clear <em>external</em> waste.
                    </p>
                    
                    <p>
                        Brain phagocytes, including microglia, astrocytes, and macrophages, clear cellular debris and toxic proteins. Microglia, the primary phagocytes, engulf damaged neurons, dead cells, and toxic proteins. Astrocytes help clear apoptotic cells (cells dying in a controlled manner) and excess neurotransmitters, supporting microglia in debris removal. Macrophages, present in the perivascular space, also perform phagocytosis, though they are less involved than microglia. 
                    </p>
                    
                    <p>
                        Phagocytes perform the initial cleanup, breaking down harmful proteins like Î±-synuclein within themselves, with the remainder either recycled or expelled for further clearance. The glymphatic system helps by flushing extracellular waste from the brain via <abbr title="Cerebrospinal fluid">CSF</abbr>.
                    </p>
                    
                    <p>
                        In PD, misfolded Î±-synuclein accumulation triggers neuroinflammation, impairing phagocytosis and worsening Î±-synuclein aggregation. This neuroinflammation impairs phagocytosis, which in turn exacerbates Î±-synuclein aggregation. This buildup of Î±-synuclein leads to further aggregation, oligomerization, and fibrillization, forming Lewy bodies and advancing neurodegeneration and senescent cells. Additionally, collagen cross-linking caused by advanced glycation endproducts (AGEs) from high blood sugar, oxidative stress, or chronic inflammation further impairs phagocytosis.
                    </p>
                    <p>
                        Cells, impacted by this toxicity, become senescent, not functioning but failing to die and impairing phagocytic function and blocking extracellular waste clearance pathways. This leads to a feedback loop where more toxic proteins accumulate, increasing neuroinflammation and mitochondrial damage.
                    </p>
                    
                    <div id="bwms-diagram" class="flow-diagram diagram">
                        <div class="concept">
                            <h6>Î±-synuclein Misfolds in Neurons</h6>
                            <p>Misfolded Î±-synuclein forms toxic oligomers and fibrils.</p>
                            <div class="arrow"></div>
                        </div>
                    
                        <div class="concept">
                            <h6>Impaired UPS and ALP</h6>
                            <p><abbr title="ubiquitin proteasome system">UPS</abbr> and <abbr title="autophagy-lysosomal pathway">ALP</abbr> are overwhelmed, leading to toxic buildup of Î±-synuclein within neurons.</p>
                            <div class="arrow"></div>
                        </div>
                        <div class="concept">
                            <h6>Neuroinflammation &amp; Mitochondrial Stress âŸ³</h6>
                            <p>Accumulated Î±-synuclein fibrils cause neuroinflammation and mitochondrial dysfunction, exacerbating the <abbr title="ubiquitin proteasome system">UPS</abbr> and <abbr title="autophagy-lysosomal pathway">ALP</abbr>.</p>
                            <div class="arrow"></div>
                        </div>
                    
                        <div class="concept">
                            <h6><b class="updown-arrow">&uarr;</b> BBB Permeability</h6>
                            <p>Chronic neuroinflammation weakens the BBB, allowing harmful substances into the brain from the bloodstream.</p>
                            <div class="arrow"></div>
                        </div>
                        <div class="concept">
                            <h6>Choroid Plexus Damage</h6>
                            <p>Choroid plexus damage reduces CSF production and waste clearance, allowing Î±-synuclein to accumulate and damage epithelial cells.</p>
                            <div class="arrow"></div>
                        </div>
                        <div class="concept">
                            <h6>Impaired Glymphatic &amp; CSF Clearance</h6>
                            <p>Waste clearance systems, like the glymphatic system and CSF, struggle to remove extracellular protein aggregates.</p>
                            <div class="arrow"></div>
                        </div>
                    
                        <div class="concept">
                            <h6>Protein Buildup &amp; Feedback Loop</h6>
                            <p>As extracellular waste builds up, it further impairs phagocytosis and clearance mechanisms, worsening neuroinflammation and Î±-synuclein aggregation.</p>
                            <div class="arrow"></div>
                        </div>
                    
                        <div class="concept">
                            <h6>Cycle Continues</h6>
                            <p>Neuroinflammation, mitochondrial stress, protein accumulation, and waste clearance create a vicious cycle, exacerbating waste buildup and neuronal damage.</p>
                        </div>
                    </div>

                    <h5>Solutions</h5>
                    <p>
                        A multifaceted approach can be used to try to stop the feedback loop, including measures to prevent Î±-synuclein aggregation, restore choroid plexus and BBB integrity, improve UPS and ALP function, reduce neuroinflammation, and improve mitochondrial health.
                    </p>
                    
                    <h6>Assessing BBB and Choroid Plexus Integrity</h6>
                    <p>
                        Elevated BBB permeability affects waste clearance, including the movement of Î±-synuclein. Contrast agents are used in <abbr title="Dynamic Contrast-Enhanced MRI">DCE-MRI)</abbr> to visualize changes in BBB permeability.
                    </p>
                    
                    <h6>Strengthening the BWMS</h6>
                    <p>
                        Health strategies that promote collagen formation and support the <abbr title="extracellular matrix">ECM</abbr> may help counteract the effects and degradation of the BBB. Promoting <abbr title="extracellular matrix">ECM</abbr> stability and collagen synthesis contributes to maintaining the structural integrity of the BBB and reduces its permeability to harmful substances, thereby mitigating a <em>major</em> etiological pathway of PD. 
                    </p>
                    
                    <p>
                        These include HRT, DHEA, pregnenolone, Growth hormone (GH) and secretagogues (tesamorelin, CJC-1295), collagen peptides (especially collagen type IV), hyaluronic acid, vitamin C, tocotrienols, vitamin K2, vitamin D3, PQQ, beta-glucan (from mushrooms), <abbr title="Mesenchymal signalling cells">MSCs</abbr>, photobiomodulation, and last but not least, intense exercise.
                    </p>
                    
                    <h6>Improving the Ubiquitin Proteasome System (UPS) and Autophagy-Lysosome Pathway (ALP)</h6>
                    <p>
                        Exercise, fasting, caloric restriction, and compounds like trehalose promote autophagy by enhancing cellular stress responses. mTOR inhibitors (such as rapamycin) reduce inhibitory signals on autophagy, increasing the clearance of misfolded proteins. Lithium helps stimulate autophagy and protects against neurodegeneration. Senolytics eliminate senescent cells that impair waste clearance. Mitochondrial enhancers, including Urolithin A and NAD+ boosters, support cellular energy production, further improving <abbr title="ubiquitin proteasome system">UPS</abbr> and <abbr title="autophagy-lysosomal pathway">ALP</abbr> efficiency. 
                    </p>
                    
                    <h6>Strengthening Brain Phagocytes</h6>
                    
                    <p>
                        Addressing the root causeâ€”Î±-synuclein aggregationâ€”addresses the primary disruption in phagocytosis, which in turn reduces neuroinflammation and limits neuronal damage. Reducing Î±-synuclein aggregation should be considered a first line of prevention to improve brain phagocytosis.
                    </p>
                    
                    <p>
                        Other health strategies to improve brain phagocytosis include reducing neuroinflammation, increasing blood flow, and increasing neurotrophins. These include supplementing DHA, beta-glucan (from mushrooms), lion's mane, cordyceps, turmeric, ginseng, creatine, EGCG (matcha), ALCAR, phosphatidylserine, tocotrienols, and senolytics. Pyridoxamine (vitamin B6) and aminoguanidine can reduce collagen cross-linking. Growth hormone (GH) and secretagogues (tesamorelin, CJC-1295) photobiomodulation and physical exercise increase neurotrophins. Mesenchymal signaling cells reduce neuroinflammation. 
                    </p>
                    
                    <h6>Increasing CSF Production</h6>
                    <p>
                        Cholinergics and related supplements can support brain function and potentially influence cerebrospinal fluid (CSF) production. Higher choline levels can improve membrane integrity and fluidity, improve BBB integrity and cellular function, and might indirectly support glymphatic system performance.
                    </p>
                    
                    <h6>Do interventions targeting collagen/<abbr title="extracellular matrix">ECM</abbr> strengthen the glymphatic system?</h6>
                    <p>
                        Yes, interventions that improve the health of the <abbr title="extracellular matrix">ECM</abbr> and strengthen collagen may have a beneficial effect on the structural support around blood vessels and thus support glymphatic function. The <dfn title="the areas surrounding blood vessels">perivascular spaces</dfn> which direct CSF flow in the glymphatic system, rely on the surrounding ECM for waste clearance. In PD, these spaces enlarge, reducing waste clearance efficiency. Restoring collagen and ECM health should reduce the size of the perivascular spaces, improving glymphatic function and waste clearance of Î±-synuclein.
                    </p>
                    
                <h4>References</h4>
                <ol class="reference-list">
                    <li id="perez-acuna">
                        <a href="https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-023-01059-1"
                        title="Î±-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis"
                        target="_blank"
                        >Î±-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis</a>, Dayana PÃ©rez-AcuÃ±a, et al.
                    </li>
                    <li id="solar">
                        <a href="https://fluidsbarrierscns.biomedcentral.com/articles/10.1186/s12987-020-00196-2"
                        title="Choroid plexus and the bloodâ€“cerebrospinal fluid barrier in disease"
                        target="_blank"
                        >Choroid plexus and the bloodâ€“cerebrospinal fluid barrier in disease</a>, Peter SolÃ¡r, et al.
                    </li>
                    <li id="al-bachari">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784911/"
                        title="Bloodâ€“Brain Barrier Leakage Is Increased in Parkinsonâ€™s Disease"
                        target="_blank"
                        >Bloodâ€“Brain Barrier Leakage Is Increased in Parkinsonâ€™s Disease</a>, Sarah Al-Bachari, et al.
                    </li>
                    
                    <li id="saunders">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678431/"
                        title="The choroid plexus: a missing link in our understanding of brain development and function"
                        target="_blank"
                        >The choroid plexus: a missing link in our understanding of brain development and function</a>, Norman R. Saunders, et al.
                    </li>
                    <li id="tadayon">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094632/"
                        title="Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimerâ€™s and Parkinsonâ€™s disease"
                        target="_blank"
                        >Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimerâ€™s and Parkinsonâ€™s disease</a>, Ehsan Tadayon, et al.
                    </li>
                </ol>
            </section>

            <section id="mitochondrial-dysfunction">
                <h4>Mitochondrial Dysfunction</h4>
                
                <p>
                    Mitochondrial dysfunction is a primary problem in PD. Disrupted energy production, increased oxidative stress, and calcium imbalances all worsen neurodegeneration. This section explores how these mitochondrial dysfunctions accelerate disease progression along with targeted strategies to support mitochondrial resilience, reduce oxidative damage, and improve cellular stability in PD.
                <p>
                <p>
                    Damage to mitochondria can cause Î±-synuclein aggregation by disrupting cellular processes and increasing oxidative stress. Mitochondria, the <q>powerhouse of the cell</q>, produce ATP, the <q>energy currency of the cell</q>. When mitochondria are impaired, energy production drops and oxidative stress rises, damaging neurons. This creates a cycle where disrupted cellular processes cause protein misfolding and aggregation, which worsens oxidative stress, recursively accelerating mitochondrial dysfunction and neurodegeneration. <cite class="reflink"><a href="#daley">Daley</a></cite>
                </p>
                
                <h5>Mitochondrial Dysfunction and Waste Clearance</h5>
                <p>
                    Mitochondrial dysfunction, coupled with impaired mitophagy, the process of mitochondrial degradation and recycling, allows dysfunctional mitochondria to accumulate, leading to cellular senescence. Senescent cells release reactive oxygen species (ROS) and inflammatory cytokines, which damage neighboring cells and promote neurodegeneration. This cycle accelerates the buildup of misfolded proteins like Î±-synuclein and impairs essential processes like autophagy and mitophagy, exacerbating neurodegeneration.
                </p>
                
                <p>
                    Mitochondrial dysfunction impairs the brain's waste management systems (<abbr title="Brain Waste Management System">BWMS</abbr>), including the <abbr title="ubiquitin proteasome system">UPS</abbr> and <abbr title="autophagy-lysosomal pathway">ALP</abbr>, leading to an accumulation of misfolded proteins. Improving mitochondrial health reduces oxidative stress and supports waste clearance, helping to break the cycle of neurodegeneration.
                </p>
                <p>
                    Improving mitochondrial health decreases the amount of this waste burden and reduces the damage to the systems that remove it, thereby improving the clearance of waste from the brain.
                </p>
                
                <h5>Mitochondrial DNA Damage</h5>
                <p>
                    Mitochondrial DNA damage further impairs function. Ineffective autophagy and mitophagy fail to remove damaged mitochondria and proteins, leading to the formation of senescent cells. These senescent cells resist lysosomal degradation due to protein aggregation, worsening cellular damage. <cite class="reflink"><a href="#korolchuk">Korolchuk</a></cite>
                </p>
                
                <h5>Brain Inflammation</h5>
                <p>
                    Chronic brain inflammation, also known as <dfn title="Chronic, low-grade brain inflammation characterized by upregulation of pro-inflammatory pathways in glial cells, such as astrocytes and microglia">neuroinflammaging</dfn>, is a state of neuroinflammation and immunosenescence, a chronic, low-grade inflammatory state. This chronic, low-grade inflammatory state is both a consequence and a driver of mitochondrial dysfunction. Mitochondrial damage contributes to neuroinflammaging, while the resulting inflammation can further impair mitochondrial function, creating a vicious cycle that accelerates neurodegenerative processes.
                </p>

                <h5 id="mitochondrial-calcium-dysregulation">Mitochondrial Calcium Dysregulation</h5>
                <p>
                    Besides producing energy, mitochondria help regulate calcium levels in nerve cells by acting as a â€œbuffer", absorbing excess calcium to maintain proper neuron function. Calcium is essential for neuron signaling; however, neurons are particularly sensitive to calcium levels, and its excess can be toxic. Learning about excess calcium can help inform options for testing and managing it, as described further in this section.
                </p>

                <p>
                    Mitochondria regulate cellular calcium to prevent mitochondrial permeability transition pore (mPTP) opening, a process that leads to to cell death, particularly in neurodegenerative diseases like PD. Calcium dysregulation in mitochondria exacerbates oxidative stress, disrupting ATP production and causing neuronal damage.
                </p>

                <p>
                    Excess intracellular calcium occurs through three main pathways. First, channels at the cell surface (<abbr title="voltage-gated calcium channels">VGCCs</abbr>) allow calcium inside. Second, the mitochondrial calcium uniporter (MCU) regulates calcium entry directly into mitochondria for safe storage. Third, the inositol triphosphate receptor (IP3R) moves calcium from the cellâ€™s internal stores into mitochondria. In Parkinsonâ€™s Disease, damaged mitochondria lose their ability to manage this calcium effectively, which leads to overload, energy issues, and cell death. In PD and similar conditions, mitochondrial damage (due to oxidative stress and other issues) and excess calcium disrupts the <abbr title="mitochondrial calcium uniporter">MCU</abbr>â€™s function, leading to uncontrolled, excess calcium uptake and an opening of the <abbr title="mitochondrial permeability transition pore">mPTP</abbr>, leading to neuronal death.
                </p>


                <p>
                    High calcium levels outside cellsâ€”often due to supplementationâ€”can trigger the <abbr title="inositol triphosphate receptor">IP3R</abbr> pathway, which further transports calcium from the <abbr title="endoplasmic reticulum">ER</abbr> to the mitochondria. This further overloads mitochondria, reducing ATP production and eventually triggering cell death. 
                </p>

                <h6>Hormonal Loss and Calcium Supplementation (Warning)</h6>
                
                <p>
                    Hormonal loss, often occurring with age, disrupts calcium handling in both men and women. However, postmenopausal women face an increased risk of calcium imbalance, exacerbated by the common healthcare recommendation to supplement calcium. Rather than relying on calcium supplementation, focusing on bone strength through targeted exercise and supportive nutrients that promote calcium uptake into bones may offer a safer and more effective approach. 
                </p>
                
                <h6>Blood Calcium Tests and Intracellular Calcium Levels</h6>
                <p>
                    While standard blood calcium tests measure calcium in the bloodstream, they do not indicate levels within neurons or mitochondria. Discussing options like calcium imaging with a healthcare provider can offer insight into calcium levels specific to cellular and mitochondrial health.
                </p>
                
                <h6>Solutions to Calcium Dyregulation</h6>
                <p>
                    The understated problem of calcium dyregulation is only worsened by the dearth of solutions. Pharmaceutical <abbr title="voltage-gated calcium channels">VGCC</abbr> blockers (L-type) have been proposed <cite class="reflink"><a href="#ntetsika">Ntetsika</a></cite>, however, those come with side effects and worse, clinical trials (STEADY III) results have been poor. A more comprehensive solution to addressing calcium management is in order.
                </p>
                <p>
                    Excess intracellular calcium can be managed with natural (non-pharmaceutical) <abbr title="voltage-gated calcium channels">VGCC</abbr> (L-type) blockers, <abbr title="inositol triphosphate receptor">IP3R</abbr> modulators, and osmolytes, as well as by reducing excess extracellular calcium, which contributes to excess intracellular calcium (via the  <abbr title="inositol triphosphate receptor">IP3R</abbr> pathway). Excess extracellular calcium can be reduced by stimulating bone uptake of calcium. See the Calcium Dysregulation solutions in the <a href="#problems-list">problems list</a> for more. 
                </p>
                 
                <h6>Calcium AKG vs Strontium â€” Which to Supplement?</h6>
                <p>
                    Calcium supplementation puts one at risk of calcium excess. Calcium alpha-ketoglutarate (Ca-AKG) assists with calcium regulation and improves mitochondrial function (it also reduces inflammation) <cite class="reflink"><a href="#zimmermann">Zimmermann</a>, <a href="#zimmermann">Gyanwali</a></cite>. In PD, where mitochondrial health is compromised, Ca-AKG at ~500 mg per day along with 250 mg strontium citrate and other aforementioned bone-supportive supplements, offers a more comprehensive and safer option. Strontium, while structurally similar to calcium, does not overload mitochondria in the same way, offering superior support without increased mitochondrial stress. Individual needs may vary, and patients should discuss this approach with their healthcare provider to determine the most appropriate dose and evaluate personal calcium needs beyond blood tests alone. 
                </p>

                <h6>Osmolytes</h6>
                <p>
                    Osmolytes help maintain a stable environment within cells by balancing water and ion concentrations, preventing mitochondrial overloads of calcium and other ions that can stress the cell. Common osmolytes include glycine, taurine, and betaine, as well as the electrolyte chloride, which together help stabilize cellular and mitochondrial environments by managing calcium and other ion concentrations.
                </p>

                <p>
                    Mitochondrial dysfunction, in the greater context of PD, also disrupts GABA-producing neurons, impairing GABAergic signaling. As GABA function declines, calcium influx increases, causing abnormal neuronal firing and excitotoxicity, accelerating neurodegeneration, contributing to disease progression. <cite class="reflink"><a href="#matuz-mares">Matuz-Mares</a></cite>
                </p>
                
                <h5>Reactive Oxygen and Nitrogen Species (RONS)</h5>
                <p>
                    Mitochondrial dysfunction and Reactive Oxygen and Nitrogen Species (RONS) can cause Î±-synuclein to misfold and aggregate, forming toxic mutant species. Combined with calcium dysregulation and inflammation, this toxic Î±-synuclein contributes to neuronal death and the pathology of PD.
                     <cite class="reflink"><a href="#s-hu">Hu</a></cite>
                </p>

                <h5>Solutions</h5>
                <p>
                    Several strategies discussed in this document can improve mitochondrial function. These include growth hormone (GH) and secretagogues, vitamin C, tocotrienols, creatine, vitamin K2, vitamin D3, PQQ, beta-glucan, NAD+ and precursors, NAC, and many others detailed in this document.
                </p>
                <p>
                    Photobiomodulation, intermittent fasting, sauna, and cold plunges all improve mitochondrial function. <cite class="reflink"><a href="#toro">Toro</a>, <a href="#hunt">Hunt</a>, <a href="#n-chung">Chung</a></cite>
                </p>
                <p>
                    An exercise routine focused on HIIT can fight neurodegeneration and increase cerebral blood flow, improving oxygen delivery, increasing neurotrophins and growth factors, and aiding the penetration of exogenous compounds into deeper brain regions where they can exert therapeutic effects. Many substances that improve health also hasten exercise recovery, further optimizing health. 
                </p>
                <p>
                    Once a comprehensive health optimization protocol is established, <abbr title="Mesenchymal signalling cells">MSCs</abbr> can be used to stop neuroinflammation and induce healing. 
                </p>
                
                <h5>References</h5>
                <ol class="reference-list">
                    <li id="korolchuk">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514379/"
                        title="Mitochondria in Cell Senescence: Is Mitophagy the Weakest Link?"
                        target="_blank"
                        >Mitochondria in Cell Senescence: Is Mitophagy the Weakest Link?</a>, Viktor I. Korolchuk, et al.
                    </li>
                    <li id="ntetsika">
                        <a href="https://molmed.biomedcentral.com/articles/10.1186/s10020-021-00279-2#Sec1"
                        title="Novel targeted therapies for Parkinsonâ€™s disease"
                        target="_blank"
                        >Novel targeted therapies for Parkinsonâ€™s disease</a>, Theodora Ntetsika, et al.
                    </li>
                    
                    <li id="zimmermann">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8676818/"
                        title="Long-term treatment with calcium-alpha-ketoglutarate corrects secondary hyperparathyroidism"
                        target="_blank"
                        >Long-term treatment with calcium-alpha-ketoglutarate corrects secondary hyperparathyroidism</a>, E Zimmermann, et al.
                    </li>
                    <li id="gyanwali">
                        <a href="https://www.sciencedirect.com/science/article/abs/pii/S1043276021002666"
                        title="Alpha-Ketoglutarate dietary supplementation to improve health in humans"
                        target="_blank"
                        >Alpha-Ketoglutarate dietary supplementation to improve health in humans</a>, Bibek Gyanwali, et al.
                    </li>
                    <li id="toro">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122786/"
                        title="Effects of Twelve Sessions of High-Temperature Sauna Baths on Body Composition in Healthy Young Men"
                        target="_blank"
                        >Effects of Twelve Sessions of High-Temperature Sauna Baths on Body Composition in Healthy Young Men</a>, VÃ­ctor Toro, et al.
                    </li>
                    <li id="hunt">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965159/"
                        title="Could Heat Therapy Be an Effective Treatment for Alzheimerâ€™s and Parkinsonâ€™s Diseases? A Narrative Review"
                        target="_blank"
                        >Could Heat Therapy Be an Effective Treatment for Alzheimerâ€™s and Parkinsonâ€™s Diseases? A Narrative Review</a>, Andrew P. Hunt, et al.
                    </li>
                    <li id="n-chung">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545200/"
                        title="The effects of exercise and cold exposure on mitochondrial biogenesis in skeletal muscle and white adipose tissue"
                        target="_blank"
                        >The effects of exercise and cold exposure on mitochondrial biogenesis in skeletal muscle and white adipose tissue</a>, Nana Chung, et al.
                    </li>
                </ol>
            </section>
            
            <section id="er-dysfunction">
                <h4>Endoplasmic Reticulum (ER) Dysfunction</h4>
                <p>
                    The endoplasmic reticulum (ER) as a cellular organelle primarily responsible for protein folding, lipid synthesis, and calcium storage. The ER and mitochondria communicate closely through structures called mitochondrial-associated <abbr title="endoplasmic reticulum">ER</abbr> membranes (MAMs), which manage the flow of calcium between them. Normally, this interplay between the <abbr title="endoplasmic reticulum">ER</abbr> and mitochondria helps balance cellular energy needs and signaling.
                </p>
                <p>
                    In PD, accumulation of misfolded Î±-synuclein and other proteins disrupts <abbr title="endoplasmic reticulum">ER</abbr> function, leading to <abbr title="endoplasmic reticulum">ER</abbr> stress. These disruptions in normal ER function compromise protein homeostasis and destabilize <abbr title="mitochondrial-associated ER membranes">MAMs</abbr>, weakening the ER-mitochondria interface and promoting mitochondrial calcium overload. This overload disrupts cellular signaling and contributes to mitochondrial permeability, inflammation, and cell death. <cite class="reflink"><a href="#matuz-mares">Matuz-Mares</a></cite>
                </p>
                
                <section>
                    <h5>Proteostasis and Chaperone Proteins</h5>
                    <p>
                        <dfn>Proteostasis</dfn> is the <q>protein quality control</q> mechanism of the cell, facilitated by <dfn>chaperone</dfn> proteins. <cite class="reflink"><a href="#lautenschlager">LautenschlÃ¤ger</a></cite>
                    </p>
                    
                    <p> 
                        Chaperone proteins, like <dfn>heat shock protein 70 (Hsp70)</dfn>, help correctly fold and refold proteins, including Î±-synuclein, reducing misfolding which leads to aggregation. ER stress worsens when these mechanisms are overwhelmed in PD. <cite class="reflink"><a href="#s-hu">Hu</a></cite>
                    </p>
                    
                    <h6>Solutions</h6>
                    <p>
                        Chaperone function can be stimulated by heat exposure from sauna therapy and <a href="#pbm">photobiomodulation</a>, both of which stimulate the production of Hsp70 and other protective proteins. Curcumin, resveratrol, and glycyrrhizin (from licorice root), also increase the expression of chaperones like HSP70. These interventions can improve protein homeostasis, reduce oxidative stress, and aid in the clearance of misfolded proteins.
                    </p>
                </section>

                <ol class="reference-list">
                    <li id="lautenschlager">
                        <a href="https://www.biorxiv.org/content/10.1101/561134v2.full"
                        title="Intra-mitochondrial proteostasis is directly coupled to alpha-synuclein and Amyloid Î² 1-42 pathology"
                        target="_blank"
                        >Intra-mitochondrial proteostasis is directly coupled to alpha-synuclein and Amyloid Î² 1-42 pathology</a>, Janin LautenschlÃ¤ger, et al.
                    </li>
                </ol>
            </section>

            <h4>References
             <!-- Causes (outer section) Shared References -->
            </h4>
            <ol class="reference-list">
            
                <li id="verma">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8304385/"
                    title="Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinsonâ€™s Disease Models"
                    target="_blank"
                    >Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinsonâ€™s Disease Models</a>, Dinesh Kumar Verma, et al.
                </li>
                <li id="yu-ting-sui"> 
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4378645/"
                    title="Alpha synuclein is transported into and out of the brain by the blood-brain barrier"
                    target="_blank"
                    >Alpha synuclein is transported into and out of the brain by the blood-brain barrier</a>, Yu-Ting Sui, et al.
                    <p>
                        This rodent model study showed Î±-synuclein is transported across the BBB bidirectionally, in both the brain-to-blood and blood-to-brain directions.
                    </p>
                </li>     

                <li id="k-burton"> 
                    <a href="https://www.medscape.com/viewarticle/994849"
                    title="Why Genetic Testing May Be Our Best Shot at Progress in PD"
                    target="_blank"
                    >Why Genetic Testing May Be Our Best Shot at Progress in PD</a>, Kelli Whitlock Burton
                    <p>
                        Previous studies have shown that some genetic variants increase the risk for PD after exposure to environmental factors such as pesticides. Research has also shown that patient genotype can indicate survival time and treatment approaches.
                    </p>
                </li>
                <li id="v-c-ruf">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30605594/"
                    title="Different Effects of Î±-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements"
                    target="_blank"
                    >Different Effects of Î±-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements</a>, Viktoria C Ruf, et al.
                    <p>
                    This study showed the differential mechanisms of metals, such as iron, in Î±-synuclein pathology at the molecular level.
                    </p>
                </li>
                <li id="jie-li">
                    <a href="https://pubs.acs.org/doi/10.1021/bi010616g"
                    title="Effect of Familial Parkinson's Disease Point Mutations A30P and A53T on the Structural Properties, Aggregation, and Fibrillation of Human Î±-Synuclein"
                    target="_blank"
                    >Effect of Familial Parkinson's Disease Point Mutations A30P and A53T on the Structural Properties, Aggregation, and Fibrillation of Human Î±-Synuclein</a>, Jie Li, et al.
                    <p>
                        This rodent study showed that the <dfn title="Alpha-53-Thr mutation: point mutation in the human alpha-synuclein (Î±-synuclein) gene, associated with early-onset familial PD">A53T</dfn> and <dfn title="point mutation in the alpha-synuclein (SNCA) gene associated with autosomal dominant Parkinsonâ€™s disease">A30P</dfn> genetic mutations in Î±-synuclein have an increased propensity to aggregate compared with the wild-type protein, and this shows how mutant Î±-synuclein contributes to PD.
                    </p>
                    <p>
                        They note Î±-synuclein in PD arose from gene-linkage experiments in familial early-onset Parkinsonâ€™s disease, which revealed the A53T mutation.
                    </p>
                </li>

                <li id="jae-hyeon-park"> 
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31931835/"
                    title="Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway"
                    target="_blank"
                    >Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway</a>, Jae-Hyeon Park, et al.
                    <p>
                        This rodent model showed that pesticides can initiate the progression of PD pathology and that this progression is based on the transneuronal and <dfn>"retrograde axonal transport"</dfn> (that &alpha;-synuclein goes back into the cell) of alpha-synuclein. If confirmed in patients, this study would have crucial implications for strategies used to prevent and treat PD.
                    </p>
                </li>                           
                <li id="f-pan-montojo">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/23205266/"
                    title="Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice"
                    target="_blank"
                    >Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice</a>, F. Pan-Montojo, et al.
                    <p>
                        This rodent model showed that pharmacologically increasing SIRT3, as recommended in this article, can counteract Î±-synuclein-induced mitochondrial dysfunction by reducing Î±-synuclein oligomers and normalizing mitochondrial bioenergetics. 
                    </p>
                </li>
                <li id="betarbet">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16439141/"
                    title="Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system"
                    target="_blank"
                    >Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system</a>, Ranjita Betarbet, et al.
                </li>
                    
                <li id="m-vlag">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496448/"
                    title="The contribution of Parkin, PINK1 and DJâ€1 genes to selective neuronal degeneration in Parkinson's disease"
                    target="_blank"
                    >The contribution of Parkin, PINK1, and DJâ€1 genes to selective neuronal degeneration in Parkinson's disease</a>, Marc van der Vlag, et al.

                </li>
                <li id="christine-klein"> 
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253033/"
                    title="Genetics of Parkinsonâ€™s Disease"
                    target="_blank"
                    >Genetics of Parkinsonâ€™s Disease</a>, Christine Klein and Ana Westenberger.
                    <p>
                        This 2014 paper provides compelling arguments that the identification of PD gene mutations, especially in patients with early-onset PD, can provide information on prognosis and will affect treatment choices in cases of PD that were initially suspected to be psychogenic. <em>Why is this 10-year-old paper not the standard of care!?</em>
                    </p>
                </li>

                <li id="alpha-synuclein-net">
                    <a href="https://alpha-synuclein.net/mutations/"
                    title="ALPHA-SYNUCLEIN: MUTATIONS"
                    target="_blank"
                    >ALPHA-SYNUCLEIN: MUTATIONS</a>
                    <p>
                        Individuals who developed a triplication of the <abbr title="Synuclein Alpha Gene">SNCA gene</abbr>, as opposed to a duplication, displayed more severe symptoms including early-onset parkinsonism with dementia. This indicates a dose-dependent correlation between the progression of PD and <abbr title="Synuclein Alpha">SNCA</abbr> gene dosage. <cite class="reflink"><a href="#alpha-synuclein-net">alpha-synuclein-net</a></cite>
                    </p>
                </li>
                <li id="a-schaffner"> 
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30858560/"
                    title="Vitamin B12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection"
                    target="_blank"
                    >Vitamin B12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection</a>, Schaffner, et al.
                    <p>
                        This in vitro study found that adenosylcobalamin (a form of B-12) protects dopaminergic neurons from LRRK2-G2019S-induced neurotoxicity in C. elegans.
                    </p>
                </li>

                <li id="daley">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625652/"
                    title="Prion-like mechanisms in Parkinson Disease"
                    target="_blank"
                    >Prion-like mechanisms in Parkinson Disease</a>, Laura Volpicelli-Daley and Patrik Brundin.
                </li>
                <li id="matuz-mares">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9138001/"
                    title="Mitochondrial Calcium: Effects of Its Imbalance in Disease"
                    target="_blank"
                    >Mitochondrial Calcium: Effects of Its Imbalance in Disease</a>, Deyamira Matuz-Mares, et al.
                </li>
                <li id="s-hu">
                    <a href="https://www.sciencedirect.com/science/article/pii/S096999612100276X"
                    title="Molecular chaperones and Parkinson's disease"
                    target="_blank"
                    >Molecular chaperones and Parkinson's disease</a>, Shenglan Hu, et al.
                </li>
            </ol>
        </section>
        
            <section id="testing-for-pd">
                <h3>Testing for PD</h3>
                
                <p>
                    Upon clinical diagnosis of PD (via <abbr title="Unified Parkinson's Disease Rating Scale">UPDRS</abbr> score), serious damage has already been done to nerve cells of the substantia nigra. This underscores the importance of early testing and genetic testing. <cite class="reflink"><a href="#f-nouri-emamzadeh">F. Nouri Emamzadeh</a></cite>
                </p>
    
                <p>
                    Alpha-synuclein oligomers are higher in PD patients than in healthy subjects. This can be tested with AlphaSyn-SAA salivary test or Syn-One skin biopsy.
                </p>
                <h3>Early Testing and Diagnosis with AlphaSyn-SAA</h3>
                <p>
                    The AlphaSyn-SAA salivary test measures the levels of salivary alpha-amylase (SAA). The results are used to assess autonomic nervous system activity, particularly sympathetic nervous system activation. This test can, with some margin of error, identify people at risk of developing Parkinsonâ€™s disease <em>up to ten years</em> before symptoms appear. 
                </p>
                <h3>Syn-One</h3>
                <p>
                    The Syn-One skin biopsy detects the presence of phosphorylated alpha-synuclein in the skin. This is a much more accurate test than the AlphaSyn-SAA and is usually used as confirmation, rather than a preventive diagnostic. 
                </p>
                <section id="genetic-testing">
                    <h4>Genetic Testing</h4>
                    <p>
                        Most cases of Parkinson's Disease are not classified as genetic. Genetic testing for PD is not routinely performed because only about 15% of cases are determined to be genetic. It's a classic <dfn>absence of evidence</dfn> fallacy.
                    </p>
                    <p>
                        Genetic testing can provide valuable information to guide treatment, as different genetic mutations may affect disease progression and response to therapies.  (See also: <a href="https://www.michaeljfox.org/what-know-about-genetic-testing"
                        target="_blank"
                        >What to Know about Genetic Testing</a>) <cite class="reflink"><a href="#l-cook">L. Cook</a></cite>
                    </p>
            
                    <p>
                        All genetic forms of PD should be considered when developing treatment strategies, with the focus varying depending on the specific mutation and its molecular pathway. Healthcare teams are encouraged to discuss genetic testing and its implications for personalized treatment.
                    </p>
                    <h5>Test Your Children</h5>
                    <p>
                        Children of PD patients should be tested <em>before</em> they exhibit symptoms similar to those of PD. Symptoms may take up to 10 years to present. 
                    </p>
                    
                    <h5>Testing Locations</h5>
            
                    <p>
                    Genetic testing for these mutations can be done at specialized medical centers and genetic testing companies. Some notable places include:
                    </p>
                    <ul>
                        <li>
                            <a href="https://www.mayo.edu/research/labs/parkinsons-disease/overview" target="_blank">Mayo Clinic</a>
                        </li>
                        <li>
                            <a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/parkinsons-disease/the-genetic-link-to-parkinsons-disease" target="_blank">Johns Hopkins Medicine</a>
                        </li>
                        <li>
                            <a href="https://www.23andme.com/topics/health-predispositions/parkinsons-disease/" target="_blank">23andMe</a>
                        </li>
                        <li>
                            <a href="https://www.invitae.com/us/providers/test-catalog/gene-21080" target="_blank">Invitae</a>
                        </li>
                        <li>
                            <a href="https://providers.genedx.com/tests/detail/parkinson-disease-panel-1005" target="_blank">GeneDx</a>
                        </li>
                    </ul>
                    <h4>Genetic Forms of PD and Corresponding Treatments</h4>
                    <dl id="genetic-forms-treatments">
                        <dt><abbr title="Synuclein Alpha Gene">SNCA gene</abbr></dt>
                        <dd><strong>Problem:</strong> Mutations increase the aggregation of Î±-synuclein.</dd>
                        <dd><strong>Strategy:</strong> Anti-aggregant, antifibrillogenic, antioxidant, neuroprotective.</dd>
    
                        <dt><abbr title="Leucine Rich Repeat Kinase 2">LRRK2</abbr></dt>
                        <dd><strong>Problem:</strong> Mutations disrupt autophagy and lead to neuroinflammation.</dd>
                        <dd><strong>Strategy:</strong> LRRK2 inhibitors, anti-inflammatory, neuroprotective, <a href="#dbs" title="Deep Brain Stimulation">dbs</a>, b-12.</dd>
    
                        <dt><abbr title="PTEN-induced Kinase 1">PINK1</abbr> &amp; Parkin</dt>
                        <dd><strong>Problem:</strong> Parkin tags damaged mitochondria for degradation through mitophagy. Mutations reduce the efficiency of this process, allowing dysfunctional mitochondria to persist and exacerbate oxidative stress.</dd>
                        <dd><strong>Strategy:</strong> Mitochondrial, mitophagy, antioxidant.</dd>
    
                        <dt><abbr title="Parkinsonism-Associated Deglycase 1 or Park7">DJ-1</abbr> &amp; <abbr title="PTEN-induced Kinase 1">PINK1</abbr></dt>
                        <dd><strong>Problem:</strong> These proteins are involved in protecting cells from oxidative stress. Mutations impair their ability to manage mitochondrial dysfunction, leading to increased production of <abbr title="reactive oxygen species">ROS</abbr>, which can damage neurons.</dd>
                        <dd><strong>Strategy:</strong> Antioxidant, mitochondrial, <a href="#vitamin-b1">thiamine</a>.</dd>
                    </dl>
    
                    <h4>Genetic Treatment Approaches</h4>
    
                    <p>
                        A custom-tailored care plan based on the genetic type of PD will predict the best outcomes.
                    </p>
                    <p>
                        Effective treatment must approach PD from multiple angles. The review <cite>"Current Therapies in Clinical Trials of Parkinsonâ€™s Disease: A 2021 Update"</cite>, provides a fair overview of PD.
                    </p>
            
                    <h4>References</h4>
                    <ol class="reference-list">
                        <li id="f-nouri-emamzadeh">
                            <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122110/"
                            title="Alpha-synuclein structure, functions, and interactions"
                            target="_blank"
                            >Alpha-synuclein structure, functions, and interactions</a>, Fatemeh Nouri Emamzadeh.
                            <p>
                                Upon clinical diagnosis of PD, serious damage has already been done to nerve cells of the substantia nigra pars compacta. This underscores the importance of early testing and genetic testing. 
                            </p>
                        </li>
    
                        <li id="l-cook"> 
                            <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101316/"
                                title="Genetic Testing for Parkinson Disease"
                                target="_blank"
                            >Genetic Testing for Parkinson Disease</a>, Lola Cook, et al.
                            <p>
                                In some cases, identification of PD variants may aid in the diagnosis, management, and prediction of disease course.
                            </p>
                        </li>
                    </ol>
                </section>
            </section>
        </section>
    </section>
        
    <section id="etiological-solutions">
        <!-- TODO: Move this to Causes, rewrite introduction-->
        <h3>Etiological and Holistic Approach</h3>
        <p>
            This guide uses an etiological holistic approach. That is, it is comprehensive, evidence-based, and addresses the root causes of PD with care, precision, and skepticism â€” considerations that should be applied to the veracity of all healthcare claims.
        </p>

        <!-- TODO: Move to new peptides section? p>
            Peptide therapy, by practitioner in-home visits, can be used (SS-31, AICAR, Epitalon, Pinealon).
        </p -->
        
        <p>
            Here are some approaches to target underlying problem areas:
        </p>
        <dl id="problems-list">
                    
            <dt class="antifibrillogenic">Antifibrillogenic</dt>
            <dd> â€” prevents fibril formation of Î±-synuclein </dd>
            <dd class="es">
                Phosphatidylserine, uridine, tocotrienols and tocopherols, curcumin, ginger, ginseng, PQQ, saffron.
            </dd>
        
            <dt class="anti-aggregant">Anti-aggregant</dt>
            <dd> â€” prevents aggregation of fibrils and other junk</dd>
            <dd class="es">
                Phosphatidylserine, uridine, tocotrienols and tocopherols, curcumin, ginseng, PQQ, CDP-Choline, Alpha-GPC, saffron, sauna.
            </dd>

            <dt class="anti-inflammatory">Anti-inflammatory</dt>
            <dd> â€” reduces neuroinflammation</dd>
            <dd class="es">
                DHA, phosphatidylserine, tocotrienols and tocopherols, curcumin, ginseng, PQQ, phosphatidylserine, saffron, photobiomodulation, HRT (testosterone/estradiol), exercise (moderate aerobic), sauna.
            </dd>
        
            <dt class="antioxidant">Antioxidant</dt>
            <dd> â€” reduces oxidative stress that causes Î±-synuclein aggregation and neuroinflammation. <cite class="reflink"><a href="#s-j-won">S.J. Won</a></cite></dd>
            <dd class="es">
                Creatine, DHA, tocotrienols and tocopherols, curcumin, PQQ, ginseng, saffron, taurine, TMG, phosphatidylserine, photobiomodulation.
            </dd>
            
            <dt class="bbb-dysfunction">BBB and Barrier Dysfunction</dt>
            <dd> â€” improves protein clearance mechanisms: BBB, choroid plexus, CSF, ventricles, basement membrane, glymphatic system, UPS and ALP, brain phagocytes, etc</dd>
            <dd class="es">
                Collagen peptides (especially collagen type IV), hyaluronic acid, CDP-Choline, Alpha-GPC, phosphatidylserine DHA, uridine, tocotrienols and tocopherols, curcumin, ginger, ginseng, PQQ, saffron, exercise (<abbr title="high-intensity interval training">HIIT</abbr>), HRT, DHEA, pregnenolone, growth hormone (GH) and secretagogues (tesamorelin, CJC-1295), vitamin C, vitamin K2, vitamin D3, beta-glucan (from mushrooms), MSCs, photobiomodulation.
            </dd>

            <dt class="mitochondrial">Mitochondrial</dt>
            <dd> â€” promotes mitochondrial health (mitogenesis, mitophagy)</dd>
            <dd class="es">
                Creatine, Na-r-ALA, DHA, UMP, Alpha-GPC, PQQ, <abbr title="Acetyl-L-Carnitine">ALCAR</abbr>, tocotrienols and tocopherols, berberine, ginger, ginseng, CDP-Choline, exercise (<abbr title="high-intensity interval training">HIIT</abbr>, resistance training, zone 2), B-1 (thiamine), p-5-p, B-12, beta-glucan, <abbr title="N-Acetylecysteine">NAC</abbr>, NAD+ precursors, MOTS-c, tesamorelin, photobiomodulation, <abbr title="Mesenchymal Stem Cells">MSC</abbr> therapy, cold therapy.
            </dd>
            
            <dt>Endoplasmic Reticulum (ER) Dysfunction </dt>
            <dd class="es">
                Osmolytes: Trehalose, taurine, betaine, Alpha-GPC. <abbr title="N-Acetylecysteine">NAC</abbr>, vitamin C, Hsp70 inducers (sauna), quercetin, magnesium. 
            </dd>
            
            <dt id="solution-calcium-dysregulation">Calcium Dysregulation</dt>
            <dd>
                â€” prevents excess intracellular calcium and reduces extracellular calcium through bone formation 
            </dd>
            
           
            <dd class="es">
            	<strong><small>Intracellular Calcium:</small></strong>
                <dl class="compact-inline-list">
                    <dt>Osmolytes:</dt><dd> Trehalose, taurine, betaine, creatine, hydromax glycerol, Alpha-GPC, uridine monophosphate, sarcosine.</dd>

<dt>Electrolytes:</dt><dd> Magnesium (intracellular calcium antagonist), sodium, potassium (stabilizes cellular resting membrane potential via sodium-potassium pump), chloride (both an osmolyte and electrolyte).</dd>

<dt>VGCC Blockers:</dt><dd> Ginger ([6]-gingerol and [6]-shogaol), ginseng (ginsenosides), magnesium, quercetin, EGCG (from green tea).</dd>

<dt><abbr title="inositol triphosphate receptor">IP3R</abbr> Pathway Modulators:</dt><dd> Ginseng (ginsenosides), curcumin, Vitamin D3 (indirectly supports regulation of IP3 receptors via calcium homeostasis).</dd>

<dt>Mitochondrial Protectors:</dt><dd> Ubiquinol, L-Carnitine, taurine, Vitamin K2, DHA (omega-3 fatty acid), CoQ10.</dd>
                </dl>
            </dd>
            
            <dd class="es">
            	<strong><small>Extracellular Calcium: Bone formation and resorption inhibition:</small></strong> 
                Taurine, D3, high-dose K-2 (5mg), magnesium, collagen peptides (especially collagen type IV), hyaluronic acid, boron, zinc, strontium, creatine, turmeric, ginger, vitamin C, quercetin, <abbr title="epigallocatechin gallate">EGCG</abbr> (from matcha), DHEA, pregnenolone, HRT, growth hormone and secretagogues, intense weight-bearing exercise, vibration table, photobiomodulation.
            </dd>
            
            <dt class="senolytic">Senolytic</dt>
            <dd> â€” targets senescent cells; promoting autophagy; improving UPS and ALP dysfunction </dd>
        
            <dd class="es">
                Urolithin-A, resveratrol, fisetin, quercetin, surforaphane, apigenin, piperlongumine, theaflavin, blueberry (pterostilbene), Exercise (HIIT, resistance training), mitochondrial support (DHA, UMP), curcumin, PQQ, ginseng, saffron, fasting and caloric restriction, trehalose, all mitochondrial enhancers, NAD+ and precursors (NMN, NR, and Niacin). Berberine improves the ubiquitin-proteasome system.
            </dd>
            
            <dt class="anti-ischemic">Anti-ischemic</dt>
            <dd> â€” promotes blood flow deep within the brain</dd>
            <dd class="es">
                Photobiomodulation, DHA, exercise (aerobic and resistance training), fasting, GH and secretogogues, k2, nattokinase, ginseng, PQQ, saffron, photobiomodulation, sauna.
            </dd>
            
            <dt>Cognition</dt>
            <dd> â€” improves cognitive function, attention, and memory</dd>
            <dd class="es">
                <abbr title="Acetyl-L-Carnitine">ALCAR</abbr>, cacao, creatine, DHA, UMP, CDP-Choline, Alpha-GPC, B-12, PQQ, K2, ubiquinol, ginseng, ginger, ginko biloba, bacopa monnieri, lutein, zeaxanthin, blueberry, lion's mane, cordyceps, turkey tail, tiger milk mushroom, exercise, B-12, phosphatidylserine.
            </dd>
            
            <!-- dt>GABA Dysfunction</dt>
            <dd>GABA, taurine, theanine, melatonin</dd-->
            
            <dt class="sleep">Sleep</dt>
            <dd> â€” addresses insomnia and sleep quality</dd>
            <dd class="es">
                Early exercise, photobiomodulation, phosphatidylserine, <abbr title="N-Acetylecysteine">NAC</abbr> curcumin, magnesium-L-threonate, melatonin, theanine, GABA, 5-HTP, saffron, HRT, DHEA, pregnenolone, TMG.
            </dd>
            
            <dt class="gi">Gastrointestinal</dt>
            <dd> â€” improves gastrointestinal health and function</dd>
            <dd class="es">Probiotic (fermeted) foods, beta-glucan from mushrooms, inulin, collagen, hyaluronic acid (MW >1000 kDa)</dd>
            
            <dt class="dopaminergic">DRT Side Effects</dt>
            <dd> â€” helps side-effects caused by DRT (dopamine replacement therapy) (e.g., dyskinesia, impulse control disorders, cytotoxicity)</dd>
            <dd class="es">
                Phosphatidylserine, magnesium L-threonate, B-1 (thiamine), berberine, B-1 (thiamine), p-5-p, B-12, TMG.
            </dd>
        </dl>


        <h4>References</h4>
        <ol class="reference-list">
            <li id="s-j-won">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774295/"
                title="Neuronal Oxidative Stress Promotes Î±-Synuclein Aggregation In Vivo"
                target="_blank"
                >Neuronal Oxidative Stress Promotes Î±-Synuclein Aggregation In Vivo</a>, Seok Joon Won, et al.
                <p>
                
                </p>
            </li>
        </ol>
    </section>

    <section id="how-to-build-a-supplement-plan">
        <h3>How to Build a Supplement Plan</h3>
        <p>
            Supplements and dietary recommendations are components of a comprehensive health program targeting total human performance at the cellular level. This approach focuses not only on physical exercise but also on non-motor aspects such as sleep, cognitive function, and overall well-being. 
        </p>
        
        <p>
            Brief explanations of what the supplements do accompany the plan. The etiological problems they address are detailed under Causes and Risk Factors. Details on each supplement is listed under its respective section. 
        </p>
        <h4>First, Do No Harm</h4>
        <p>
            It should go without saying that, before embarking on a serious plan to improve health, other lifestyle factors must be in order. That means no smoking and no alcohol, as even 1-2 drinks per week reduce cortical thickness and grey matter. Additionally, maintaining good sleep hygiene is essential.
        </p>
        
        <h4>Exercise</h4>
        <p>
            Without regular, strategic exercise, supplementation will have limited benefits. Exercise increases brain blood flow, helping supplements reach targeted areas (among its many other benefits). Conversely, many supplements enhance exercise performance and recovery.  (See also: <a href="#exercise">Exercise</a>) 
        </p>
        
        <p>
            The following general-purpose solution serves as a customizable starting point to address health with PD from multiple angles, targeting each of the underlying <a href="#etiological-solutions">Etiological Problems</a>.
        </p>
        
        <h4>Mixing and Storing Powders</h4>
        
        <p>The mixed powders "Pre-Workout Mix", "Cacao Mix", and "Post-Workout" powders must be made in batches and should be stored in a cool, dry place with a desiccant pack (like silica gel) inside the powder to prevent clumping and contamination (mold). Silica packs commonly shipped with raw powders and supplements can be reused.
        </p>
        
        <h4>Weighing and Mixing Powders</h4>
        <p>
            A sturdy gram scale or reliable, accurate food scale that measures to the nearest 0.01g (10mg) is necessary to ensure accuracy. To help ensure proper ingredient dispersal, mix the smaller ingredients first and blend in the larger ingredients.
        </p>
            
        <h4>Daily Supplements (2x daily)</h4>
        <table border="1" class="supplement-table">
            <thead>
                <tr>
                    <th>Supplement</th>
                    <th>Dose</th>
                    <th>Mechanism</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Ubiquinol</td>
                    <td>300mg</td>
                    <td>Mitochondrial function, Antioxidant, Improves ATP production</td>
                </tr>
                <tr>
                    <td>PQQ (Pyrroloquinoline Quinone)</td>
                    <td>30mg</td>
                    <td>Mitochondrial biogenesis, Antioxidant, Neuroprotective, Anti-aggregant</td>
                </tr>
                <tr>
                    <td>CDP-Choline (Citicoline)</td>
                    <td>500mg</td>
                    <td>Neuroprotective, Enhances dopamine release, Supports phospholipid synthesis</td>
                </tr>
                <tr>
                    <td>Active B Complex (Integrative Therapeutics)</td>
                    <td>1 capsule</td>
                    <td>Supports methylation, Cognitive function, Energy metabolism</td>
                </tr>
                <tr>
                    <td>Nattokinase</td>
                    <td>100mg</td>
                    <td>Cardiovascular health, Anti-thrombotic, Improves blood flow</td>
                </tr>
                <tr>
                    <td>Vitamin K2</td>
                    <td>1,000mcg</td>
                    <td>Prevents vascular calcification, Supports mitochondrial function</td>
                </tr>
                <tr>
                    <td>Berberine</td>
                    <td>500mg</td>
                    <td>Improves mitochondrial function, ubiquitin-proteasome function, and gut bacteria to produce L-dopa, increasing brain dopamine, and reducing DRT-induced cytotoxicity, thereby reducing overreliance of DRT and reducing its side effects.</td>
                </tr>               
                <tr>
                    <td>Thiamine</td>
                    <td>50mg</td>
                    <td>Supports neurological function, Enhances mitochondrial energy production</td>
                </tr>
            </tbody>
        </table>
        
        <p>
            The Daily Supplements improve mitochondrial function, support cognitive performance, and address many etiological pathways in PD. Ubiquinol and PQQ improve mitochondrial energy production and biogenesis, CDP-Choline improves dopamine release, supports phospholipid synthesis, strengthens cellular membranes and improves neurotransmitter production. The Active B Complex facilitates methylation and energy metabolism and makes up for some deficits caused by DRT. Nattokinase reduces amyloid fibrils and promotes Î±-synuclein ubiquitination, supporting proteasomal degradation and autophagyâ€”a problem in PD progressionâ€”by regulating protein misfolding and enhancing cellular waste clearance. Vitamin K2 helps prevent vascular calcification and supports mitochondrial function and may indirectly improve neurological function. Berberine improves mitochondrial function, gut-derived L-dopa production, and the ubiquitin-proteasome system, reducing dependency on DRT. Thiamine further enhances mitochondrial energy production and supports neurological health.
        </p>
        
        <h4 id="mitochondrial-powder">Pre-Workout Mix Powder â€” 10-Day Supply</h4>
        <p>
            This 10-day serving can be taken daily while beginning the main workout.
        </p>
        <ul class="recipe-list">
            <li>Niacin â€” 2g</li>
            <li>Coffeeberry Extract â€” 2.5g</li>
            <li>Uridine Monophosphate (UMP) â€” 5g</li>
            <li>NR â€” 5g</li>
            <li>Matcha â€” 7.5g</li>
            <li>Sodium Bicarbonate â€” 8g</li>
            <li>NMN â€” 10g</li>
            <li>Lion's Mane â€” 10g</li>
            <li>Cordyceps â€” 10g</li>
            <li>Glucomannan â€” 10g</li>
            <li>Hydromax Glycerol Powder â€” 15g</li>
            <li>Trehalose â€” 20g</li>
            <li>Taurine â€” 25g</li>
            <li>Inulin â€” 40g</li>
            <li>Organic Greens Powder â€” 20g</li>
            <li>Organic Fruits Powder â€” 40g</li>
            <li>Micronized Creatine Monohydrate (CreaPureÂ®) â€” 50g</li>
            <li>Citrulline Malate â€” 60g</li>
        </ul>
        <h5>Total Weight: 340g</h5>
        
		<table class="nutrition-facts" id="pre-workout-supplement-facts">
			<caption class="nutrition-facts-title">Pre-Workout Powder Supplement Facts</caption>
			<thead>
				<tr>
					<th class="serving">Serving Size: 34 g</th>
				</tr>
			</thead>
			<tbody>
				<tr>
					<th>Amount Per Serving</th>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Calories <div class="weight">~90</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Total Fat <div class="weight">~1 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Total Carbohydrates <div class="weight">~13 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="indent line">
						<div class="labellight">Dietary Fiber <div class="weight">~8 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="indent line">
						<div class="labellight">Sugars <div class="weight">~2 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Protein <div class="weight">~1.5 g</div></div>
					</td>
				</tr>
				<!-- Supplements -->
				<tr>
					<td class="line">
						<div class="label">Niacin (Vitamin B3) <div class="weight">200 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">NMN (Nicotinamide Mononucleotide) <div class="weight">1 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">NR (Nicotinamide Riboside) <div class="weight">500 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Uridine Monophosphate (UMP) <div class="weight">500 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Matcha Powder <div class="weight">750 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Sodium Bicarbonate <div class="weight">800 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Coffeeberry Extract <div class="weight">250 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Lion's Mane Mushroom Powder <div class="weight">1 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Cordyceps Mushroom Powder <div class="weight">1 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Trehalose <div class="weight">2 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Taurine <div class="weight">2.5 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Glucomannan (Konjac Root Fiber) <div class="weight">1 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Inulin (Chicory Root Fiber) <div class="weight">4 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">HydroMaxÂ® Glycerol Powder <div class="weight">1.5 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Micronized Creatine Monohydrate (CreaPureÂ®) <div class="weight">5 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Organic Greens Powder <div class="weight">3 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Organic Fruits Powder <div class="weight">3 g</div></div>
					</td>
				</tr>
				<!-- Micronutrients -->
				<tr>
					<td class="line">
						<div class="label">Vitamin C (from Organic Fruits) <div class="weight">~15 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Polyphenols (from Coffeeberry, Matcha, Greens) <div class="weight">~300 mg</div></div>
					</td>
				</tr>
			</tbody>
			<tfoot>
				<tr>
					<td class="line nutrition-note">
						Nutritional details are estimates and should be used for guidance.
		
						<div class="advisory">
							<h4>Advisory</h4>
							<p>
								Niacin: Sensitive individuals may still experience flushing.
								UMP/NR/NMN: While within safer dose ranges, users should consult healthcare providers if they take concurrent NAD+ boosters.
								Taurine: High doses (â‰¥2 g) may cause gastrointestinal discomfort in sensitive users.
							</p>
						</div>
					</td>
				</tr>
			</tfoot>
		</table>

        <h5>Instructions for Pre-Workout Mix</h5>
        <p>
            Mix 28g of the powder with water. Add 1-2 tablespoons of FruitFast pomegranate or blueberry concentrate and 2 tbsp Inner Eco Probiotic Coconut Water. Stir thoroughly and consume with morning supplements before primary workout. Store in a cool, dry place to prevent clumping.
        </p>

        <h5>Pre-Workout Mix Benefits</h5>
        <p>
            The Pre-Workout Mix enhances mitochondrial function as well as cognitive and overall health. <abbr title="Uridine Monophosphate">UMP</abbr> improves neurotransmission and synaptic plasticity. NMN and NR increase NAD+ levels, improving mitochondrial energy production. Niacin increases NAD+ and reduces inflammation. Cordyceps boosts ATP production and is neuroprotective and anti-inflammatory. Lionâ€™s Mane promotes neurogenesis, and Trehalose prevents protein aggregation. Taurine is an osmolyte that improves calcium regulation, improves mitochondrial dysfunction, and improves recovery. Inulin, glucomannan, polyphenols, and probiotic coconut water all support gut health, and coffeeberry extract, rich in chlorogenic acids and polyphenols, improves cognitive function through antioxidant mechanisms.
        </p>
	
		<h5>A Note on Fruits Powders</h5>

		<p>
			Blueberries get more cognitive research attention than other berries. This is partly due to their commercial scale and supporting agriculture and marketing. Industry-funded associations (such as the U.S. Highbush Blueberry Council) promote their cognitive benefits, which boosts consumer demand, leading to more studies, which further solidifies blueberries proven cognitive benefits.
        </p>
				
        <p>
			Other berries like Maqui, Aronia, aÃ§aÃ­, and elderberry have similar antioxidant benefits, are high in anthocyanins and other bioactive compounds, and may confer cognitive benefits, despite a dearth of research. Powders from Navitas and other reputable brands are great options that compliment effects of blueberries.
		</p>

        <h4>Cacao Mix Powder â€” 10 Day Supply</h4>
        <p>
            This ~10-day serving can be taken in hot water 1-2x daily, earlier in the day. Add coconut oil and organic ginger juice.
        </p>
        <ul class="recipe-list">
            <li>Niacin â€” 1g</li>
            <li>Turmeric â€” 7g</li>
            <li>Matcha â€” 7g</li>
            <li>Lion's Mane â€” 10g</li>
            <li>Cordyceps â€” 10g</li>
            <li>Turkey Tail â€” 10g</li>
            <li>Ceylon Cinnamon â€” 12g</li>
            <li>Salt Mix â€” 15g</li>
            <li>Ginger Powder â€” 15g</li>
            <li>Trehalose â€” 20g</li>
            <li>Raw Cacao â€” 100g</li>
        </ul>
        
        <h5>Instructions for Cacao Mix</h5>
        <p>
            Mix 19 g of the mixed powder to about 24 oz below-boiling water to preserve the properties of the ingredients. Add coconut oil.
        </p>
        
        <h5>Cacao Mix Benefits</h5>
        <p>
            The Cacao Mix provides stimulating cognitive effects for neurotransmitter balance and mitochondrial function. Raw Cacao increases PEA and catechins, boosting mood and cognitive function. Cordyceps improves ATP production and is neuroprotective. Lionâ€™s Mane supports neurogenesis and synaptic plasticity. Niacin increases NAD+ levels for mitochondrial energy, while Turmeric is anti-inflammatory, antifibrillogenic, and anti-aggregation. Ginger improves BBB function, stimulates mitophagy, and supports gastrointestinal function.
        </p>

		<h4>Salt Mix</h4>
		<p>
			60/40 blend of Ava Jane's Colima Salt and Boulder Salt. This blend was chosen to combine the trace minerals and natural purity of Colima salt with Boulder Salt's superior potassium, magnesium, and bicarbonate levels, creating a well-rounded electrolyte profile that can be used for various culinary needs while maintaining cost-efficiency and purity with negligible levels of heavy metals and microplastics.
		</p>
		<table class="nutrition-facts" id="salt-mix-nutrition-facts">
			<caption class="nutrition-facts-title">Salt Mix Nutrition Facts</caption>
			<thead>
				<tr>
					<th class="serving">Serving Size: 1/4 tsp (about 1.5g)</th>
				</tr>
			</thead>
			<tbody>
				<tr>
					<th>Amount Per Serving</th>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Calories <div class="weight">0</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Total Fat <div class="weight">0 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Sodium <div class="weight">Sodium	490 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Chloride <div class="weight">730 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Potassium <div class="weight">62 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Magnesium <div class="weight">48 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Calcium <div class="weight">37 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Bicarbonate <div class="weight">97 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Trace Minerals (various) <div class="weight"> &lt; 1 mg</div></div>
					</td>
				</tr>
			</tbody>
			<tfoot>
				<tr>
					<td class="line nutrition-note">
						This mix combines Ava Jane's Ancient Salts and Boulder Salts (60/40) to balance sodium and trace minerals. Ideal for pre/post-workout hydration and electrolyte replenishment.
					</td>
				</tr>
			</tfoot>
		</table>


        <h4>Pre-Workout Supplements</h4>
        <table border="1" class="supplement-table">
            <tr>
                <th>Supplement</th>
                <th>Dose</th>
                <th>Mechanism</th>
            </tr>
            <tr>
                <td>ALCAR (Acetyl-L-Carnitine)</td>
                <td>1.5g</td>
                <td>Mitochondrial function, Enhances energy and focus, Promotes synaptic plasticity</td>
            </tr>
            <tr>
                <td>Alpha-GPC</td>
                <td>300-600mg</td>
                <td>Choline source, Enhances acetylcholine production, Supports cognitive function</td>
            </tr>
            <tr>
                <td>Vinpocetine</td>
                <td>10-30mg</td>
                <td>Improves cerebral blood flow, Supports memory and focus, Anti-inflammatory</td>
            </tr>
            <tr>
                <td>Noopept</td>
                <td>10-30mg</td>
                <td>Enhances cognitive function, Promotes neurogenesis, Reduces oxidative stress</td>
            </tr>
            <tr>
                <td>4â€™-DMA-7,8-DHF (Dihydroxyflavone, passion flower extract)</td>
                <td>30-50mg</td>
                <td><abbr title="Brain-Derived Neurotrophic Factor">BDNF</abbr> signaling (TrkB agonist), Enhances synaptic plasticity, Reduces neuroinflammation</td>
            </tr>
            <tr>
                <td>Na-r-ALA (Na-R-Alpha-Lipoic Acid)</td>
                <td>300-600mg (with 2-5g trehalose)</td>
                <td>Antioxidant, Improves glucose uptake (taken with trehalose for optimal effect), Mitochondrial support</td>
            </tr>
            <tr>
                <td>Triacetyluridine</td>
                <td>25-50mg</td>
                <td>Enhances synaptic plasticity, Dopaminergic function, Supports cognitive health</td>
            </tr>
            <tr>
                <td>Ginkgo Biloba</td>
                <td>120-240mg</td>
                <td>Increases cerebral blood flow, Improves cognitive performance, Reduces oxidative stress</td>
            </tr>
            <tr>
                <td>Tiger Milk Mushroom</td>
                <td>500-1000mg</td>
                <td>Contains ergosterol (regulates membrane fluidity), Beta-glucan for ECM support, Immunomodulatory</td>
            </tr>

            <tr>
                <td>Pterostilbene</td>
                <td>50mg</td>
                <td>
                    Antioxidant, anti-inflammatory, cognitive.
                </td>
            </tr>
            <tr>
                <td>FruitFast Blueberry Extract</td>
                <td>1 tbsp</td>
                <td>
                    Antioxidant, anti-inflammatory, cognitive.
                </td>
            </tr>
            <tr>
                <td>FruitFast Pomegranate Extract</td>
                <td>1 tbsp</td>
                <td>
                    Antioxidant, anti-inflammatory, cognitive.
                </td>
            </tr>
        </table>

        <h5>Pre-Workout Supplements Benefits</h5>
        <p>
            The Pre-Workout Supplements support cognitive function, stamina, and mitochondrial energy, complementing the broader supplement regimen with athletic performance support specifically selected and relevant to PD, with no evidence linking these enhancers to increased dyskinesias. These compounds improve mental clarity, fight fatigue, and reduce stress from exercise. ALCAR and Na-r-ALA support mitochondrial efficiency, while Alpha-GPC aids acetylcholine production without worsening dyskinesias. Vinpocetine and Ginkgo Biloba improve cerebral blood flow, and Salidroside counteracts fatigue by modulating dopamine and serotonin. 
        </p>
        <p> * Note: For Na-r-ALA, pairing with a carbohydrate source, like 3-5g trehalose, is recommended to optimize glucose uptake. The Pre-Workout Mix could be used as a carbohydrate source if additional trehalose is added. 
        </p>
        
        <h4>Post-Workout Mixed Powder â€” 10-Workout Supply</h4>
        <p>This 10-day supply of powder can be pre-mixed and stored a cool, dry place.</p>
        <ul class="recipe-list">
            <li>Niacin â€” 1g</li>
            <li>Cognance Enhanced Bacopa Powder â€” 1g</li>
            <li>NR â€” 2.5g</li>
            <li>Rhodiola Rosea â€” 2.5g</li>
            <li>R-ALA Cyclodextrin Powder â€” 3g</li>
            <li>NMN â€” 5g</li>
            <li>Turmeric â€” 7g</li>
            <li>Sodium Bicarbonate â€” 10g</li>
            <li>Natto Powder â€” 10g</li>
            <li>HMB â€” 10g</li>
            <li>TMG (Betaine) â€” 10g</li>
            <li>Lion's Mane â€” 10g</li>
            <li>Tremella â€” 10g</li>
            <li>Reishi â€” 10g</li>
            <li>Chaga â€” 10g</li>
            <li>Taurine â€” 10g</li>
            <li>Glucomannan â€” 10g</li>
            <li>Ceylon Cinnamon â€” 12g</li>
            <li>Ginger Powder â€” 12g</li>
            <li>Turkey Tail â€” 20g</li>
            <li>Collagen Peptides â€” 30g</li>
            <li>Inulin â€” 40g</li>
            <li>Trehalose â€” 40g</li>
            <li>BCAA 4:1:1 â€” 40g</li>
            <li>Micronized Creatine Monohydrate (CreaPureÂ®) â€” 50g</li>
            <li>Organic Greens Powder â€” 30g</li>
            <li>Organic Fruits Powder â€” 70g</li>
            <li>Whey Protein Isolate â€” 350g</li>
        </ul>
        <h5>Total Weight: 815g</h5>
        
        <h5>Mixing Instructions</h5>
        <p>
        	Combine Small Ingredients First: Begin with the smallest quantities, like Niacin and Cognance Enhanced Bacopa Powder, and mix thoroughly. This ensures even distribution and reduces "hot spots" where one scoop might have a disproportionate concentration of these potent ingredients. Mash clumps with a spoon.
        </p>
        <p>
				Gradually Add Larger Ingredients: Add the medium-sized amounts (e.g., NMN, Sodium Bicarbonate) and mix again.
		</p>
		<p>
			Incorporate Bulk Ingredients Last: Introduce the largest-volume ingredients (e.g., Whey Protein Isolate, Organic Fruits Powder) and mix thoroughly. Use a large container to allow space for even blending.
		</p>


		<table class="nutrition-facts">
			<caption class="nutrition-facts-title">Post-Workout Powder Supplement Facts</caption>
			<thead>
				<tr>
					<th class="serving">Serving Size: 81.5 g</th>
				</tr>
			</thead>
			<tbody>
				<tr>
					<td>Amount Per Serving</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Calories <div class="weight">~300</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Total Fat <div class="weight">~3 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Total Carbohydrates <div class="weight">~25 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="indent line">
						<div class="labellight">Dietary Fiber <div class="weight">~7 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="indent line">
						<div class="labellight">Sugars <div class="weight"><1 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Protein <div class="weight">~39 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Niacin <div class="weight">100 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Cognance Enhanced Bacopa Powder <div class="weight">100 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">NR (Nicotinamide Riboside) <div class="weight">250 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Rhodiola Rosea <div class="weight">250 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">NMN (Nicotinamide Mononucleotide) <div class="weight">500 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Turmeric <div class="weight">700 mg</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Sodium Bicarbonate <div class="weight">1 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Collagen Peptides <div class="weight">3 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Micronized Creatine Monohydrate (CreaPureÂ®) <div class="weight">5 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Inulin <div class="weight">4 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Trehalose <div class="weight">4 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">BCAA 4:1:1 <div class="weight">4 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Organic Greens Powder <div class="weight">3 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Organic Fruits Powder <div class="weight">7 g</div></div>
					</td>
				</tr>
				<tr>
					<td class="line">
						<div class="label">Turkey Tail <div class="weight">2 g</div></div>
					</td>
				</tr>
			</tbody>
			<tfoot>
				<tr>
					<td class="line nutrition-note">
						Nutritional details are estimates and should only be used as a guide.
					</td>
				</tr>
			</tfoot>
		</table>



        <h5>Instructions</h5>
        <p>
            Pre-mix 79 g powder with water. Add a low-sugar probiotic (plain kefir or yogurt, from whole milk) and 1-2 tbsp of FruitFast blueberry or pomegranate concentrate. Consume immediately after exercise (bring it to the gym).
        </p>
        
        <h5>Post-Workout Mix Benefits</h5>
        <p>
            This Post-Workout Mix aids in muscle recovery, reduces brain inflammation, and supports mitochondrial function. Whey protein is an excellent source of cysteine, which supports the production of glutathione, thereby reducing oxidative stress. BCAAs reduce brain inflammation by decreasing excess glutamate, improve exercise recovery, and increase cognitive function in older persons <cite class="reflink"><a href="caldo-silva">Caldo-Silva</a></cite>. NMN and NR boost NAD+ and repair mitochondria. Taurine is senolytic, improves mitochondrial dysfunction, and is an endogenous neuromodulator that acts as an inhibitory neurotransmitter, activating GABA receptors. TMG (Betaine) regulates GABA and glycine, increases glutathione activity, and lowers homocysteine. Turkey Tail, rich in beta-glucan and ergothioneine, supports cognitive function and protects neurons. Collagen peptides support ECM integrity and gray matter. Lionâ€™s Mane stimulates neurogenesis. Sodium bicarbonate helps restore the acid-base balance in the body, following intensive exercise.
        </p>

        <h4>Dinner Supplements ðŸ½ï¸</h4>
        <p>
            Fat-soluble substances are better absorbed when taken with dietary fats.
        </p>
        <table border="1" class="supplement-table">
            <thead>
                <tr>
                    <th>Supplement</th>
                    <th>Dose</th>
                    <th>Mechanism</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>DHEA</td>
                    <td>50mg</td>
                    <td>Hormonal balance, ECM support, IGF-1 levels</td>
                </tr>
                <tr>
                    <td>Pregnenolone</td>
                    <td>30mg</td>
                    <td>Hormonal balance, cognitive support, ECM</td>
                </tr>
                <tr>
                    <td>Sesamins (Sesaminol)</td>
                    <td>100-200mg</td>
                    <td>Antioxidant, Anti-inflammatory, Supports mitochondrial function, Regulates lipid metabolism, Protects membrane structure</td>
                </tr>
                <tr>
                    <td>NAC</td>
                    <td>600-1200mg</td>
                    <td>Antioxidant, Glutathione precursor</td>
                </tr>
                <tr>
                    <td>Geranyl Geraniol</td>
                    <td>500mg</td>
                    <td>Mitochondrial function, Dopaminergic side-effect modulation</td>
                </tr>
                <tr>
                    <td>Urolithin-A</td>
                    <td>1000mg</td>
                    <td>Senolytic, Mitochondrial biogenesis, Anti-inflammatory</td>
                </tr>
                <tr>
                    <td>Resveratrol</td>
                    <td>1000mg</td>
                    <td>Senolytic, Antioxidant, Neuroprotective, Anti-inflammatory</td>
                </tr>
                <tr>
                    <td>Fisetin</td>
                    <td>500mg</td>
                    <td>Senolytic, Anti-inflammatory</td>
                </tr>
                <tr>
                    <td>Quercetin</td>
                    <td>500mg</td>
                    <td>Anti-apoptotic, Anti-inflammatory, Neuroprotective, Mitochondrial, Motor deficits</td>
                </tr>
                <tr>
                    <td>Sulforaphane</td>
                    <td>50mg</td>
                    <td>Senolytic, Antioxidant, Detoxification</td>
                </tr>
                <tr>
                    <td>Apigenin</td>
                    <td>50mg</td>
                    <td>Neuroprotective, Anti-inflammatory</td>
                </tr>
                <tr>
                    <td>Piperlongumine</td>
                    <td>50mg</td>
                    <td>Senolytic, Enhances bioavailability of curcumin and bioactives</td>
                </tr>
                <tr>
                    <td>Zeaxanthin</td>
                    <td>10mg</td>
                    <td>Neuroprotective, Antioxidant</td>
                </tr>
                <tr>
                    <td>Lutein</td>
                    <td>10mg</td>
                    <td>Neuroprotective, Antioxidant</td>
                </tr>
                <tr>
                    <td>Mixed Tocopherols/Tocotrienols</td>
                    <td>150-300 IU</td>
                    <td>Neuroprotective, <abbr title="ubiquitin proteasome system">UPS</abbr> dysfunction, BBB integrity, Mitochondrial health</td>
                </tr>
                <tr>
                    <td>Hyaluronic Acid (MW >1600 kDa)</td>
                    <td>100-300mg</td>
                    <td>ECM support, modulates postsynaptic calcium channels, protects dopaminergic neurons</td>
                </tr>
            </tbody>
        </table>

        
        <h4>Golden Milk Recipe â€” Nighttime Anti-Inflammatory Drink â€” 10-Day Supply.</h4>
        <ul class="recipe-list">
            <li>Saffron â€” 300mg</li>
            <li>Cardamom powder â€” 5g</li>
            <li>Lion's Mane â€” 10g</li>
            <li>Tremella â€” 10g</li>
            <li>Reishi â€” 10g</li>
            <li>Chaga â€” 10g</li>
            <li>Ceylon Cinnamon â€” 12g</li>
            <li>Ginger Powder â€” 12g</li>
            <li>Turkey Tail â€” 20g</li>
            <li>Turmeric â€” 20g</li>
            <li>Collagen Peptides â€” 70g</li>
        </ul>
        
        <h5>Instructions for Golden Milk</h5>
        <p>
            Bring 2-3 long peppers (Piper longum) to boil (enhances bioavailability) in 8 oz water. Add 8 oz milk. Add 18g of the mixed powder into warm (not boiling) water and milk. Stir thoroughly and avoid overheating to preserve the beneficial compounds. (The long peppers can be reused until they lack strength, or may be reused for cooking recipes.)
        </p>
        
        <h5>Golden Milk Benefits</h5>
        <p>
            This Golden Milk reduces inflammation and supports brain health and mitochondrial function. The turmeric and saffron improve sleep. Cinnamon improves blood glucose (which should not be elevated when sleeping). Turmeric is anti-inflammatory, antifibrillogenic, and prevents protein aggregation. Ginger enhances mitophagy, protects the BBB, and reduces inflammation. Tremella, Reishi, Lionâ€™s Mane, and Chaga provide beta-glucan for ECM support and contain flavonoids such as apigenin, quercetin, and anthocyanins. Turkey Tail offers ergothioneine and beta-glucan to support cognitive function and protect neurons. Collagen peptides increase gray matter and improve memory. The long peppers improve curcuminoid absorption and are senolytic.
        </p>
                
        <h4>Sleep Supplements (7:00 pm - 9:00 pm) ðŸ’¤</h4>
        <table border="1">
            <tr>
                <th>Supplement</th>
                <th>Dose</th>
                <th>Mechanism</th>
            </tr>
			<tr>
                <td>Bacopa Monnieri</td>
                <td>300-500mg</td>
                <td>Improves memory, Enhances cognitive function, Reduces oxidative stress</td>
            </tr>
            <tr>
                <td>Melatonin (Sleep3)</td>
                <td>10mg</td>
                <td>Regulates sleep-wake cycle, Antioxidant, Neuroprotective, Mitochondrial support</td>
            </tr>
            <tr>
                <td>5-HTP</td>
                <td>50-100mg</td>
                <td>Serotonin precursor, Supports mood and sleep, Reduces dopaminergic side effects</td>
            </tr>
            <tr>
                <td>GABA</td>
                <td>1000mg-2000mg</td>
                <td>Inhibitory neurotransmitter, Promotes relaxation and sleep, Reduces excitotoxicity</td>
            </tr>
            <tr>
                <td>Magnesium Threonate</td>
                <td>300mg</td>
                <td>Enhances synaptic plasticity, Supports memory and sleep, Mitochondrial function. Calcium antagonist in cells, helping to restore intracellular calcium balance and reduce excitotoxicity.</td>
            </tr>
            <tr>
                <td>Chelated Magnesium</td>
                <td>150mg</td>
                <td>Promotes relaxation, Supports neurotransmitter balance, Enhances muscle function</td>
            </tr>
            <tr>
                <td>Theanine</td>
                <td>250-750mg</td>
                <td>Calming, Improves cognitive function, Promotes sleep quality and focus</td>
            </tr>
        </table>
        <ol class="reference-list">
            <li id="caldo-silva">
                <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8066027/"
                title="Effect of Training-Detraining Phases of Multicomponent Exercises and BCAA Supplementation on Inflammatory Markers and Albumin Levels in Frail Older Persons"
                target="_blank"
                >Effect of Training-Detraining Phases of Multicomponent Exercises and BCAA Supplementation on Inflammatory Markers and Albumin Levels in Frail Older Persons</a>, Adriana Caldo-Silva, et al.
            </li>
        </ol>
    </section>
    <section id="food">
        <h3>
            Food
        </h3>

        <p>
            Certain compounds found in food and supplements help protect against neurodegeneration, with some supporting exercise performance and others improving sleep. Some are synergistic, and some require dietary fats, like eggs or coconut oil, for absorption. This section explores dietary choices, treating food as medicine for PD.
        </p>
        
        <h3>
             Dietary Strategies for Parkinson's Disease
        </h3>
        <p>
            A diet for PD should prioritize gut health, blood sugar control, and the inclusion of bioactives that aid disease management.
        </p>
        <p>
            To manage blood glucose, eliminate all refined sugars, reduce starch intake, and include protein (whey protein post-workout; glycine at night). Fats rich in <abbr title="medium chain triglycerides">MCTs</abbr>, like coconut oil, provide an efficient energy source for the brain and improve the absorption of fat-soluble compounds such as turmeric.
        </p>
        
        <h4>When Protein Increases Glutathione</h4>
        <p>
            
        </p>
        <p>
        
        </p>
        <h4>Eliminating Sugar</h4>
        <p>
            Gut health can be improved by diet. Eliminating refined sugars, especially fructose and sucrose, is an important first step to improving gut health and blood glucose. Dietary sugar alters gut microbiota, leading to endotoxemia (leaky gut), low-grade systemic inflammation, metabolic dysregulation, with many downstream health effects. <cite class="reflink"><a href="#satokari">R. Satokari</a></cite>
        </p>
        
        <h4>Probiotics, Fiber, and Polyphenols</h4>
        <p>
             Fermented foods like yogurt and kimchi, prebiotic fibers like inulin and glucomannan, and polyphenols in foods all promote the production of beneficial short-chain fatty acids and postbiotics, which improve gut health and help regulate appetite.
        </p>
        
        <p>
             Polyphenols, fermentation byproducts, bioactive peptides, and organic acids enhance gut health and short-chain fatty acid (<abbr title="short-chain fatty acid">SCFA</abbr>) production through various mechanisms. These mechanisms include promoting prebiotic activity, supporting beneficial bacteria growth, and beneficial fermentation byproducts and organic acids. This synergistic effect supports a balanced gut microbiome, improves digestive health, and enhances overall well-being. <cite class="reflink"><a href="#x-wang">X. Wang</a></cite>
        </p>
        
        <h4>Polyphenols and SCFAs</h4>
        <p>
            <abbr title="short-chain fatty acid">SCFA</abbr>s are fatty acids with fewer than six carbons, produced by fermenting indigestible fibers in the gut. Polyphenols, like <abbr title="Epigallocatechin gallate">EGCG</abbr> from green tea, increase SCFA production. This reduces gut inflammation and strengthens the colon barrier, which can help prevent enteritis. <cite class="reflink"><a href="#z-wu">Z. Wu</a></cite>
        </p>
        
        <p>
            SCFAs maintain the gut lining and nourish beneficial bacteria. Dietary fiber, fermented by gut bacteria, is the primary source of SCFAs. These fatty acids help regulate appetite, reduce cravings for sugary foods, and improve blood glucose and insulin sensitivity. Lower inflammation further enhances metabolic health. <cite class="reflink"><a href="#xiong">R. Xiong</a>, <a href="#c-de-luca">C. de Luca</a></cite>
        </p>
        
        <h4>Food and the Gut-Brain Axis in Parkinson's Disease</h4>
                
        <p>
            Restoring balance to the gut microbiome through probiotics and prebiotics can improve gastrointestinal function. In PD, gut issues are common, and addressing them may slow neurodegeneration.
        </p>
        <p>
            Recent research has explored the use of probiotics in PD, including constipation, endothelial health, and the gut-brain axis. A 2022 study titled <q>Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling</q> found that gut microbiota help maintain adequate concentrations of dopamine via bidirectional communication along the gut-brain axis. <cite class="reflink"><a href="#s-romano">S. Romano</a>, <a href="#a-h-tan">A.H. Tan</a>, <a href="#hamamah">Hamamah</a></cite>
        </p>

        <h4>Insulin Resistance (IR) in PD</h4>
        <p>
            According to a 2018 study, nearly 60% of non-diabetic PD patients may have undiagnosed insulin resistance, despite having normal blood sugar levels. And although higher body mass index (BMI) was associated with increased IR, even lean PD patients showed a higher percentage (41%) of IR compared to healthy adults without PD.
        </p>
        
        <p>
            Studies have consistently shown that individuals with PD exhibit alterations in their gut microbiome, characterized by reduced diversity and altered composition compared to healthy individuals. This dysbiosis may contribute to the development and progression of PD symptoms.
        </p>
        
        <h4>Meal Ideas for Brain Health</h4>
        <p>
            These meals use ingredients known for neuroprotective, anti-inflammatory, ECM, and brain health benefits. 
        </p>
        
        <h5>Meal 1: Eggs with Mushrooms</h5>
        <h6>Nutrition Facts</h6>
        <ul>
            <li>Calories: ~321-756 kcal</li>
            <li>Protein: ~18-38 g</li>
            <li>Carbohydrates: ~7-10 g</li>
            <li>Fat: ~24-81 g
                <ul>
                    <li>Min (with Wiley's 1 tsp): 24 g</li>
                    <li>Max (with Nordic Naturals 2 tbsp): 74 g</li>
                </ul>
            </li>
            <li>Carbohydrates: ~9-13g</li>
        </ul>
        
        <h6>Cooking Instructions</h6>
        <p>
            SautÃ©e 4-6 oz organic mushrooms (3-10 shiitake, wood ear, button mushrooms) for 10 minutes with one pre-soaked long pepper (piper longum) in 2 tsp coconut oil. Add 2-5 free-range eggs with 1-2 cloves organic garlic and cook lightly on medium heat for a short duration for runny yolks, to minimize fat oxidation. Remove from heat. Add 1.5g of turmeric, 2 tbsp dried organic parsley 2 oz fresh organic broccoli sprouts, 10 threads of saffron, and 2g of powdered natto. Drizzle enough high-DHA fish oil to provide 2,000 - 5,000 mg of DHA.
        </p>

        <p>
            For the DHA, 1 tsp of <q>Wiley's Finest Wild Alaskan Fish Oil Summit DHA Liquid - 2140mg of DHA</q> (providing ~2,140 mg DHA), or 2 tbsp of <q>Nordic Naturals Children's DHA</q> (providing approximately 2,040 mg DHA per tablespoon).
        </p>

        <h6>Egg Scramble with Mushrooms Benefits</h6>
        <p>
            This meal supports brain health through anti-inflammatory effects from every ingredient. Natto and free-range eggs support mitochondrial function. The eggs and mushrooms provide a source of protein. The fats help absorb fat-soluble compounds in turmeric, saffron, and supplements. Broccoli sprouts provide sulforaphane. Natto provides probiotic Bacillus subtilis for gut health. Alfalfa contains many bioactives, including kaempferol, quercetin, and other anti-inflammatory compounds. DHA in the fish oil supports membrane fluidity, brain structure, neurotransmission, synaptic plasticity, decreased neuroinflammation, mood, and cognitive function. The parsley provides 5-10mg of apigenin (an insufficient amount alone), a senolytic.
        </p>

        <p>
            The caloric and fat ranges are broad due to the flexibility in ingredient choices of eggs and oil type.
        </p>

        <h4>References</h4>
        <ol class="reference-list">
        
            <li id="satokari">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284805/"
                    title="High Intake of Sugar and the Balance between Pro- and Anti-Inflammatory Gut Bacteria"
                    target="_blank"
                    >High Intake of Sugar and the Balance between Pro- and Anti-Inflammatory Gut Bacteria</a>, Reetta Satokari.
            </li>
            <li id="x-wang">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220293/"
                title="Dietary Polyphenol, Gut Microbiota, and Health Benefits"
                target="_blank"
                >Dietary Polyphenol, Gut Microbiota, and Health Benefits</a>, Xiaofei Wang, et al.
            </li>
            <li id="z-wu">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424887/"
                title="Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis"
                target="_blank"
                >Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis</a>, Zhenhua Wu, et al.
            </li>
            
            <li id="xiong">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498509/"
                title="Health Benefits and Side Effects of Short-Chain Fatty Acids"
                target="_blank"
                >Health Benefits and Side Effects of Short-Chain Fatty Acids</a>, Ruo-Gu Xiong, et al.
            </li>
            <li id="c-de-luca">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246086/"
                title="Inflammation and Insulin Resistance"
                target="_blank"
                >Inflammation and Insulin Resistance</a>, Carl de Luca and Jerrold M. Olefsky.
            </li>
            
            <li id="s-romano">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946946/"
                title="Meta-analysis of the Parkinsonâ€™s disease gut microbiome suggests alterations linked to intestinal inflammation"
                target="_blank"
                >Meta-analysis of the Parkinsonâ€™s disease gut microbiome suggests alterations linked to intestinal inflammation</a>, Stefano Romano, et al.
            </li>
            <li id="a-h-tan">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035463/"
                title="Probiotics for Parkinson's disease: Current evidence and future directions"
                target="_blank"
                >Probiotics for Parkinson's disease: Current evidence and future directions</a>, Ai Huey Tan, et al.
            </li>
            <li id="hamamah">
                <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8962300/"
                title="Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling"
                target="_blank"
                >Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling</a>, Sevag Hamamah, et al.
            </li>
        </ol>
    </section>
    <section id="treatment-approaches">
        <h2>Treatment Approaches</h2>
        <section id="treatment-approaches-overview">
            <h3>Overview</h3>
            <!-- p>
                This section lists treatments for which strategies can be developed by one's care team.
            </p -->
        
            <!-- p>
                The approach recommended herein is not the tired "listen to your doctor," but to get informed and build a team of healthcare professionals with multiple specialties with whom to collaborate on an individualized treatment plan. 
            </p -->
        
            <p>
                Treatment strategies can be grouped into <dfn>symptomatic</dfn>, <dfn>disease progression</dfn>, <dfn>etiological</dfn>, and <dfn>holistic</dfn> categories, with some overlap.
            </p>
            <dl>
                <dt>Symptomatic Approach
                <dd>addresses symptoms rather than slowing or stopping their progression
                
                <dt>Disease-Progression Approach
                <dd>manages progression of the disease once it has already developed
                
                <dt>Etiological Approach
                <dd>targets the underlying causes of disease with thorough investigation and research
                <dt>Holistic Approach
                <dd>patient-centered care that targets underlying causes and addresses them more comprehensively
                </dl>
        </section>
        <section id="symptomatic-approach">
            <h3>Symptomatic Approach</h3>
            <h5>Gold Standard: Dopamine Agonism</h5>
            <p class="call-out">
                The gold standard for managing PD is symptomatic management via dopamine agonism (<abbr title="Levodopa / Dopa-decarboxylase inhibitors">LD/DDC inhibitors</abbr>, MAO-B inhibitors, and <abbr title="catechol-O-methyltransferase">COMT</abbr> inhibitors). Unfortunately, that leads to other neurological imbalances, causes other nutrient deficiencies, and leads to <abbr title="progressive neurodegeneration">PN</abbr>.
            </p>
            <p>
                Maintaining dopamine levels in the brain helps alleviate motor problems and can reduce fibrillization. However, unilateral dopamine replacement therapy creates some problems. This is because DRT does not address the root cause and in fact contributes to dyskinesias, as discussed further herein.
            </p>
                        
            <p>
                Some doctors may attempt to enhance dopamine function by suppressing the cholinergic system using anticholinergics, but this approach leads to adverse effects.
            </p>
            
        </section>
        
        <section id="disease-progression-approach">
            <h4>Disease-Progression Approach</h4>
            <p>
                Doctors tend to discount the idea of slowing the progression of the disease. Some off-handedly discount supplements and nutrition as "complementary" care without examination. Many of these same doctors once prescribed anticholinergics. (If the doctor falls into that category, finding a new doctor may be advisable.)
            </p>
        </section>
        <section id="etiological-approach">
         <h3>Etiological Approach</h3>
         
        <p>
            Etiological treatments target the underlying causes of disease. These providers address the root causes with scientific rigor however, some may rely on conventional medicine and focus on the disease itself, rather than individual factors and health optimization.
        </p> 
        </section>
        
        <section id="holistic-approach">
            <h3>Holistic Approach</h3>
            <p>
                The holistic approach is patient-centered care that aims to address the underlying causes of disease and promote overall health. However, some holistic providers use implausible or disproven strategies (e.g. homeopathy, reiki, "mind, body, spirit", etc). 
            </p>
        </section>
    <!-- TODO: Move where??
            <h4>The Role of Nutrition</h4>
            <p>
                Nutritional deficiencies can exacerbate symptoms in individuals with PD and may sometimes be mistaken for progressive neurodegeneration. This misinterpretation can lead to inappropriate management strategies if the underlying nutritional issues are not addressed.
            </p>
            <p>
                Furthermore, certain nutrient deficiencies can trigger cascading effects, exacerbating PD symptoms or hasten the decline of the condition. For example, deficiencies in vitamins B12, folate, and vitamin D have been implicated in PD and can affect neurological function and overall health. Inadequate intake of essential nutrients can also impair mitochondrial function, increase oxidative stress, and compromise neurotransmitter synthesis and signaling, all of which are implicated in PD pathophysiology.
            </p>
            <p>
                Additionally, levodopa/carbidopa therapy can reduce vitamin B6 levels, which is essential for the synthesis of neurotransmitters.
            </p>
            <p>
                It's crucial to build a comprehensive plan that strikes a balance between supplementation, nutrition, lifestyle, and regular monitoring to slow disease progression.
            </p>
            <p>
                Don't just "talk to your doctor", collaborate with a team of healthcare professionals with multiple specialties to create individualized treatment plans that include nutrition, lifestyle, supplementation, and medication. Regularly test and monitor status with symptoms and biochemical markers to assess the effectiveness of interventions and make adjustments as needed.
            </p>
            <p>
                <dfn>Antifibrillogenics</dfn> mitigate formation of Î±-synuclein fibrils. Anti-aggregants aim to prevent the accumulation of fibrils and other misfolded proteins into lewy bodies. By preventing the formation of Î±-synuclein fibrils and aggregates, these compounds address the underlying pathology of Parkinson's disease at a more fundamental level, potentially offering therapeutic benefits in managing the condition.
            </p>
            <p>
                Preventing fibril aggregation (<dfn>anti-aggregant</dfn>): These treatments focus on inhibiting the aggregation of Î±-synuclein fibrils into Lewy bodies, potentially slowing the spread of pathology and neurodegeneration.
            </p>
            <p>
                It is necessary to work with doctors who focus on what works. Focus on the facts and evidence, consider risk/reward, and work on total health. Avoid doctors who won't look at the evidence you present them.
            </p>
            
            <h4>What Do Doctors Miss?</h4>
            <p>
                Doctors typically prioritize symptoms over addressing the underlying causes. Specifically, they tend to focus on the dopamine pathway with medications like levodopa/carbidopa, to enhance dopamine levels in the brain, and COMT inhibitors, to inhibit its breakdown by catechol-O-methyltransferase (COMT).
            </p>
            <p>
                Approaches to mitigating the underlying cause can extend longevity, improve quality of life, and reduce the dependence on medication which is not without side effects. Address these key areas for a more comprehensive approach to managing PD. (For solutions, see: <a href="#problem-list">Problem List</a>)
            </p>
            <ul>
                <li class="senolytic">Senescence: Senolytics</li>
                <li class="mitochondrial">Mitochondrial health: Mitophagy and mitogenesis</li>
                <li class="neuroprotective">Neuroprotective measures</li>
                <li class="neuroinflammation">Anti-inflammatory: Reducing neuroinflammation</li>
                <li class="cytotoxicity">Reducing cytotoxicity</li>
                <li class="multiple-pathways">Addressing Dopaminergic, serotonergic, and GABAergic systems</li>
                <li class="fibrils">Preventing fibril formation and aggregation</li>
                <li class="sleep">Sleep management</li>
                <li class="total-health">
                    Overall health promotion
                </li>
            </ul>

            <p>
                Many approaches overlap more than one problem area and have synergistic benefits. For example, 5-HTP is converted into serotonin in the brain. It inhibits the release of glutamate, mitigates oxidation modulates dopamine
                release, improves mitochondrial function, and improves sleep, which improves overall health, leading to a better sense of well-being and better exercise capacity and recovery.
            </p>
            -->
    </section>
    
    <section id="treatments">
        <h2>Detailed Treatments</h2>
        <section id="medications">
            <h3>Medications</h3>
            
            <h4>Standard of Care Medications</h4>
            <p class="call-out">
                Conventional medicine treats PD with symptomatic management. This includes dopamine replacement therapy (DRT) using Levodopa/Carbidopa  (dopamine precursors), <abbr title="catechol-O-methyltransferase">COMT</abbr> inhibitors and <abbr title="monoamine oxidase B">MAO-B</abbr> inhibitors that prevent dopamine breakdown, and anticholinergics.
            </p>
            
            <h4>Criticism of Standard of Care</h4>
            
            <p>
                Standard pharmacological treatments offer short-term relief of motor symptoms but exacerbate neurotransmitter imbalances, leading to permanent damage. Weâ€™ll explore why these limitations persist in healthcare and how to address the underlying problems more comprehensively.
            </p>
                        
            <h4>Shortcomings of Standard Pharmacological Treatments</h4>
            <p>
                <abbr title="dopamine replacement therapy">DRT</abbr>, the gold standard, offers short-term relief of motor symptoms but overlooks multiple problems and underlying etiological pathways.
            </p>
            <p>
                Non-motor symptoms, including cognitive decline, sleep disturbances, and autonomic dysfunction, indicate deeper systemic dysfunction that requires careful attention. Ignoring these symptoms accelerates disease progression, making neurodegeneration a self-fulfilling outcome of DRT-focused treatment.
            </p>
            <p>
                Mitochondrial dysfunctionâ€”a major pathology of disease progressionâ€”along with neuroinflammation, cellular senescence, Î±-synuclein pathology, and failure of the brain's waste management systems are all ignored by standard treatments.
            </p>
            <p>
                Aside from temporarily addressing decreased dopamine levels, standard treatments largely overlook these mechanistic issues. Worse, DRT's interaction with Î±-synuclein contributes to cellular damage and the development of <abbr title="L-Dopa-induced dyskinesias">LIDs</abbr>, further complicating the patient's condition.
            </p>
            
            <h4>Educational and Industry Bias</h4>
            <p>
                Medical school bias towards conventional treatments persists with pharmaceutical influence over leadership, faculty, curricula, and culture <cite class="reflink"><a href="#anderson">Anderson</a></cite>. Students, unaware of this bias, adopt industry-supported ideologies while rejecting other approaches, forming the basis for provider bias.
            </p>
            
            <p>
                According to <a href="https://www.biopharmadive.com/news/who-are-the-22-pharma-board-members-who-also-lead-healthcare-nonprofits/543144/" target="_blank">BioPharma Dive</a>, twelve of the 19 largest pharmaceutical and biotech companies in the world had at least one director simultaneously serving in a leadership position at a nonprofit healthcare organization. Researchers who point out such conflicts of interest on corporate boards risk job security and alienation by colleagues.
            </p>
            
            <h4>Peer Pressure and Not Invented Here (NIH) Syndrome</h4>
            <p>
                Peer pressure in the healthcare community influences medical decision-making. Cultural and professional norms, pharmaceutical influence, and perceived lack of evidence lead to conformity over critical evaluation. Healthcare providers are embedded in a culture that emphasizes adherence to established protocols and guidelines influenced by institutional norms and the broader medical community. This creates a reluctance to deviate from conventional practices, even when proven ineffective or harmful, or when alternative approaches are supported by emerging evidence.
            </p>
            
            <p>
                Government policies and regulations shape medical practice, creating conflicts of interest that favor pharmaceutical interests over patient needs. For example, the FDAâ€™s accelerated approval of Aduhelm in 2021, despite mixed trial results, was influenced by Biogen's lobbying.
            </p>
            <p>
                For example, <a href="https://www.nice.org.uk/guidance/ng71/chapter/Recommendations#pharmacological-management-of-motor-symptoms" target="_blank">NICE guidelines</a> discourage the use of all over-the-counter supplements, specifically mentioning <a href="#ubiquinol">CoQ10</a>, <a href="#creatine">Creatine</a>, and <a href="#tocotrienols">Vitamin E</a>â€”which have neuroprotective effects. Simultaneously, they recommend anticholinergics, despite their well-documented negative impact on cognitive function and neuronal integrity <cite class="reflink"><a href="#campbell">Campbell</a>, <a href="#yasumasa">Yasumasa</a></cite>. This shows institutional preference for pharmaceutical solutions over patient-centered care, pushing symptom management through reliance on drugs and missing opportunities for neuroprotection through non-pharmaceutical means.
            </p>

            <p>
                Although DRT is the standard of care used to manage motor symptoms, its over-reliance leads to permanent damage and complications such as motor fluctuations and dyskinesias, which will be discussed further below. These examples show the limitations of standard treatment approaches and the need for strategies that address underlying pathologies, minimize harmful effects, and optimize health. 
            </p>
            
            <h4>Genetic Testing</h4>
            <p>
                Moreover, identifying PD gene mutations, especially in early-onset cases, can provide valuable information for prognosis and can influence treatment decisions, particularly in cases initially suspected to be psychogenic. Despite this, genetic testing is not part of the standard of care. 
            </p>

            <h4>There is Hope!</h4>
            <p>
                There is hope! Understanding the problems is necessary for informed action to address the underlying etiological pathways. The right knowledge and strategy is the key toÂ regaining control over personal health. This guide addresses the etiological pathways overlooked by healthcare with scientific evidence, providing specific approaches to address them.
            </p>
            <p>
                First, we'll cover DRT and its limits. Next, we'll dive deeper into the multisystem dysfunction of PD, including GABA, serotonin, and cholinergic imbalance. Finally, we'll discuss broader therapeutic approaches (holistic strategies that address neurotransmitter imbalance, mitochondrial health, neuroprotection, etc.)
            <section id="dopamine-agonists">
                <section id="drt-introduction">
                    <h3>Dopamine Replacement Therapy (DRT)</h3>
                    <h4>Introduction to DRT</h4>
                    <p>
                        DRT includes levodopa with a decarboxylase inhibitor (LD/DDC inhibitor) to increase dopamine levels in the brain, alleviate motor symptoms, and improve quality of life. This is the gold standard for PD; however, it misses the broader problem of neurotransmitter dysfunction, which ultimately causes more problems. 
                    </p>
                    
                    <p>
                        This is because PD involves the failure of <em>multiple</em> neurotransmitter systems, including GABA, serotonin, and acetylcholineâ€”not just dopamine. Addressing just the dopaminergic system while neglecting these other systems leads to neurotransmitter imbalance and worsening symptoms over time. 
                    </p>
                </section>
                <section id="produodopa">
                    <h4>Produodopa â€” Improved DRT</h4>
                    <p>
                        Foslevodopa-foscarbidopa (Produodopa) provides continuous 24-hour DRT infusion via a portable pump for more stable dopamine levels and reduced side effects. This approach decreases cellular stress and dysfunction associated with traditional DRT methods. Ask your doctor about this DRT option. <cite class="reflink"><a href="#rosebraugh">Rosebraugh</a></cite>
                    </p>
                </section>
                
                <section id="impact-dopamine-agonists">
                    <h4>Impact of DRT</h4>
                    <p>
                        DRT, while incomplete on its own, does improve PD symptoms and can provide some other benefits initially. We'll cover some of its benefits before examining its shortcomings.
                    </p>
                        
                    <h5>Fibrillization Inhibition</h5>
                    <p>
                        Dopamine initially reacts with Î±-synuclein to inhibit its fibrillization. This is good, as fibrils contribute to Lewy bodies, cellular damage, senescent cells, and neurodegeneration. <cite class="reflink"><a href="#dorszewska">Dorszewska</a></cite>
                    </p>
                    
                    <p>
                        Although DRT initially improves motor symptoms, focusing solely on dopamine replacement overlooks broader PD complexities, leading to more problems.
                    </p>
                    
                    <h5>DRT Problems â€”Â Is a Multisystem Approach Better?</h5>
                    <p>
                        PD affects multiple neurotransmitter systems, not just the dopaminergic system. Disruptions in the GABAergic, serotonergic, and cholinergic pathways contribute to non-motor symptoms such as depression, anxiety, and cognitive decline. Failing to address these systems leads to imbalanced treatment outcomes.
                    </p>
                                        
                    <h5>DRT-induced Dyskinesias</h5>
                    <p>
                        Although DRT raises dopamine levels and alleviates symptoms, it fails to restore GABAergic inhibition within motor circuits. Without proper GABAergic control, excitatory signals persist, leading to motor pathway hyperactivation and dyskinesias.
                    </p>

                    <p>
                        Cholinergic overactivity worsens rigidity and postural instability in PD, while the loss of GABAergic inhibition exacerbates this imbalance. Treatments targeting both the GABA and acetylcholine pathways are necessary to restore neurotransmission balance.
                    </p>
                    
                    <h5>DRT-induced Gut Dysbiosis</h5>
                    <p>
                        DRT can contribute to gut dysbiosis by altering the gut microbiota's composition and function. In turn, gut dysbiosis can affect dopamine synthesis and breakdown and, worse, exacerbate Î±-synuclein misfolding, accelerating PD progression <cite class="reflink"><a href="#keshavarzian">Keshavarzian</a></cite>. This is yet another reason to minimize and avoid DRT overreliance over a more comprehensive program that includes gut health. 
                    </p>
                    
                    <h5>Solutions</h5>
                    <p>
                        Addressing multisystem neurotransmitter dysfunction requires a comprehensive approach. Solutions to the GABAergic, cholinergic, and seratonergic systems failures, along with other etiological pathways will follow the discussion of those problems. 
                    </p>
                    
                    <p>
                        Dietary solutions for gut dysbiosis are discussed under the section titled <a href="#food">food</a>. 
                    </p>
                    
                    <h5>Delaying DRT vs Holistic Neurotransmitter Balance</h5>
                    <p>
                        Some patients delay DRT to avoid early dyskinesias. However, early intervention targeting GABAergic dysfunction can help manage both motor and non-motor symptoms, providing better symptom control in early-stage PD and greater longevity.
                    </p>
                </section>
                
                <section id="neurochemical-imbalances">
                    <h4>Neurochemical and Vitamin Imbalances</h4>                   
                    <p>
                        The overreliance on DRT to increase dopamine levels without addressing GABAergic dysfunction can result in dyskinesias. Without proper GABAergic inhibition, excitatory signals persist in motor circuits, leading to involuntary movements. For a more detailed discussion of neurotransmitter imbalance and its broader impact, see <a href="#multiple-neurotransmitter-systems-damage">Multiple Neurotransmitter Systems Damage</a>.
                    </p>

                    <p>
                        Dopamine agonists also deplete active vitamin B6 levels in the body. They do this by irreversibly binding to and permanently deactivating pyridoxal 5â€™-phosphate (P5P), the active form of vitamin B6. This leads to various side effects and exacerbates the progression of the disease, as B6 is essential for dopamine synthesis and is involved in other metabolic pathways.
                    </p>
    
                    <h5>Progressive Neurodegeneration</h5>
                    <p>
                        Dopamine is but one of many neurochemical systems in the midbrain. Focusing solely on the dopaminergic system without considering other neurotransmitter systems leads to progressive neurodegeneration (PN) exacerbating motor and non-motor symptoms.
                    </p>
                    
                    <h5 class="diagram-header">DRT Neurodegeneration Cycle Diagram</h5>
                    <div id="drt-diagram" class="flow-diagram diagram">
                        <div class="concept">
                            <h6>Dopamine Agonists</h6>
                            <p>Dopamine agonists initially inhibit fibrillization by interacting with Î±-synuclein.</p>
                            <div class="arrow"></div>
                        </div>
                    
                        <div class="concept">
                            <h6>Fibrillization Inhibition</h6>
                            <p> Reduces the formation of Lewy bodies. 
                            </p>
                            <div class="arrow"></div>
                        </div>
                    
                        <div class="concept">
                            <h6>Problems</h6>
                            <p>Dopamine interacts with Î±-synuclein forming toxic non-fibrillar oligomers, cell damage, and neurodegeneration. <cite class="reflink"><a href="he-jin-lee">Lee</a>, <a href="#mor2">Mor<sub>2</sub></a></cite></p>
                            <div class="arrow"></div>
                        </div>
                    
                        <div class="concept">
                            <h6>Harmful Cycle</h6>
                            <p>The cycle continues with increased dopamine use leading back to cell damage and neurodegeneration.</p>
                        </div>
                    </div>
    
                    <h4>Senescence and Cellular Dysfunction from SATB1 Inhibition</h4>
                    <p>
                        DRT fails to address cellular senescence and mitochondrial dysfunction, and it may contribute to the inhibition of SATB1, a transcription factor that prevents cellular dysfunction.
                    </p>
                    <p>
                        SATB1 represses <dfn title="cyclin-dependent kinase inhibitor 1">p21</dfn>, a protein that promotes the survival of senescent cells, even with persistent DNA damage, contributing to senescence. <cite class="reflink"><a href="#markus-riessland">Riessland</a></cite>
                    </p>

                    <p>
                        In PD, <abbr title="Special AT-rich sequence-binding protein 1">SATB1</abbr> inhibition increases levels of p21, reduces <abbr title="cyclin-dependent kinases">CDKs</abbr> activity, and leads to the accumulation of senescent cells, driving <abbr title="progressive neurodegeneration">PN</abbr>. DRT exacerbates the cellular conditions that contribute to SATB1 inhibition. <cite class="reflink"><a href="#markus-riessland">Riessland</a></cite>
                    </p>               
                     
                    <h5 class="diagram-header">SATB1 Pathway Diagram</h5>
                    
                    <div id="satb-diagram" class="diagram">
                        <div class="step">SATB1 Inhibition
                            <div class="arrow"></div>
                        </div>
                        <div class="step"><b class="updown-arrow">&uarr;</b> p21
                            <div class="arrow"></div>
                        </div>
                        <div class="step"><b class="updown-arrow">&darr;</b> <abbr title="cyclin-dependent kinases">CDKs</abbr>
                            <div class="arrow"></div>
                        </div>
                        <div class="step"><b class="updown-arrow">&uarr;</b> Senescent Cells
                            <div class="arrow"></div>
                        </div>
                        
                        <div class="step">SATB1 Inhibition</div>
                    </div>
                    <p>
                        Senescent cells cease to function and divide, damaging healthy neighboring cells by secreting inflammatory factors and contributing to further tissue dysfunction and senescence.
                    </p>
        
                    <h5>Interruption of Progressive Neurodegeneration (PN)</h5>
                    <p>
                        <abbr title="progressive neurodegeneration">PN</abbr> may be slowed or mitigated using senolytics, mitochondrial support, antioxidants, and other neuroprotective approaches discussed throughout this document.
                    </p>
                    
                    <h5>Mitochondrial Dysfunction</h5>
                    <p>
                        Mitochondrial dysfunction is a major factor of disease progression, making it a critical target for intervention. Solutions to mitochondrial dysfunction are addressed with respective proportion herein. 
                    </p>
                </section>
                
                <section id="drt-solutions">
                    <h3>Solutions</h3>
                    <p>
                         For <strong>GABA dysfunction</strong>,  <strong>GABA</strong> and <strong>theanine supplements</strong> strengthen inhibitory signaling and support the brainâ€™s waste management systems, including the <strong>BBB</strong> and <strong>CSF circulation</strong>. DHEA and, for women, <strong>Estrogen replacement therapy (ERT)</strong> increases GABA receptor density, and high-dose <strong>vitamin K2</strong> can help reduce calcium levels, protecting against calcium-induced neurodegeneration. 
                    </p>
                    <p>
                        The serotonergic system can be supported by 5-HTP, which helps alleviate mood disturbances and fatigue, and improves sleepâ€”common non-motor symptoms in PD.
                    </p>
                    
                    <p>
                        <strong>Cholinergics</strong> like <strong>CDP Choline</strong> or <strong>Alpha-GPC</strong> help the cholinergic system, as well as phospholipid synthesis for membrane repair. They should be part of an integrated approach rather than viewed as alternative or adjunctive therapies to DRT.
                    </p>
                    
                    <p>
                        Solutions for issues with the brain's waste management systems are discussed in detail in the relevant section.
                    </p>
                    <p>
                        Mitochondrial dysfunction is addressed in its own section. Neuroinflammation, cellular senescence, Î±-synuclein pathology (fibrillization, aggregation, and Lewy bodies) are discussed throughout the document.
                    </p>
                    <p>
                        <a href="#senolytics">Senolytics</a> are substances that induce apoptosis (programmed cell death) in senescent cells, removing them and preventing their harmful effects on surrounding tissues.
                    </p>
                </section>
                <section id="drt-summary">
                    <h5>DRT Summary</h5>
                    <p>
                       Although DRT can significantly improve PD symptoms by raising dopamine levels, overreliance on it without addressing other affected neurotransmitter systems and other etiological factors leads to imbalances and complications, and worsening non-motor symptoms. DRT is powerful but incomplete when used in isolation.
                    </p>
                    <p>
                        Instead, a comprehensive treatment strategy addressing these systems in conjunction with a more conservative DRT approach can offer better symptom control, particularly in early-stage PD, leading to improved long-term outcomes and longevity. <cite class="reflink"><a href="#mor">Mor</a>, <a href="#thompson">Thompson</a></cite>
                    </p>
                    
                    <p>
                        DRT should be used at the minimum effective dose (MED). This can be done using a holistic approach to address neuroprotection, neurorestoration, antioxidation, and mitochondrial health. Consider Produodopa for even, continuous dopamine levels with reduced side effects. Also, explore strategies to address multiple neurotransmitter systems and minimize DRT with your care team.
                    </p>
                </section>
                
                <h5>References</h5>
                <ol class="reference-list">
                    <li id="anderson">
                        <a href="https://jamanetwork.com/journals/jama/fullarticle/1853147"
                        title="Academic Medical Center Leadership on Pharmaceutical Company Boards of Directors"
                        target="_blank"
                        >Academic Medical Center Leadership on Pharmaceutical Company Boards of Directors</a>, Timothy S. Anderson, et al.
                    </li>
                    <li id="campbell">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697587/"
                            title="The cognitive impact of anticholinergics: A clinical review"
                            target="_blank"
                            >The cognitive impact of anticholinergics: A clinical review</a>, Noll Campbell, et al.
                    </li>
                    <li id="yasumasa">
                        <a href="https://www.sciencedirect.com/science/article/pii/S096999611100283X"
                        title="Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model"
                        target="_blank"
                        >Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model</a>, Yasumasa Yoshiyama, et al.
                    </li>
                    <li id="rosebraugh">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609688/"
                        title="Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion"
                        target="_blank"
                        >Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion</a>, Matthew Rosebraugh, et al.
                    </li>
                    <li id="dorszewska">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958954/"
                        title="Molecular Effects of L-dopa Therapy in Parkinsonâ€™s Disease"
                        target="_blank"
                        >Molecular Effects of L-dopa Therapy in Parkinsonâ€™s Disease</a>, Jolanta Dorszewska, et al.
                    </li>
                    <li id="keshavarzian">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32247371/"
                        title="The gut microbiome in Parkinson's disease: A culprit or a bystander?"
                        target="_blank"
                        >The gut microbiome in Parkinson's disease: A culprit or a bystander?</a>, Ali Keshavarzian, et al.
                    </li>
                    <li id="mor">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379109/"
                        title="The usual suspects, dopamine and alpha synuclein, conspire to cause neurodegeneration"
                        target="_blank"
                        >The usual suspects, dopamine and alpha synuclein, conspire to cause neurodegeneration</a>, Danielle E. Mor, et al.

                    </li>
                    
                    <li id="thompson">
                        <a href="https://www.stressmarq.com/alpha-synuclein-oligomers-dopamine-stabilization-and-neurodegeneration/"
                        title="Alpha Synuclein Oligomers: Dopamine Stabilization and Neurodegeneration"
                        target="_blank"
                        >Alpha Synuclein Oligomers: Dopamine Stabilization and Neurodegeneration</a>, Patricia Thompson.
                        <p>
                        
                        </p>
                    </li>
                    <li id="mor2">
                        <a href="https://www.nature.com/articles/nn.4641"
                        title="Dopamine induces soluble Î±-synuclein oligomers and nigrostriatal degeneration"
                        target="_blank"
                        >Dopamine induces soluble Î±-synuclein oligomers and nigrostriatal degeneration</a>, Danielle E Mor, et al.
                    </li>
                    
                    <li id="he-jin-lee">
                        <a href="https://www.nature.com/articles/emm201126"
                        title="Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
"
                        target="_blank"
                        >Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
</a>, He-Jin Lee, et al.
                    </li>
                    
                    <li id="markus-riessland"> 
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30858560/"
                        title="Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons"
                        target="_blank"
                        >Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons</a>, Markus Riessland, et al.
                        <p>
                            <strong>Highlights:</strong> Moreover, we found that SATB1 directly represses the expression of the pro-senescence factor p21 in dopaminergic neurons. Our data implicate senescence of dopamine neurons as a contributing factor in the pathology of Parkinson's disease.
                        </p>
                    </li>
                </ol>
            </section>
            <section id="comt-inhibitors">   
                <h4>COMT Inhibitors</h4>
                
                <p>
                    Extend the action of levodopa by inhibiting the enzyme catechol-O-methyltransferase (COMT), which breaks down catecholamines, including dopamine, norepinephrine, and epinephrine. This results in sustained levels of these catecholamines.
                </p>
                <p>
                    Tolcapone, a <abbr title="catechol-O-methyltransferase">COMT</abbr> inhibitor, has been associated with a higher risk of liver damage, which can be severe in some cases.
                </p>
                <p>
                    Entacapone, another <abbr title="catechol-O-methyltransferase">COMT</abbr> inhibitor, has been linked to an increased risk of dyskinesias and other dopaminergic side effects.
                </p>
            </section>
            <section id="mao-b-inhibitors">
                 <h4>MAO-B Inhibitors</h4>
                 <p>
                    Increase dopamine levels by blocking the enzyme monoamine oxidase B. Problems with MAO-B Inhibitors, such as side effects, dietary restrictions, and potential interactions with other medications, have contributed to a decline in their use.
                 </p>
            </section>

            <section id="amantadine">
                <h3>Amantadine</h3>
                <p>
                     Amantadine may help reduce dyskinesias and offer modest symptomatic relief with anticholinergic and serotonergic effects <cite class="reflink"><a href="#rascol">Rascol</a></cite>.  However, Amantadine reduces GABA levels in the brain, which is implicated in the pathogenesis of PD <cite class="reflink"><a href="#walia">Walia</a></cite>.
                </p>
                <ol class="reference-list">
                    <li id="rascol">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34678171/"
                        title="Amantadine in the treatment of Parkinson's disease and other movement disorders"
                        target="_blank"
                        >Amantadine in the treatment of Parkinson's disease and other movement disorders</a>, Olivier Rascol, et al.
                    </li>
                    
                    <li id="walia">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31838141/"
                        title="Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways"
                        target="_blank"
                        >Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways</a>, Vaibhav Walia, et al.
                    </li>
                </ol>
            </section>
            
            <section id="synuclean-d-and-minzasolmin">
                <h4>SynuClean-D and Minzasolmin ðŸ§ª</h4>
                <p>
                SynuClean-D and Minzasolmin are in the research phase. There are outlets for research chemicals, and there are ongoing clinical trials.
                <p>
                    https://sciencebeta.com/synuclean-d-parkinsons/
                </p>
                <ol>
                    <li>
                        <h4>SynuClean-D Can Revert Neurodegeneration Caused By Parkinson's</h4>
                        <p>
                            SynuClean-D inhibits &alpha;-synuclein aggregation, disrupts amyloid fibrillization, prevents degeneration of dopaminergic neurons (<a href="https://pubmed.ncbi.nlm.nih.gov/30249646/"><abbr title="Proceedings of the National Academy of Sciences">reference</abbr></a>), and inhibits &alpha;-synuclein aggregation.
                        </p>
                        <p>
                            SynuClean-D is available as a research chemical. It is being studied in a Phase 2 clinical trial of 450 early-stage PD patients with an expected completion date in mid-2024.
                        </p>
                    </li>
                    <li>
                        <h4>Minzasolmin</h4>
                        <p>
                            Minzasolmin is a misfolding inhibitor, whereas SynuClean-D is an aggregation inhibitor. While Minzasolmin is in clinical development for Parkinsonâ€™s disease, SynuClean-D is primarily mentioned as a research compound.
                        </p>
                        <p>
                           Patients with Parkinsonâ€™s disease can apply to participate in clinical trials for Minzasolmin. The clinical trial information is available on ClinicalTrials.gov (ID: NCT04658186; EudraCT Number 2020-003265).
                        </p>
                    </li>
                </ol>
                <h4>Summary</h4>
                <p>
                    Minzasolmin and SynuClean-D both seem promising in inhibiting the misfolding and aggregation of &alpha;-synuclein aggregation respectively. Ask your team about clinical trials or apply to participate directly with those trials' clinicians.
                </p>
            </section>
        </section>
        
        <section id="hormonal-interventions">
            <h3>Hormonal Interventions</h3>
            
            <p>
                Hormone replacement therapy (HRT) may offer neuroprotection to improve mobility and mood, cognitive function, and quality of life in both men and women. Risk of developing PD is twice as high in men but is also elevated in women with early menopause. Estrogen and testosterone are both neuroprotective. <cite class="reflink"><a href="#cerri">Cerri</a></cite> 
            </p>
            
            <h4>Collagen Degradation, BBB Permeability, and Î±-synuclein</h4>
            <p>
                Estrogen directly affects collagen synthesis and integrity, including connective tissues, including the extracellular matrix (ECM). Loss of estrogen accelerates collagen degradation, weakening the <abbr title="extracellular matrix">ECM</abbr> of the BBB and choroid plexus, making the junctions of these barriers more permeable, and allowing harmful substances, including Î±-synuclein, to aggregate, form fibrils, and enter the brain. 
            </p>
            
            <p>
                Disease progression might involve distinct pathogenic mechanisms (or the same mechanism but in a different way) in male and female patients, and HRT for men and women may offer benefits. Alternatively, DHEA can also be used in conjunction with or independently of HRT, which, at least for women, may present a lower risk of cancer compared to steroid hormone therapies.
            </p>
            <p>
                Protocols that promote collagen formation and support the <abbr title="extracellular matrix">ECM</abbr> may help counteract the effects of estrogen loss on the brain waste management system, which includes the BBB, choroid plexus, CSF, glymphatic system, and perivascular spaces. 
            </p>
            <section id="hrt">            
                <h5>Hormone Replacement Therapy (HRT) for Women</h5>
                <p>
                    HRT for women may include estrogens (17 beta-estradiol, estrone, and estriol), progesterone, pregnenolone, and DHEA. <!-- neurologysolutions -->
                </p>
                <h5>Early Menopause: PD and HRT â€”Â Estrogen and Progesterone</h5>
                <p>
                    Early menopause is statistically more common in women with PD. Several studies have associated postmenopausal HRT with a reduced risk of PD. Research indicates that women with PD are less likely to have used HRT compared to those without PD. The neuroprotective effects of estrogen replacement have shown positive results in animal models of PD and in early menopausal women with PD. <cite class="reflink"><a href="#l-currie">L. Currie</a>, <a href="#d-brann">D. Brann</a></cite>
                </p>
                
                <p>
                    Women's HRT is primarily aimed at alleviating vasomotor (VMS) and vaginal symptoms, but can also address osteopenia. VMS, related to thermoregulation, involves neuroendocrine, autonomic, and somatosensory systems, and is influenced by serotonergic and noradrenergic neurotransmitter pathways â€”systems often associated with depression. Dysfunction in these interconnected neurotransmitter systems may contribute to PD development.
                </p>
                
                <p>
                    A 2020 meta-analysis titled <q>The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis</q>, presented evidence supporting ERT for the treatment of AD and PD, regardless of age, sample size, hormone therapy ascertainment, duration of the treatment, or route of administration. 
                </p>
                <p>
                    Researchers determined that the beneficial effects of estrogen on dopamine receptors can delay the progression of PD. <cite class="reflink"><a href="#y-song">Yu-jia Song</a></cite>
                </p>
                
                <p>
                    A 2023 study published in Alzheimer's Research &amp; Therapy found that hormone replacement therapy (HRT) is linked to better memory and increased size of brain areas involved in memory and emotions, but only in people with the <abbr title="Apolipoprotein E allele 4">APOE4</abbr> gene. Since <abbr title="Apolipoprotein E allele 4">APOE4</abbr> is also associated with more Î±-synuclein buildup in PD, these findings could open new research paths for HRTâ€™s effects on memory and brain structure in PD patients with the <abbr title="Apolipoprotein E allele 4">APOE4</abbr> gene. <cite class="reflink"><a href="#r-saleh">R. Saleh</a></cite>
                </p>
                <p>
                    A retrospective chart review of a computerized patient database was performed at Columbia-Presbyterian. The review included only women who had symptoms of presumed PD for less than 5 years and who had not yet been on L-dopa. This research found a positive association between estrogen use and lower symptom severity in women with early PD who were not yet taking L-dopa. This indicates that estrogen therapy may be beneficial for women with early PD who also entered menopause early and have not yet started <abbr title="Dopamine Replacement Therapy">DRT</abbr>. <cite class="reflink"><a href="#r-pullman">R Saunders-Pullman</a></cite>
                </p>
                <p>
                     In a rodent model of PD, estrogen replacement reduced dopaminergic neuron loss, promoted maturation of <dfn title="the breakdown and degradation of cellular components by the cell itself">autophagy</dfn>, improved motor function and other symptoms, and slowed disease progression. <cite class="reflink"><a href="#x-li">X.Z. Li</a></cite>
                </p>
                <p>
                    Estrogen and progesterone replacement for early menopausal women with PD may offer neuroprotective benefits, given the observed positive effects and known beneficial effects of estrogen on dopamine receptors in delaying the progression of PD.
                </p>
                
                <h5>Osteocalcin â€” Estrogen's Effects on Osteoblasts</h5>
                <p>
                    Estrogen stimulates osteoblasts, which produce osteocalcin (OCN). OCN is partially modified by vitamin K into carboxylated OCN, while the rest remains undercarboxylated (ucOCN). Carboxylated OCN improves bone strength.
                </p>
                <p>
                     Undercarboxylated OCN acts as a hormone in the body and brain. OCN crosses the blood-brain barrier and has been shown to reach the midbrain and brainstem and influence brain functions such as memory and cognition. <cite class="reflink"><a href="#obri">A. Obri</a></cite>
                </p>
                
                <p>
                    Decreased production of osteocalcin, including its undercarboxylated form, during menopause can reduce neuroprotection and cognitive function.
                </p>
                
                <h5>Risks of HRT in Women</h5>
                <p>
                    Estrogen replacement carries risks such as vascular disease and certain cancers, requiring careful medical supervision. Alternatives to increasing osteocalcin levels include high-impact and weight-bearing exercise, and supplementation of vitamin K, magnesium, strontium, collagen, sleep, and vitamin D.
                </p>
                
                <h4>Progesterone: A Neuroprotective Steroid of the Intestine</h4>
                
                <p>
                    A 2023 study explored how progesterone might protect nerve cells in the enteric nervous system (ENS) ("the gut"), which can be affected early in Parkinsonâ€™s Disease (PD). Researchers tested nerve cells from rats to see if they had the receptors needed to respond to progesterone. Then, they damaged these cells using <dfn title="1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine â€” is a protoxin that can cause parkinsonism similar to PD">MPTP</dfn>, a toxin that mimics the damage seen in PD. Progesterone treatment reduced cell death by 45%, indicating a significant protective effect linked to a specific progesterone receptor. The impressive results require further human trials to confirm progesterone's effectiveness in reducing <abbr title="enteric nervous system">ENS</abbr> dysfunction in PD. <cite class="reflink"><a href="#stegemann">Stegemann</a></cite>
                </p>
                
                <p>
                    Combining DHEA with HRT (ERT + progesterone) may offer overall hormone balance, including testosterone and the estrogen to progesterone ratio. This combination may improve bone health and brain function by increasing estradiol and IGF-I, stimulating osteoblasts to release neuroprotective osteocalcin.
                </p>
                
                <p>
                    Adding pregnenolone as a DHEA precursor might help optimize hormonal balance, as progesterone is a precursor to many other hormones, including DHEA, progesterone, estrogen, and cortisol, providing more raw material to convert into these hormones as needed.
                </p>
                
                <p>
                    Managing HRT requires collaboration with an endocrinologist to balance PD symptom relief with potential risks.<!-- Neurology Solutions may provide HRT for women with PD --> 
                </p>
                
                <h5>TRT for Men</h5>
                <h4>Testosterone</h4>
                <p>
                    Testosterone has neuroprotective effects. Beyond sexual function, androgens maintain mood and cognition, and also brain efficiency (the brainâ€™s ability to optimize its functioning, processing, and energy consumption), reducing the incidence of dementia. Conversely, its absence may contribute to neurodegenerative processes (Wahjoepramono, et al, cited in Bianchi).
                </p>
                <p>
                Testosterone stimulates neuronal differentiation, thereby maintaining neuronal plasticity, promoting synaptic density, increasing connectivity of hypothalamic neurons, and stimulating neurite outgrowth. <cite class="reflink"><a href="#v-e-bianchi">V.E. Banchi</a></cite>.  A portion of testosterone (~5-10%) is converted to estradiol via aromatase, which contributes to its neuroprotective effects. Raising testosterone to optimal levels (e.g., ~600-800 ng/dL) through TRT may enhance these benefits by increasing estradiol production. 
                </p>

                <p>
                    A 2020 review concluded that TRT offered dose-dependent neuroprotection, reducing neuroinflammation and neurodegeneration. The researchers noted that testosterone improves the survival of human neurons and astrocytes, acting directly on the mitochondrial membrane, inhibiting the generation of <abbr title="Reactive Oxygen and Nitrogen Species">RONS</abbr>, as well as sirtuin-1 expression.
                </p>

                <p>
                    Poor results in some studies can be attributed to flawed designs, particularly the use of testosterone enanthate administered at intervals that exceeded its eight-day half-life, leading to wide fluctuations in testosterone levels. In contrast, stable elevation of total testosterone in men with low testosterone showed improvements in motor and non-motor symptoms of PD. <cite class="reflink"><a href="#okun">Okun</a></cite>
                </p>
                
                <p>
                    Under endocrinologist supervision, raising testosterone levels to the mid-to-upper range of normal (600-900 ng/dL), based on individual needs, may offer neuroprotective and neurological benefits, including improved mood and cognitive function. 
                </p>
                <h4>References</h4>
                
                <ol class="reference-list">
                    <li id="cerri">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700650/"
                        title="Parkinsonâ€™s Disease in Women and Men: Whatâ€™s the Difference"
                        target="_blank"
                        >Parkinsonâ€™s Disease in Women and Men: Whatâ€™s the Difference</a>, Silvia Cerri, et al.
                    </li>
                    <li id="l-currie">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15210525/"
                        title="Postmenopausal estrogen use affects risk for Parkinson disease"
                        target="_blank"
                        >Postmenopausal estrogen use affects risk for Parkinson disease</a>, Lillian J Currie, et al.
                    </li>
                    <li id="d-brann">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048656/"
                        title="Neurotrophic and Neuroprotective Actions of Estrogen: Basic Mechanisms and Clinical Implications"
                        target="_blank"
                        >Neurotrophic and Neuroprotective Actions of Estrogen: Basic Mechanisms and Clinical Implications</a>, Darrell W. Brann, et al.
                    </li>
                    <li id="m-borque">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356083/"
                        target="_blank"
                        title="ale/female differences in neuroprotection and neuromodulation of brain dopamine"
                        >Male/female differences in neuroprotection and neuromodulation of brain dopamine</a>, MÃ©lanie Bourque, et al.
                        <p>
                            This review paper concluded that exogenous 17Î²-estradiol and/or progesterone treatments show neuroprotective properties against nigrostriatal dopaminergic toxins while androgens fail to induce any beneficial effect.
                        </p>
                    </li>
                    <li id="r-saleh">
                        <a href="https://alzres.biomedcentral.com/articles/10.1186/s13195-022-01121-5"
                        title="Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimerâ€™s Disease (EPAD) cohort"
                        target="_blank"
                        >Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimerâ€™s Disease (EPAD) cohort</a>, Rasha N. M. Saleh, et al.
 
                    </li>
                    <li id="r-pullman">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10227628/"
                        title="The effect of estrogen replacement on early Parkinson's disease"
                        target="_blank"
                        >The effect of estrogen replacement on early Parkinson's disease</a>, R Saunders-Pullman, et al.

                    </li>
                    
                    <li id="x-li">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095307/"
                        title="The effects and mechanism of estrogen on rats with Parkinsonâ€™s disease in different age groups"
                        target="_blank"
                        >The effects and mechanism of estrogen on rats with Parkinsonâ€™s disease in different age groups</a>, Xue-Zhong Li, et al.
                        <p>
                        
                        </p>
                    </li>
                    <li id="obri">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958904/"
                        title="Osteocalcin in the brain: from embryonic development to age-related decline in cognition"
                        target="_blank"
                        >Osteocalcin in the brain: from embryonic development to age-related decline in cognition</a>, Arnaud Obri, et al.
 
                    </li>
                    <li id="y-song">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076111/"
                        title="The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis
"
                        target="_blank"
                        >The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis</a>, Yu-jia Song, et al.
                    </li>

                    <li id="stegemann">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37190115/"
                        title="Progesterone: A Neuroprotective Steroid of the Intestine"
                        target="_blank"
                        >Progesterone: A Neuroprotective Steroid of the Intestine</a>, Lennart Norman Stegemann, et al.
                    </li>
                    
                    <li id="v-e-bianchi">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568521/"
                        title="Androgen Therapy in Neurodegenerative Diseases"
                        target="_blank"
                        >Androgen Therapy in Neurodegenerative Diseases</a>, Vittorio Emanuele Bianchi, et al.
                    </li>
                </ol>
            </section>

            <section id="dhea">
                <h4 class="neuroprotective">Dehydroepiandrosterone (DHEA)</h4>
                <p>
                    DHEA, produced by the adrenal glands, ovaries, and brain, converts into hormones such as estrogen, testosterone, and cortisol, which influence various physiological processes like sleep, memory, and stress response.
                </p>
                <p>
                    DHEA's conversion to cholesterol regulation may help manage PD symptoms.
                </p>
                                
                <h5>Blood-Brain Barrier (BBB)</h5>
                <p>
                    DHEA is fat-soluble, allowing it to cross the BBB easily, and is available as a dietary supplement.
                </p>
                
                <h5>Hormonal Effects in Women</h5>
                <h6>IGF-I Levels</h6>
                <p>
                    A 2020 review concluded that estrogen, particularly in women, may help PD by increasing IGF-I levels and activating its signaling pathways, possibly inhibiting aggregation and fibrillization of Î±â€synuclein. Another 2020 review found that DHEA supplementation may raise IGF-I levels in women and older adults, which could benefit women in early menopause. <cite class="reflink"><a href="#cortazar">Castilla-CortÃ¡zar</a>, <a href="#min-xie">Xie</a></cite>
                </p>
                
                <h6>Testosterone and Estradiol Levels</h6>
                <p>
                     A 2021 meta-analysis found that DHEA administration significantly increased testosterone levels and decreased BMI in elderly women, suggesting its hormonal effects. <cite class="reflink"><a href="#y-hu">Y. Hu</a></cite>
                </p>
                <p>
                    Another 2021 meta-analysis found that postmenopausal women 60 years and above on 50 mg/day DHEA for at least 26 weeks had a more pronounced elevation of the circulating estradiol levels. <cite class="reflink"><a href="#y-zhu">Y. Zhu</a></cite>
                </p>
                                
                <p>
                    A 2016 review found a positive correlation between DHEA-S levels and global cognition in both sexes. DHEA-S correlated with working memory, attention, and verbal fluency in women, possibly due to its effects on menopausal cognitive decline. DHEA supplementation increases DHEA-S levels, so it can be expected to have these effects. <cite class="reflink"><a href="#k-menezes">K. Menezes</a>, <a href="#s-vale">S. Vale</a></cite>
                </p>
                
                <h6>Contradicting Symptomatic Evidence</h6>
                
                <p>
                    A 2006 Cochrane study found no improvement in memory or cognitive function in non-demented older adults from DHEA supplements. Subsequent studies, including those mentioned above, however, have shown more promising results. <cite class="reflink"><a href="#j-evans">J. Evans</a></cite>
                </p>    

                <h6>Osteoblast Stimulation</h6>
                <p>
                    A second mechanistic action of DHEA involves its effects on the bone-brain axis. As discussed in the section on IGF-I levels, DHEA's metabolism into estradiol (E2) and other hormones may influence osteoblasts and chondrocytes, contributing to its overall effects.
                </p>
                <p>
                    A 2020 study found that DHEA improved <abbr title="Unified Parkinson's Disease Rating Scale">UPDRS</abbr> scores in  <dfn title="1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine â€” is a protoxin that can cause parkinsonism similar to PD">MPTP</dfn> monkeys, a model of PD, indicating potential benefits for PD management. <cite class="reflink"><a href="#n-belanger">BÃ©langer</a></cite>
                </p>
                <p>
                    These results may be partly explained by DHEA signaling osteoblasts and chondrocytes directly and through its metabolites, including E2 and dihydrotestosterone (DHT). Osteoblast stimulation increases osteocalcin levels, which may affect the bone-brain axis and enhance cognitive function.  <cite class="reflink"><a href="#d-kirby">D. Kirby</a></cite>
                </p>
                
                <p>
                    Osteocalcin promotes spatial learning and memory and prevents anxiety-like behavior. This complex interplay between the bones and the central nervous system, influencing each other's function and behavior, is elaborated on under the section on K2 supplementation and elsewhere in the document.
                </p>

                <h5>Supplementation</h5>
                <p>
                    Supplementing with 50-100 mg DHEA may alleviate age-related hormonal declines, improving bone density (especially in older women), skin aging, and mild to moderate depression. It may also help manage menopausal symptoms by raising estradiol levels. Though DHEA was once thought to increase breast cancer risk, recent evidence suggests it may actually inhibit breast cancer cell proliferation and migration. Consult a knowledgeable provider to discuss DHEA supplementation. <cite class="reflink"><a href="#colin-val">ColÃ­n-Val</a></cite>
                </p>
                
                <h6>Safer HRT Alternative</h6>
                <p>
                    DHEA and pregnenolone can also be used independently of HRT, which may present a lower risk of cancer compared to steroid hormone therapies.
                </p>
                
                <h5>References</h5>
                <ol class="reference-list">
                    <li id="min-xie">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32304719/"
                        title="Impact of dehydroepianrosterone (DHEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): A dose-response meta-analysis of randomized controlled trials"
                        target="_blank"
                        >Impact of dehydroepianrosterone (DHEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): A dose-response meta-analysis of randomized controlled trials</a>, Min Xie, et al.
                        <p>
                            Despite the misspelling in the title, <q>dehydroepianrosterone</q> (WRONG), this study shows DHEA supplementation may increase serum IGF-I levels especially in women and older subjects. 
                        </p>
                    </li>
                    
                    <li id="cortazar">
                        <a href="https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02223-0"
                        title="Is insulin-like growth factor-1 involved in Parkinsonâ€™s disease development?"
                        target="_blank"
                        >Is insulin-like growth factor-1 involved in Parkinsonâ€™s disease development?</a>, Inma Castilla-CortÃ¡zar, et al.
                    </li>
                    
                    <li id="n-belanger">
                        <a href="https://www.sciencedirect.com/science/article/abs/pii/S0197458005003003"
                        >DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys</a>, Nancy BÃ©langer, et al.
                    </li>
                    <li id="j-evans">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988513/"
                        title="Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people"
                        target="_blank"
                        >Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people</a>, John Grimley Evans, et al.
                    </li>

                    <li id="y-hu">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33220453/"
                        title="Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A meta-analysis of randomized controlled trials"
                        target="_blank"
                        >Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A meta-analysis of randomized controlled trials</a>, Ying Hu, et al.
                    </li>
                    
                    <li id="y-zhu">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34246664/"
                        title="The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: A dose-response and meta-analysis of randomized clinical trials"
                        target="_blank"
                        >The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: A dose-response and meta-analysis of randomized clinical trials</a>, Yan Zhu, et al.
                    </li>
                    
                    <li id="k-menezes">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894834/"
                        title="Dehydroepiandrosterone, Its Sulfate and Cognitive Functions"
                        target="_blank"
                        >Dehydroepiandrosterone, Its Sulfate and Cognitive Functions</a>, Karina Junqueira de Menezes, et al.
                    </li>
                    <li id="s-vale">
                        <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0104869"
                        title="The Relationship between Dehydroepiandrosterone (DHEA), Working Memory and Distraction â€“ A Behavioral and Electrophysiological Approach"
                        target="_blank"
                        >The Relationship between Dehydroepiandrosterone (DHEA), Working Memory and Distraction â€“ A Behavioral and Electrophysiological Approach</a>, SÃ³nia do Vale, et al.
                    </li>

                    <li id="d-kirby">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32504237/"
                        title="DHEA in bone: the role in osteoporosis and fracture healing"
                        target="_blank"
                        >DHEA in bone: the role in osteoporosis and fracture healing</a>, David J Kirby, et al.
                    </li>

                    <li id="colin-val">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33508440/"
                        title="DHEA inhibits proliferation, migration and alters mesenchymal-epithelial transition proteins through the PI3K/Akt pathway in MDA-MB-231 cells"
                        target="_blank"
                        >DHEA inhibits proliferation, migration and alters mesenchymal-epithelial transition proteins through the PI3K/Akt pathway in MDA-MB-231 cells</a>, Zaira ColÃ­n-Val, et al.
                    </li>
                </ol>
            </section>
            <section id="pregnenolone">
                <h4>Pregnenolone</h4>
                <p>
                    Pregnenolone is a neurosteroid and precursor to various hormones, including cortisol, DHEA, and progesterone. It has been explored as a potential candidate for hormone replacement therapy (HRT) in female reproductive disorders targeting estrogen receptor beta (ERÎ²) and may improve cognitive function where it has been impaired by elevated blood glucose (in diabetics). <cite class="reflink"><a href="#yy-shin">Shin</a></cite>
                </p>
                <p>
                    A 2022 study on a rodent model of insulin resistance concluded that a short-term diet high in processed foods, refined sugars, and unhealthy fats impairs memory, but this is reversible by pregnenolone, which mediates memory function via the hippocampus. <cite class="reflink"><a href="#s-ramirez">RamÃ­rez</a></cite>
                </p>
                <p>
                    Cholesterol is converted into pregnenolone. Pregnenolone can then be converted into progesterone or DHEA, and DHEA can further be converted into androgens and estrogens. 
                </p>
                
                <h5>Pregnenolone and DRT</h5>
                <p>
                    Pregnenolone reduces levodopa-induced dyskinesias (LIDs) without compromising L-DOPA's motor benefits. The mechanism could be DHEA-S or PREG-S agonism on NMDA receptors to exert an antagonistic activity on <abbr title="Î³-Aminobutyric acid type A (GABA[A] ) receptors">GABA-A</abbr> receptors. <cite class="reflink"><a href="#corsi">Corsi</a></cite>
                </p>
                
                <h5>Pregnenolone Dosage</h5>
                <p>
                    Pregnenolone is available as a dietary supplement and is typically safe in doses ranging from 10 to 50 mg per day.
                </p>
                <p>
                    Pregnenolone is fat-soluble and crosses the BBB. Once in the brain, pregnenolone can be converted into other neurosteroids, such as allopregnanolone, which have various effects on neuronal function and behavior.
                </p>                
                <p>
                    Several clinical studies have investigated pregnenolone as a treatment for Parkinsonâ€™s disease. One study found that pregnenolone dose-dependently countered <abbr title="L-Dopa-induced dyskinesias">LIDs</abbr> without affecting L-DOPA-induced motor improvements. 
                </p>
    
                <h4>References</h4>
                <ol class="reference-list">
                    <li id="s-ramirez">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815774/"
                        title="Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders"
                        target="_blank"
                        >Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders</a>, Sara RamÃ­rez, et al.
                    </li>
                    <li id="yy-shin">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30411422/"
                        title="Pregnenolone as a potential candidate for hormone therapy for female reproductive disorders targeting ERÎ²"
                        target="_blank"
                        >Pregnenolone as a potential candidate for hormone therapy for female reproductive disorders targeting ERÎ²</a>, Ye Young Shin, et al.
                    </li>
                    <li id="corsi">
                        <p>
                            A study found that DHEA administration alone improved the mean parkinsonian score in moderately and severely impaired MPTP monkeys, a model of Parkinsonâ€™s disease. 
                            <a title="Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease"
                           target="_blank" href="https://www.sciencedirect.com/science/article/pii/S0014488623000547"
                            >Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease</a>, Sara Corsi, et al.
                        </p>
                    </li>
                </ol>
            </section>
            <section id="gh">
                <h4>Growth Hormone and Secretagogues</h4>
                <p>
                    Human growth hormone (GH) stimulates growth, cell repair, and metabolism, and reduces inflammation. <cite class="reflink"><a href="#masternak">Masternak</a></cite>
                </p>
                
                <h5>GH, IGF-1, and MGF</h5>
                <p>
                    GH increases levels of Insulin-like Growth Factor 1 (IGF-1), which can then be further metabolized into Mechano Growth Factor (MGF) in response to mechanical stimuli, such as intense exercise. Mechano-growth factor is neuroprotective. (GH stimulates the liver to produce IGF-1. IGF-1 is further metabolized into MGF through alternative splicing of IGF-1 mRNA by lactate and other stress signals.)
                </p>

                <h5>Brain Waste Management System (BWMS), Collagen, and IGF-I</h5>
                <p>
                    IGF-1 promotes collagen synthesis by fibroblasts, which strengthens connective tissues, including those in the BBB and choroid plexus. Increased collagen production enhances the function and structural integrity of the brain waste management system (BWMS), reducing permeability and improving waste clearance through several coordinated mechanisms of the BWMS.
                </p>
                
                <p>
                    IGF-1 increases the synthesis of <abbr title="extracellular matrix">ECM</abbr> proteins beyond collagen, such as proteoglycans and glycosaminoglycans, which contribute to the structural framework of tissues. 
                </p>
                <p>
                    Growth and repair of the choroid plexus, where CSF is produced, improve its functioning. Increased CSF production enhances waste clearance by increasing the volume of fluid available to remove metabolic byproducts and harmful substances from the brain. 
                </p>
                
                <p>
                     Lower inflammation may improve the function of the choroid plexus and its ability to produce CSF.
                </p>
                
                <h5>Gh Secretagogues CJC-1295 and Tesamorelin</h5>
                <p>
                    Growth hormone secretagogues, such as tesamorelin and CJC-1295, are peptides that stimulate the secretion of GH. The increase in GH levels from these secretagogues is generally less pronounced compared to direct GH injections.
                </p>
                
                <h5>Side Effects</h5>
                <p>
                    Blood glucose control and hyperglycemia are known side effects of growth hormone. Potential side effects at higher doses may include joint pain, insulin resistance, and swelling. It is important to monitor for these effects and consult a healthcare provider. <cite class="sigalos"><a href="#masternak">Sigalos</a></cite>
                </p>
                <ol class="reference-list">
                <li id="masternak">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417471/"
                    title="Growth hormone, inflammation and aging"
                    target="_blank"
                    >Growth hormone, inflammation and aging</a>, Michal M. Masternak and Andrzej Bartke.
                </li>
                <li id="matheny">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840678/"
                    title="Minireview: Mechano-Growth Factor: A Putative Product of IGF-I Gene Expression Involved in Tissue Repair and Regeneration"
                    target="_blank"
                    >Minireview: Mechano-Growth Factor: A Putative Product of IGF-I Gene Expression Involved in Tissue Repair and Regeneration</a>, Ronald W. Matheny, et al.
                </li>
                <li id="sigalos">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632578/"
                    title="The Safety and Efficacy of Growth Hormone Secretagogues"
                    target="_blank"
                    >The Safety and Efficacy of Growth Hormone Secretagogues</a>, John T. Sigalos and Alexander W. Pastuszak.
                </li>
            </ol>
            </section>
            <section id="peptides">
                <h3>Peptides</h3>
            <!-- 
                <h4>Peptides</h4>
                <h5>BPC-157</h5>
                <p>
                    BPC-157, administered subcutaneously (Sub-Q), has shown potential in repairing BBB integrity and promoting neurovascular health, which could be beneficial in the context of PD.
                </p>
                
                <h5>Selank</h5>
                <h5>Semax</h5>
                <h5>SS-31</h5>
                <h5>AICAR</h5>
                <h5>Epitalon</h5>
                <h5>Pinealon</h5>
                -->
            </section>
        </section>
        <section id="dbs" class="neuroprotective">
            <h3>Deep Brain Stimulation (DBS)</h3>
            <p>
                Deep Brain Stimulation (DBS) uses electrodes implanted in the brain to deliver electrical impulses to the globus pallidus internus (GPi). This helps to regulate brain activity.
            </p>
            
            <h4>LRRK2-G2019S and DBS</h4>
            <p>
                <abbr title='Leucine-Rich Repeat Kinase 2 gene with a glycine to serine substitution at position 2019'>LRRK2-G2019S</abbr> mutations tend to have relatively good outcomes with DBS compared to other genetic types. 
            </p>
            
            <p>
                DBS of the globus pallidus internus (GPi) primarily targets the GABAergic output neurons of the basal ganglia, influencing motor output and reducing motor symptoms in PD. However, the therapeutic effects of GPi stimulation in PD extend beyond modulating GABAergic transmission within the basal ganglia circuitry and can indirectly impact cortical glutamatergic <em>input</em> to the basal ganglia.
            </p>
            <p>
                While GPi stimulation primarily targets the GABAergic output of the basal ganglia, the dopaminergic system remains a core problem in PD pathology and treatment. Dopamine depletion in the basal ganglia is a hallmark feature of PD and leads to motor symptoms such as bradykinesia, tremors, and rigidity, and DBS helps treat these problems.
            </p>
            <p>
                Other neurotransmitter systems affected by DBS include the serotonergic, cholinergic, noradrenergic, and glutamatergic systems. Due to the delicate balance between all these systems stimulation of the entire GPi can more easily achieve a positive, balanced effect, compared to medication and supplementation with l-dopa/carbidopa and supplements like 5-HTP and GABA.
            </p>
            <p>
                This normalizes basal ganglion activity resulting in reduced excitotoxicity, better neuronal function, and greater cell longevity.
            </p>
            <p>
                Medication alone leads to PN. DBS reduces the need for medication, thus mitigating PN. Supplementation further reduces the need for medication, and thus PN. A team of specialists to craft a program with DBS, medication,
                and supplementation may offer the best possible outcome with the least PN and greater longevity.
            </p>
            <p>
                Crafting a personalized treatment program that incorporates DBS, medication, and supplementation requires the expertise of a multidisciplinary team of specialists, including neurologists, movement disorder specialists,
                neurosurgeons, pharmacists, dietitians, and other healthcare professionals. This team can collaborate to tailor treatment to the individual patient's needs, optimize therapy, and minimize PN.
            </p>
        </section>
        
        <section id="gene-therapy">
            <h3>Gene Therapy</h3>

            
            <p>
                Gene therapy is designed to repair the dopamine system. The procedure involves injecting a gene into the brain.
            </p>
            
            <h3>Cell Therapies</h3>
            <p>
                <dfn>Cell replacement</dfn> is the injection of dopamine cells into the brain to replace those that are lost or dying. 
            </p>

            <h4>References</h4>
            <ol class="reference-list">
                <li>
                    <a href="https://www.parkinson.org/blog/research/gene-cell-based-therapies"
                    title="Exploring the Potential of Gene and Cell-Based Therapies in Parkinsonâ€™s"
                    target="_blank"
                    >Exploring the Potential of Gene and Cell-Based Therapies in Parkinsonâ€™s</a>, (Anonymous)
                    <p>
                    
                    </p>
                </li>
            </ol>
        </section>
        <section id="stem-cell">
            <h4 class="neuroprotective neurorestorative">Stem Cells (MSC, iPSC)</h4>
            <h5>Mesenchymal Stem Cells (MSCs)</h5>
            <p>
                Systemic injection of mesenchymal stem cells helps restore dopaminergic neurons. <cite class="reflink"><a 
         href="#h-j-park">Park</a></cite>
            </p>
            
            <p>
                The concomitant use of cell therapy and photobiomodulation therapy can improve the symptoms of PD. <cite class="reflink"><a 
         href="#b-ahrabi">Ahrabi</a></cite>
            </p>
            
            <h5>Induced Pluripotent Stem Cells (iPSCs)</h5>
            <p>
                Induced pluripotent stem cells (iPSCs) are generated by reprogramming adult somatic cells, such as skin or blood cells, to express the same genes as embryonic stem cells in a process called <dfn>induced pluripotency</dfn>. iPSCs can differentiate into any cell type in the body, similar to embryonic stem cells, but they are generated from adult cells, which makes them a promising source for regenerative medicine and tissue engineering. 
            </p>
            <p>
                When injected into the striatum and substantia nigra, iPSCs may promote the regeneration of lost dopaminergic neurons. However, this practice is not well-established and carries potential risks, including tumor formation. <cite class="reflink"><a href="#shastry">Shastry</a>, <a href="#bin-song">Bin Song</a></cite>
            </p>
            <p>
                Few clinics use iPSCs. <a href="https://stemaid.com/">Stemaid</a> is one of them. Stemaid is located in San JosÃ© del Cabo, Mexico. <a href="https://cynata.com/contact-us">Cynata</a> in Victoria, Australia is another. Please note that no endorsement or evaluation of these clinics is being provided.
            </p>
            
            <h5>References</h5>
            <ol class="reference-list">
                <li id="w-chen">
                     <a href="https://pubmed.ncbi.nlm.nih.gov/30346716/"
                     title="Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease"
                     target="_blank">Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease</a>
                    <p>
                        <q>Stable cell sources, such as Embryonic stem cells (ESCs) and induced pluripotent stem cell (iPSCs), are far more suitable for clinical application than hfVM- and embryonic or fetal brain-derived NSCs.</q>
                    </p>
                </li>
                <li id="h-j-park">
                 <a href="https://pubmed.ncbi.nlm.nih.gov/18665911/"
                 title="Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease."
                 >Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease.</a>, Hyun Jung Park, et al.

                 </li>
                 
                <li id="b-ahrabi">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841383/"
                    title="Photobiomodulation Therapy and Cell Therapy Improved Parkinsonâ€™s Diseases by Neuro-regeneration and Tremor Inhibition"
                    target="_blank"
                    >Photobiomodulation Therapy and Cell Therapy Improved Parkinsonâ€™s Diseases by Neuro-regeneration and Tremor Inhibition</a>, Behnaz Ahrabi, et al.
                    <p>
                        This review study showed the concomitant use of cell therapy and photobiomodulation therapy can improve the symptoms of PD.
                    </p>
                </li>
                <li id="shastry">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747991/"
                    title="Cell Therapy for Parkinsonâ€™s Disease"
                    target="_blank"
                    >Cell Therapy for Parkinsonâ€™s Disease</a>, Surabhi Shastry, et al.
                </li>
                <li id="bin-song">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994130/"
                    title="Human autologous iPSCâ€“derived dopaminergic progenitors restore motor function in Parkinsonâ€™s disease models"
                    target="_blank"
                    >Human autologous iPSCâ€“derived dopaminergic progenitors restore motor function in Parkinsonâ€™s disease models</a>, Bin Song, et al.
                </li>
             </ol>
        </section>
        <section id="exercise">
            <h3>Exercise</h3>
            <p>
                Maintaining a high degree of athleticism will have a positive impact on neurodegeneration by increasing blood flow to the brain, promoting neuroplasticity, and improving mood, sleep, and cognitive function. 
            </p>
            
            <p>
                Becoming an athlete requires maintaining a strong mindset to apply consistency with nutrition, lifestyle, exercise, supplementation. Focus on relative progress over current state. You can get better.
            </p>
            
            <h4>Physiological Response in the Brain</h4>
            <p>
             <abbr title="High intensity interval training">HIIT</abbr>, more than any other type of exercise, has been shown to fight neurodegeneration. It simultaneously stimulates multiple pathways and increases cerebral blood flow. Moderate and lower intensity cardiovascular exercise. "Zone 3" and "Zone 2" respectively, and active recovery provide supplementary benefits. <cite class="reflink"><a href="#lenhart">Lenhart</a>, <a href="#s-e-lucas">S.E. Lucas</a></cite>
            </p>
            
            <p>
                <abbr title="High-Intensity Interval Training">HIIT</abbr>, high-intensity cardiovascular training, resistance training, and endurance training are respectively the most effective at increasing neurotrophins such as <abbr title="Brain-Derived Neurotrophic Factor">BDNF</abbr>, <abbr title="Nerve Growth Factor">NGF</abbr>, <abbr title="Glial Line-Derived Neurotrophic Factor">GDNF</abbr>, <abbr title="Fibroblast Growth Factor 2">FGF2</abbr>, and <abbr title="Neurotrophin-3">NT-3</abbr>. These neurotrophins help protect neurons and glial cells.
            </p>
            <p>
              Such higher-intensity exercise increases the production of neuropeptides (<abbr title="Neuropeptide Y">NPY</abbr>, <dfn title="Substance P â€” neuropeptide involved in various physiological processes.">Substance P</dfn>, Enkephalins) and signaling hormones (<abbr title="Insulin-like Growth Factor 1">IGF-I</abbr>, <abbr title="vascular endothelial growth factor">VEGF</abbr>, Cortisol). 
            </p>

            <h5>IGF-I Benefits</h5>
            
            <p>
                IGF-I supports dopaminergic neuron survival by activating its receptors and inhibiting apoptosis. It also improves insulin sensitivity and glucose uptake, a problem that often accompanies disease progression.
            </p>
            
            <p>             
                By upregulating creatine transporters, IGF-I optimizes cellular energy metabolism, supporting neuronal health and cognitive function. Its anti-inflammatory and antioxidant properties reduce oxidative stress and inflammation, preserving cerebrovascular integrity and protecting the blood-brain barrier and choroid plexus.
            </p>
            
            <p>
                These combined effects promote autophagy, which removes dysfunctional proteins and organelles, improve mitochondrial function through ATP synthesis, and reduce neural apoptosis. This can improve ischemic conditions and sleep.
            </p>
            
            <h4>Lower-intensity Exercise (Zone 2)</h4>   
            <p>         
                Lower-intensity exercise, such as "Zone 2", is moderately low-intensity aerobic exercise, such as fast walking or hiking, that occurs just below the lactate threshold and can be sustained for a long period without strain or heavy breathing. Although low-intensity exercise may not boost neurotrophic factors as acutely as high-intensity workouts, it supports overall brain health and helps maintain a baseline level of these factors for improved endurance, enhanced recovery, increased mitochondrial production, and reduced overtraining, making it an excellent addition to any fitness routine.
            </p>
            
            <h4>Proprioceptive Activities</h4>
            <p>
                Complex motor activities that require significant proprioception, such as dancing, have been shown to be beneficial and may increase blood flow to the midbrain. Further research is needed to clarify their precise effects on <abbr title="Glial Line-Derived Neurotrophic Factor">GDNF</abbr>. <cite class="reflink"><a href="#baudet">Baudet</a>, <a href="#aman">Aman</a></cite>
            </p>
           
            <h4>Peak Performance</h4>
            <p>
                Increasing exercise intensity, VO<sub>2</sub> max, duration, and frequency leads to greater benefits. Contrary to the "minimum effective dose" approach in medicine, with exercise, more is better. Improving the limits of exercise tolerance through supplementation and recovery strategies can improve physiological performance and decrease recovery times, allowing for more exercise to be performed, conferring more neurological and physical benefits. 
            </p>
            
            <h4>Limits to Exercise</h4>
            <p>
                Intense exercise, while beneficial, is physically and mentally taxing, increasing Reactive Oxygen and Nitrogen Species (RONS) and creating metabolic waste. To maximize the benefits of exercise, incorporate active recovery strategies such as mobility work, supplementation, and red light therapy to enhance exercise tolerance.
            </p>
            
            <h4>Supplementation and Recovery</h4>
            <p>
                Timing supplementation around exercise is beneficial as it enhances nutrient delivery to the brain due to increased cerebral blood flow. Pre- and intra-workout supplementation can boost performance, while post-workout supplementation aids in recovery and improves subsequent performance. Protein intake immediately after exercise can increase satiety and reduce energy intake, which helps regulate blood glucose levels. <cite class="reflink"><a href="#querido">Querido</a>, <a href="#clayton">D. Clayton</a>, <a href="#monteyne">A. Monteyne</a></cite>
            </p>
            
            <p>
                For example, <a href="#creatine">creatine monohydrate supplementation</a> increases brain creatine levels. During stress or trauma, such as intense exercise, creatine helps reduce oxidative DNA damage and restores normal brain and body creatine levels.
            </p>
            <h4>Types of Exercise</h4>
            <p>
                The categories of exercise that elicit a physiological effect on the brain include:
            </p>
            <dl>
                <dt>HIIT  â€” High-Intensity Interval Training
                <dd> short periods of high-intensity effort, followed by brief periods of rest or low-intensity activity. This alternating pattern is repeated until exhaustion to maintain heart rate throughout the workout.
                </dd>
                
                <dt> HIT â€” High-Intensity Training
                </dt>
                
                <dd> strength training with high intensity and brief workouts. This improves cognitive function and brain health by increasing cerebral blood flow, <abbr title="Brain-derived Neurotrophic Factor">BDNF</abbr>, IGF-1, and osteocalcin. <cite class="reflink"><a href="#browne">Browne</a></cite>
                </dd>
                
                <dt>Zone 4 cardio</dt>
                <dd>High-intensity exercise zone,  80-90% of maximum heart rate (HRmax), Typically 2-10 minutes with a maximum sustained duration of around 15 minutes. Also known as "lactate threshold" or redline training.
                </dd>
                
                <dt> Zone 3 â€” Moderate-intensity cardiovascular training (70-80% of HRmax) 
                </dt>
                <dd> Enhances cerebral blood flow, metabolic, and cardiovascular health with a reduced risk of injury.
                </dd>               
                <dt> Zone 2 â€”Â Low-intensity cardiovascular training
                </dt>
                <dd>  Boosts aerobic endurance and promotes recovery with minimal injury risk.
                </dd>               
            </dl>

            <h4>Active Recovery</h4>
            <p>
                Active recovery elevates heart rate, enhancing blood flow to deliver nutrients, remove waste from tissues, and hasten recovery. It can address mobility issues such as tight hips and a weak core or glutes, reducing injury risk.
            </p>
            
            <p>
                Exercise increases brain blood flow, delivering oxygen and nutrients to brain cells. This triggers processes like neurogenesis, increased neurotransmitter production, and improved stress tolerance. Additionally, it boosts <abbr title="Brain-derived Neurotrophic Factor">BDNF</abbr>, promotes autophagy, reduces proinflammatory cytokines, and lowers blood sugar. These effects enhance memory, cognition, and mood, helping to counter neurodegeneration.
            </p>
            
            <p>
                This results in better memory and cognition and improved mood, countering or staving off neurodegeneration.
            </p>
            
            <h4>Mitochondrial Benefits</h4>
            <p>
                Regular exercise enhances NAD+ biosynthesis, activates AMP-activated protein kinase (AMPK) and sirtuins, and stimulates mitochondrial biogenesis. It also promotes mitochondrial turnover and mitophagy, supporting healthy mitochondrial function.
            </p>
            
            <h4>Sample Exercise Plan</h4>
            <ul>
                <li>Day 1: HIT + Zone 2 Cardio
                </li><li>Day 2: Zone 3 Cardio (40 min ergometer)
                </li><li>Day 3: HIIT + Active Recovery
                </li><li>Day 4: Zone 3 Cardio
                </li><li>Day 5: HIT + Zone 2 Cardio
                </li><li>Day 6: Zone 3 Cardio
                </li><li>Day 7: HIIT + Active Recovery
                </li>
            </ul>
            
            <h4>Summary</h4>
            <p>
                Intense exercise counteracts neurodegeneration and enhances neurological health by increasing cerebral blood flow, promoting neurogenesis, boosting neurotransmitter production, and reducing inflammation. Different exercise types, including <abbr title="High intensity interval training">HIIT</abbr>, <abbr title="High intensity training">HIT</abbr>, Zone 3, and Zone 2, offer distinct benefits. Balancing intense exercise with active recovery helps reduce injury and hasten recovery to improve exercise tolerance and maximize the results.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                
                <li id="s-e-lucas">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640257/"
                    title="High-intensity interval exercise and cerebrovascular health: curiosity, cause, and consequence"
                    target="_blank"
                    >High-intensity interval exercise and cerebrovascular health: curiosity, cause, and consequence</a>, Samuel J E Lucas, et al.
                </li>
            
                <li id="lenhart">
                    <a href="https://journals.lww.com/acsm-msse/fulltext/2019/06001/the_impact_of_varying_exercise_protocols_on.2347.aspx"
                    title="The Impact of Varying Exercise Protocols on Neurogenesis and Angiogenesis in the Dentate Gyrus"
                    target="_blank"
                    >The Impact of Varying Exercise Protocols on Neurogenesis and Angiogenesis in the Dentate Gyrus</a>, Lenhart, Darrin.
                </li>
                <li id="baudet">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/11003834/"
                    title="Positive and negative interactions of GDNF, NTN and ART in developing sensory neuron subpopulations, and their collaboration with neurotrophins"
                    target="_blank"
                    >Positive and negative interactions of GDNF, NTN and ART in developing sensory neuron subpopulations, and their collaboration with neurotrophins</a>, C Baudet, et al.
                </li>
                <li id="aman">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309156/"
                    title="The effectiveness of proprioceptive training for improving motor function: a systematic review"
                    target="_blank"
                    >The effectiveness of proprioceptive training for improving motor function: a systematic review</a>, Joshua E. Aman, et al.
                </li>
                <li id="querido"> 
                    <a href="https://pubmed.ncbi.nlm.nih.gov/17722948/" title="Regulation of cerebral blood flow during exercise" target="_blank" rel="noopener">Regulation of cerebral blood flow during exercise</a>, Jordan S Querido, A William Sheel. 
                </li>
                <li id="clayton">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25049135/"
                    title="The effect of post-exercise drink macronutrient content on appetite and energy intake"
                    target="_blank"
                    >The effect of post-exercise drink macronutrient content on appetite and energy intake</a>, David J Clayton, et al.
                </li>
                <li id="monteyne">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845592/"
                    title="Whey protein consumption after resistance exercise reduces energy intake at a post-exercise meal"
                    target="_blank"
                    >Whey protein consumption after resistance exercise reduces energy intake at a post-exercise meal</a>, Alistair Monteyne, et al.
                </li>
                <li id="browne">
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S0079612317300535"
                    title="Chapter 9 - Effects of acute high-intensity exercise on cognitive performance in trained individuals: A systematic review"
                    target="_blank"
                    >Chapter 9 - Effects of acute high-intensity exercise on cognitive performance in trained individuals: A systematic review</a>, Sarah E. Browne, et al.
                </li>
            </ol>
        </section>   
        <section id="pbm">
            <h3 class="neuroprotective">Photobiomodulation (PBM)</h3>
            <p>
                Photobiomodulation (PBM) is a non-invasive, low-risk treatment that improves cellular function using specific wavelengths of light. It can be done in clinics using high intensity lasers and at home using consumer devices, offering flexibility for patients seeking ongoing treatment.
            </p>
            
            <p>
                Despite the large body of experimental and early clinical evidence, there is still much resistance to the use of photobiomodulation by patients and health professionals.
            </p>
            
            <ul>
                <li>Enhances mitochondrial function and ATP production. <cite class="reflink"><a href="#m-r-hamblin1">Michael Hamblin<sup>1</sup></a></cite></li>
                <li>
                    Protects cells from misfolded protein accumulation via <abbr title="Reactive Oxygen Species">ROS</abbr> production and <abbr title="adenosine triphosphate">ATP</abbr> generation. 
                    <cite class="reflink"><a href="#w-fu">W. Fu</a></cite>
                </li>
                <li>Increases expression <abbr title="Brain-derived Neurotrophic Factor">BDNF</abbr>. <cite class="reflink"><a href="#meng">Chengbo Meng</a></cite></li>
                <li>Reduces oxidative stress and inflammation. <cite class="reflink"><a href="#michael-r-hamblin">Michael Hamblin</a></cite></li>
                <li>Promotes neuroprotection and neuroregeneration. <cite class="reflink"><a href="#michael-r-hamblin">Michael Hamblin</a></cite></li>
                <li>Improves cognitive function in PD patients. <cite class="reflink"><a href="#nizamutdinov1">Damir Nizamutdinov<sup>1</sup></a>, <a href="#damir-nizamutdinov">Damir Nizamutdinov</a></cite></li>
                <li>Improves sleep. <cite class="reflink"><a href="#jiexiu-zhao">Jiexiu Zhao</a></cite></li>
            </ul>
            
            <h4>PBM and Neurological Health</h4>
            <h5>Oxidative Stress and Brain Inflammation</h5>
            <p>
                PBM inhibits oxidative stress-related damage in the hippocampus and elevates <abbr title="Brain-derived Neurotrophic Factor">BDNF</abbr> levels, effectively treating nerve damage and neuroinflammation. <cite class="reflink"><a href="#j-c-heo">J.C. Heo</a></cite>
            </p>

            <h5>Ischemia and Blood Flow</h5>

            <p>
                Ischemia can affect the delivery of therapeutic agents to the desired target in the midbrain. During ischemic events, blood flow to affected brain regions can be significantly compromised, limiting the delivery of oxygen, nutrients, and therapeutic compounds like mesenchymal cells (as mentioned elsewhere), melatonin, or any substance entering the brain.
            </p>
            
            <h4>Effects on Parkinsonâ€™s Disease</h4>
            <h5>Red Light's Impact on Motor Cortex and Stem Cells</h5>
            <p>
                Red light reaches the motor cortex, influences stem cell function, offers neuroprotection, restores functional activity, improves motor behaviors and reduces clinical signs, reduces <dfn title="Gliosos â€” when glial cells, CNS cells that support nerve cells, proliferate or hypertrophy in response to damage">gliosis</dfn>, and induces expression of trophic growth factors. 
                <cite class="reflink"><a href="#c-hamilton">C. Hamilton</a></cite>
            </p>
            
            <h5>Impact on Kidney Function</h5>
            <p>
                Parkinsonâ€™s disease impairs renal function due to Î±-synuclein aggregation, inflammation, autonomic nervous system (ANS) dysfunction, and dopamine depletion (dopamine influences renal blood flow, blood pressure, and kidney function). Although the effects are less pronounced until the later stages of the disease, the damage begins earlier. <cite class="reflink"><a href="#bozic">Bozic</a></cite>
            </p>
            <p>
                Red light improves renal function by improving renal blood flow for healing and waste clearance.  <cite class="reflink"><a href="#j-bian">Bian</a></cite>
            </p>
            
            <h4>Near-Infrared (NIR) vs Red Light Therapy</h4>
            <p>
                Although numerous positive results have been observed in humans, depth penetration of the light waves is a concern. NIR light penetrates deeper than NIR, and coherent NIR (<abbr title="Light Amplification by Stimulated Emission of Radiation">laser</abbr>) even deeper. Cellular effects observed in rodents with NIR light can't be extrapolated to the much larger head thickness (and midbrain depth) of humans. <cite class="reflink"><a href="#y-lampl">Y. Lampl</a></cite>
            </p>
            <p>
                Near-infrared (NIR) light has a deeper penetration depth than red light, allowing it to reach deeper tissues and organs, including the brain, without overstimulating the skin. <cite class="reflink"><a href="#t-a-henderson">T.A. Henderson</a></cite>
            </p>

            <p>
                Red light can also be effective but the longer duration and stronger intensity required for efficacy may overstimulate the skin. Consumer LED devices that allow blending NIR and red frequencies should use lower intensity for the red frequencies to avoid burning or overstimulating the skin. This strategy can take advantage of their dermal benefits without damaging the skin while getting more intense NIR for the deep regions of the brain.
            </p>
            
            <h4>Practical Applications of PBM</h4>
            <h5>Timing and Frequency</h5>
            <p>
                The timing of PBM, in conjunction with the administration of substances like melatonin, may help improve delivery by mitigating the effects of ischemic inhibition on nutrient delivery to the midbrain. Whole body irradiation with red light improves sleep quality. Using it before sleep may offer better sleep effects. <cite class="reflink"><a href="#jiexiu-zhao">Jiexiu Zhao</a></cite>
            </p>

            <h4>Frequency</h4>
            <p>
                Alzheimerâ€™s and Parkinsonâ€™s disease models require daily treatments to show benefits. In-home devices offer convenience, comfort, and affordability. <cite class="reflink"><a href="#michael-r-hamblin">Hamblin</a></cite>
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                
                <li id="m-r-hamblin1">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523874/"
                    title="Mechanisms and applications of the anti-inflammatory effects of photobiomodulation"
                    target="_blank"
                    >Mechanisms and applications of the anti-inflammatory effects of photobiomodulation</a>, Michael R Hamblin.
                    <p>
                        Cytochrome c Oxidase (CCO) absorbs NIR light, leading to increased <abbr title="electron transport chain">ETC</abbr> activity and greater production of ATP.
                    </p>
                </li>
                <li id="w-fu">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252451/"
                    title="625 nm Light Irradiation Prevented MC3T3-E1 Cells from Accumulation of Misfolded Proteins via ROS and ATP Production"
                    target="_blank"
                    >625 nm Light Irradiation Prevented MC3T3-E1 Cells from Accumulation of Misfolded Proteins via ROS and ATP Production</a>, Wenqi Fu, et al.
                </li>
                <li id="nizamutdinov1">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400541/"
                        title="Transcranial near-infrared light in treatment of neurodegenerative diseases"
                        target="_blank"
                        >Transcranial near-infrared light in treatment of neurodegenerative diseases</a>, Damir Nizamutdinov, et al.
                        <p>
                        
                        </p>
                    </li>
                <li id="meng">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705158/"
                    title="Low-Level Laser Therapy Rescues Dendrite Atrophy via Upregulating BDNF Expression: Implications for Alzheimer's Disease"
                    target="_blank"
                    >Low-Level Laser Therapy Rescues Dendrite Atrophy via Upregulating BDNF Expression: Implications for Alzheimer's Disease</a>, Chengbo Meng, et al.
                    <p>
                        Synaptogenesis was found.
                    </p>
                </li>
                <li id="jiexiu-zhao">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499892/"
                    title="Red light and the sleep quality and endurance performance of Chinese female basketball players
"
                    target="_blank"
                    >Red light and the sleep quality and endurance performance of Chinese female basketball players</a>, Jiexiu Zhao, et al.
                    <p>
                        Our study confirmed the effectiveness of body irradiation with red light in improving the quality of sleep of elite female basketball players and offered a nonpharmacologic and noninvasive therapy to prevent sleep disorders after training.
                    </p>
                </li>
                
                <li id="michael-r-hamblin"> 
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581558/"
                    title="Transcranial photobiomodulation for the brain: a wide range of clinical applications"
                    target="_blank"
                    >Transcranial photobiomodulation for the brain: a wide range of clinical applications</a>, Michael R. Hamblin.
                    <p>
                        This review discussed the highly effective use of PBMT in treating Alzheimerâ€™s and Parkinsonâ€™s disease models using repeated daily exposures and the mechanisms that affect the mitochondria.
                    </p>
                </li>
                
                <li id="damir-nizamutdinov"> 
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219492/"
                    title="Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia"
                    target="_blank"
                    >Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia</a>, Damir Nizamutdinov, et al.
                    <p>
                        This placebo-controlled, randomized, double-blinded human study examined 6 min, twice daily eight weeks transcranial near-infrared (tNIR) light NIR light with wavelength of 1060-1080nm and 15,000mW, irradiance or power density= 23.1mW/cm2, ~650cm2 per treatment area compared with a sham placebo.
                    </p>

                    <p>
                        The study group showed significant improvements in cognitive functions in several tests and showed less anxiety, improved mood, energy, and positive daily routine after ~14-21 days of treatment. 
                    </p>
                    <p>
                        Patients with sham treatment did not demonstrate significant changes
                    </p>
                </li>
                
                <li id="t-a-henderson"> 
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552256/"
                        title="Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?"
                        target="_blank"
                    >Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?</a>, Theodore A Henderson, Larry D Morries.
                    <p>
                        Higher-wattage NIR lasers can deliver therapeutic effects to greater depths of the brain without tissue heating or damage. 
                    </p>
                </li>
                    
                <li id="a-liebert">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/34215216/">Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study</a>, Ann Liebert, et al.
                    
                    <p>
                        This small study showed <abbr title="photobiomodulation">PBM</abbr> was safe and effective for symptoms of PD including mobility, cognition, dynamic balance, and fine motor skills. Improvements were maintained for as long as treatment continued, for up to one year. 
                    </p>
                </li>
                
                <li id="j-c-heo">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625994/"
                        title="Photobiomodulation (660â€‰nm) therapy reduces oxidative stress and induces BDNF expression in the hippocampus"
                        target="Photobiomodulation (660â€‰nm) therapy reduces oxidative stress and induces BDNF expression in the hippocampus"
                    >Photobiomodulation (660â€‰nm) therapy reduces oxidative stress and induces BDNF expression in the hippocampus</a>, Jin-Chul Heo, et al.
                    <p>
                        These data demonstrate that PBMT inhibits hippocampal damage induced by oxidative stress and increases the expression of BDNF in the hippocampus, a part of the brain used for learning and memory, located deep in the temporal lobe. 
                    </p>
                    <p>
                        To examine the cellular process in the hippocampus, mice were used. Although the data are impressive, the problem with extrapolating data to humans is the size of the human head is much larger, thereby damping the intensity of the NIR waves as they aim toward the deep brain regions. A possible workaround is to direct the light towards the back, to target the CSF.
                    </p>
                </li>
                <li id="bozic">
                    <a href="https://www.nature.com/articles/s41467-020-15732-9"
                    title="Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis"
                    target="_blank"
                    >Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis</a>, Milica Bozic, et al.
                </li>
                 <li id="j-bian">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320354/"
                    title="Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease"
                    target="_blank"
                    >Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease</a>, Ji Bian, et al.
                </li>
                <li id="y-lampl">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/17463313/"
                        title="Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1)"
                    target="_blank"
                    >Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1)</a>, Yair Lampl, et al.
                    <p>
                        The NeuroThera Laser System therapeutic approach involves infrared laser technology and has shown significant and sustained beneficial effects in animal models of ischemic stroke. 
                    </p>
                </li>
                <li id="c-hamilton">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128061/"
                        title="Exploring the use of transcranial photobiomodulation in Parkinson's disease patients"
                        target="_blank"
                    >Exploring the use of transcranial photobiomodulation in Parkinson's disease patients</a>, Catherine Hamilton, et al.
                    <p>
                        This study found photobiomodulation penetrates the motor cortex, modulating stem cell activity, offers neuroprotection, restores functional activity, improves motor behaviors, reduces clinical signs of PD, reduces gliosis, and induces expression of trophic growth factors.
                    </p>
                </li>
            </ol>
        </section>
    </section>
    <section id="care-team">
        <h2>
            How to Build a Care Team
        </h2>
        <section id="care-team-introduction">
            <h3>Introduction</h3>

            <p>
                Optimizing health is complex, and a PD diagnosis increases that. Conventional medicine fails to adequately address peripheral and autonomic nervous system (ANS) dysfunction, which typically manifests as GI issues, loss of bladder and bowel control, sleep problems, and ultimately, heart failure and death. 
            </p>
            <p>
                Seeking 'alternative' approaches without critical analysis is equally flawed. The only true alternative to effective treatment is ineffective treatment, and that raises the problem of determining efficacy.
            </p>
            
            <p>
                Many medical professionals, whether conventional or alternative, fall short. Trusting them may lead you to take medications that do not improve health and may hasten disease progression. In PD, this may include beta-3 agonists, anticholinergics, or fludrocortisones. Worse, they may also offer "mind-body-spirit" treatments lacking scientific support or clear mechanisms of action.
            </p>
                        
            <p>
                It is the patient's responsibility to audit his medical team. Begin by consulting independent specialists and exploring reputable integrative medicine practices. Seek out patient communities for recommendations on doctors who prioritize a comprehensive approach.
            </p>

            <p>
                The onus of responsibility to learn, assess claims, and take actions for your health is on you. This involves understanding the science behind treatments and engaging in self-advocacy to actively participate in the decision-making process. Skepticism isnâ€™t just healthy; itâ€™s essential for survival and well-being.
            </p>
        </section>

        <!-- section id="how-to-interview-neurologist">
            <h3>Questions to Ask a Potential Neurologist</h3>
                How can I test my mitochondrial function?
                
        </section -->
        <section id="hypothetical-care-team">
            <h3>
                Hypothetical Care Team
            </h3>
            <p>
                This is a structured, customizable framework designed for self-directed health optimization in Parkinson's Disease.
            </p>

            <ol>
                <li>Neurologist for planning, diagnosis, and oversight.
                <li>Functional and Integrative Medicine Specialist for personalized, holistic approach.
                <li>Movement Specialist.
                <li>Physical Therapist.
                <li>Research involvement for cutting-edge options.
                <li>Biomarker Testing Laboratory for personalized testing to monitor disease progression, treatment response, and optimization.
            </ol>
            
            <h3>How to Interview Neurologists</h3>
            <p>
               Doctors may be limited by institutional protocols.
             </p>
             <p>
                Assessing provider competence requires a more thorough approach than just checking credentials, affiliations, and years of experience.
            </p>
            <p>
                Approach the interview from a position of informed knowledge without revealing too much. When given the opportunity to speak freely, how do they err?
            </p>
            
            <p>
                The effectiveness of that strategy depends on one's knowledge and comprehension â€” specifically the depth and breadth of understanding and the ability to evaluate and scrutinize the accuracy of the interlocutor's information.
            </p>
            
            <p>
                Better results are achieved by preparing detailed questions that delve into the neurologist's expertise in the specific area of concern.
            </p>
            
            <section>
                <h3>Q &amp; A</h3>
                <p>
                    Below are example questions from the perspective of an <em>active participant</em>. These questions should be critically examined and may be used as the basis for better questions.
                </p>
    
                <h4><q>In your initial assessment of a patient suspected to have Parkinson's Disease, what tests and evaluations do you conduct?</q></h4>
    
                <h4>
                    Listen for:
                </h4>
                <ul class="good-answers">
                    <li> Diagnostic imaging with DaTscan (Dopamine Transporter Scan) and <abbr title="Functional Magnetic Resonance Imaging">fMRI</abbr> to map dopamine distribution in the brain and assess broader brain function, respectively.
                    <li> Syn-One skin biopsy
                </ul>
                <p>
                    â€” and that is beyond the very basic fundamentals of:&mdash;
                </p>
    
                <ul class="baseline-answers">
                    <li> Detailed medical history and symptom review.
                    <li> Thorough examination of motor symptoms.
                    <li> Evaluation of non-motor symptoms such as sleep disturbances, autonomic dysfunction, and mood disorders.
                </ul>
    
                <h4 class="answer">
                    Be cautious of:
                </h4>
                <p>
                    Not mentioning genetic testing without providing context or justification. Preferring simpler imaging over more detailed <abbr title="Functional Magnetic Resonance Imaging">fMRI</abbr> and <abbr title="Dopamine Transporter Scan">DaTscan</abbr> â€”Â techniques to detect changes in dopamine transporter density and inform broader strategies, including supplementation. Generalization without specifying the detailed steps of the neurological examination and symptom review.
                </p>
    
                <h4><q>Why do you include or exclude genetic testing in your initial assessment for Parkinson's Disease?</q></h4>
    
                <h4 class="answer">What to expect:</h4>
                <p>
                    Acknowledgment of the importance of genetic factors in (1) creating custom-tailored solutions and (2) testing one's offspring for inherited traits. 
                <h4 class="answer">Be cautious if: </h4>
                <p>
                    The doctor says that genetic testing does not lead to more effective therapies or disease modification. Evidence to the contrary is provided throughout this document (See also: <a href="#genetic-factors">genetic factors</a>).
                </p>
                
                <h4><q>How do you address non-motor symptoms in the management of Parkinson's Disease?</q></h4>

                <h4 class="answer">Pay attention to:</h4>
                <p>
                    How the doctor explains non-motor symptom management, such as sleep or mood disorders. Ideally, they should be able to discuss conventional and less common treatments in simple terms.
                </p>
    
                <h4 class="answer">Be cautious of:</h4>
                <ul class="bad-answers">
                    <li>
                        Generalizations about 'alternative' treatments that show bias or knowledge gaps.
                    </li>
                    <li>
                         If the doctor can't explain the mechanisms of action (e.g., of turmeric, photobiomodulation) in simple terms, he likely doesn't understand them well himself.
                    </li>
                </ul>
    
                <h4><q>Can you provide an example of how you adapted a treatment plan based on new research findings in Parkinson's Disease?</q></h4>
    
                <h4 class="answer">What to listen for:</h4>
                <p>
                    A good response should include a recent example of implementing new research-based treatment, with evidence, rationale, and measured results.
                </p>
            </section>
            
            <h4>Summary</h4>
                <p>
            These questions and expected answers help ensure doctors follow a comprehensive, current approach to PD but also demonstrate critical thinking and a nuanced understanding of the disease. Doctors are not immune to common mental errors.
            </p>
        </section>
        <section id="tips-for-selecting-providers">
                <h3>Tips for Selecting Providers</h3>
                <p>
                    Referrals typically come from a PCP or neurologist, but some patients also seek input from functional medicine specialists. The goal is to assemble a comprehensive care team, regardless of the initial referral source.
                </p>
                <p>
                    Institutional protocols often influence treatment approach. It's important to have a neurologist who is willing to consider evidence-based treatments beyond the conventional standard of care.
                </p>
                <p>
                    Patient-centered care addressing root causes and individualized needs predicts the best results. Starting with a Functional and Integrative Medicine Specialist can be great. However, to avoid unqualified practitioners, it's essential to be well-informed.
                </p>
                <p>
                    During your initial consultation with a neurologist, discuss the <a href="#impact-dopamine-agonists">side-effects of <abbr title="Dopamine Replacement Therapy">DRT</abbr></a>.  Ask about specific treatments such as <a href="#hrt" title="hormone replacement therapy">HRT</a>, <a title="Photobiomodulation" href="#pbm">PBM</a>, and <a href="#5-htp">5-HTP</a>, and how they might interact with <abbr title="Dopamine Replacement Therapy">DRT</abbr>. If the doctor cannot explain their benefits or potential interactions, it may be worth seeking another opinion.
                </p>
        
                <blockquote>
                    <p>
                        &ldquo;It is better to know some of the questions than all of the answers.&rdquo;
                    </p>
                    <cite>&mdash; James Thurber</cite>
                </blockquote>
        
                <p>
                    Creating a health optimization plan is difficult, especially for PD, which requires specialized expertise. Those who approach this with seriousness and understanding can expect to achieve a better quality of life and longevity.
                </p>
            </section>

    </section>
    <section id="introduction-to-health">
        <h2>HealthÂ Assessments</h2>
    
        <h3>Basic Assessments</h3>
        <ul>
            <li>CBC with WBC differential</li>
            <li><abbr title="Comprehensive Metabolic Panel">CMP</abbr></li>
            <li>Thyroid Panel</li>
            <li>Complete Sex Hormone Panel</li> 
        </ul>
    
        <h3>Metabolic Health</h3>
        <ul>
            <li><abbr title="dual-energy X-ray absorptiometry">DEXA</abbr> (body composition and visceral fat).</li>
            <li>Resting heart rate below 60 BPM (fitness trackers, Oura Ring, etc).</li>
            <li>Normal blood pressure (around 120/80 mmHg).</li>
            <li>Stable blood glucose levels maintained by insulin sensitivity (<abbr title="Oral Glucose Tolerance Test">OGTT</abbr>, <abbr title="Continuous Glucose Monitor">CGM</abbr>).</li>
            <li>Cardio IQÂ® Advanced Lipid Panel (<em>high</em> <abbr title="Large, Buoyant Low-Density Lipoprotein">lbLDL</abbr> and <abbr title="Large, Buoyant Low-Density Lipoprotein">lbHDL</abbr>, low <abbr title="Small, Dense Low-Density Lipoprotein">sdLDL</abbr> and <abbr title="Small, Dense High-Density Lipoprotein">sdHDL</abbr>, and a high ratio of <abbr title="Large, Buoyant High-Density Lipoprotein">lbHDL</abbr> to <abbr title="Large, Buoyant Low-Density Lipoprotein">lbLDL</abbr>)</li>
            <li>Omega-3 Blood Test (<a target="_blank" href="https://requestatest.com/omega-3-blood-test">OmegaCheckÂ®</a>)</li>
        </ul>
    
        <h3>Neuroimaging</h3>
        <ul>
            <li>Dopamine transporter density: DaTscan.</li>
            <li>Brain structures: <abbr title="Functional Magnetic Resonance Imaging">fMRI</abbr>, <abbr title="Single Photon Emission Computed Tomography">SPECT</abbr>, and Dynamic Contrast-Enhanced MRI (DCE-MRI).
            </li>
            <li>PET imaging with specific radiotracers for brain inflammation markers (microglial activity).</li>
            <li>Calcium imaging: visualization of intracellular calcium fluxes, useful for detecting mitochondrial dysfunction.
            </li>
            <li>Rhodamine-based calcium imaging (e.g., Rhod-2)
        </ul>
    
        <h3>Brain Fluid Tests</h3>
        <ul>
            <li>Neurotransmitter levels (dopamine, serotonin, and norepinephrine): <abbr title="Liquid Chromatography-Tandem Mass Spectrometry">LC-MS/MS</abbr> and <abbr title="High-Performance Liquid Chromatography">HPLC</abbr>.</li>
            <li>Blood and CSF cytokine levels via <abbr title="Enzyme-Linked ImmunoSorbent Assay">ELISA</abbr> or <abbr title="Polymerase Chain Reaction">PCR</abbr> methods.</li>
            <li>Neurotrophin Tests (<abbr title="Brain-derived Neurotrophic Factor">BDNF</abbr>).</li>
        </ul>
        
        <h3>Cognitive Evaluations</h3>
        <ul>
            <li><abbr title="Montreal Cognitive Assessment">MoCA</abbr> (for memory and executive function).
            </li>
            <li>
                <abbr title="Digit Symbol Substitution Test">DSST</abbr>
            </li> 
            <li>Stroop Test</li>
            <li>Addition Test</li>
            <li>Processing Speed Index (PSI)</li>
            <li>Spatial Reasoning Test</li>
            <li>
                Mini-Mental State Examination (MMSE)
            </li>
        </ul>
            
        <h3>Biological Age and Cellular Health</h3>
        <ul>
            <li>DNA Testing (<a href="https://www.innerbody.com/dna-testing/dna-health-testing">Finding the Best DNA Health Test</a>)</li>
            <li>Advanced hormone testing (<a href="https://dutchtest.com/info-dutch-complete/">Dutch Complete</a>)</li>
            <li>Evaluation of mitochondrial function (ATP assays, e.g., <a target="_blank" href="https://www.caymanchem.com/product/701010">MitoCheck</a>).</li>
    
            <li><a title="TruAge COMPLETE at-home epigenetic test" href="https://shop.trudiagnostic.com/products/truage-complete-epigenetic-collection">TruAge</a> (Cellular repair mechanisms and longevity).</li>
            <li>Healthy methylation (Genova Diagnostics Methylation Panel).</li>
            <li>Inflammation Markers</li>
            <li>Inflammation markers (Cytokine Panel).</li>
            <li>Oxidative stress markers (ROS, Glutathione tests (<a target="_blank" href="https://www.labcorp.com/tests/007700/glutathione-total">CPT: 82978</a>)
            </li>
            <li>Mitochondrial health monitoring: JC-1 Assay</li>
            <li>Cell Viability ATP Assay (<a target="_blank" href="https://www.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-luminescent-cell-viability-assay/">CellTiter-GloÂ®</a>)
            </li>
            
            <li>Lymphocyte subsets and tracking using the <abbr title="Co-Stimulatory Activity Test for Immune Modulation">COSTIM</abbr> bioassay and Antibody Response Exam (ARE) via <abbr title="Enzyme-Linked Immunosorbent Assay">ELISA</abbr>).</li>          
        </ul>
        
        <blockquote>
            <p>
                <q>If you are not your own doctor, you are a fool.</q>
            </p>
            <p>
                <cite>â€” Hippocrates</cite>
            </p>
        </blockquote>
    </section>

    <section id="supplements">
        <h3>
            Supplements
        </h3>
        <p>
            Supplements complement food and help manage PD by addressing specific <a href="#problems-list">mechanisms</a> involved in its progression. They also enhance exercise performance, aid in recovery, support better sleep, and improve overall health and well-being. An overview of each supplement is provided following the legend below.
        </p>

		<h3>Warning on Supplements</h3>
		<p>
			Dietary supplements have limited safety and purity regulation.
		</p>
		<p>
			Supplement manufacturers commonly and legally use titanium dioxide (TiOâ‚‚) as a coating in supplements. The problem is that it can harm cellular function and brain health. A 2021 BioNanoScience review and supporting studies have shown review published in BioNanoScience, have shown TiOâ‚‚ nanoparticles induce oxidative stress, cause cellular inflammation, disrupt mitochondrial function, and cause genetic damage. In the brain, TiOâ‚‚ can damage neurons via oxidative stress, impair spatial memory, disturb neurotransmitter balance, and has potential to accumulate in brain tissues. While many excipients are harmless in the amounts used in supplements, someâ€”especially TiOâ‚‚â€”are not. Additionally, many artificial food colorings, such as Red #40, Yellow #5, and Blue #1, have been linked to potential health concerns. The US FDA does not require safety testing for supplement coatings, including TiOâ‚‚, which puts the onus on the consumer to stick to reputable brands and formulations and <strong>read the ingredients label</strong>. <cite class="reflink"><a href="#shabbir">shabbir</a>, <a href="#herrera-rodriguez">Herrera-RodrÃ­guez</a></cite>
		</p>
		
        <h4>Nutrition</h4>
        <h5>Nutritional Impact on Parkinsonâ€™s Disease</h5>
        <p>
            Some nutritional deficiencies can exacerbate PD symptoms and may be misinterpreted as progressive neurodegeneration, leading to inappropriate management if not addressed.
        </p>
        <p>
            Others can trigger cascading effects and hasten neurodegeneration. For example, deficiencies in vitamins B6, B12, folate, and D3 impair mitochondrial function, increase oxidative stress, and affect neurotransmitter synthesis, impacting neurological and overall health. These deficiencies can be caused by diet, lack of sun exposure, metabolic loss, or medications.
        </p>
<!--
        <h5>Dietary Considerations</h5>
        <p>
            Eggs are a source of omega-3 fatty acids, choline, lutein, zeaxanthin, vitamin E, beta carotene, vitamin A, and selenium. Pasture-raised eggs contain more bioactive compounds and less saturated fat and cholesterol. 
        </p>
        <p>
            Many plants contain phytochemicals that can improve conditions and inhibit the progression of PD. (See also:
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433754/"
>Plant Extracts and Phytochemicals Targeting &alpha;-Synuclein Aggregation in Parkinson's Disease Models</a>.)
        </p>
        -->
        <h4>Comprehensive Treatment Plans</h4>
        <p>
            A comprehensive, individualized treatment plan around nutrition and supplements involve everyone on the patient's team, encompassing exercise specialists and doctors. Regular testing and monitoring of symptoms and biochemical markers should be conducted to assess the effectiveness of interventions and make adjustments as needed. The patient must take an active role and own the treatment plan, rather than relying solely on his doctor.
        </p>  
        
        <h4>Antifibrillogenic Compounds</h4>
        <p>
            <dfn>Antifibrillogenic</dfn> compounds mitigate <dfn>fibrillogenesis</dfn>, the formation of Î±-synuclein fibrils from aggregates, a fundamental pathology in PD.
            
        </p>
        
        <h5>Delayed Causality</h5>
        <p>
            Although evidence for these compounds is limited and their effects not be immediately noticeable, this does not mean they are ineffective. Just as the development of PD often goes unnoticed for years before diagnosis, reventing fibrillogenesis won't produce immediate, noticeable effects. Both the disease and its counteraction aren't noticeable through daily symptom monitoring. Fibrillization is harmful, and stopping it is beneficial, even if not immediately apparent.
        </p>
        
        <h4>Preventing Fibril Aggregation</h4>
        <p>
            Preventing fibril aggregation: These treatments focus on inhibiting the aggregation of Î±-synuclein fibrils into Lewy bodies, potentially slowing the spread of pathology and neurodegeneration.
        </p>
        
        <p>
            The effects of antifibrillogenic interventions cannot be measured in laboratory settings. Regular neurological evaluations and symptom monitoring can offer some indirect evidence of changes in disease progression or symptom management but cannot establish any effect on fibrillization. Until laboratory assessments become available, combining clinical assessments with research insights remains the best approach for evaluating the potential impact of antifibrillogenic interventions.
        </p>
        
        <h4>Choosing Effective Treatments and Practitioners</h4>
        <p>
            Doctors who prioritize effective treatments should be favored, and those who dismiss claims without examination avoided. Focus should be placed on facts and evidence, risk versus reward, and health optimization. 
        </p>
		
		<ol class="reference-list">
			<!-- This list goes on top, so the user doesn't lose context from a long scroll -->
			<li id="shabbir">
				<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7835448/"
				title="Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO2NPs) and Their Jeopardy to Human Population"
				target="_blank"
				>Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO2NPs) and Their Jeopardy to Human Population</a>, Samina Shabbir, et al.
			</li>
			<li id="herrera-rodriguez">
				<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10655394/"
				title="Food-grade titanium dioxide and zinc oxide nanoparticles induce toxicity and cardiac damage after oral exposure in rats"
				target="_blank"
				>Food-grade titanium dioxide and zinc oxide nanoparticles induce toxicity and cardiac damage after oral exposure in rats</a>, Manuel Alejandro Herrera-RodrÃ­guez, et al. 
			</li>
		</ol>
        <section id="glynac">
            <h3>GlyNAC (Glycine-N-Acetyl Cysteine)</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms:</th>
                    <td>Antioxidant, Anti-inflammatory, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose:</th>
                    <td>6g per day ðŸ’¤</td>
                </tr>
                <tr>
                    <th>Fat-soluble:</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB:</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety:</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy:</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
                GlyNAC (Glycine-N-Acetyl Cysteine) is a combination of two separate amino acids, glycine, and N-acetylcysteine (NAC), both non-essential amino acids, administered together in a 1:1 ratio to promote the body's synthesis of glutathione, the master antioxidant. In addition to enhancing glutathione synthesis, GlyNAC offers several other physiological benefits.
            </p>
            
            <p>
                Beyond improving glutathione production, GlyNAC supplementation improves mitochondrial function, reduces inflammation, supports neurotrophic factor expression, and improves cognitive function. <cite class="reflink"><a href="#g-lizzo">g-lizzo</a>, <a href="#p-kumar">Premranjan Kumar</a>, <a href="#p-kumar_o-osahon">P. Kumar 2</a>, <a href="#p-kumar_r-sekhar">Premranjan Kumar (2)</a></cite>
            </p>

			<h4>Cognitive Effects</h4>
			<p>
			A 2021 clinical trial showed GlyNAC improves glutathione levels, mitochondrial function, and insulin sensitivity while reducing oxidative stress and inflammation.f NMDARs showed pro-cognitive and antidepressant effects. <cite class="reflink"><a href="#p-kumar">Premranjan Kumar</a></cite>
			</p>
			
			<h4>Glycine, Collagen, and NAC</h4>
			<p>
				While the effects of the 1:1 ratio of glycine to NAC is proven, glycine and NAC can be taken independently for a fraction of the cost, with the same benefits. 
			</p>
			
			<p>
				Collagen is about 20% glycine, making its supplementation a substantial contributor to glycine intake, shattering the patented "GlyNAC" 1:1 ratio formula. Nighttime collagen supplementation was shown to improve sleep in physically active males with sleep complaints, possibly due to its glycine content <cite class="reflink"><a href="#thomas">Thomas</a></cite>. Collagen's high glycine content, however, does not necessarily obviate its benefits on bone and connective tissue, including <abbr title="cerebrospinal fluid">CSF</abbr> production and barrier support in the brain, choroid plexus, basement membrane, dura mater, and structural support in neurons. 
			</p>
			
			<h4>Sleep-Promoting Effects</h4>
			<p>
				Glycine supplementation has been shown in multiple studies to improve sleep quality both subjectively and objectively. The mechanism seems to be via peripheral vasodilatation through the activation of NMDA receptors in the hypothalamus, which has the effect of increasing peripheral blood flow and lowering core temperature. These effects can also explain how it improves ischemic conditions. <cite class="reflink"><a href="#kawai">Kawai</a>, <a href="#villanueva">Quintanilla-Villanueva</a></cite>
			</p>
            
            <h4>Supplementation</h4>
            <p>
                 GlyNAC supplementation up to 7.2g per day is safe and well tolerated in older adults. GlyNAC is best taken at night. A cost-effective alternative approach would be to take 10g collagen peptides, 1g glycine powder, and 3g NAC.
            </p>
            <p>
                The half-life of NAC in the body is about 6 hours, and the half-life of glycine is anywhere from 25-250 minutes, so taking it at night allows for optimal utilization of the amino acids. <cite class="reflink"><a href="#p-kumar_o-osahon">P. Kumar 2</a></cite>
            </p>
            
            <h4>Side Effects</h4>
            <p>
                N-acetyl cysteine (NAC) can cause next-day lethargy. If experiencing this, the dose should be reduced, taken earlier in the evening, and bedtime adjusted accordingly.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
            
                <li id="g-lizzo">
                  <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261343/"
                  title="A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage"
                    target="_blank">A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage</a>, Giulia Lizzo, et al.
                    <p>
                        This double-blind RCT investigated supplementation with glycine and n-acetylcysteine (GlyNAC) at three different daily doses for 2 weeks (low dose: 2.4 g, medium dose: 4.8 g, or high dose: 7.2 g/day, 1:1 ratio) in a randomized, controlled clinical trial in 114 healthy volunteers.
                    </p>
                </li>
                
                <li id="p-kumar">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8002905/"
                      title="Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial"
                      target="_blank"
                      >Glycine and N-Acetylcysteine in Older Adults</a>, Premranjan Kumar, et al.
                      <p>
                          This clinical trial showed GlyNAC improves glutathione levels, mitochondrial function, and insulin sensitivity while reducing oxidative stress and inflammation.
                      </p>
                </li>
              	<li id="kawai">
					<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4397399/"
					title="The Sleep-Promoting and Hypothermic Effects of Glycine are Mediated by NMDA Receptors in the Suprachiasmatic Nucleus"
					target="_blank"
					>The Sleep-Promoting and Hypothermic Effects of Glycine are Mediated by NMDA Receptors in the Suprachiasmatic Nucleus</a>, Nobuhiro Kawai, et al.
				</li>
				<li id="thomas">
					<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10799148/"
					title="Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints"
					target="_blank"
					>Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints</a>, Craig Thomas, et al.
				</li>
				
              	<li id="villanueva">
					<a href="https://www.mdpi.com/2813-2475/3/2/16"
					title="The Role of Amino Acid Glycine on Cardiovascular Health and Its Beneficial Effects: A Narrative Review"
					target="_blank"
					>The Role of Amino Acid Glycine on Cardiovascular Health and Its Beneficial Effects: A Narrative Review</a>, Gabriela Elizabeth Quintanilla-Villanueva, et al.
				</li>
                <li id="p-kumar_o-osahon">
                      <a href="https://www.mdpi.com/2076-3921/12/5/1042"
                      title="GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Mice Increases Length of Life by Correcting Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Abnormalities in Mitophagy and Nutrient Sensing, and Genomic Damage"
                      target="_blank">GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Mice Increases Length of Life by Correcting Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Abnormalities in Mitophagy and Nutrient Sensing, and Genomic Damage</a>, Premranjan Kumar, Ob W. Osahon, and Rajagopal V. Sekhar.
                  <p>
                    This placebo-controlled rodent study showed that <q>GlyNAC supplementation improves age-associated cognitive decline and supports brain health in aging by improving/correcting brain GSH deficiency, elevated oxidative stress, mitochondrial dysfunction, abnormal mitophagy and autophagy, inflammation, impaired glucose transport/uptake, elevated genomic damage, and reversing the decline in brain neurotrophic growth factors.</q>
                  </p>
                </li>
                <li id="p-kumar_r-sekhar">
                    <a 
                      target="_blank"
                      title="GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Old Mice Improves Brain Glutathione Deficiency, Oxidative Stress, Glucose Uptake, Mitochondrial Dysfunction, Genomic Damage, Inflammation and Neurotrophic Factors to Reverse Age-Associated Cognitive Decline: Implications for Improving Brain Health in Aging"
                      href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215265/">GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Old Mice Improves Brain Glutathione Deficiency, Oxidative Stress, Glucose Uptake, Mitochondrial Dysfunction, Genomic Damage, Inflammation and Neurotrophic Factors to Reverse Age-Associated Cognitive Decline: Implications for Improving Brain Health in Aging</a>, Premranjan Kumar, et al.
                    <p>
                          This rodent study demonstrated improved age-associated cognitive decline (ACD) with GlyNAC.
                    </p>
                </li>
            </ol>
        </section>
        
        <section id="collagen-peptides">
            <h3>Collagen Peptides</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Brain structural Support, ECM, Anti-inflammatory, BBB Dysfunction</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>7.5g ED ðŸ’¤ (Improves sleep if taken at night)</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Somewhat Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            
            <p>
                Collagen makes up 30% of the body's protein and supports the extracellular matrix (ECM), the physical scaffolding that surrounds and supports cells throughout various tissues in the body. In the brain, the <abbr title="extracellular matrix">ECM</abbr> also maintains neuronal structure and synapse function. This can be compromised in PD.
            </p>
            <p>
                Collagen peptide (CP) supplementation increases glycosaminoglycan (GAG) production, which maintains tissue flexibility and moisture. It also influences gene expression related to collagen and elastin, promoting <abbr title="extracellular matrix">ECM</abbr> stability and tissue repair. When combined with exercise, CP may improve joint health and mobility, addressing some of the physical challenges faced by PD patients.
            </p>
            
            <p>
                CP is comprised of amino acids, with glycine making up roughly 20-22% of their total weight. Glycine is one of the three amino acids necessary for glutathione (GSH) synthesis, an important antioxidant in the body.
            </p>

            <h4>Sleep Benefits</h4>
            <p>
                A 2024 <abbr title="randomized controlled trial">RCT</abbr> showed collagen peptides reduced sleep interruptions and improved cognitive function in athletic males. <cite class="reflink"><a href="#thomas">Thomas</a></cite> 
            </p>
            
            <h4>Relevance to PD</h4>
            
            <p>
                CP supplementation was correlated with increased gray matter, improved memory, standard verbal paired associate learning (S-PA) tests, and changes in the physical, mental, and role/social component summary scores, reflecting improved brain health. <cite class="reflink"><a href="#koizumi">Koizumi</a></cite> 
            </p>
            <p>
                 In PD, tissue repair and resilience are weakened. Collagen peptides supplementation strengthens the <abbr title="extracellular matrix ">ECM</abbr> and related structures such as the BBB and choroid plexus. This could help protect against neurodegenerative damage.
            </p>
            <p>
                Research shows that <abbr title="extracellular matrix ">ECM</abbr> pathways are dysregulated in dopaminergic neurons from PD patients, impacting synaptic activity and neuronal function <cite class="reflink"><a href="#rosh">Rosh</a></cite>. Collagen peptides can improve <abbr title="extracellular matrix ">ECM</abbr> health and might help mitigate some of the neurodegenerative effects seen in PD.
            </p>
            <p>
                Research indicates that glycine supplementation can increase glycine levels in cerebrospinal fluid (CSF), potentially offering neuroprotective effects. <cite class="reflink"><a href="#bannai">Bannai</a></cite> 
            </p>
            
            <p>
                A 2019 study gave collagen hydrolysates (CH) to 30 healthy people, aged 49 to 63 years, once a day for 4 weeks. This resulted in a positive effect on gray matter volume, brain structure, and cognitive language ability. <cite class="reflink"><a href="#koizumi">Koizumi</a></cite>
            </p>
                            
            <h5>Collagen Peptides, The Choroid Plexus, and CSF Production</h5>

            <p>
                <abbr title="Collagen Peptides">CP</abbr> strengthens the choroid plexus and BBB and supports CSF production. <abbr title="cerebrospinal fluid">CSF</abbr>. 
            </p>
            <p>
                The choroid plexus produces most of the CSF and serves as a barrier between the blood and CSF, regulating the exchange of substances between the two. 50-60% of the choroid plexus is loose connective tissue, which supports the production and regulation of CSF. <abbr title="Collagen Peptides">CP</abbr> improves connective tissue health, so probably improves the choroid plexus.
            </p>
            <p>
                When the choroid plexus is weakened, the damage to the barrier it creates leads to neuroinflammation and impaired clearance of toxic metabolites. In PD, mutant Î±-synuclein spreads into the CSF, and this is proportionally facilitated by choroid plexus dysfunction. Mutant Î±-synuclein may also accumulate in the epithelial cells of the choroid plexus and be transported into the CSF, potentially disrupting its clearance between the brain and CSF. <abbr title="Collagen Peptides">CP</abbr> supplementation improves neurological health and strengthens the <abbr title="extracellular matrix ">ECM</abbr>, and strengthening the choroid process is likely part of the mechanism of action. This could aid in mitigating neuroinflammation and facilitating protein clearance in conditions like PD. <cite class="reflink"><a href="#rosh">Rosh</a>, <a href="#koizumi">Koizumi</a></cite>
            </p>
            
            <p>
                Collagen, especially types IV and XVII, is a major  structural protein in the BBB that supports the basal lamina, a layer anchoring and separating epithelial cells from the underlying connective tissues such as blood vessels and nerves. Supplementing collagen types I and IV can increase type XVII (COL17) production, and IGF-I may further enhance this. 
            </p>
            
            <h5>Hyaluronic Acid â€” Collagen Peptides' BBB Synergist</h5>
            <p>
                Hyaluronic acid (HA) retains moisture in the <abbr title="extracellular matrix ">ECM</abbr> and helps maintain tight junctions between endothelial cells. These tight junctions are essential for the BBBâ€™s selective barrier, preventing harmful substances from entering the brain. Together, collagen peptides and HA support the BBBâ€™s strength and flexibility.
            </p>
            
            <h4>Supplementation</h4>
            <p>
                Taking 7-10 grams of collagen peptides at night may promote relaxation, lower core temperature, reduce awakenings, and improve cognitive function. <cite class="reflink"><a href="#bannai">Bannai</a>, <a href="#thomas">Thomas</a></cite> 
            </p>
            
            <h4>Collagen with NAC</h4>
            <p>
                Taking collagen peptides with N-acetylcysteine (NAC) helps increase glutathione (GSH) levels, reduces inflammation, and supports mitochondrial function. This combination can be an effective alternative to <abbr title="Glycine N-acetylcysteine">GlyNAC</abbr>. 1.5g of <abbr title="N-acetylcysteine">NAC</abbr> combined with 7.5g of <abbr title="Collagen Peptides">CP</abbr> should provide benefits similar to 3g of GlyNAC. CP is approximately 20-22% glycine, so 7.5g of <abbr title="Collagen Peptides">CP</abbr> contains roughly 1.5g of glycine.
            </p>
            
            <h4>Measuring Efficacy</h4>
            <p>
                Measure <abbr title="glycosaminoglycan">GAG</abbr> levels before and after the intervention to directly assess changes in ECM health. Non-invasive techniques, such as ultrasound, can evaluate soft tissue or joint health. Additionally, motor tests assessing joint flexibility and movement may provide useful insights.
            </p>
            <p>
                Procollagen Type I and III tests assess new collagen production, indicating connective tissue and ECM health. This provides a useful indicator of <abbr title="extracellular matrix ">ECM</abbr> health.
            </p>
            <h4>References</h4>
            <ol class="reference-list">
            <li id="rosh">
                <a href="https://www.nature.com/articles/s41531-024-00653-x"
                title="Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinsonâ€™s disease patients"
                target="_blank"
                >Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinsonâ€™s disease patients</a>, Idan Rosh, et al.
            </li>
            <li id="bannai">
                <a href="https://www.sciencedirect.com/science/article/pii/S1347861319305729"
                title="New Therapeutic Strategy for Amino Acid Medicine: Glycine Improves the Quality of Sleep"
                target="_blank"
                >New Therapeutic Strategy for Amino Acid Medicine: Glycine Improves the Quality of Sleep</a>, Makoto Bannai and Nobuhiro Kawai.
            </li>
            <li id="thomas">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10799148/"
                title="Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints"
                target="_blank"
                >Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints</a>, Craig Thomas, et al.
            </li>
            <li id="koizumi">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019356/"
                title="Effects of Collagen Hydrolysates on Human Brain Structure and Cognitive Function: A Pilot Clinical Study"
                target="_blank"
                >Effects of Collagen Hydrolysates on Human Brain Structure and Cognitive Function: A Pilot Clinical Study</a>, Seiko Koizumi, et al.
            </li>
        </ol>
        </section>
        <section id="creatine">
            <h3>Creatine Monohydrate</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>10g ED</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <h4>Creatine and Energy Production</h4>
            <p>
                Creatine is a naturally occurring amino acid that the body produces and obtains from diet. It stores and supplies energy to muscle, brain, and cardiac cells. Creatine helps regenerate ATP, the primary energy source for cells, in what is called the <dfn>phosphagen</dfn> or ATP-PC (Adenosine Triphosphate-Phosphocreatine) system, for rapid energy production during high demand.
            </p>

            <p>
                 Creatine reduces oxidative stress by lowering mitochondrial workload and scavenging free radicals, thereby minimizing mitochondrial damage, protecting cells, and reducing their death. <cite class="reflink"><a href="#c-rae">C. Rae</a>, <a href="#a-c-passaquin">A.C. Passaquin</a>, <a href="#h-arazi">H. Arazi</a></cite>
            </p>
            
            <h4>Creatine and Exercise</h4>
            <p>
                Creatine improves muscular strength and exercise recovery, supporting health optimization when combined with physical activity. <cite class="reflink"><a href="#h-chang">H. Chang</a></cite>
            </p>
            
            <h4>Cellular Mechanism of Action</h4>
            <p>
                Understanding the <abbr title="Adenosine Triphosphate-Phosphocreatine">ATP-PC</abbr> systemâ€”how its energy production helps cognitive and neural healthâ€”can inform supplementation. However, this knowledge isn't required to benefit from creatine use.
            </p>
            
            <p>
                Mitochondria generate energy primarily through the citric acid cycle and oxidative phosphorylation (<abbr title="oxidative phosphorylation">OXPHOS</abbr>). The citric acid cycle converts acetyl-CoA into energy intermediates like <abbr title="Nicotinamide adenine dinucleotide Hydrogen (reduced)">NADH</abbr>, which fuel <abbr title="oxidative phosphorylation">OXPHOS</abbr> to produce <abbr title="adenosine triphosphate">ATP</abbr>, the main energy source for cells. During this process, CO<sub>2</sub> is released, and <abbr title="Reactive Oxygen and Nitrogen Species">RONS</abbr> are produced. In the cell, creatine (<abbr title="creatine monohydrate">CM</abbr>) is converted by creatine kinase (CK) to creatine phosphate (CP), which quickly replenishes <abbr title="adenosine triphosphate">ATP</abbr> during high-energy demands, alleviating stress on <abbr title="oxidative phosphorylation">OXPHOS</abbr> and reducing <abbr title="Reactive Oxygen and Nitrogen Species">RONS</abbr> production. This supports cellular function and mitochondrial health.
            </p>

            <h5>Creatine as Cellular Energy for Synapses</h5> 
            <p>
                The brain is highly glucose-dependent, accounting for roughly 20% of the bodyâ€™s total energy expenditure despite its small size. Neuronal synapses require a lot of energy to release neurotransmitters, which need <abbr title="adenosine triphosphate">ATP</abbr>. Inside neurons, creatine is bound to phosphate as <abbr title="Creatine Phosphate">CP</abbr>, just as it does in skeletal muscle cells. Creatine donates a phosphate to <abbr title="adenosine diphosphate">ADP</abbr> to form <abbr title="adenosine triphosphate">ATP</abbr>, which then supplies the energy needed for synaptic function.
            </p>
            
            <p>
                Creatine supplementation increases brain creatine levels. During stress or trauma, such as intense exercise, creatine supplementation improves oxidative DNA injury and normalizes brain and body creatine levels. <cite class="reflink"><a href="#s-forbes">S. Forbes</a></cite>
            </p>

            <p>
                A 2023 review study published in Sports Medicine found long-term high-dosage creatine supplementation increases brain creatine stores, improves cognition and memory, especially in older adults or during times of metabolic stress (e.g. sleep deprivation), improves aspects of recovery from traumatic brain injury in children, and has the potential to reduce symptoms of depression and anxiety. <cite class="reflink"><a href="#d-candow">D. Candow</a></cite>
            </p>
            
            <h4>Creatine and PD</h4>
            <p>
                Creatine has shown neuroprotection in PD patients with cognitive decline via creatine transporter uptake. In a rodent model, high-dosage creatine was shown to exert anti-inflammatory, antioxidative, and anti-aggregant effects on Î±-synucleinopathy. <cite class="reflink"><a href="#y-leem">Y. Leem</a>, <a href="#h-chang">H. Chang</a></cite>
            </p>
            
            <p>
                A long-term, multicenter, double-blind, parallel-group, placebo-controlled, 1:1 randomized efficacy trial for 10g of creatine in PD patients showed benefit to the <abbr title="Unified Parkinson's Disease Rating Scale">UPDRS</abbr> both at 1 year and at 18 months but eventually terminated early with no determined harm or benefit. <cite class="reflink"><a href="#k-kieburtz">K. Kieburtz</a></cite>
            </p>
            
            <p>
                These results are not entirely disappointing. The study's lack of focus on pairing creatine with intensive exercise may have limited its ability to detect potential benefits.
            </p>
                
            <p>
                <abbr title="High Intensity Interval Training">HIIT</abbr> significantly mitigates and may partially reverse progressive neurodegeneration. However, high-intensity exercise also depletes brain creatine, which impacts neurological function. 
            </p>
            <p>             
                Had the patients in this study been assigned to a <abbr title="High Intensity Interval Training">HIIT</abbr> regimen, they would have benefitted from the exercise. HIIT depletes creatine levels and may deplete brain creatine levels. Creatine supplementation might result in less exercise-induced depletion of creatine, less oxidative damage caused by the exercise, and better exercise recovery (allowing for more frequent training). Such a design might have revealed a more significant benefit to the 10g ED creatine supplementation. However, despite the study's design, beneficial effects <em>were</em> observed at 1 year and at 18 months. <cite class="reflink"><a href="#b-laat">B. Laat</a></cite>
            </p>
            
            
            <h4>Supplementation</h4>
            
            <p>
                Taking creatine with food improves absorption. Eating stimulates insulin-like growth factor-1 (IGF-1) production, which helps increase creatine uptake. Because dosages recommended for neurological function tend to be much higher, in excess of 20g per day, those with impaired kidney function might consider a more moderate dose as a compromise. 
            </p>
             
            <h4>Safety and Efficacy</h4>
            <p>
                Creatine is commonly used with minimal adverse effects reported in clinical studies.
            </p>
            <p>
                Creatine supplementation alone may not significantly slow the progression of Parkinson's disease, especially not in the later stages. But its neuroprotective and antioxidant effects contribute to overall disease management when used as part of a comprehensive treatment approach, particularly in combination with exercise, to stave off disease progression in the early stages of the disease. Because creatine helps with exercise recovery, its use allows for more frequent training to enjoy the benefits of exercise.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="c-rae">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1691485/"  title="Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial."
                    target="_blank"
                    >Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial</a>, Caroline Rae, et al
                    <p>
                        Creatine supplementation had a significant positive effect on both working memory (backward digit span) and intelligence (Raven's Advanced Progressive Matrices), both tasks that require speed of processing. 
                    </p>
                </li>

                <li id="h-chang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10844727/" title="The potential role of creatine supplementation in neurodegenerative diseases"
                    target="_blank"
                    >The potential role of creatine supplementation in neurodegenerative diseases</a>, Hyukki Chang, et al.
                    <p>
                        This review study concluded creatine supplementation had neuroprotective effects in animal models and in vitro studies of certain neurodegenerative diseases, but that clinical trials failed to reproduce favorable outcomes.
                    </p>
                </li>
                <li id="a-c-passaquin">
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S0960896601002735" title="Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice"
                    target="_blank"
                    >Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice</a>, Anne-Catherine Passaquin , et al.
                    <p>
                        This study found creatine supplementation in mice improves muscle health and may provide a scientific basis for its use as adjuvant therapy in Duchenne muscular dystrophy.
                    </p>
                </li>
                
                <li id="h-arazi">
                    <a href="https://www.mdpi.com/2072-6643/13/3/869" 
                    title="Creatine Supplementation, Physical Exercise and Oxidative Stress Markers: A Review of the Mechanisms and Effectiveness"
                    target="_blank"
                    >Creatine Supplementation, Physical Exercise and Oxidative Stress Markers</a>, Hamid Arazi, et al.
                    <p>
                        This review study concluded creatine's antioxidant mechanisms include reduced <abbr title="Reactive Oxygen Species">ROS</abbr> and <abbr title="Reactive Nitrogen Species">RNS</abbr>, and that creatine can maintain mitochondrial integrity, increase creatine phosphate (CP) resources, act as a cellular energy buffer, and protect two important cellular targets, mtDNA and RNA, from oxidative damage. 
                    </p>
                </li>

                <li id="y-leem">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/38262563/"
                    title="Creatine supplementation with exercise reduces Î±-synuclein oligomerization and necroptosis in Parkinson's disease mouse model"
                    target="_blank"
                    >Creatine supplementation with exercise reduces Î±-synuclein oligomerization and necroptosis in Parkinson's disease mouse model</a>, Yea-Hyun Leem, et al.
                    <p>
                        These authors found that creatine supplementation with exercise has anti-inflammatory, antioxidative, and anti-Î±-synucleinopathy effects, thereby reducing necroptotic cell death in a PD mouse model.
                    </p>
                </li>
                
                <li id="s-forbes">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912287/"
                    title="Effects of Creatine Supplementation on Brain Function and Health"
                    target="_blank"
                    >Effects of Creatine Supplementation on Brain Function and Health</a>, Scott C. Forbes, et al.
                    <p>
                    
                    </p>
                </li>
                
                <li id="d-candow">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721691/"
                    title="&ldquo;Heads Up&rdquo; for Creatine Supplementation and its Potential Applications for Brain Health and Function&rdquo;"
                    target="_blank"
                    >&ldquo;Heads Up&rdquo; for Creatine Supplementation and its Potential Applications for Brain Health and Function&rdquo;</a>, Darren G. Candow, et al.
                    <p>
                    
                    </p>
                </li>
                
                <li id="k-kieburtz">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349346/"
                    title="Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease"
                    target="_blank"
                    >Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease</a>, Karl Kieburtz, et al.
                    <p>
                        This researchers of this RCT found 10g creatine daily was not harmful, and showed benefits at 12 months and 18 months, but then concluded that this did not support the use of creatine monohydrate in patients with Parkinson disease.
                    </p>
                </li>
                
                <li id="b-laat">
                    <a href="https://www.nature.com/articles/s41531-024-00641-1"
                    title="Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinsonâ€™s disease"
                    target="_blank"
                    >Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinsonâ€™s disease</a>, Bart de Laat, et al.
                    <p>
                    
                    </p>
                </li>
            </ol>
        </section>
        
        <section id="taurine">
            <h3>Taurine</h3>
            
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Mitochondrial, Calcium Dysregulation, Endoplasmic Reticulum (ER) Dysfunction, Antioxidant </td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>3g Pre-Workout </td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âŒ </td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ </td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span> </span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span> </span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            
            <p>
                Taurine is a naturally occurring non-essential amino acid found in meat, fish, and eggs, with benefits for cardiovascular and neurological health, mitochondrial function, antioxidant protection, bone and cartilage formation, and calcium regulation. Taurine acts as an antioxidant and osmolyte, helping to regulate intracellular osmotic pressure and maintaining cellular homeostasis, helping to protect against DNA damage and prevent cell death.
            </p>
            
            <h4>Taurine and Aging</h4>
            <p>
            	A 2023 study on taurine in various animals found that circulating taurine levels decreased with age. Supplementation with taurine slowed markers of aging, including DNA damage, telomerase deficiency, impaired mitochondrial function, and cellular senescence. Loss of taurine in humans was associated with aging-related diseases, and concentrations of taurine and its metabolites increased in response to exercise. Taurine supplementation improved lifespan in mice and healthspan in monkeys. 
            </p>
            <p>
            	For one of their experiments, the researchers gave 14-month-old miceâ€”middle-aged miceâ€”500 or 1000mg taurine per day for 10-12 months. This supplementation increased median lifespan by 10 to 12%. When they investigated the health of taurine-fed middle-aged mice, they found an improved functioning of bone, muscle, pancreas, brain, fat, gut, and immune system, indicating an overall increase in health span. <cite class="reflink"><a href="#singh">Singh</a></cite>
            </p>
            
            <h4>Calcium-Regulating Effects</h4>
            <p>
                Taurine helps the body use and regulate calcium, both intracellularly, by preventing its excessive entry into neurons and systemically, by helping shuttle extracellular calcium into bones. 
            </p>
            <p> 
                Taurine's functioning as an osmolyte helps to prevent calcium overload, counteracting the adverse effects of glutamate toxicity, reducing endoplasmic reticulum stress, and sparing mitochondrial function. Under excitotoxic conditions (e.g., excess glutamate), intracellular calcium can increase due to NMDA receptor hyperactivity. Taurineâ€™s osmoregulatory effect helps buffer against these sudden ionic shifts and subsequent calcium influx that would otherwise contribute to ER stress and mitochondrial overload.
<cite class="reflink"><a href="#baliou">Baliou</a>, <a href="#schaffer">Schaffer</a></cite>
            </p>
            
            <p> 
	             Taurine influences calcium, including voltage-gated calcium channels and the NMDA receptor channel, by stabilizing membrane potential, or difference in the concentration of electrolytes between the intracellular and extracellular environments, and reducing excitability. This moderates excessive calcium entry into the cell without directly acting as a strong agonist of GABA receptors. <cite class="reflink"><a href="#schaffer">Schaffer</a></cite>
            </p>
             
             
            <p> 
                 Taurine also uses calcium to help promote differentiation of neural progenitor cells (NPCs), leading to neurite outgrowth (neurogenesis), part of a regulated process in progenitors that allows for beneficial calcium entry without overstimulation, beneficial to the brain and cognitive health. <cite class="reflink"><a href="#gutierrez-castanada">GutiÃ©rrez-CastaÃ±eda</a></cite>
            </p>
            
            <h5>Effects on Bone and Cartilage</h5>
            <p>
                Taurine stimulates osteogenesis (bone formation) and chondrogenesis (cartilage formation), improving bone density, development, and remodeling. It stimulates osteoblasts and inhibits osteoclasts, favoring osteocalcin production, signaling calcium uptake into bone. Taurine helps cartilage maintenance by increasing the synthesis of <abbr title="extracellular matrix">ECM</abbr> components, such as glycosaminoglycans and collagen, in chondrocytes. <cite class="reflink"><a href="#perez-hernandezn">PÃ©rez-HernÃ¡ndez</a></cite>
            </p>
            
            <p>
                Taurine's osteogenic effects draw calcium from the blood, reducing excess extracellular calcium from damaging neurons or calcifying arteries. Because excess extracellular calcium can contribute to neuronal intracellular calcium overload, taurine's effects on intracellular and extracellular calcium strongly support mitochondrial protection and neuronal health in PD. <cite class="reflink"><a href="#w-q-chen">W Q Chen</a></cite>
            </p>
                
            <h4>Ergogenic Effects</h4>
            <p>
                 Taurine's calcium-regulating effects in both skeletal muscle and cardiac tissue significantly improve several performance metrics, including muscle force, lipid metabolism, and insulin sensitivity. A 2020 review found taurine supplementation improved anaerobic and aerobic performance metrics, including VO2 max, time to exhaustion, muscle damage, peak power, and recovery. <cite class="reflink"><a href="#kurtz">Kurtz</a></cite>
            </p>
            
            <p>
	            Taurine's osmolytic effects stabilize cell membranes and regulate electrolyte balance, which helps restore muscle cells to their resting state after intense physical activity. This stabilizing effect reduces muscle fatigue and oxidative stress post-exercise, improving exercise recovery.
            </p>
            
            <h4>Supplementation</h4>
            <p>
                 3 grams of taurine pre-workout safely improves performance, reduces cellular damage, and improves recovery. The high dose used on rodents in the Singh study (1000mg/kg/day for mice), translates to a higher, but still safe human dose of about 5.6g for a 70kg person (1000mg/kgÃ—0.081 = 81mg/kg/day for humans).
            </p>
            
            <ol class="reference-list">
                 <li id="perez-hernandez">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9449101/"
                    title="A Key Metabolic Regulator of Bone and Cartilage Health"
                    target="_blank"
                    >A Key Metabolic Regulator of Bone and Cartilage Health</a>, Elizabeth PÃ©rez-HernÃ¡ndez, et al.
                </li>
                <li id="singh">
                    <a href="https://www.science.org/doi/10.1126/science.abn9257"
                    title="Taurine deficiency as a driver of aging"
                    target="_blank"
                    >Taurine deficiency as a driver of aging</a>, Parminder Singh, et al.
                </li>
                <li id="schaffer">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5933890/"
                    title="Effects and Mechanisms of Taurine as a Therapeutic Agent"
                    target="_blank"
                    >Effects and Mechanisms of Taurine as a Therapeutic Agent</a>, Stephen Schaffer, Ha Won Kim.
                </li>
                <li id="baliou">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8240184/"
                    title="Protective role of taurine against oxidative stress"
                    target="_blank"
                    >Protective role of taurine against oxidative stress</a>, Stella Baliou, et al.
                </li>
                <li id="gutierrez-castanada">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10181976/"
                    title="Taurine Promotes Differentiation and Maturation of Neural Stem/Progenitor Cells from the Subventricular Zone via Activation of GABAA Receptors"
                    target="_blank"
                    >Taurine Promotes Differentiation and Maturation of Neural Stem/Progenitor Cells from the Subventricular Zone via Activation of GABAA Receptors</a>, GutiÃ©rrez-CastaÃ±eda, et al.
                </li>
                <li id="w-q-chen">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/11746381/"
                    title="Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons"
                    target="_blank"
                    >Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons</a>, W Q Chen, et al.
                </li>
                <li id="kurtz">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8152067/"
                    title="Taurine in sports and exercise"
                    target="_blank"
                    >Taurine in sports and exercise</a>, Jennifer A Kurtz, et al.
                </li>
            </ol>
        </section>
        
        <section id="citrulline">
			<h3>Citrulline Malate</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Anti-ischemic, Cognitive </td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>4-8 g Pre-Workout </td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âŒ </td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ </td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span> </span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span> </span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            
            <p>
				Citrulline malate is a 2:1 compound of L-citrulline, a non-essential amino acid, with malic acid to enhance absorption. It promotes vasodilation and circulation, exercise recovery, and is an intermediary in the urea cycle.
			</p>
			
			<h4>Pre-Workout Benefits</h4>
			<p>
				Citrulline malate works best when used as a pre-workout supplement, due to its ability to increase nitric oxide production, delay muscle fatigue, improve oxygen delivery, increase energy production, and help workout performance and recovery.
			</p>
			
			<h4>Anti-Oxidant Effects</h4>
			<p>
				 In a 2021 <abbr title="randomized controlled trial">RCT</abbr> on diabetic patients, L-citrulline supplementation increased the activity of antioxidant enzymes <abbr title="superoxide dismutase">SOD</abbr> and catalase, which neutralize reactive oxygen species (ROS). <cite class="reflink"><a href="#s-azizi">Azizi</a></cite>
			</p>
			
			<h4>Cognitive Effects</h4>
			<p>
				A three-month study on mice with Alzheimer's found that males given citrulline showed improved memory performance in maze tests, possibly due to higher arginine levels in cerebrospinal fluid. This suggests a nitric oxide-related benefit for cognitive function. <cite class="reflink"><a href="#martinez-gonzalez">MartÃ­nez-GonzÃ¡lez</a></cite>
			</p>

			<p>
				Oral administration of L-citrulline was shown to prevent hippocampal neuron loss and capillary damage after brain ischemia in mice, likely due to restored expression of eNOS, nitric oxide synthase, in endothelim,  the layer of cells that line blood vessels and lymphatic vessels. This finding may have implications for neuroprotection in PD. <cite class="reflink"><a href="#yabuki">Yabuki</a></cite>
			</p>
			
			<h4>Supplementation</h4>
			<p>
				A pre-workout dose of 4-8 grams of citrulline malate effectively improves blood flow and recovery for most individuals without adverse effects. Start with a lower dose, adjusting based on body size and workout intensity. <cite class="reflink"><a href="#varvik">VÃ¥rvik</a></cite>
			</p>
			<ol class="reference-list">
                <li id="yabuki">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/23685189/"
                    title="Oral l-Citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection"
                    target="_blank"
                    >Oral l-Citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection</a>, Y. Yabuki, et al.
                </li>
                <li id="martinez-gonzalez">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/33940559/"
                    title="Citrulline supplementation improves spatial memory in a murine model for Alzheimer's disease."
                    target="_blank"
                    >Citrulline supplementation improves spatial memory in a murine model for Alzheimer's disease.</a>, Katia MartÃ­nez-GonzÃ¡lez, et al.
                </li>
                <li id="varvik">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/34010809/"
                    title="Acute Effect of Citrulline Malate on Repetition Performance During Strength Training: A Systematic Review and Meta-Analysis."
                    target="_blank"
                    >Acute Effect of Citrulline Malate on Repetition Performance During Strength Training: A Systematic Review and Meta-Analysis.</a>,  F. T. VÃ¥rvik, et al
                </li>
                <li id="s-azizi">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32683790/"
                    title="Oxidative stress and nitrate/nitrite (NOx) status following citrulline supplementation in type 2 diabetes: a randomised, double-blind, placebo-controlled trial."
                    target="_blank"
                    >Oxidative stress and nitrate/nitrite (NOx) status following citrulline supplementation in type 2 diabetes: a randomised, double-blind, placebo-controlled trial.</a>, S Azizi, et al.
                </li>
            </ol>
        </section>
        <section id="cacao">
            <h3>Raw Cacao</h3>
            
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Anti-ischemic, Antioxidant, Anti-inflammatory</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>7g ED â˜€ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ… (Theobromine, caffeine, and flavonoids are somewhat fat-soluble. The Fatty Acids and Phytosterols are very fat-soluble)</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Somewhat Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            
            <h4>Raw Cacao vs Cocoa (Processed Chocolate)</h4>
            <p>
                Raw cacao is made from cold-pressed, unroasted cocoa beans, preserving the nutritional content, in contrast to cocoa, which is heavily processed, roasted at high temperatures, and often has added sugar. 
            </p>
            
            <h4>Health Benefits</h4>
            <p>
                Raw cacao contains polyphenols and stimulants that contribute to its neuroprotective, cognitive, and physical performance-enhancing effects. Cacao's flavonoids improve blood flow, reduce inflammation, and provide antioxidant neuroprotection. Catechin and epicatechin may enhance neurotransmitter function. Stimulants like theobromine, caffeine, phenylethylamine (PEA), theophylline, tyramine, and anandamide, a natural endocannabinoid, all improve neurotransmitter function, alertness, and mood. Together, these compounds synergistically protect neurons to support cognitive function and physical performance, providing multifaceted benefits for conditions like PD.
            </p>
            
            <h4>Stimulants and Neurotransmitters</h4>
            <p>
                While cacao contains several stimulants, its overall effects are generally milder and more sustained compared to caffeine. Theobromine, in particular, has a slower onset and longer duration of action than caffeine. Phenylethylamine, tyramine, and anandamide are all endogenously produced neurotransmitters, also present in cacao, and are all significantly lowered in PD, which may contribute to disease progression. Consuming cacao improves these levels, and catechin and epicatechin may help prolong their effects.  <cite class="reflink"><a href="#g-zhou">Zhou</a></cite>
            </p>
            
            <h5>Phenylethylamine (PEA)</h5>
            <p>
                Phenylethylamine (PEA) is a naturally occurring neurotransmitter also present in cacao, but is significantly decreased in PD. PEA affects mood, attention, and motivation, and reduced levels seen in PD might contribute to the non-motor symptoms of mood, depression, and cognitive decline. <cite class="reflink"><a href="#miura">miura</a></cite>
            </p>
            
            <h5>Anandamide</h5>
            <p>
                Anandamide, a known endocannabinoid also present in cacao, is decreased in PD. By reducing NMDA receptor-mediated calcium influx through cannabinoid receptor-dependent mechanisms, anandamide might reduce the excitatory pathways that lead to calcium influx and damage dopaminergic neurons, which are calcium-sensitive and thus particularly vulnerable to excitotoxic damage in PD and exacerbated by DRT (see also: <a href="#impact-dopamine-agonists">Impact of DRT</a>). <cite class="reflink"><a href="#hampson">hampson</a></cite>
            </p>
            <p>
                GABAergic dysfunction in PD impairs inhibitory signaling, contributing to prolonged nueronal excitatory states. This leads to unregulated NMDA receptor activity and subsequent calcium overload. Anandamide helps this by modulating NMDA receptor activity and reducing calcium influx via cannabinoid receptor activation, helping to dampen glutamate-induced excitotoxicity, possibly reducing neuronal damage associated with GABAergic dysfunction and prolonged excitatory states. 
            </p>
            <h4>Cognitive Benefits</h4>
            <p>
                Studies on raw cacao show cognitive improvement in healthy individuals of various ages. A 2024 single-blind study from Japan examined the cognitive effects of high versus low polyphenol cacao. The high polyphenol group showed improvements in mental and physical fatigue, stress, boredom, sleepiness, motivation, healing, enjoyment, relaxation, concentration, and willingness after two sets of cognitive performance tests. <cite class="reflink"><a href="#r-lalonde">R. Lalonde</a>, <a href="#a-sasaki">A. Sasaki</a></cite>
            </p>
            
            <h4>Preparation</h4>
            <p>
                To maximize the health benefits of cacao, it should be consumed in its raw or minimally processed form, such as raw cacao paste or powder. Heat processing degrades beneficial flavonoids and other nutrients, so should be minimized during preparation. Additionally, added sugar not only diminishes the potential health benefits but also contributes to the formation of advanced glycation end-products (AGEs), which are associated with aging and various chronic diseases. Unsweetened, high-quality cacao is best for optimal health.
            </p>
            
            <p>
                Cacao powder contains fat-soluble compounds but can be dissolved in hot water as a beverage with fats like coconut oil added.
            </p>
            <h4>Stimulatory Effects</h4>
            <p>
                Cacao contains theobromine (dimethylxanthine), a stimulant similar to caffeine but less methylated. Both bind to adenosine receptors in the brain, increasing activity and alertness, and can interfere with sleep. Therefore, it is advisable to avoid consuming cacao later in the day.
            </p>

            <h4>References</h4>
            <ol class="reference-list">
            
                <li id="miura">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/11197147/"
                    title="Plasma beta-phenylethylamine in Parkinson's disease"
                    target="_blank"
                    >Plasma beta-phenylethylamine in Parkinson's disease</a>, Y Miura.
                </li>
                
                <li id="hampson">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/9453561/"
                    title="Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission"
                    target="_blank"
                    >Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission</a>, A J Hampson, et al.
                </li>
                
                <li id="g-zhou">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169850/"
                    title="Decreased Î²-phenylethylamine in CSF in Parkinson's disease"
                    target="_blank"
                    >Decreased Î²-phenylethylamine in CSF in Parkinson's disease</a>, G. Zhou, et al.
                </li>
                
                <li id="a-sasaki">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10780455/"
                    title="Cacao Polyphenol-Rich Dark Chocolate Intake Contributes to Efficient Brain Activity during Cognitive Tasks: A Randomized, Single-Blinded, Crossover, and Dose-Comparison fMRI Study"
                    target="_blank"
                    >Cacao Polyphenol-Rich Dark Chocolate Intake Contributes to Efficient Brain Activity during Cognitive Tasks: A Randomized, Single-Blinded, Crossover, and Dose-Comparison fMRI Study</a>, Akihiro Sasaki, et al.
                </li>
                
                 <li id="r-lalonde">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35993474/"
                        title="
Cocoa Flavanols and the Aging Brain"
                        target="_blank"
                        >Cocoa Flavanols and the Aging Brain</a>, Robert Lalonde, Catherine Strazielle.
                </li>
            </ol>
        </section>
            
        <section id="cinnamon">
            <h3>Cinnamon</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antidiabetic</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>4g ED</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ… (Cinnamaldehyde and eugenol are moderately fat-soluble)</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Somewhat Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            
            <p>
                Cinnamon is a spice obtained from the inner bark of several species of trees. Ceylon cinnamon is preferred, as it contains no coumarin, a natural carcinogen. Cinnamon contains both water-soluble and fat-soluble compounds. Cinnamon's fat-soluble compounds include cinnamaldehyde and epicatechin and its water-soluble compounds include procyanidin type-A trimer, cinnamic acid, and various flavonoids. 
            </p>
            
            <h4>Antidiabetic Effects</h4>
            <p>
                Cinnamon exhibits anti-hyperglycemic properties, with the most significant effects observed in Ceylon cinnamon. These effects are species-specific.  <cite class="reflink"><a href="#n-j-hayward">N.J. Hayward</a></cite>
            </p>
            
            <p>
                It does this by mimicking insulin receptor kinase, increasing glucose uptake, and glycogen synthase activity, and increasing GLP-1 concentrations. <cite class="reflink"><a href="#n-kizilaslan">n-Kizilaslan</a>, <a href="#j-hlebowicz">J. Hlebowicz</a></cite>
            </p>
            
            <p>
                In a 2006 randomized, placebo-controlled, double-blind study, an aqueous solution of cinnamon found improvements on fasting blood glucose and systolic blood pressure, and improvements in body composition in men and women with metabolic syndrome. <cite class="reflink"><a href="#ziegenfuss">T. Ziegenfuss</a></cite>
            </p>
            
            <h4>Neuroprotective Effects</h4>
            <p>
                Glucose metabolism is impaired in PD. Improved glucose response and blood glucose levels from cinnamon's antidiabetic effects may benefit PD patients. <cite class="reflink"><a href="#a-marques">A. Marques</a></cite>
            </p>
            <p>
                Ingested cinnamon metabolizes to sodium benzoate (NaB). Both cinnamon and NaB upregulate neuroprotective molecules (Parkin and DJ-1) and protect the nigrostriatum in a mouse model. <cite class="reflink"><a href="#s-khasnavis">S. Khasnavis</a></cite>
            </p>
            
            <h4>Supplementation</h4>              
            <p>
                Translating the mouse dosage used in the Khasnavis study to a human dosage, using the study's 100 mg/kg to a 12x k-factor results in 1.2 g/kg. For a 50 lb human, this equates to 60 grams of cinnamon daily â€” an impractical amount. Consuming 3g daily is only 5% of the suggested dose, offering minimal neuroprotection. This small dose can be achieved by adding cinnamon to premixed powders such as the cacao mix, post-workout protein mix, and golden milk. Consuming CinnulinPF can achieve more optimal levels. <cite class="reflink"><a href="#d-patel">Patel</a></cite>
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
            
                <li id="ziegenfuss">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129164/"
                    title="Effects of a Water-Soluble Cinnamon Extract on Body Composition and Features of the Metabolic Syndrome in Pre-Diabetic Men and Women"
                    target="_blank"
                    >Effects of a Water-Soluble Cinnamon Extract on Body Composition and Features of the Metabolic Syndrome in Pre-Diabetic Men and Women</a>, Tim N Ziegenfuss, et al.
                </li>

                <li id="n-j-hayward">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900266/"
                    title="Cinnamon Shows Antidiabetic Properties that Are Species-Specific: Effects on Enzyme Activity Inhibition and Starch Digestion"
                    target="_blank"
                    >Cinnamon Shows Antidiabetic Properties that Are Species-Specific: Effects on Enzyme Activity Inhibition and Starch Digestion</a>, Nicholas J. Hayward, et al.
                </li>
                
                <li id="n-kizilaslan">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425402/"
                    title="The Effect of Different Amounts of Cinnamon Consumption on Blood Glucose in Healthy Adult Individuals"
                    target="_blank"
                    >The Effect of Different Amounts of Cinnamon Consumption on Blood Glucose in Healthy Adult Individuals</a>, Nildem Kizilaslan
                    <p>
                        3â€“6â€‰g of cinnamon consumption was found to affect certain blood parameters of individuals positively. 
                    </p>
                </li>
                
                <li id="s-khasnavis">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167597/e"
                    title="Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease"
                    target="_blank"
                    >Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease</a>, Saurabh Khasnavis, et al.
                    <p>
                    
                    </p>
                </li>
                
                <li id="j-hlebowicz">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/19158209/"
                    title="Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects"
                    target="_blank"
                    >Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects</a>, Joanna Hlebowicz, et al.
                    <p>
                        Ingestion of 3 g cinnamon reduced postprandial serum insulin and increased GLP-1 concentrations without significantly affecting blood glucose, GIP, ghrelin concentration, satiety, or GER in healthy subjects. The results indicate a relation between the amount of cinnamon consumed and the decrease in insulin concentration.
                    </p>
                    
                    <p>
                        (<dfn>GIP</dfn>, is a <dfn>glucose-dependent insulinotropic polypeptide</dfn>, an <dfn>incretin</dfn> hormone secreted by <dfn title="K Cells or GIP cells are enteroendocrine cells found in the small intestine">K cells</dfn> in the upper small intestine in response to nutrient ingestion, particularly glucose.)
                </li>
                
                <li id="a-marques">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29866628/"
                    title="Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?"
                    target="_blank"
                    >Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?</a>, Ana Marques, et al.
                    <p>
                        Glucose control is impaired in moderate to advanced non-diabetic PD patients, due to impaired adaptive insulin response which may be a novel non-motor consequence of PD-associated dysautonomia.
                    </p>
                </li>
                
                <li id="d-patel">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708487/"
                    title="Cinnamon and its metabolite protect the nigrostriatum in a mouse model of Parkinsonâ€™s disease via astrocytic GDNF"
                    target="_blank"
                    >Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinsonâ€™s Disease Via Astrocytic GDNF</a>, Dhruv Patel, et al.

                    <p>
                        In this mouse model of <dfn title="1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a protoxin that can cause parkinsonism similar to PD">MPTP</dfn>-induced PD, mice were treated with either cinnamon or NaB dissolved in 0.5% methylcellulose at individual doses (100 mg/kg, orally) once daily for 7 days, and following behavior analysis the mice were sacrificed for biochemical studies.
                    </p>
                </li>

            </ol>
        </section>
        <section id="cavracrol">
            <h3>Carvacrol (TODO)</h3>
            <p>
                Carvacrol is a a volatile oil present in mint, basil, oregano, thyme, and other herbs, exhibiting various biological activities that may help neurodegenerative conditions with anti-inflammatory, antioxidant, and anticholinesterase effects. <cite class="reflink"><a href="#azizi">Azizi</a>, <a href="#ciulla">Ciulla</a></cite>
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="azizi">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9121261/"
                    title="Neuroprotective effects of carvacrol against Alzheimerâ€™s disease and other neurodegenerative diseases: A review"
                    target="_blank"
                    >Neuroprotective effects of carvacrol against Alzheimerâ€™s disease and other neurodegenerative diseases: A review</a>, Zahra Azizi, et al.
                    <p>
                        Established that carvacrol is also able to inhibit acetylcholinesterase activity, with positive effects on memory and cognitive performance in PD.
                    </p>
                </li>
                <li id="ciulla">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681233/#B67-biomolecules-09-00271"
                    title="Role of Dietary Supplements in the Management of Parkinsonâ€™s Disease"
                    target="_blank"
                    >Role of Dietary Supplements in the Management of Parkinsonâ€™s Disease</a>, Michele Ciulla, et al.
                </li>
            </ol>

        </section>
        <section id="lions-mane">
            <h3>Lion's Mane</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Neurorestorative, anti-aggregant, anti-inflammatory</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>2000mg ED</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ… hericenones and erinacines are fat-soluble; beta-glucan is water-soluble</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            
            <p>
                Lionâ€™s mane is a white, edible mushroom that grows on hardwood and has neuroprotective effects. It contains fat-soluble bioactive compounds, hericenones and erinacines, and water-soluble beta-glucans, which are found in the cell walls of various mushrooms, including lion's mane.
            </p>
            
            <h4>Beta-glucans</h4>
            <p>
                Beta-glucans, found in the cell walls of many mushrooms, including lion's mane and cordyceps, are potent immunomodulators that improve synaptic plasticity, provide neuroprotective effects, and enhance cognition and behavior. These effects are particularly relevant in PD, where cognitive decline and synaptic damage are common issues. <cite class="reflink"><a href="#c-cerletti">c-cerletti</a></cite>
            </p>
            
            <p>
                A 2022 study on mice found that mushroom-derived Î²-glucans significantly increased synaptic thickness in the prefrontal cortex (PFC), but Î²-glucans from oats and curdlan did not. <abbr title="Brain-derived neurotrophic factor">BDNF</abbr> and the post-synaptic protein 95 (PSD95) increased in the <abbr title="pre-frontal cortex">PFC</abbr> of all groups. <cite class="reflink"><a href="#hu">hu</a></cite>
            </p>
            <p>
                A 2015 rodent study demonstrated a decrease in Î±-synuclein levels in the substantia nigra of Parkinsonâ€™s disease rat models following beta-glucan administration. <cite class="reflink"><a href="#rahayu">Rahayu</a></cite>
            </p>
            <p>
                A pilot clinical trial involving children with autism spectrum disorder (ASD) found that beta-glucan supplementation (Nichi Glucan) improved behavior and sleep patterns, along with increased melatonin levels. <cite class="reflink"><a href="#raghavan">Raghavan</a></cite>
            </p>
            <p>
                Beta-glucans improve gut microbiota and integrity, leading to a saccharolytic shift and increased short-chain fatty acids (SCFAs). This may have implications for PD, as alterations in gut microbiota have been linked to the condition. <cite class="reflink"><a href="#bhardwaj">bhardwaj</a></cite>
            </p>
            
            <h4>Hericinones and Erinacines</h4>
            <p>
                Hericenones and erinacines increase <abbr title="Brain-derived neurotrophic factor">BDNF</abbr> and NGF levels, promote neurite outgrowth, support neuronal survival, and enhance memory and cognitive function. <cite class="reflink"><a href="#koichiro-mori">Mori</a>, <a href="#sarah-docherty">Docherty</a></cite>
            </p>
            <p>
                However, in some studies, hericenones failed to promote NGF gene expression in human astrocytoma cells while <dfn>erinacine A</dfn> successfully upregulated them in rats. <cite class="reflink"><a href="#i-chen-li">Li</a></cite>
            </p>
            <p>
                A 2022 <abbr title="randomized controlled trial">RCT</abbr> found that lion's mane supplementation improved cognitive performance in elderly patients with mild cognitive impairment, potentially due to its positive effects on blood biomarkers and reduced brain structural deterioration in regions associated with memory. <cite class="reflink"><a href="#i-chen-li">Li</a></cite>
            </p>

            <h4>Lion's Mane in PD</h4>
            <p>
                Lionâ€™s mane promotes neurogenesis through increased <abbr title="Brain-derived neurotrophic factor">BDNF</abbr> and <abbr title="Nerve Growth factor">NGF</abbr> activity, which helps regenerate neurons and improves cognitive function. <cite class="reflink"><a href="#koichiro-mori">Mori</a>, <a href="#i-chen-li">Li</a>, <a href="#sarah-docherty">Docherty</a>, <a href="#puei-lene-lai">Lai</a></cite>
            </p>
        
            <h4>Supplementation</h4>
            <p>
                Lion's mane is generally safe and well-tolerated at doses between 1-3 grams per day. When selecting reputable lion's mane supplements, look for brands that provide Certificates of Analysis (CoA) to ensure product quality and authenticity. Some well-regarded brands known for their quality and CoA include Nammex, Real Mushrooms, Host Defense, and Mushroom Science.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="c-cerletti">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308413/"
                    title="Edible Mushrooms and Beta-Glucans: Impact on Human Health"
                    target="_blank">Edible Mushrooms and Beta-Glucans: Impact on Human Health</a>, Chiara Cerletti, et al.
                </li>
                <li id="hu">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927932/"
                    title="Three Different Types of Î²-Glucans Enhance Cognition: The Role of the Gut-Brain Axis"
                    target="_blank"
                    >Three Different Types of Î²-Glucans Enhance Cognition: The Role of the Gut-Brain Axis</a>, Minmin Hu, et al.
                </li>
                
                <li id="rahayu">
                    <a href="https://www.jns-journal.com/article/S0022-510X(15)02143-7/fulltext"
                    title="The effect of beta glucan of saccharomyces cerevisae in the parkinsonâ€™s wistar strain rats (rattus norvegicus) model induced with rotenone"
                    target="_blank"
                    >The effect of beta glucan of saccharomyces cerevisae in the parkinsonâ€™s wistar strain rats (rattus norvegicus) model induced with rotenone</a>, M. Rahayu, et al.
                </li>
                <li id="raghavan">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480952/"
                    title="Improvement of sleep and melatonin in children with autism spectrum disorder after Î²â€1,3/1,6â€glucan consumption: An openâ€label prospective pilot clinical study"
                    target="_blank"
                    >Improvement of sleep and melatonin in children with autism spectrum disorder after Î²â€1,3/1,6â€glucan consumption: An openâ€label prospective pilot clinical study</a>, Kadalraja Raghavan, et al.
                </li>
                <li id="bhardwaj">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198134/"
                    title="Î²-glucans: a potential source for maintaining gut microbiota and the immune system"
                    target="_blank"
                    >Î²-glucans: a potential source for maintaining gut microbiota and the immune system</a>, Ravindra Pal Singh and Aditi Bhardwaj.
                </li>
                <li id="koichiro-mori">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/18844328/"
                    title="Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial"
                    target="_blank"
                    >Improvement of Cognitive Functions by Oral Intake of Hericium erinaceus</a>, Koichiro Mori, et al.
                    <p>
                        This double-blind, parallel-group, placebo-controlled RCT found that elderly men and women with mild cognitive impairment who took Lion's mane mushroom extract for 16 weeks showed significant improvements in cognitive function compared to the placebo group.
                    </p>
                </li>
                <li id="i-chen-li">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283924/"
                    title="Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study"
                    target="_blank"
                    >Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study</a>, I Chen Li, et al.
                </li>
                
                <li id="sarah-docherty"> 
                    <a href="https://www.mdpi.com/2072-6643/15/22/4842"
                    title="The Acute and Chronic Effects of Lionâ€™s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study">Lionâ€™s Mane Supplementation on Cognitive Function, Stress, and Mood in Young Adults</a>, Sarah Docherty, et al.
                    
                    <p>
                        The findings tentatively suggest that Hericium erinaceus may improve performance speed and reduce subjective stress in healthy, young adults.
                    </p>
                </li>
                
                <li id="puei-lene-lai"> 
                    <a href="https://www.mdpi.com/2072-6643/15/22/4842"
                    title="Neurotrophic Properties of the Lionâ€™s Mane
Medicinal Mushroom, Hericium erinaceus (Higher
Basidiomycetes) from Malaysia">Neurotrophic Properties of the Lionâ€™s Mane
Medicinal Mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia</a>, Puei-Lene Lai, et al
                    
                    <p>
                        The extract contained neuroactive compounds that induced the secretion of extracellular NGF in NG108-15 cells, thereby promoting neurite outgrowth activity.
                    </p>
                
                </li>
            </ol>
        </section>
        
        <section id="cordyceps" class="neuroprotective anti-inflammatory">
            <h3>Cordyceps</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Anti-inflammatory, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>1-3g EDï¸ pre-workout â˜€ï¸ðŸ‹ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ cordycepin, adenosine, and beta-glucan are all water-soluble</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
       
            <p>
                Cordyceps militaris is a parasitic fungus used in traditional Chinese medicine (TCM). It has gained attention in Western countries for improving exercise tolerance and performance. It is neuroprotective, anti-inflammatory, and has mitochondrial benefits. Its main bioactive components include cordycepin, adenosine, and beta-glucans (see discussion under <a href="#lions-mane">lion's mane</a>). <cite class="reflink"><a href="#tuli">Tuli</a></cite>
            </p>
            
            <p>
                A systematic review on cordycepin, analyzing 192 studies, found strong, consistent evidence for its therapeutic potential for reducing tumor growth, protecting brain function, improving respiratory and cardiac health, and alleviating metabolic disorders. Cordycepin's demonstrated ability to reduce inflammation, improve mitochondrial function, and promote cell survival makes it a promising candidate for drug development, especially for age-related diseases. However, questions about its mechanism, toxicity, and biodistribution remain. <cite class="reflink"><a href="#radhi">Radhi</a></cite>
            </p>
            
            <h4>Cordycepin</h4>
            <p>
                Cordycepin, one of the bioactive components of cordyceps, reduces neuroinflammation by regulating cytokine production. Cytokine dysregulation is an etiological pathway of PD, whereby pro-inflammatory cytokines are upregulated and anti-inflammatory cytokines are downregulated. This imbalance exacerbates neuroinflammation, leading to increased tissue damage and neurological dysfunction. By modulating this cytokine balance, cordycepin helps mitigate inflammation and its associated damage in neurodegenerative conditions like PD. <cite class="reflink"><a href="#lazarro">Lazarro</a>, <a href="#radhi">Radhi</a></cite>
            </p>
            
            <p>
                A 2021 study published in The Journal of Neuroinflammation demonstrated that cordycepin provides long-term neuroprotection, preserves blood-brain barrier (BBB) integrity, and shifts the inflammatory response of brain immune cells (microglia and macrophages) from pro-inflammatory to anti-inflammatory. This study also found that cordycepin and adenosine modulate macrophage activity and enhance immune responses through mechanisms like phagocytosis (a process by which a cell engulfs a particle, such as a bacterium, dead cell, or foreign substance, and digests it). These findings present cordycepin and adenosine as promising candidates for brain inflammation. <cite class="reflink"><a href="#wei">Wei</a></cite>
            </p>

            <h5>Relevance to PD</h5>    
            <p>
                A 2020 study found that cordycepin protects brain cells in a PD mouse model by reducing inflammation and preventing certain types of harmful cell death. Cordycepin was again shown to block pathways that trigger the release of inflammatory chemicals known to damage neurons in PD. These findings suggest cordycepin could have potential as a treatment reduce to neuroinflammation in PD. <cite class="reflink"><a href="#y-sun">Sun</a></cite>
            </p>

            <h4>Cardiovascular Performance</h4>
            <p>
                A 2016 double-blind, placebo-controlled study found that supplementing with a Cordyceps militaris mushroom blend improved exercise performance over time. While one week of supplementation slightly improved time to exhaustion, three weeks led to significant gains in VO2 max, time to exhaustion, and ventilatory threshold, suggesting chronic use enhances exercise capacity and recovery.
            </p>

            <p>
                Given the benefits of high-intensity exercise for PD, improved exercise tolerance enables more frequent and intense sessions, for greater neuroprotective and physical benefits over time. <cite class="reflink"><a href="#hirsh">hirsh</a></cite>
            </p>                    
            
            <h4>BBB</h4>
            <p>
                Cordycepin is a small molecule (<abbr title="molecular weight">MW</abbr> ~251 <abbr title="Daltons &ndash; unit of molecular mass">Da</abbr>) that can cross the BBB and improve its tight junction. <cite class="reflink"><a href="#j-yuan">Yuan</a></cite>
            </p>
            
            <h4>Immunomodulation</h4>
            
            <p>
                Cordycepin and adenosine work together to regulate inflammation by modulating the immune response, balancing inflammatory and anti-inflammatory to reduce excess inflammation. <cite class="reflink"><a href="#s-shin">Shin</a>, <a href="#s-j-jung">Jung</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                Typical Dosage Range: 1,000 to 3,000 mg per day of Cordyceps extract, divided into two or three doses, taken pre-workout, in the morning for energy, exercise performance, and neurological benefits. To prevent potential sleep disturbances, it's best to avoid taking Cordyceps in the late afternoon or evening.
            </p>
            <p>                                     
                When selecting reputable Cordyceps supplements, look for brands that provide Certificates of Analysis (CoA) to ensure product quality and authenticity. Some well-regarded brands known for their high-quality Cordyceps supplements with <abbr title="Certificates of Analysis">CoA</abbr> include Host Defense, Four Sigmatic, Real Mushrooms, Life Extension, and Mushroom Wisdom.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="tuli">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909570/"
                    title="Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin"
                    target="_blank"
                    >Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin</a>, Hardeep S. Tuli, et al.
                </li>
                
                <li id="radhi">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510467/"
                    title="A Systematic Review of the Biological Effects of Cordycepin"
                    target="_blank"
                    >A Systematic Review of the Biological Effects of Cordycepin</a>, Masar Radhi, et al.
                </li>
                <li id="lazarro">
					<a href="https://www.sciencedirect.com/science/article/pii/S096999612300387X"
					title="Differential profiles of serum cytokines in Parkinson's disease according to disease duration"
					target="_blank"
					>Differential profiles of serum cytokines in Parkinson's disease according to disease duration</a>, Giulia Di Lazzaro, et al.
				</li>
                <li id="wei">
                    <a href="https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-021-02188-x"
                    title="Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury"
                    target="_blank"
                    >Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury</a>, Pengju Wei, et al.
                    
                </li>
                <li id="y-sun">
                    <a 
                    title="Neuroprotective effects of natural cordycepin on LPS-induced Parkinsonâ€™s disease through suppressing TLR4/NF-ÎºB/NLRP3-mediated pyroptosis"
                    target="_blank"
href="https://www.sciencedirect.com/science/article/pii/S1756464620304989"
                    >Neuroprotective effects of natural cordycepin on LPS-induced Parkinsonâ€™s disease through suppressing TLR4/NF-ÎºB/NLRP3-mediated pyroptosis</a>, Ying Sun, et al.
                </li>
                
                <li id="hirsh">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236007/"
                    title="Cordyceps militaris improves tolerance to high intensity exercise after acute and chronic supplementation"
                    target="_blank"
                    >Cordyceps militaris improves tolerance to high intensity exercise after acute and chronic supplementation</a>, Katie R. Hirsch, et al.
                </li>
                
                <li id="j-yuan">
                    <a 
                        title="Cordycepin attenuates traumatic brain injury-induced impairments of blood-brain barrier integrity in rats"
                        target="_blank"
href="https://pubmed.ncbi.nlm.nih.gov/27646481/"
                        >Cordycepin attenuates traumatic brain injury-induced impairments of blood-brain barrier integrity in rats</a>, Jing Yuan, et al.
                </li>
                
                <li id="s-j-jung">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441223/"
                    title="Immunomodulatory effects of a mycelium extract of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial"
                    target="_blank"
                    >Immunomodulatory effects of a mycelium extract of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial</a>, Su-Jin Jung, et al.
                </li>
            </ol>
        </section>
        
        <section id="turkey-tail">
            <h3>Turkey Tail (TODO)</h3>
        </section>
        
        <section id="reishi">
            <h3>Reishi (TODO)</h3>
        </section>
        
        <section id="chaga">
            <h3>Chaga (TODO)</h3>
        </section>
                           
        <section id="tremella">
            <h3>Tremella (TODO)</h3>
        </section>         
                              
        <section id="tigermilk">
            <h3>Tiger Milk Mushroom (TODO)</h3>
        </section>
        
        <section id="turmeric" class="neuroprotective antifibrillogenic">
            <h3>Turmeric</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Neuroprotection, Anti-inflammatory, Antifibrillogenic, Anti-aggregation</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>2-5 g daily ðŸ½ï¸ ðŸ’¤</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ… turmerones and curcuminoids are both fat-soluble</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… <cite class="reflink"><a href="#n-sharma">N. Sharma</a></cite></td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            
            <p>
                Turmeric, the rhizome of Curcuma longa, contains curcumin as its primary active compound along with other bioactives. Turmerones enhance the bioavailability of curcumin <cite class="reflink"><a href="#yue">Yue</a></cite>, while the curcuminoids bisdemethoxycurcumin and demethoxycurcumin complement its anti-inflammatory and antioxidant effects. Together, these compounds synergistically reinforce the therapeutic benefits of turmeric.
            </p>
            
            <p>
                Curcumin crosses the blood-brain barrier to reach deep brain structures, including the midbrain, to exert beneficial effects directly.
            </p>

            <h4>How Turmeric Helps PD</h4>
            <p>
                Turmeric promotes neuroprotection and neurogenesis, prevents Î±-synuclein aggregation, reduces neuronal iron deposition, and decreases oxidative stress. <cite class="reflink"><a href="#s-mishra">S Mishra</a></cite>
            </p>
                            
            <h4>Curcumin Improves Gait in PD Models</h4>
            <p>
                A 2022 rodent study on curcumin oil formulation found that it improved gait, providing evidence closely related to clinic practices on gait analysis. <cite class="reflink"><a href="#x-geng">X. Geng</a></cite>
            </p>
                
            <h4>Curcumin and Î±-Synuclein Aggregation</h4>
            <p>
                A 2012 study examined how curcumin affects Î±-synuclein aggregation. The researchers found that curcumin binds strongly to the protein, increasing its flexibility and movement, making it less likely to aggregate. By weakening the internal interactions within Î±-synuclein, curcumin allows the protein to reconfigure more quickly, preventing the formation of harmful clumps like oligomers and fibrils, which can eventually form into Lewy bodies. Curcumin mitigates this problem by preventing misfolding. <cite class="reflink"><a href="#b-ahmad">B. Ahmad</a></cite>
            </p>
            <p>
                A 2017 study on rats found other mechanisms by which curcumin improves upon Î±-synuclein aggregation. They found curcumin significantly improved inflammation, replenished <abbr title="Glutathione">GSH</abbr>, and prevented iron deposition and Î±-synuclein aggregation in dopaminergic neurons. <cite class="reflink"><a href="#n-sharma">N. Sharma</a></cite>
            </p>

            <h4>Challenges with Curcumin Absorption</h4>
            <p>
                Curcumin pills are convenient but poorly absorbed and rapidly metabolized. Frequent turmeric consumption throughout the day with fatty foods, black pepper or long pepper, and phosphatidylserine, fixes these problems.
            </p>
        
            <h4>Supplementation (Eating Turmeric)</h4>
            <p>
                Turmeric contains turmerones, which improve curcumin absorption. Consuming turmeric is generally safe at 1-10 g daily. However, very high doses may cause stomach upset or kidney strain, while lower doses may not be effective.
            </p>
            
            <h4>Self-Emulsifying Drug Delivery Systems SEDDS</h4>
            <p> 
                Self-emulsifying Drug Delivery Systems (SEDDS) are lipid-based formulations that create emulsions to improve the oral bioavailability of lipophilic substances found in turmeric. The increased bioavailability means that a greater effect can be achieved without increasing the dose, thereby reducing the risk of side effects from overconsumption.
            </p>
            
            <h4>Enhancing Absorption with Food</h4>
            <p>                         
                Food formulations offer better absorption by acting as a <abbr title="Self-emulsifying Drug Delivery Systems">SEDDS</abbr>. Turmeric is good in curries with coconut oil, eggs, and in the cacao mix, when blended with coconut oil or butter. Turmeric can be added to other dishes, like soups, or blended into warm milk as <dfn>"golden milk"</dfn> with saffron, cinnamon, and other spices, or mixed into mustard as a garnish. 
            </p>
            
            <p>
                Piperine and piper longumine, from black pepper and long pepper, respectively, also increase curcumin bioavailability, and the latter is also senolytic. <cite class="reflink"><a href="#k-kesarwani">K. Kesarwani</a></cite>
            </p>
                
            <h4>Supplementation Recommendations</h4>
            <p>
                Turmeric powder provides a convenient way to add turmeric to food and, as mentioned above, contains turmerones which improve curcumin's bioavailability. 
            </p>

            <h4>Safety Concerns</h4>
            <p>
                Turmeric thins the blood, which may increase the risk of bleeding, especially in individuals taking blood-thinning medications or those with bleeding disorders or who are planning surgery. It may interact with blood thinners, diabetes medications, and medications that reduce stomach acid production.
            </p>

            <h4>
                References
            </h4>
            
            <ol class="reference-list">
                <li id="yue">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282471/"
                    title="The Role of Turmerones on Curcumin Transportation and P-Glycoprotein Activities in Intestinal Caco-2 Cells"
                    target="_blank"
                    >The Role of Turmerones on Curcumin Transportation and P-Glycoprotein Activities in Intestinal Caco-2 Cells</a>, Grace G.L. Yue, et al.
                </li>
                <li id="s-mishra">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781139/"
                    title="The effect of curcumin (turmeric) on Alzheimer's disease: An overview"
                    target="_blank"
                    >The effect of curcumin (turmeric) on Alzheimer's disease: An overview</a>, Shrikant Mishra and Kalpana Palanivelu.
                </li>
                                        
                <li id="n-sharma">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29027056/" 
                    title="Curcumin affords neuroprotection and inhibits Î±-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model"
                    target="_blank">Curcumin neuroprotection and anti- Î±-synuclein aggregation rodent PD model</a>, Neha Sharma and Bimla Nehru.
                </li>
                
                <li id="x-geng">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372469/" 
                    title="A novel curcumin oil solution can better alleviate the motor activity defects and neuropathological damage of a Parkinsonâ€™s disease mouse model"
                    target="_blank">A novel curcumin oil solution can better alleviate the motor activity defects and neuropathological damage of a Parkinsonâ€™s disease mouse model</a>, Xiwen Geng, et al.
                    
                    <p>
                        This rodent study provided comprehensive strong evidence regarding the effect of a novel curcumin oil solution on preventing movement disorders. This confirmed <dfn>n vivo</dfn> that the curcumin oil solution has higher bioavailability than curcumin alone.
                    </p>
                    <p>
                        Curcumin had a greater protective effect on dopaminergic neurons in the compact part of the substantia nigra along with the PD process according to pathological evaluation.
                    </p>
                </li>
                
                <li id="b-ahmad">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308736/" 
                    title="Curcumin Prevents Aggregation in Î±-Synuclein by Increasing Reconfiguration Rate"
                    target="_blank">Curcumin Prevents Aggregation in Î±-Synuclein by Increasing Reconfiguration Rate</a>, Basir Ahmad and Lisa J. Lapidus.
                    <p>
                        This rodent study found curcumin rescues the protein from aggregation by increasing the reconfiguration rate into a faster regime.
                    </p>
                </li>
                
                <li id="k-kesarwani">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634921/"
                    title="Bioavailability enhancers of herbal origin: An overview"
                    target="_blank"
                    >Bioavailability enhancers of herbal origin: An overview</a>, Kritika Kesarwani and Rajiv Gupta.
                </li>
            </ol>
            
            <h4>Turmeric Products</h4>
                
            <ul class="product-list">
                <li>
                    <figure>
                        <img alt="Frontiers Bulk Turmeric" src="img/frontiers_turmeric-sm.png">
                        <figcaption>
                            <p>
                                <a href="https://www.amazon.com/Frontier-Bulk-Turmeric-Powder-Trade/dp/B006K0C1RE">Frontier Co-op Organic Fair Trade Ground Turmeric Root 1lb</a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
                <li>
                    <figure>
                        <img src="img/turmeric-mykind.jpeg" alt="MyKind Turmeric">
                        <figcaption>
                             <p>
                                <a
                                href="https://www.amazon.com/gp/product/B07NXQHXV3/ref=as_li_tl?ie=UTF8&amp;camp=1789&amp;creative=9325&amp;creativeASIN=B07NXQHXV3&amp;linkCode=as2&amp;tag=garrettsmit02-20&amp;linkId=143e5904cc8bab43c355acfc7eed8bc2"
                            >Garden of Life, MyKind Organics, Extra Strength Turmeric
                                </a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
                <li>
                    <figure>
                        <img src="img/curcumin.jpeg" alt="CurcuGreen Curcumin">
                        <figcaption>
                            <p>
                                <a href="https://www.amazon.com/gp/product/B01ELXB3MA/ref=as_li_tl?ie=UTF8&tag=garrettsmit02-20&camp=1789&creative=9325&linkCode=as2&creativeASIN=B01ELXB3MA&linkId=ab05fa8195a7a04384554288ef47d9bd">Curcumin as BCM-95&reg; (CURCUGREEN&reg;)</a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
            </ul>
        </section>
        <section id="saffron">
            <h3>
                Saffron
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antifibrillogenic, Antioxidant, Sleep</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>~50mg of Saffron (about 15 threads) ðŸ½ï¸ðŸ’¤</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ…/âŒ Partially (safranal is fat-soluble; crocin and picrocrocin are water-soluble)</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… crocetin has therapeutic effects on neurodegenerative diseases due to its ability to penetrate the BBB <cite class="reflink"><a href="#y-bian">Y. Bian</a></cite></td>
                </tr>

                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
                Saffron is a spice made from the red stigmas or "threads" of the Crocus flower used in South Asian and Middle Eastern medicine as an <dfn title="substance that induces menstrual flow, even if it is delayed or absent.">emmenagogue</dfn>, general tonic, aphrodisiac, and nerve stimulant in low doses either in tea or in meals.
            </p>
            
            <p>
                Saffron has antioxidant, anti-inflammatory, and neuroprotective effects. Scientific research shows its beneficial effects on improving mood and sleep, enhancing cognitive function, and supporting cardiovascular health. The primary active components, such as crocin and picrocrocin, are water-soluble, while safranal, responsible for saffron's aroma, is fat-soluble.
            </p>
            
            <h4>Sleep</h4>
            <p>
            A 28-day, parallel-group, double-blind <abbr title="randomized controlled trial">RCT</abbr> recruited sixty-three healthy adults aged 18â€“70 with self-reported sleep problems who were randomized to receive either saffron or a placebo. Results showed that saffron was associated with greater improvements in the Insomnia Severity Index (ISI), Restorative Sleep Questionnaire (RSQ), and the Pittsburgh Sleep Diary (PSD) and was well-tolerated with no reported adverse effects. <cite class="reflink"><a href="#a-lopresti">A. Lopretsi</a></cite>
            </p>
            
            <h4>Saffron in Neurodegenerative Disease</h4>
            
            <p>
                Saffron has been proven to alleviate the symptoms of AD and its effects on PD are of continuing research, particularly for its antidepressant and anxiolytic effects. <cite class="reflink"><a href="#y-bian">Y. Bian</a></cite>
            </p>
            <p>
                A 2024 review found that saffron's compounds inhibit neuroinflammation and excitotoxic pathways, modulate autophagy and apoptosis, attenuate oxidative damage, and activate defensive antioxidant enzymes, providing neuroprotection against neurodegenerative diseases. <cite class="reflink"><a href="#hamedani">S. G.-Hamedani</a></cite>
            </p>
            
            <p>
                A 2019 rodent model study found saffron had a neuroprotective
effect and could be recommended as a possible therapeutic agent to prevent neurotoxicity allied to heavy metals and related neurodegenerative disorders like PD. <cite class="reflink"><a href="#tamegart">L. Tamegart</a></cite>
            </p>
            
            <p>
                Saffron inhibits damage and inflammation to astrocytes, a type of glial cell, through multiple pathways. Its active compounds modulate oxidative stress, reduce pro-inflammatory cytokine production, and support the maintenance of cellular integrity, thereby protecting astrocytes from injury and dysfunction. <cite class="reflink"><a href="#maqbool">Maqbool</a></cite>
            </p>
            <p>
                Glial cells, and specifically astrocytes, support the function and survival of neurons. Astrocytes can release neurotransmitters, such as glutamate and <abbr title="adenosine triphosphate">ATP</abbr>, which can influence neuronal activity.
            </p>
            <p>
                Glial scar formation is a common pathological feature in various central nervous system (CNS) diseases, including PD. In PD, the glial scars form around damaged dopaminergic neurons, blocking their repair.
            </p>
            
            <h4>Antifibrillogenic Effects</h4>
            <p>
                A few in vitro studies found that saffron dose-dependently inhibited Î±-synuclein aggregation and dissociated Î±-synuclein fibrils. Although the antifibrillogenic evidence is preliminary, daily consumption of saffron might help with this. Given its other more established beneficial effects and the mild to no side effects in moderate doses, thereâ€™s really no good reason not to enjoy this delicious, beautiful spice. <cite class="reflink"><a href="#saffari">Saffari</a>, <a href="#inoue">Inoue</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                Some of the compounds in saffron are fat-soluble, while others are water-soluble. Saffron can be drunk with turmeric and cinnamon in golden milk. Excessive amounts may cause bloating and gas and gut microbiota may positively affect the gut-brain axis, therefore, it's a good idea to consume saffron with prepared food.
            </p>
            
            <figure class="flex-row">
                <img src="img/saffron-liquid-sm.png" alt="saffron in water">
                <figcaption style="margin-left: 1rem">
                    <h5>DIY Saffron Extract</h5>
                    <p>Place dry saffron in a jar and add water for an easy and convenient aqueous ready for daily use.
                    </p>
                </figcaption>
            </figure>
            <!--
            
            <h4>
                    Saffron Productss
            </h4>
            <ul class="product-list">
                <li>
                    <a href=""></a>
                </li>
                <li>
                    <figure>
                        <img src="" alt="">          
                        <figcaption>
                            <p>
                                <a href=""
                                target="_blank"></a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
            </ul>
            
                <a    href="https://www.amazon.com/gp/product/B07Q23DCZC/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07Q23DCZC&amp;linkId=a89eecbeabe1c12666d9093201834fce"
                title=""
                >Saffron Extract Supplements
                </a>
            </div>
            <p>
                <img src="img/saffron.jpeg" title="saffron">
            </p>
            <div>
                Turmeric and Saffron can also be prepared together as a warm night drink of golden milk with a calming effect. Both can be purchased online.
            </div>
            <div>
                <strong>
                    Turmeric and Saffron Product:
                </strong>
                <a
                    href="https://www.amazon.com/gp/product/B07BH6KBN4/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07BH6KBN4&amp;linkId=5726ef5550d5890bb7fd0e237f6a7791"
                >
                    Turmeric Latte with Saffron
                </a>
            </div>
            <p>
                <img src="img/turmeric-latte.jpeg" alt="turmeric latte" />
            </p>
        -->
            <h4>Saffron References</h4>
            <ol class="reference-list">
            
                <li id="hamedani">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827773/"
                    title="Therapeutic effects of saffron and its components on neurodegenerative diseases"
                    target="_blank"
                    >Therapeutic effects of saffron and its components on neurodegenerative diseases</a>, Sahar Golpour-Hamedani, et al.
                </li>
                
                <li id="y-bian">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573929/"
                    title="Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside"
                    target="_blank"
                    >Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside</a>, Yaqi Bian, et al.
                    <p>
                        This review study discussed the neuroprotective effects of crocin and crocetin, and that both could provide neuroprotection by reducing AÎ² aggregation.
                    </p>
                </li>
                <!--li id="n-skladnev">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361500/"
                    title="Neuroprotective properties of dietary saffron: more than just a chemical scavenger?"
                    target="_blank"
                    >Neuroprotective properties of dietary saffron: more than just a chemical scavenger?</a>, Nicholas V. Skladnev, et al.
                    <p>
                        This review study discussed the mechanism of actions of saffron to induce dose-dependent neuroprotective response.
                    </p>
                </li -->
                <li id="l-tamegart">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30573341/"
                    target="_blank"
                    title="Crocus sativus restores dopaminergic and noradrenergic damages induced by lead in Meriones shawi: A possible link with Parkinson's disease"
                    >Crocus sativus restores dopaminergic and noradrenergic damages induced by lead in Meriones shawi: A possible link with Parkinson's disease</a>, Lahcen Tamegart, et al.
                    <p>
                        This rodent study showed that movement disorder caused by Pd (lead)-induced damage to dopaminergic and noradrenergic systems in the midbrain was reversed by saffron (crocus sativus).
                    </p>
                </li>
                <li id="a-lopresti">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849671/"
                    title="Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial"
                    target="_blank"
                    >Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial
</a>, Adrian L Lopresti, et al.
                    <p>
                        This 28-day, parallel-group, double-blind, randomized controlled trial included sixty-three healthy adults aged 18-70 with self-reported sleep problems. Subjects were randomized to receive either saffron extract (saffron; 14 mg twice daily) or a placebo.
                    </p>
                    <p>
                        Conclusions: Saffron intake was associated with improvements in sleep quality in adults with self-reported sleep complaints.
                    </p>
                </li>
                <li id="s-r-rao">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/26705857/"
                    target="_blank"
                    title="Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism"
                    >Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism</a>, Sriranjini Venkat Rao, et al.
                    <p>
                        This drosophila model of parkinsonism study showed the neuroprotective effects of saffron and crocin. It concluded that these effects may be largely attributable to its antioxidant action and recommended saffron be exploited as a supplementary therapeutic agent in PD and other oxidative stress-mediated neurodegenerative conditions.
                    </p>
                </li>
                <li id="maqbool">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526642/"
                    title="Potential Role of Phytochemical Extract from Saffron in Development of Functional Foods and Protection of Brain-Related Disorders"
                    target="_blank"
                    >Potential Role of Phytochemical Extract from Saffron in Development of Functional Foods and Protection of Brain-Related Disorders</a>, Zahra Maqbool, et al.
                </li>
                <li id="saffari">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/34636232/"
                    title="Crocin Inhibits the Fibrillation of Human Î±-synuclein and Disassembles Mature Fibrils: Experimental Findings and Mechanistic Insights from Molecular Dynamics Simulation"
                    target="_blank"
                    >Crocin Inhibits the Fibrillation of Human Î±-synuclein and Disassembles Mature Fibrils: Experimental Findings and Mechanistic Insights from Molecular Dynamics Simulation</a>, Babak Saffari, Mehriar Amininasab.
                </li>
                <li id="inoue">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29147836/"
                    title="Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on Î±-synuclein fibrils"
                    target="_blank"
                    >Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on Î±-synuclein fibrils</a>, Eiji Inoue, et al.
                </li>
            </ol>
        </section>
        
        <section id="coconut-oil">
            <h3>
                Coconut Oil
            </h3>
                            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>~30 ml of Coconut Oil per day ðŸ½ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ…</td>
                </tr>

                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… (coconut oil itself does not cross the BBB, but <abbr title="Medium chain fatty acids">MCFAs</abbr> from its digestion do)</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            
            <p>
                Coconut oil is extracted from the meat of mature coconuts. It is high in saturated fats and commonly used in cooking and food preparations.
            </p>
            
            <p>
                Rich in lauric acid and <abbr title="medium-chain triglyceride">MCTs</abbr>, coconut oil supports heart health by increasing HDL and providing antimicrobial effects. Lauric acid, a 12-carbon variety, may contribute to its positive effects on HDL. <abbr title="medium-chain triglyceride">MCTs</abbr> boost energy and enhance metabolic health, which can improve brain function and aid conditions like AD, PD, and MS. Additionally, coconut oil supports fat loss, nutrient absorption, and gut health.
            </p>
            
            <h4>Metabolic Health Effects</h4>
            <p>
                A 2018 double-blind <abbr title="randomized controlled trial">RCT</abbr> investigated the effects of various vegetable oils, including coconut, safflower, chia, and soybean (placebo) oils, on obese women following a hypocaloric diet.
            </p>
            <p>
                The coconut oil group showed significant improvements in cardiovascular risk factors, including reduced abdominal adiposity, decreased waist circumference, decreased waist-to-height ratio, lower blood glucose and glycated hemoglobin levels, reduced body fat, and increased lean mass. <cite class="reflink"><a href="#oliveira-de-lira">Oliveira de Lira</a></cite>
            </p>
            
            <p>
                The increase in lean mass was likely due to MCTs, which provide quick energy, enhance exercise performance, and stimulate muscle growth without promoting fat storage. Maintaining or increasing lean mass supports metabolic health and cardiovascular outcomes. The quick energy boost also makes coconut oil a good pre-workout option.
            </p>
            
            <h4>Mitigating PD</h4>
            
            <p>A 2022 review study found that coconut oil improves PD through multiple pathways, mediating oxidative stress, neuroinflammation, mitochondrial dysfunction, apoptosis, and excitotoxicity in various in vitro and in vivo models. Dietary intake of coconut oil has also been associated with a reduced incidence of PD. During digestion, coconut oil is broken down into smaller molecules, such as ketone bodies (KBs). These KBs can cross the <abbr title="blood-brain barrier">BBB</abbr> and serve as an alternative energy source for the brain, making coconut oil a significant natural remedy for neurodegenerative conditions. <cite class="reflink"><a href="#deepika">deepika</a></cite>
            </p>
            
            <p>
                Coconut oil has been shown to reduce obesity, improve insulin resistance, and support metabolic health. These improvements can reduce inflammation, enhance mitochondrial function, and increase cerebral blood flow. These effects may help explain how coconut oil potentially benefits neurodegenerative disorders such as AD, PD, and MS. <cite class="reflink"><a href="#oliveira-de-lira">Oliveira de Lira</a>, <a href="#ibrahim">Ibrahim</a></cite>
            </p>
            
            <h4>Mitochondrial Effects</h4>
            <p>
                Although progressive damage to dopaminergic neurons in the substantia nigra is a primary etiological pathway in PD, mitochondrial dysfunction and oxidative stress contribute substantially to its pathogenesis. Coconut oil's <abbr title="medium-chain triglyceride">MCTs</abbr> are metabolized into glycerol and medium-chain fatty acids, which support mitochondrial <abbr title="adenosine triphosphate">ATP</abbr> production and may enhance mitochondrial biogenesis. <cite class="reflink"><a href="#ying-wang">Ying Wang</a></cite>
            </p>

            <p>
                A 2020 rodent model study even showed that coconut oil helped neural function and mitigated the effects of L-dopa supplementation, lending its use as a potential strategy to reduce reliance on <abbr title="dopamine replacement therapy">DRT</abbr>. <cite class="reflink"><a href="#shehata">Shehata</a></cite>
            </p>
            <!-- strong>
                Coconut Oil Product:
            </strong>
            <a href="https://www.amazon.com/gp/product/B00CQ7TNDK/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B00CQ7TNDK&amp;linkId=f32fa29138420ac8f79b25b5f9f8849f"
            >Dr. Bronner's - Organic Virgin Coconut Oil</a>
            <p>
                <img src="img/coconut-oil.jpeg" alt="coconut oil" />
            </p-->
            
            
            <h4>References</h4>
            <ol class="reference-list">
            
                <li id="oliveira-de-lira">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073593/"
                    title="Supplementation-Dependent Effects of Vegetable Oils with Varying Fatty Acid Compositions on Anthropometric and Biochemical Parameters in Obese Women"
                    target="_blank"
                    >Supplementation-Dependent Effects of Vegetable Oils with Varying Fatty Acid Compositions on Anthropometric and Biochemical Parameters in Obese Women</a>, Luciene Oliveira de Lira, et al.
                </li>
                
                <li id="deepika">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/36208039/"
                    title="Neuroprotective role of coconut oil for the prevention and treatment of Parkinson's disease: potential mechanisms of action"
                    target="_blank"
                    >Neuroprotective role of coconut oil for the prevention and treatment of Parkinson's disease: potential mechanisms of action</a>, 
                </li>
                <li id="ibrahim">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/36208039/"
                    title="Beneficial Effects of Coconut Oil in Treatment
of Parkinsonâ€™s Disease"
                    target="_blank"
                    >Beneficial Effects of Coconut Oil in Treatment
of Parkinsonâ€™s Disease</a>, K. S. Ibrahim and E. M. El-Sayed.
                </li>
                <li id="ying-wang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805166/"
                    title="Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism"
                    target="_blank"
                    >Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism</a>, Ying Wang, et al.
                </li>


                <li id="shehata">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32707436/"
                    target="_blank"
                    title="Neurochemical, neurobehavioral and histochemical effects of therapeutic dose of l-dopa on striatal neurons in rats: Protective effect of virgin coconut oil"
                    >Neurochemical, neurobehavioral and histochemical effects of therapeutic dose of l-dopa on striatal neurons in rats: Protective effect of virgin coconut oil</a>, Ahmed M Shehata, et al.
                </li>
            </ol>
        </section>
        <section id="ginger" class="antifibrillogenic">

            <h3>Ginger</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>BBB Dysfunction (improves BBB protection), Antifibrillogenic , Anti-aggregant, Calcium Dysregulation (<abbr title="voltage gated caclium channel">VGCC</abbr> blocker, type L), Anti-inflammatory (via NF-ÎºB inhibition), Antioxidant (via Nrf2 pathway activation), Mitochondrial (enhances mitogenesis and mitophagy via AMPK and PGC-1Î± pathways), Gastrointestinal (improves gut function and reduces inflammation via gut-brain axis).</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>Estimated human equivalent dose (HED) for ginger: 2â€“4 grams/day with specific bioactive concentrations of 6-shogaol and 6-gingerol contributing to the efficacy. This HED synthesizes the general use of fresh ginger and supplements, with whole ginger typically consumed in 1â€“2 grams per meal or as supplementation for medicinal purposes.</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>Yes</td>
                </tr>

                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>Crosses the BBB based on demonstrated neuroprotective effects in vivo using MPTP and 6-OHDA PD models, particularly from bioactives like 6-shogaol and 6-gingerol.</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Strong</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderate</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
                Ginger, a rhizome, contains healthful bioactive compounds  with neuroprotective and anti-inflammatory effects that are beneficial for PD.
            </p>
            
            <h4>Heated, Dried, or Cooked?</h4>
            <p>
                Fresh ginger contains gingerols, gingerone, trace amounts of kaempferol, quercetin, apigenin, naringenin, and the protease zingibain. Dried ginger contains no gingerone, which contributes to its flavor, and and less gingerols, which convert into shogaols and zingerone during drying, yielding greater antioxidant and anti-inflammatory effects. Heat degrades zingibain and gingerone, losing the health effects of these compounds present in small quantities in fresh ginger. 
            </p>
            <p>
                For neuroprotective and anti-inflammatory effects, dried ginger's concentrated shogaols and zingerone may be better. Although fresh ginger offers broader health benefits.
            </p>
            
            <h4>Benefits in PD: 6-Shogaol</h4>
            <p>
                A 2022 review study titled <q>Elucidating the Beneficial Effects of Ginger (Zingiber officinale Roscoe) in Parkinsonâ€™s Disease</q>, conducted in Greece, analyzed the impact of ginger's bioactive compounds on PD. The study found that compounds such as 6-shogaol and 6-gingerol effectively prevent Î±-synuclein fibril aggregation and reduce oxidative stress, leading to less cellular damage in neurons and improving mitochondrial function, promoting energy production. 
            </p>
            
            <h4>Gastrointestinal and Digestive Help</h4>
            <p>
                Ginger supports gastrointestinal health and reduces systemic inflammation, which is neuroprotective. <cite class="reflink"><a href="#angelopoulou">Angelopoulou</a></cite> 
            </p>
            
            <h4>Calcium Dysregulation</h4>
            <p>
                Ginger extract has been shown to lower blood pressure through mild L-type <abbr title="voltage-gated calcium channel">VGCC</abbr> blocking, which improves vasodilation and reduces excess calcium influx. This can benefit brain blood flow and neuronal health, as excessive calcium entry into neurons and their mitochondria is is a problem in PD. <cite class="reflink"><a href="#ghayur">Ghayur</a></cite> 
            </p>
            
            <h4>Kaempferol's Effects in PD Models</h4>
            <h5>Antioxidant and Neuroprotective Effects</h5>
            <p>
                Kaempferol is anti-inflammatory, antioxidant, neuroprotective, anti-diabetic, cardioprotective, and antifibrillogenic, all of which are beneficial for PD. Ginger contains approximately 0.1% to 0.4% kaempferol, while capers contain significantly more; around 2%.
            </p> 
            <p>
                A 2020 study examined kaempferol's effects in a rat model of PD with four groups: a control group, 10 mg/kg of kaempferol, 20 mg/kg, and a positive control receiving levodopa. After treatment, apomorphine (used in advanced PD during "off" phases) was administered to assess rotational behavior.
            </p>
            <p>
                The study found that kaempferol significantly and dose-dependently improved antioxidant markersâ€”catalase, glutathione (GSH), glutathione peroxidase (GPX), and superoxide dismutase (SOD)â€”indicating a strong causal relationship. Additionally, kaempferol reduced rotational dyskinesia in PD rats. <cite class="reflink"><a href="#x-pan">Pan</a></cite>
            </p>
            
            <p>
                Another study on kaempferol, this one out of Japan, published in 2021, revealed potent antifibrillogenic effects, providing significant protection against Î±-synuclein-related neurotoxicity and induced autophagy through an increase in the biogenesis of lysosomes, reducing the accumulation of Î±-synuclein and preventing neuronal cell death. <cite class="reflink"><a href="#inden">Inden</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                The human equivalent of the minimum 10 mg/kg kaempferol in rats is approximately 0.81 mg/kg, or 56.7 mg for a 70 kg person, which corresponds to about 35 g of fresh ginger or 3.5 g of dry ginger. This dose should also confer very mild cellular calcium-regulating effects and slight vasodilation with reduced blood pressure.
            </p>

            <h4>
                Ginger References
            </h4>
            <ol class="reference-list">
                <li id="angelopoulou">
                    <a 
                    title="Elucidating the Beneficial Effects of Ginger (Zingiber officinale Roscoe) in Parkinsonâ€™s Disease"
                    target="_blank"
                    href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578130/">Elucidating the Beneficial Effects of Ginger (Zingiber officinale Roscoe) in Parkinsonâ€™s Disease</a>, Efthalia Angelopoulouk, et al.
                </li>

                <li id="ghayur">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/15613983/"
                    title="Ginger lowers blood pressure through blockade of voltage-dependent calcium channels"
                    target="_blank"
                    >Ginger lowers blood pressure through blockade of voltage-dependent calcium channels</a>, Muhammad Nabeel Ghayur, Anwarul Hassan Gilani.
                </li>
                
                <li id="x-pan">
                    <a href="https://www.sciencedirect.com/science/article/pii/S1756464620303649"
                    title="Antioxidant, anti-inflammatory and neuroprotective effect of kaempferol on rotenone-induced Parkinsonâ€™s disease model of rats and SH-S5Y5 cells by preventing loss of tyrosine hydroxylase"
                    target="_blank"
                    >Antioxidant, anti-inflammatory and neuroprotective effect of kaempferol on rotenone-induced Parkinsonâ€™s disease model of rats and SH-S5Y5 cells by preventing loss of tyrosine hydroxylase</a>, Xiaohua Pan, et al.
                </li>
                
                <li id="inden">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584179/"
                    title="Kaempferol Has Potent Protective and Antifibrillogenic Effects for Î±-Synuclein Neurotoxicity In Vitro"
                    target="_blank"
                    >Kaempferol Has Potent Protective and Antifibrillogenic Effects for Î±-Synuclein Neurotoxicity In Vitro</a>, Masatoshi Inden, et al.
                </li>
            </ol>
        </section>
        <section id="egcg">
            <h3>Matcha</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>2-5g</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>

                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>L-theanine can bypass the BBBâ€™s natural barriers and reach the brain, where it is believed to have a positive impact on sleep, focus, learning, and symptoms of anxiety.</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            

            <h4>Bioactive Compounds</h4>
            <p>
                Matcha is a finely ground Japanese green tea powder rich in bioactives, including lutein, vitamin K, and polyphenols, particularly catechins like epigallocatechin gallate (EGCG), and caffeine. EGCG exhibits potent antioxidant and neuroprotective effects that help mitigate oxidative stress, neuroinflammation, and neurodegeneration.
            </p>
            
            <h4>Cognitive Effects</h4>
            
            <p>
                A 2020 randomized, double-blind, placebo-controlled trial over 12 weeks on 15 men and 39 women found that Matcha improved cognitive function (<abbr title="Montreal Cognitive Assessment">MoCA</abbr> test), with the effects being more pronounced in women than in men, especially in the cognitive domain of language. Researchers speculated that this may be associated with physiological changes that accompany estrogen loss and menopause in elderly women, attributing the potential effects to matcha's EGCG, vitamin K, and lutein content. <cite class="reflink"><a href="#k-sakurai">Sakurai</a></cite>
            </p>
            
            <h4>Metabolic Effects</h4>
            <p>
                A 2017 review found that EGCG exhibited a wide range of therapeutic properties including anti-atherosclerosis, anti-diabetes, anti-inflammatory, and antioxidant effects. The reduction in plasma glucose and inflammatory markers and the inhibition of <abbr title="Reactive Oxygen Species">ROS</abbr> generation have multiple benefits to cardiopulmonary and neurological health. <cite class="reflink"><a href="#q-y-eng">Eng</a></cite>
            </p>

            <p>
                Low-dose EGCG and caffeine, two components of matcha, elicit substantial synergistic anti-obesity effects by improving gut microbiota and enhancing short-chain fatty acid (SCFA) production. The gut microbiota regulates obesity and metabolic disorders through various physiological pathways, including SCFAs and their receptors. These effects on the gut microbiota may help explain the metabolic and cognitive benefits associated with matcha consumption. <cite class="reflink"><a href="#zhu">Zhu</a></cite>
            </p>
            
            <h4>Anti-aggregant and Antifibrillogenic Effects</h4>
            <p>
                EGCG has been shown to inhibit the effects of preformed oligomers of Î±-synuclein and other proteins from damaging vesicle membranes and causing cytotoxicity in rat brains. <cite class="reflink"><a href="#lorenzen">Lorenzen</a>, <a href="#j-zhao">Zhao</a></cite>
            </p>
            
            <p>
                A few in vitro studies have explored EGCG's antifibrillogenic potential with positive results. EGCG has been shown to prevent the formation of amyloid plaques and the misfolding of disease proteins and prions. Researchers demonstrated that EGCG inhibits Î±-synuclein and amyloid-Î² fibrillogenesis and can disaggregate amyloid fibrils of Î±-synuclein in a dose-dependent manner. <cite class="reflink"><a href="#bieschke">bieschke</a>, <a href="#y-xu">Xu</a></cite>
            </p>
            
            <p>
                EGCG's anti-aggregant and antifibrillogenic effects in humans are not supported by clinical trials, primarily due to the difficulty and cost of such studies. However, positive evidence from in vitro and rodent studies suggests that regular consumption might have a dose-dependent effect, potentially slowing disease progression. Considering the minimal mild side effects, there is no strong reason not to include matcha or an EGCG supplement in a PD regimen.
            </p>
            
            <h4>Ceremonial-Grade Matcha</h4>
            <p>
                Ceremonial-grade matcha is made from the youngest tea leaves with higher concentrations of chlorophyll and lower fluoride content compared to culinary-grade matcha made from older leaves, which accumulate fluoride from the soil as they grow.
            </p>
            
            <h4>Fluoride and Oxalates Warning</h4>
            <p>
                Matcha also has moderate levels of oxalates with younger leaves having higher oxalate concentrations than older leaves. Oxalates can contribute to inflammation and kidney damage. Moderate amounts of quality ceremonial-grade matcha are safe for drinking (10 g of matcha contains approximately 60 mg of oxalate). Those seeking a much higher dose of EGCG and lutein without the fluoride and oxalate can consider supplemental EGCG.
            </p>
            
            <h4>Matcha Preparation</h4>
            <ul>
                <li><strong>Grade:</strong> Use ceremonial-grade matcha for higher polyphenols and less caffeine and fluoride.</li>
                <li><strong>Timing:</strong> Consume in the morning or early afternoon to avoid nighttime caffeine effects.</li>
                <li><strong>Water Temperature:</strong> Heat water to 160â€“175Â°F (70â€“80Â°C; well below boiling) to preserve polyphenols.</li>
                <li><strong>Milk:</strong> Avoid milk to maintain polyphenol effectiveness.</li>
            </ul>

            <h4>Reducing LIDs vs Too Much Caffeine</h4>
            <p>
                Caffeine was shown to reduce the risk of <abbr title="L-Dopa-induced dyskinesias">LIDs</abbr> in a large-scale clinical trail and its cohort <cite class="reflink"><a href="#willis">Willis</a></cite>. However, higher doses can increase the production of <abbr title="reactive oxygen species">ROS</abbr>, which exacerbates oxidative stress.
            </p>
            
            <h4>Dose and Supplementation</h4>
            <p>
                For caffeine-sensitive individuals, lower doses of matcha (1â€“2 g), paired with supplemental EGCG and theanine, offer a more balanced neuroprotective strategy. This combination allows for beneficial polyphenol intake while theanine mitigates caffeineâ€™s stimulating effects, reducing the risk of excessive caffeine-induced ROS production and the potential exacerbation of LIDs. Higher doses (up to 5 g) earlier in the day may provide increased pre-workout energy without affecting sleep.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="k-sakurai">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760932/"
                    title="Effects of Matcha Green Tea Powder on Cognitive Functions of Community-Dwelling Elderly Individual"
                    target="_blank"
                    >Effects of Matcha Green Tea Powder on Cognitive Functions of Community-Dwelling Elderly Individual</a>, Keisuke Sakurai, et al.
                </li>
                
                <li id="lorenzen">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118093//"
                    target="_blank"
                    title="How Epigallocatechin Gallate Can Inhibit Î±-Synuclein Oligomer Toxicity in Vitro"
                    >How Epigallocatechin Gallate Can Inhibit Î±-Synuclein Oligomer Toxicity in Vitro</a>, Nikolai Lorenzen, et al.
                </li>
                
                <li id="y-xu">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/27364962/"
                    title="Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinsonâ€™s Disease"
                    target="_blank">Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinsonâ€™s Disease</a>, Yan Xu, et al.
                    <p>
                        This study found EGCG significantly decreased the number of cerebral SNCA aggregates and their activity in mice.
                    </p>
                </li>

                <li id="willis">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608707/"
                    title="Caffeine Consumption and Risk of Dyskinesia in CALM-PD"
                    target="_blank"
                    >Caffeine Consumption and Risk of Dyskinesia in CALM-PD</a>, Anne-Marie A. Wills, et al,
                </li>
                
                <li id="q-y-eng">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/28864169/"
                    title="Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases"
                    target="_blank"
                    >Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases</a>, Qian Yi Eng, et al.
                </li>
                
                <li id="zhu">
                    <a href="https://pubs.rsc.org/en/content/articlelanding/2021/fo/d0fo01768j"
                    title="Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism"
                    target="_blank"
                    >Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism</a>, Ming-zhi Zhu, et al.
                </li>
                
                <li id="bieschke">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867908/"
                    title="EGCG remodels mature Î±-synuclein and amyloid-Î² fibrils and reduces cellular toxicity"
                    >remodels mature &alpha;-synuclein and amyloid-&beta; fibrils and reduces cellular toxicity</a>, Jan Bieschke, et al.
                </li>
                 <li id="j-zhao">
                    <a href="https://pubs.rsc.org/en/content/articlelanding/2017/ra/c7ra03752j"
                    title="Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of Î±-synuclein, and protects PC12 cells against Î±-synuclein-induced toxicity"
                    target="_blank"
                    >Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of Î±-synuclein, and protects PC12 cells against Î±-synuclein-induced toxicity</a>, Juan Zhao, et al.
                </li>
            </ol>
        </section>
        <section id="ginsenoside">
            <h3>
                Ginseng
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Anti-inflammatory, Antioxidant, Mitochondrial, Antifibrillogenic, Calcium Dysregulation, Anti-Ischemic</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>200 - 400 mg (10% ginsenosides) pre-workout â˜€ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ… Ginsenosides are fat-soluble.</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… Ginsenosides can cross the blood-brain barrier, but transport may be poor. <cite class="reflink"><a href="#y-n-zhao">Zhao</a></cite></td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
                Ginseng is a traditional herbal medicine used for energy and vitality, metabolic (<abbr title="blood glucose">BG</abbr>) and cardiovascular health, stress relief, sexual dysfunction, and cancer protection. Its ginsenoside components, primarily Rb1 and Rg1, and saponins have shown neuroprotective effects, alleviating PD symptoms and slowing disease progression.
            </p>
            
            <h4>Ginseng and Physical Performance</h4>
            <p>
                 In a placebo controlled trial, panax ginseng administered 1 hour  before endurance performance increased lipolysis, eased heart rate, and reduced plasma lactate concentrations. <cite class="reflink"><a href="#cpf-wong">Wong</a></cite>
            </p>
            <p>
                A 2022 review assessed dose responses of ginseng at low (&lt;300 mg/day) and high (&gt;300 mg/day), and found that ginseng showed significant short-term effects (up to 4 weeks) at high dosage for vertical jump. <cite class="reflink"><a href="#khan">Khan</a></cite>
            </p>
            
            <h4>Mitochondrial Mechanism of Action?</h4>
            <p>
                 A 2020 rodent study found that red ginseng improves exercise endurance. Rats were fed ginseng and subjected to a swim test, testing time to exhaustion. Rats fed RG had significantly longer swimming endurance. Analysis showed RG treatment enhanced ATP production levels in myoblasts and RG increased mRNA expressions of mitochondrial biogenesis regulators, suggesting mitochondrial energy-generating capacity, which would also explain the improved exercise performance. <cite class="reflink"><a href="#shin">Shin</a></cite>
            </p>
            
            <h4>Intracellular Calcium Reduction</h4>
            <p>
                Ginseng was shown to protect mitochondria by reducing intracellular calcium through increased phosphorylation of <abbr title="inositol triphosphate receptor">IP3R</abbr> <cite class="reflink"><a href="#kwon">Kwon</a></cite>. This is helpful, because in PD, excess intracellular calcium damages mitochondria, exacerbating oxidative stress, disrupting ATP production, and causing neuronal damage. Ginseng helps this by reducing excess intracellular calcium, thereby protecting mitochondria and the neurons they function in.
            </p>
            <p>
                 Secondarily, ginsenoside Rb1 extract has demonstrated inhibition of L-type calcium channels (LTCCs) in rodent studies. <abbr title="L-type calcium channel">LTCC</abbr> blocking helps keep excess calcium from entering the cell, thereby preventing excess intracellular calcium. However, significant calcium channel blocking from ginseng alone would require a human dose of ginseng thirty times that of typical supplementation, which may contribute to ginseng's neuroprotective effects, and can complement other mild calcium channel blockers, like ginger.  <cite class="reflink"><a href="#z-lin">Zhi-ying Lin</a></cite>
            </p>

            <h4>Ginseng in PD</h4>
            <p>
                Ginseng improved motor function and increased dopamine levels in PD models. These neuroprotective effects are explained by reduced oxidative stress, neuroinflammation, Î±-synuclein aggregation, and neuronal apoptosis, with no significant toxicity observed in most studies. <cite class="reflink"><a href="#he">He</a>, <a href="#ong">Ong</a>, <a href="#l-song">Song</a>, <a href="#zaafan">Zaafan</a>, <a href="#van-kampen">van-kampen</a>, <a href="#jh-choi">Choi</a></cite>
            </p>
            
            <p>
                Ginsenoside Rb1 inhibits fibrillation, oligomerization, and toxicity of Î±-synuclein, and disaggregates preformed fibrils.  <cite class="reflink"><a href="#y-heng">Heng</a>, <a href="#ardah">Ardah</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                Ginseng's energizing effects make it suitable for pre-workout or earlier in the day. Fermented ginseng offers significantly better absorption with higher ginsenoside concentration, compared to the low oral absorption of non-fermented ginsenosides (0.1 â€“ 3.7%). <cite class="reflink"><a href="#j-ryu">Ryu</a></cite> Start with 200-400 mg of 10% ginsenoside powder daily, gradually increasing the dose as needed. Select a high-quality product with clear labeling.
            </p>
            
            <h4>Side Effects</h4>
            <p>
                Side effects may include a mildly elevated heart rate, increased blood pressure, and insomnia if consumed in the evening. Ginseng may enhance the activity of MAOIs, which could allow for reductions in medication dosage. Consult a healthcare professional for potential interactions and monitoring. <cite class="reflink"><a href="#l-liu">l-liu</a></cite>
            </p>
            
            <h4>
                Products
            </h4>
            <ul class="product-list">
                <li>
                    <figure>
                        <img src="img/ginseng.jpeg" alt="ILHWA Korean Ginseng Concentrated Pure Extract">
                        <figcaption>
                            <p>
                                <a
                    target="_blank"
                    href="https://www.amazon.com/gp/product/B00KDSZ6XU/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B00KDSZ6XU&amp;linkId=d82ad47963e6dede78ec44e2184a1d36"
                >ILHWA Korean Ginseng Concentrated Pure Extract</a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
            </ul>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="y-n-zhao">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29576053/"
                    title="Qualitative detection of ginsenosides in brain tissues after oral administration of high-purity ginseng total saponins by using polyclonal antibody against ginsenosides"
                    target="_blank"
                    >Qualitative detection of ginsenosides in brain tissues after oral administration of high-purity ginseng total saponins by using polyclonal antibody against ginsenosides</a>, Yu-Nan Zhao, et al.
                </li>
                
                <li id="cpf-wong">
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S1875686711600286"
                    title="Effects of Panax ginseng supplementation on physiology responses during endurance performance"
                    target="_blank"
                    >Effects of Panax ginseng supplementation on physiology responses during endurance performance</a>, Chee Ping Fadzel Wong, et al.
                </li>
                <li id="khan">
                    <a href="https://www.tandfonline.com/doi/full/10.1080/02640414.2022.2162753"
                    title="Dose-response and temporal ergogenic effects of ginseng supplementation in athletes and active participants: A systematic review and meta-analysis"
                    target="_blank"
                    >Dose-response and temporal ergogenic effects of ginseng supplementation in athletes and active participants: A systematic review and meta-analysis</a>, Nasreen Khan, et al.
                </li>
                <li id="shin">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7070955/"
                    title="Red Ginseng Improves Exercise Endurance by Promoting Mitochondrial Biogenesis and Myoblast Differentiation"
                    target="_blank"
                    >Red Ginseng Improves Exercise Endurance by Promoting Mitochondrial Biogenesis and Myoblast Differentiation</a>, Eun Ju Shin, et al.
                </li>
                <li id="ong">
                    <a href="https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2015.00129/full"
                    title="Protective effects of ginseng on neurological disorders"
                    target="_blank"
                    >Protective effects of ginseng on neurological disorders</a>, Wei-Yi Ong, et al.
                </li>
                <li id="kwon">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10721468/"
                    title="Anti-thrombotic effects of ginsenoside Rk3 by regulating cAMP and PI3K/MAPK pathway on human platelets"
                    target="_blank"
                    >Anti-thrombotic effects of ginsenoside Rk3 by regulating cAMP and PI3K/MAPK pathway on human platelets</a>, Hyuk-Woo Kwon, et al.
                </li>
                <li id="z-lin">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4003359/"
                    title="Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons
"
                    target="_blank"
                    >Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons
</a>, Zhi-ying Lin, et al.
                </li>
                <li id="he">
                    <a href="https://ncbi.nlm.nih.gov/pmc/articles/PMC8027743/"
                    title="Effect of ginsenoside-Rg1 on experimental Parkinson's disease: A systematic review and meta-analysis of animal studies"
                    target="_blank"
                    >Effect of ginsenoside-Rg1 on experimental Parkinson's disease: A systematic review and meta-analysis of animal studies</a>, Yi-Bo He, et al.
                </li>
                <li id="l-song">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366755/"
                    title="A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease"
                    target="_blank"
                    >A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease</a>, Liang Song, et al.
                </li>
                <li id="zaafan">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31198107/"
                    title="The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-ÎºÎ² and Caspase-3"
                    target="_blank"
                    >The Protective Effect of Korean Red Ginseng Against Rotenone-Induced Parkinson's Disease in Rat Model: Modulation of Nuclear Factor-ÎºÎ² and Caspase-3</a>, Mai A Zaafan, et al.
                </li>
                <li id="van-kampen">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/14637121/"
                    title="Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease"
                    target="_blank"
                    >Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease</a>, Jackalina Van Kampen, et al.
                </li>
                
                <li id="jh-choi">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026382/"
                    title="Multitarget effects of Korean Red Ginseng in animal model of Parkinson's disease: antiapoptosis, antioxidant, antiinflammation, and maintenance of bloodâ€“brain barrier integrity"
                    target="_blank"
                    >Multitarget effects of Korean Red Ginseng in animal model of Parkinson's disease: antiapoptosis, antioxidant, antiinflammation, and maintenance of bloodâ€“brain barrier integrity</a>, Jong Hee Choi, et al.
                </li>
                <li id="y-heng">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/26723869/"
                    title="Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting Î±-synuclein abnormalities in the substantia nigra"
                    target="_blank"
                    >Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting Î±-synuclein abnormalities in the substantia nigra</a>, Yang Heng, et al.
                </li>
                <li id="ardah">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882765/"
                    title="Ginsenoside Rb1 inhibits fibrillation and toxicity of &alpha;-synuclein and disaggregates preformed fibrils"
                    target="_blank"
                    >Ginsenoside Rb1 inhibits fibrillation and toxicity of &alpha;-synuclein and disaggregates preformed fibrils.</a>, Mustafa T. Ardah, et al.
                </li>
                
                <li id="j-ryu">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659629/"
                    target="_blank"
                    title="The bioavailability of red ginseng extract fermented by Phellinus linteus"
                    >The bioavailability of red ginseng extract fermented by Phellinus linteus</a>, Jae Sik Ryu, et al.
                </li>
                
                <li id="l-liu">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755186/"
                    title="Functional compounds of ginseng and ginseng-containing medicine for treating cardiovascular diseases"
                    target="_blank"
                    >Functional compounds of ginseng and ginseng-containing medicine for treating cardiovascular diseases</a>, Lanchun Liu, et al.
                </li>
            </ol>
        </section>
        
        <section id="acetyl-l-carnitine">
            <h3>Acetyl-L-Carnitine (ALCAR)</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>1.5 - 2g pre-workout â˜€ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… ALCAR can easily cross the blood-brain barrier, which allows it to target brain cells more effectively than free L-carnitine. <cite class="reflink"><a href="#akihiro-inano">akihiro-inano</a></cite></td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            
            
            <p>
                Acetyl-L-Carnitine (ALCAR) is a modified form of L-Carnitine, an amino acid that transports fatty acids into the mitochondria for energy.
            </p>
            
            <h4>Blood-Brain Barrier</h4>
            <p>
                ALCARâ€™s acetyl group allows it to cross the blood-brain barrier more effectively than L-carnitine, enhancing brain energy metabolism and cognitive function.
            </p>
            
            <h4>How ALCAR Works</h4>
            <p>
                ALCAR facilitates the transport of fatty acids into mitochondria, boosting energy production decreases and reducing oxidative stress. This helps boost brain energy and neurotransmitter activity. Therapeutic benefits may include improved cognitive function, potential support for depression, reduced oxidative stress, and fat loss.
            </p>
            
            <h4>Performance and Recovery</h4>
            <p>
                Forms of l-carnitine, including ALCAR, improve exercise performance and recovery. A 2018 study published in the Journal of Exercise Nutrition and Biochemistry found that L-carnitine supplementation enhances exercise performance while attenuating blood lactate and oxidative stress responses to resistance training. <cite class="reflink"><a href="#koozehchian">Koozehchian</a></cite>
            </p>
            
            <p>
                A comprehensive 2018 review in Nutrients analyzed multiple studies across various populations, concluding that l-carnitine intake improves recovery after exercise, alleviates muscle injury, and reduces markers of cellular damage and free radical formation accompanied by attenuation of muscle soreness. Studies in older adults further showed that l-Carnitine supplementation can lead to increased muscle mass accompanied by a decrease in body weight and reduced physical and mental fatigue. <cite class="reflink"><a href="#fielding">Fielding</a></cite>
            </p>
            
            <h4>Fat Loss</h4>
            <p>
                Two other meta-analyses of high-quality <abbr title="randomized controlled trial">RCT</abbr>s found that 2 g l-carnitine supplementation improved body weight and fat mass, especially in overweight subjects. These results can be explained by carnitine's effects on energy production.  <cite class="reflink"><a href="#askarpour">Askarpour</a>, <a href="#talenezhad">Talenezhad</a></cite>
            </p>
            
            <h4>Metabolic Health</h4>
            <p>
                A 2021 review study investigated the effects of L-Carnitine, ALCAR, and Propionyl-L-Carnitine (PLCAR) on body mass in type 2 diabetes mellitus (T2DM) patients. After reviewing several studies, they concluded that 2 g/day l-carnitine for at least 2 weeks affects body mass in T2DM patients, and no differentiating effects were found in acetyl-l-carnitine or propionyl-l-carnitine groups. <cite class="reflink"><a href="#dd-wang">Wang</a></cite>
            </p>
            
            <h4>Neurological Effects</h4>

            <p>
                ALCAR protects dopaminergic neurons by reducing neuroinflammation, apoptosis, astrogliosis (damage to  astrocytes (glial cells)), and oxidative stress. ALCAR has shown neuroprotective effects in rodent models of PD, both in vitro and in vivo, protecting cells against the accumulation of alpha-synuclein. <cite class="reflink"><a href="#s-a-majd">Majd</a>, <a href="#burks">S Burks</a></cite> 
            </p>
            
            <p>
                A 1990 study on PD patients showed that 2g of ALCAR improved the H-reflex and enhanced sleep architecture, including spindle activity, in non-placebo subjects.
            </p>
            <p>
                Researchers found that the 2 g of supplemental ALCAR improved the H-response, sleep stages, and spindling in test (non-placebo) subjects. The H-response, or Hoffmann reflex, is a muscle reflex response to specific nerve stimulation, measured by latency and amplitude. Spindling refers to brain wave activity occurring during <abbr title="Non-rapid eye movement sleep">NREM</abbr> sleep, particularly in stages N2 (lighter sleep) and N3 (deeper sleep). <cite class="reflink"><a href="#puca">Puca</a></cite>
            </p>
            
            <p>
                A later 2018 multicenter, randomized double-blind, placebo-controlled 28-day clinical trial studied the efficacy of 1500 mg ALCAR per day in patients with cerebrovascular dementia. Although the study excluded patients with PD, researchers found that 1.5g of ALCAR significantly improved cognitive assessment. <cite class="reflink"><a href="#ys-yang">ys-yang</a></cite>
            </p>
            
            <p>
                A 2022 randomized, observational, double-blind, placebo-controlled study on ALCAR scheduled prefrail elderly patients. 92 patients received 3 months of treatment with ALCAR at 1.5 grams or placebo, twice daily, and then 3 months of follow-up. They found that ALCAR treatment delayed the incidence and severity of onset of degenerative disorders of the elderly in prefrail subjects with improvement in memory and cognitive processes. <cite class="reflink"><a href="#malaguarnera">Malaguarnera</a></cite>
            </p>
            
            <p>
                ALCAR supports exercise performance and recovery, mitochondrial health, cognitive function, and fat loss via its energy-producing effects in the mitochondria. Cognitive function is improved in the elderly, likely due to ALCAR's ability to stimulate mitochondrial energy production.
            </p>
            
            <h4>Supplementation</h4>
            <p>
                Taking 1.5 - 2 g ALCAR pre-workout enhances exercise performance. Intense exercise increases cerebral blood flow, potentially enhancing ALCAR uptake in the brain. It is avoid taking ALCAR before sleeping, as its stimulating effects may interfere with sleep. 
            </p>
            
            <h4>Products</h4>
            <ul class="product-list">
                <li>
                    <figure>
                        <img src="img/acetyl-l-carnitine.jpeg" alt="">
                    
                        <figcaption>
                            <p>
                                <a href="https://www.amazon.com/gp/product/B07BLMSWGN/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07BLMSWGN&amp;linkId=d5ce891282e299fedbd0358e75eafd91">Superior Labs | Acetyl L-Carnitine 1000mg</a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
            </ul>
            
            <h5>References</h5>
            <ol class="reference-list">
                <li id="akihiro-inano">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/14595704/"
                    target="_blank"
                    >Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2</a>, Akihiro Inano, et al.
                </li>

                <li id="koozehchian">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343764/"
                    title="Effects of nine weeks L-Carnitine supplementation on exercise performance, anaerobic power, and exercise-induced oxidative stress in resistance-trained malese"
                    target="_blank"
                    >Effects of nine weeks L-Carnitine supplementation on exercise performance, anaerobic power, and exercise-induced oxidative stress in resistance-trained males</a>, Majid S. Koozehchian, et al.
                </li>
                <li id="s-a-majd">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/28199883/"
                    target="_blank"
                    >Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat</a>, Siamak Afshin-Majd, et al.
                </li>
                <li id="burks">
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S0304394019301703"
                    title="Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinsonâ€™s disease mouse model: Endothelial and microglial effects"
                    target="_blank"
                    >Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinsonâ€™s disease mouse model: Endothelial and microglial effects</a>, Susan Burks, et al.
                </li>
                
                <li id="dd-wang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606643/"
                    title="The Effects of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Body Mass in Type 2 Diabetes Mellitus Patients"
                    target="_blank"
                    >The Effects of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Body Mass in Type 2 Diabetes Mellitus Patients</a>, Dong-Dong Wang, et al.
                </li>
                
                <li id="askarpour">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31743774/"
                    title="Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: An updated systematic review and dose-response meta-analysis of randomized controlled trials"
                    target="_blank"
                    >Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: An updated systematic review and dose-response meta-analysis of randomized controlled trials</a>, Moein Askarpour, et al.
                </li>
                
                <li id="talenezhad"> 
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32359762/"
                    title="Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis"
                    target="_blank"
                    >Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis</a>, Nasir Talenezhad, et al.
                </li>
                <li id="fielding">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872767/"
                    title="l-Carnitine Supplementation in Recovery after Exercise"
                    target="_blank"
                    >l-Carnitine Supplementation in Recovery after Exercise</a>, Roger Fielding, et al.
                </li>
                <li id="puca">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/2387661/"
                    title="Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease"
                    target="_blank"
                    >Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease</a>, F M Puca, et al.
                </li>
                
                <li id="ys-yang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427993/"
                    title="A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease"
                    target="_blank"
                    >A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease</a>, YoungSoon Yang, et al.
                </li>
                <li id="malaguarnera">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/36043711/"
                    title="Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial"
                    target="_blank"
                    >Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial</a>, Giulia Malaguarnera, et al.
                </li>
           </ol>
        </section>
        
        <section id="r-ala">
            <h3>Alpha-Lipoic Acid (ALA)</h3>
                            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>250-500 mg ED â˜€ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… ALCAR can easily cross the blood-brain barrier, which allows it to target brain cells more effectively than free L-carnitine. <cite class="reflink"><a href="#j-liu">J. Liu</a></cite></td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
                Alpha-Lipoic Acid (ALA) improves mitochondrial function and reduces oxidative damage. <cite class="reflink"><a href="#j-liu">J. Liu</a></cite>
            </p>
            
            <h4>Supplement Forms: s- and r-Enantiomers, and Binding</h4>

            <p>
                Most research on ALA uses both s- and r-isoforms. The naturally-occurring r-form has higher absorption and bioavailability than the synthetically produced s-form. <cite class="reflink"><a href="#b-salehi">B. Salehi</a></cite>
            </p>
            
            <h5>Na-r-ALA â€” Increased Absorption</h5>
            <p>
                Despite its advantages, free-form r-ALA is still prone to polymerization. Na-r-ALA (sodium-bound r-ALA) is comparatively more stable, less prone to polymerization, and has better absorption compared to free-form r-ALA. Lysine R-lipoate may offer greater absorption compared to r-ALA. <cite class="reflink"><a href="#d-a-carlson">D.A. Carlson</a></cite>
            </p>

            <h4>How R-ALA Works</h4>
            
            <p>
                R-ALA activates <abbr title="AMP-activated protein kinase">AMPK</abbr> which stimulates mitophagy. This leads to mitochondrial biogenesis and improved mitochondrial function. It increases glucose uptake and decreases glucose production in the liver, resulting in enhanced insulin sensitivity and reduced oxidative stress. <cite class="reflink"><a href="#y-wang">Y. Wang</a>, <a href="#w-j-lee">W. J. Lee</a></cite>
            </p>
            
            <h4>R-ALA in Parkinson's Disease</h4>
            <p>
                 Insulin resistance (IR) is commonly associated with an increased risk of developing Parkinsonâ€™s disease. IR leads to elevated brain glucose, which damages brain cells and accelerates neurodegeneration. <cite class="reflink"><a 
         href="#e-hogg">E. Hogg</a></cite>
            </p>
            
            <h5>Iron in Parkinson's Disease</h5>
            <p>
                Alpha-synuclein pathology disrupts iron homeostasis in PD. High iron levels harm dopaminergic neurons, inducing cell death and leading to more severe motor deficits with mutant Î±-synuclein. <cite class="reflink"><a 
         href="#f-jia">f-jia</a>, <a 
         href="#p-lingor">p-lingor</a></cite>
            </p>
            
            <p>
                ALA's mitochondrial and antioxidant benefits are ideal for PD. <cite class="reflink"><a href="#j-liu">J. Liu</a></cite>
            </p>
            <p>
                R-ALA decreases intracellular <abbr title="Reactive Oxygen Species">ROS</abbr> and iron levels. <cite class="reflink"><a 
         href="#s-tai">S. Tai</a></cite>
            </p>
            
            <p>
                Overexpression of Î±-synuclein inhibits <abbr title="Adenosine 5â€² Monophosphate-Activated Protein Kinase">AMPK</abbr> activity, contributing to the neurodegenerative process in PD. ALA increases AMPK, which improves mitochondrial function â€” a problem in PD. A rodent model experiment showed that treatment with acetyl-L-carnitine or Î±-lipoic acid improved motor performance, reduced oxidation, and improved ATP production. <cite class="reflink"><a href="#w-bobela">W. Bobela</a>, <a 
         href="#s-zaitone">S. Zaitone</a>, <a href="#h-zhang">H. Zhang</a></cite>
            </p>
            
            <h4>Synergy: Na-r-ALA, Creatine, ALCAR, and Carbohydrates</h4>
            
            <p>
                R-ALA, an antioxidant, helps protect the mitochondria from damage, allowing them to function more efficiently. <cite class="reflink"><a 
         href="#h-zhang">H. Zhang</a></cite>
            </p>
            <p>
                Combining ALCAR, r-ALA, and creatine amplify each other's effects, making this combination a potent pre-workout mitochondrial activator. <cite class="reflink"><a href="#d-g-burke">D.G. Burke</a></cite>
            </p>
            <h4>Side Effects</h4>
            <p>
                Gastrointestinal upset can occur. Some individuals experience this when taking Na-r-ALA on a full stomach, but not when taking r-ALA in the morning with water and fruit.
            </p>
            
            <h4>Products</h4>
            <ul class="product-list">
                <li>
                    <figure>
                        <img src="img/mitochondrial-optimizer.jpeg" alt="mitochondrial optimizer">          
                        <figcaption>
                            <p>
                                <a href="https://www.amazon.com/gp/product/B006L8DWSC/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B006L8DWSC&amp;linkId=c6c8f2664db42d477f10657223837e34"
                                >Life Extension Mitochondrial Energy Optimizer with PQQ</a>
                            </p>
                        <p>
                            Note: This product contains Taurine, which is
                            <a href="https://journeywithparkinsons.com/2018/04/05/neuroprotection-with-taurine-in-a-parkinsons-model-system/">neuroprotective </a> and
                            <a href="https://pubmed.ncbi.nlm.nih.gov/26004911/">found to be suppressed in PD patients on L-Dopa</a>.
                        </p>
                        </figcaption>
                    </figure>
                </li>
                
                <li>
                    <figure>
                        <img src="img/r-ala.jpeg" alt="r-Alpha Lipoic Acid" height="280">
                        <figcaption>
                        <p>
                            <a
href="https://www.amazon.com/gp/product/B0027YKO1C/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B0027YKO1C&amp;linkId=ebcbfd85708db0064877b27b10629629"
                            >Life Extension Super R-Lipoic Acid, 240mg
                            </a>
                        </p>
                        </figcaption>
                    </figure>
                </li>
            </ul>
            <h4>References</h4>
            <ol class="reference-list">
                <li id="j-liu">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/17605107/"
                    title="The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview"
                    target="_blank"
                    >The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview</a>, Jiankang Liu.
                    <p>
                        This review study found ALA improves upon the age-associated decline of memory, mitochondrial structure and function, age-associated increase of oxidative damage, and antioxidation. 
                    </p>
                    <p>
                        The also found that <q>co-administration of LA with other mitochondrial nutrients, such as acetyl-L-carnitine and coenzyme Q10, appears more effective in improving cognitive dysfunction and reducing oxidative mitochondrial dysfunction &hellip;</q>
                    </p>
                </li>
                
                <li id="b-salehi">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723188/"
                    title="Insights on the Use of Î±-Lipoic Acid for Therapeutic Purposes"
                    target="_blank"
                    >Insights on the Use of Î±-Lipoic Acid for Therapeutic Purposes</a>, Bahare Salehi, et al.
                    <p>
                        The R enantiomer of ALA shows better pharmacokinetic parameters, including increased bioavailability as compared to its S enantiometer.
                    </p>
                </li>
                    
                <li id="d-a-carlson">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/18069903/"
                    title="The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects"
                    target="_blank"
                    >The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects</a>, David A Carlson, et al.
                    <p>
                        Na-r-ALA is less prone to polymerization, completely soluble in water, and displays significantly higher <dfn title="maximum serum concentration">Cmax</dfn> and <abbr title="Area Under the Curve">AUC</abbr> values and decreased time to maximum concentration (Tmax) and T1/2 values than RLA or rac-LA.
                    </p>
                </li>
                
                <li id="y-wang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882509/"
                    title="Alpha-lipoic acid increases energy expenditure by enhancing AMPK-PGC-1Î± signalling in the skeletal muscle of aged mice"
                    target="_blank"
                    >Alpha-lipoic acid increases energy expenditure by enhancing AMPK-PGC-1Î± signalling in the skeletal muscle of aged mice</a>, Yi Wang, et al.
                    <p>
                    
                    </p>
                </li>
                <li id="w-j-lee">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/15913551/"
                    title="Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle"
                    target="_blank"
                    >Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle</a>, Woo Je Lee, et al.
                    <p>
                        This study suggests that ALA-induced improvement of insulin sensitivity is mediated by activation of AMPK and reduced triglyceride accumulation in skeletal muscle.
                    </p>
                </li>                   
                
                <li id="e-hogg">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29614702/"
                    target="_blank"
                    title="High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson's Disease"
                    >High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson's Disease</a>, Elliot Hogg, et al.
                    
                    <p>
                        The study revealed nearly 60% of the non-diabetic study participants may have undiagnosed insulin resistance â€” despite having normal blood sugar levels.
                    </p>
                </li>

                <li id="f-jia">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897504/"
                    target="_blank">High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein</a>, Fengju Jia, et al.
                        
                    <p>
                        These results suggested high dietary iron supplement could induce nigral dopaminergic neuron lesions in A53T mice, which might be due to the vulnerability of SN to accumulate iron.
                    </p>
                </li>
                <li id="p-lingor">
                    <a title="Alpha-synuclein and iron: two keys unlocking Parkinson's disease"
                    target="_blank"
                    href="https://pubmed.ncbi.nlm.nih.gov/28168622/">
                        Alpha-synuclein and iron: two keys unlocking Parkinson's disease</a>, Paul Lingor, et al.
                        
                    <p>
                        This short review focuses on two disease mechanisms: alpha-synuclein pathology and dysfunction of iron homeostasis, as well as their intricate interaction.
                    </p>
                </li>

                <li id="s-tai">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330090/"
                    title="Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinsonâ€™s Disease Model Induced by 6-OHDA"
                    target="_blank">Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation in PD Model</a>, Shengyan Tai, et al.
                    
                    <p>
                        This PD-induced rodent model showed that ALA could provide significant protection from 6-OHDA-induced cell damage in vitro by decreasing the levels of intracellular reactive oxygen species and iron. 
                    </p>
                </li>
                
                <li id="w-bobela">
                    <a href="https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-017-0220-x"
                    title="Modulating the catalytic activity of AMPK has neuroprotective effects against Î±-synuclein toxicity"
                    target="_blank"
                    >AMPK activation mitigates Î±-synuclein toxicity</a>, Wojciech Bobela, et al.
                    <p>
                        Researchers modulated AMPK activity to overexpress AMPK. Overexpression of AMPK mitigated Î±-synuclein toxicity in nigral dopamine neurons.
                    </p>
                </li>
                <li id="s-zaitone">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/21958946/"
                    title="Acetyl-L-carnitine and Î±-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy"
                    target="_blank">Acetyl-L-carnitine and Î±-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy</a>, Sawsan A Zaitone, et al.
                    <p>
                        Treatment with acetyl-L-carnitine or Î±-lipoic acid improved the motor performance and reduced the level of lipid peroxides in rat brains as compared to rotenone group. Further, ATP production was enhanced along with acetyl-L-carnitine treatments (pâ‰¤0.05). 
                    </p>
                </li>
                <li id="h-zhang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837594/"
                    title="Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease"
                    target="_blank"
                    >Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease</a>, Hongyu Zhang, et al.
                    <!-- p>
                        This in vitro study revealed that pretreatment with combined ALA and ALCAR increased mitochondrial biogenesis and decreased production of <abbr title="reactive oxygen species">ROS</abbr> through the up-regulation of <abbr title="Peroxisome Proliferator-activated Receptor-gamma Coactivator 1 alpha">PGC-1a</abbr> as a possible underlying mechanism.
                    </p>
                    <p>
                        <abbr title="the peroxisome proliferator-activated receptor-gamma coactivator 1 alpha">PGC-1a</abbr> is a transcriptional coactivator that regulates various cellular energy metabolism, mitochondrial biogenesis, and cellular stress responses. 
                    </p-->
                </li>
                
                <li id="d-g-burke">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/14669930/"
                    title="Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration"
                    target="_blank"
                    >Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration</a>, Darren G Burke, et al.
                    <p>
                        This small human trial found that co-ingestion of alpha-lipoic acid with creatine and a small amount of sucrose can enhance muscle total creatine content as compared to the ingestion of creatine and sucrose or creatine alone.
                    </p>
                </li>
            </ol>
        </section>
        
        <section id="trehalose">
            <h3>Trehalose (TODO)</h3>            
        </section>

        <section id="gaba-5-htp-melatonin">
            <h3>GABA, 5-HTP, and Melatonin</h3>
            <p>
                GABA, 5-HTP, and melatonin can help PD patients through multiple neurological pathways. They're grouped because they all promote sleep and should all be taken at night.
            </p>
            <h4>Dopaminergic, Serotonergic, and GABAergic Systems</h4>
            <p>
                PD affects the dopaminergic, serotonergic, and GABAergic systems, which are interdependent. Doctors typically focus on the dopaminergic system, leading to imbalances in other systems, nutrient deficiencies, and progressive neurodegeneration (PN). 
            </p>
            
            <p>
                Addressing only the dopaminergic system without considering the broader neurochemical landscape results in inadequate management of PD symptoms, exacerbates non-motor symptoms, and leads to treatment-related complications.
            </p>

            <h4>Comprehensive PD Management</h4>
            <p>
                A comprehensive approach to PD must consider not only the direct effects of medications but also their broader implications for nutritional status and metabolic function for improved outcomes and quality of life.
            </p>
            
            <h4>Medical Team Awareness</h4>
            <p>
                All medical team members must understand the broader implications of PD treatments to prevent nutrient depletion and exacerbation of neurodegeneration.
            </p>
            <section id="gaba">
                <h3>GABA</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Sleep, Dopaminergic side-effects</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>1000 mg ðŸ’¤</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                <p>
                    GABA is an inhibitory neurotransmitter that regulates dopaminergic neuron activity in the brain. 
                </p>
                
                <h4>GABA and Sleep</h4>
                <p>
                    GABA supplementation improves sleep by interacting with neurotransmitter systems in both the enteric nervous system (ENS) of the gastrointestinal tract and peripheral nervous system (PNS) receptors in the brainstem. This interaction influences the vagus nerve, leading to relaxation and better sleep quality.
                </p>

                <h4>GABA and L-Theanine Synergy</h4>
                <p>
                    A 2019 rodent model study found that a GABA and L-theanine mixture has positive synergistic effects on sleep quality and duration compared to either intervention alone. <cite class="reflink"><a href="s-kim">Kim</a></cite>
                </p>

                <p>
                    A 2021 review study published in Neuroscience discussed how some clinical manifestations (such as cognitive dysfunctions, attention deficits, etc.) emerge after abnormalities in the GABAergic system are accompanied with concomitant neurological diseases, including PD. <cite class="reflink"><a href="w-zhang">Zhang</a></cite>
                </p>
                
                <h4>GABA and Dopaminergic Side Effects</h4>
                <p>
                    In PD, the loss of GABAergic neurons in the substantia nigra contributes to motor symptoms. 
                </p>

                <p>
                    Dyskinesia is a common side effect of long-term treatment with levodopa in Parkinsonâ€™s disease. GABA supplementation at 1000mg daily has the potential to help regulate dopamine release and likely ameliorate dyskinesia. 
                </p>
                
                <p>
                    Non-pharmacological approaches, such as physical therapy and deep brain stimulation (DBS) targeting GABAergic circuits, may also help manage motor complications.
                </p>
                
                <ul class="reference-list">
                    <li id="s-kim">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366437/"
                            title="GABA and l-theanine mixture decreases sleep latency and improves NREM sleep"
                            target="_blank"
                        >GABA and l-theanine mixture decreases sleep latency and improves NREM sleep in rats</a>, Suhyeon Kim, et al.
                    </li>
                    
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031986/"
                            title="Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial"
                            target="_blank"
                        >Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial</a>
                        
                        <p>
                            This small double-blind <abbr title="randomized controlled trial">RCT</abbr> shows that treatment with 300mg unpolished-rice-germ-derived GABA improved both subjective sleep quality and objective sleep efficiency in patients with insomnia, with no severe adverse events.
                        </p>
                    </li>
                    
                    <li id="w-zhang">
                        <a href="https://www.sciencedirect.com/science/article/abs/pii/S0306452221003365"
                        title="The Role of the GABAergic System in Diseases of the Central Nervous System"
                        target="_blank">The Role of the GABAergic System in Diseases of the Central Nervous System</a>, Wen Zhang, et al.
                    </li>
                    
                    <li>
                        <a href="https://content.iospress.com/articles/journal-of-alzheimers-disease/jad120535"
                        title="GABA Attenuates Amyloid Toxicity by Downregulating its Endocytosis and Improves Cognitive Impairment"
                        target="_blank"
                        >GABA Attenuates Amyloid Toxicity by Downregulating its Endocytosis and Improves Cognitive Impairment</a>
                        <p>
                            GABA reduces amyloid toxicity by downregulating amyloid-Î² (AÎ²) endocytosis, improving cognitive impairment. High levels of GABA decrease AÎ²-induced cytotoxicity in wild-type mice through the receptor for advanced glycation end-products.
                        </p>
                    </li>
                    
                    <li>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12948617/"
                        title="Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy"
                        target="_blank">GABA(A) receptors correlated to vagus nerve stimulation</a>
                        <p>
                            In this comparative study, researchers concluded that stimulating the vagus nerve increased GABA(A) receptor density. GABAergic activation affects the vagus nerve, contributing to the regulation of sleep and relaxation.
                        </p>
                    </li>
                    
                </ul>
            </section>
            
            <section id="5-htp">
                <h3>5-HTP (5-Hydroxytryptophan)</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Sleep, Dopaminergic side-effects</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>50 - 100 mg ðŸ’¤ (at night)</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>
                <p>
                    5-HTP (5-Hydroxytryptophan) is an amino acid that converts to serotonin (5-HT) and then to melatonin, a hormone that helps regulate sleep and relaxation.
                </p>
                <p>
                    Serotonin signaling changes occur early in Parkinson's. Addressing this system early, before gastrointestinal symptoms appear is important.
                </p>
                
                <h4>DRT Side Effect Counterbalance</h4>
                <p>
                    DRT can cause involuntary movements called L-DOPA-induced dyskinesia (LID). 5-HTP supplementation helps restore serotonin levels and modulate dopamine release, which can reduce the severity of symptoms associated with LID.
                </p>
                
                <p>
                    DRT depletes vitamin B6, which is necessary for nerve health and neurotransmitter synthesis, leading to neuropathy and neurotransmitter system failure. Vitamin B12 deficiency can also contribute to neuropathy.
                </p>

                <h4>Mitigating Serotonergic Damage in PD</h4>
                <p>
                    PD affects not only the dopaminergic system but also other neurotransmitter systems, including the serotonergic system, by the same mechanisms that affect the CNS (mitochondrial dysfunction, Î±-synuclein aggregation, etc.). This leads to the degeneration of serotonergic terminals, non-motor symptoms, and complications such as gastrointestinal dysfunction and, in some cases, visual hallucinations.
                </p>
                
                <p>
                    Neurotransmitter metabolic pathways are complex. These interactions, illustrated in the figure <q>Competitive Neurotransmitter Inhibitors</q>,  function normally in healthy individuals but are disrupted in PD and further affected by <abbr title="Dopamine Replacement Therapy">DRT</abbr>. <cite class="reflink"><a href="#a-munoz">a-munoz</a>, <a href="#m-hinz">m-hinz</a></cite>
                </p>   
                
                <p>
                    A randomized, double-blind, placebo-controlled crossover study with 12 PD patients with <abbr title="L-Dopa-induced dyskinesias">LIDs</abbr> and motor fluctuations was conducted over 4 weeks. Participants received either a placebo or 50 mg of 5-HTP daily. Significant improvements in <abbr title="L-Dopa-induced dyskinesias">LIDs</abbr> were observed with 5-HTP, as measured by the UDysRS and UPDRS-IV scores. <cite class="reflink"><a href="#meloni">Meloni</a></cite>
                </p>
                
                <p>
                    A follow-up <abbr title="randomized controlled trial">RCT</abbr> crossover study compared placebo and 50 mg of 5-HTP daily over 4 weeks. Results showed significant improvements in motor function (UPDRS Part II), increased REM sleep without a rise in REM sleep behavior disorder (RBD), and enhanced global clinical impression with 5-HTP. The study demonstrated 5-HTPâ€™s safety and efficacy in improving sleep stability and overall sleep quality in PD.  <cite class="reflink"><a href="#meloni-2">Meloni 2</a></cite>
                </p> 

                <p>
                    The discussed pathways, including dopamine, norepinephrine, epinephrine, glutathione, SAMe, methionine, cysteine, tryptophan, serotonin, and vitamin B6, interact to influence neurological function, oxidative stress regulation, mood, and overall health. 
                </p>
                <p>
                    Reducing <abbr title="Dopamine Replacement Therapy">DRT</abbr> while supporting other neurotransmitter systems helps manage neurotransmitter balance more effectively.
                </p>
                
                <p>
                    A balanced approach involving diet, exercise, supplementation, and regular monitoring is essential for slowing disease progression.
                </p>
                
                <figure>
                    <img src="img/5-htp-competitive-inhibitors.jpeg" alt="Diagram of Competitive Neurotransmitter Inhibitors"
                    class="block-image">
                    <figcaption>
                        <p>
                            <strong>Competitive Neurotransmitter Inhibitors:</strong> 5-HTP is converted into serotonin in the brain, where it inhibits glutamate release, reduces oxidative stress, and modulates dopamine release.
                        </p>
                    </figcaption>
                </figure>

                <p>
                    The impact of PD on the serotonergic system is significant and often overlooked by conventional medicine approaches. Several studies have shown serotonergic dysfunction in Parkinson's disease is associated with the development of motor and non-motor symptoms and complications. <cite class="reflink"><a href="#m-politis">Politis</a></cite>
                </p>

                <p>
                    5-HTP has demonstrated neuroprotective effects in humans and in animal models of neurodegenerative diseases, including PD. It reduces oxidative stress, inflammation, and mitochondrial dysfunction, which are primary etiological pathways in progressive neurodegeneration (PN).
                </p>
                
                <h4>Supplementation</h4>
                <p>
                    A 50 mg dose of 5-HTP is typically safe and well-tolerated. PD patients should consult their care team, as DRT and 5-HTP dosages may require careful adjustment. Taking it nightly is a conservative approach to improve sleep, depression, and constipation, reduce LIDs, provide neuroprotection, and balance neurotransmitter systems. 
                </p>

                <h4>Contraindication</h4>
                <p>
                    5-HTP elevates serotonin levels without the body's typical feedback mechanisms. Serotonergic imbalance affects other neurotransmitters like dopamine and norepinephrine that share precursor pathways (tryptophan and tyrosine, respectively). The magnitude of this risk depends on dosage, medications, and individual factors. Moderate caution should be exercised. Individuals who take SSRIs or MAOIs, or have a history of serotonin-related disorders should communicate this with their healthcare providers. 
                </p>
                <p>
                    In rodent studies, high doses of 5-HTP (150 mg/kg) have compromised the blood-brain barrier (BBB). In humans, this would roughly translate to 850 mg/day for a 70 kg individual, though this is purely hypothetical and not clinically recommended. <cite class="reflink"><a href="#a-sharma">A. Sharma</a></cite>
                </p>

                
                <h4>References</h4>
                <ol class="reference-list">
                    <li id="m-politis">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201695/"
                        title="Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability"
                        target="_blank"
                        >Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability</a>, Marios Politis and Clare Loane.
                        <p>
                            This study confirms the lack of any autoregulatory feedback control in serotonergic neurons to regulate L-DOPA-derived dopamine release contributes to L-DOPA-induced dyskinesia (LID).
                        </p>
                    </li>
                    <li id="meloni">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32464351/"
                        title="Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding"
                        target="_blank"
                        >Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding</a>, Mario Meloni, et al.
                    </li>
                    
                    <li id="meloni-2">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418091/"
                        title="Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinsonâ€™s disease"
                        target="_blank"
                        >Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinsonâ€™s disease</a>, Mario Meloni, et al.
                    </li>
                
                    <li id="a-munoz">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289026/"
                        title="Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinsonâ€™s Disease and Adverse Effects of L-DOPA"
                        target="_blank"
                        >Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinsonâ€™s Disease and Adverse Effects of L-DOPA</a>, Ana MuÃ±oz, et al.
                        <p>
                        PD is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. However, other non-dopaminergic neuronal systems such as the serotonergic system are also involved. Serotonergic dysfunction is associated with non-motor symptoms and complications, including anxiety, depression, dementia, and sleep disturbances. 
                        </p>
                        <p>
                            The lack of any autoregulatory feedback control in serotonergic neurons to regulate L-DOPA-derived dopamine release contributes to the appearance of L-DOPA-induced dyskinesia (LID). 
                        </p>
                    </li>

                    <li id="m-hinz">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827589/"
                        title="Parkinsonâ€™s disease managing reversible neurodegeneration (retracted)"
                        target="_blank"
                        >Parkinsonâ€™s disease managing reversible neurodegeneration (retracted)</a>, Marty Hinz, et al.
                        <p>
                            This study explains the interactions between serotonin and dopamine along with their precursors in synthesis, transport, and metabolism. 
                        </p>
                        <p>
                            The study was retracted for conflict of interest, not factual inaccuracies.
                        </p>
                    </li>
                    
                    <li id="a-sharma">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31349924/"
                        title="5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology"
                        target="_blank"
                        >5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology</a>, Aruna Sharma, et al.
                    </li>
                </ol>
            </section>
        
            <section id="melatonin">
                <h4>Melatonin</h4>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Anti-inflammatory, Mitochondrial, Anti-ischemic</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>10 mg per day ðŸ’¤ (at night)</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

                <p>
                    Melatonin is a hormone produced by the pineal gland, a small endocrine gland located in the midbrain between the two hemispheres.
                </p>
            
                <h5>Neuroprotective</h5>
                <p>
                    Melatonin protects neurons against oxidative stress, a problem exacerbated by PD. It interacts with nuclear receptors and signaling pathways to regulate gene transcription. This causes an increase in the production of superoxide dismutase (SOD), glutathione peroxidase, and glutathione reductase.
                </p>
                
                <p>
                     Neuroinflammation leads to increased ROS production. Increased ROS production contributes to neuronal damage which perpetuates further neuroinflammation. Melatonin reduces inflammation, thereby reducing oxidative stress.
                </p>
                
                <h5>Antioxidant Effects</h5>
                <p>
                    Melatonin easily crosses the BBB and stimulates a variety of antioxidative enzymes including superoxide dismutase (SOD), glutathione peroxidase and glutathione reductase, which scavenge free radicals, reducing the oxidative burden on cells and allowing antioxidant enzymes to function more efficiently. <cite class="reflink"><a href="#reiter">Reiter</a></cite>
                </p>

                <p>
                    SOD is one of the most important antioxidant enzymes inside and outside cell membranes. However, in PD, <abbr title="superoxide dismutase ">SOD</abbr> levels decline, and melatonin's restorative effects may help counteract this deficit. <cite class="reflink"><a href="#bostantjopoulou">Bostantjopoulou</a>, <a href="#yang">Yang</a></cite>
                </p>
                
                <p>
                    Melatonin receptors MT1 and MT2 in the substantia nigra are reduced in PD patients, however supplementing it helps amend this deficit. <cite class="reflink"><a href="#jw-shin">Shin</a></cite> 
                </p>

                <h5>Vasodilation Effects</h5>
                <p>                
                    Brain ischemia, a common problem in PD, occurs when blood flow and oxygen supply are restricted to various parts of the brain. Worse, ischemia to the substantia nigra exacerbates the problem of decreased dopamine output. This impairs mitochondrial function, leading to energy depletion and cell death. Melatonin is vasodilatory effects, relaxing blood vessels, and improving blood flow. This may help improve perfusion to ischemic brain regions, potentially reducing tissue damage and promoting recovery. 
                </p>
                
                <figure>
                    <img src="img/ischemia-pathophysiology.png" alt="Diagram of ischemia pathophysiology in PD" class="block-image">
                    <figcaption>
                        <p>
                            Ischemia pathophysiology at four stages: energy failure, excitotoxicity, oxidative stress, and inflammation. <img src="img/ischemia-mechanism-icon.jpeg" alt="icon for diagram"> Represents the site of melatonin action
                        </p>
                    </figcaption>
                </figure>

            
                <h5>Mitoprotective</h5>
                <p>
                    Melatonin protects mitochondrial function and integrity, mitigating cellular damage caused by ischemia.
                </p>
                <p>
                    A 2005 review concluded that melatonin preserves mitochondrial homeostasis, reduces free radical generation by enhancing mitochondrial glutathione levels, and safeguards proton potential and ATP synthesis by stimulating complex I and IV activities. <cite class="reflink"><a href="#srinivasan">Srinivasan</a></cite> 
                </p>
                
                <h5>Supplementation</h5>
                <p>
                    Melatonin is safe to take. Excessive doses over 10-15mg may cause next-day tiredness and headache.

                <p>
                    Time-released formulations help maintain melatonin levels for a longer period. The reduced peak concentration helps maintain sleep throughout the night.
                </p>
                
                <h5>
                    Product
                </h5>
                <figure>
                    <img src="img/sleep3.png" alt="Sleep3 â€” Nature's Bounty Sleep3 Melatonin 10mg, Maximum Strength 100% Drug Free Sleep Aid, Dietary Supplement, L-Theanine & Nighttime Herbal Blend Time Release Technology, 60 Tri-Layered Tablets">
                    <figcaption>
                        <p>
                            <a
                                href="https://www.amazon.com/gp/product/B07PXT5LYR/ref=ppx_yo_dt_b_search_asin_title?ie=UTF8&psc=1;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07DJJXPDD&amp;linkId=fcbfe06c3bf2c5b2709c3b7afef8459"
                                >Sleep3 â€” Nature's Bounty â€” Time-released Melatonin â€” 10mg</a>
                        </p>
                    </figcaption>
                </figure>
                
                <h5>References</h5>
                <ol class="reference-list">
                    <li id="reiter">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10668453/"
                >Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism</a>, R J Reiter, et al.
                    </li>
                
                    <li id="srinivasan">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16179266/"
                        title="Role of Melatonin in Neurodegenerative Diseases"
                        target="_blank">Role of Melatonin in Neurodegenerative Diseases</a>, V Srinivasan, et al.

                    <li id="bostantjopoulou">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9238339/"
                        target="_blank"
                        title="Superoxide Dismutase Activity in Early and Advanced Parkinson's Disease">Superoxide Dismutase Activity in Early and Advanced Parkinson's Disease</a>, S Bostantjopoulou, et al.
                    </li>
                    
                    <li id="yang">
                        <a href="https://www.frontiersin.org/articles/10.3389/fnagi.2020.00053/full"
                        title="Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinsonâ€™s Disease Severity"
                        target="_blank"
                        >Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinsonâ€™s Disease Severity</a>, Wanlin Yang, et al.
                    </li>
                    
                    <li id="jw-shin">
                        <a href="url"
                        title="Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases"
                        target="_blank"
                        >titNeuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
    le</a>, Jung-Won Shin.
                    </li>                   
                </ol>
            </section>
        </section>

        <section id="theanine">
            <h3>L-Theanine</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Sleep, neurorestorative, antioxidant</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>100-400 mg per day ðŸ’¤ (at night)</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            <p>
                L-theanine, an amino acid found in green tea, has neuroprotective, mood-improving, and sleep-promoting effects that can help PD.
            </p>
            
            <h4>Cognitive Effects</h4>
            <p>
                A 2021 double-blind, randomized, placebo-controlled study in Japan evaluated the effects of 100.6 mg of L-theanine taken daily for 12 weeks in participants aged 50â€“69 years.
            </p>
            <p>
                The theanine group showed improved attention, reaction times, working memory, and executive functionâ€“higher-level cognitive skills for decision-making, problem-solving, and adapting to new situations. <cite class="reflink"><a href="#baba">Baba</a></cite> 
            </p>
            
            <p>
                Another double-blind, crossover <abbr title="randomized controlled trial">RCT</abbr> in Japan investigated the effects of 200 mg/day of L-theanine over four weeks on stress and cognitive function in healthy adults.
            </p> 
            <p>
                In a double-blind, crossover <abbr title="randomized controlled trial">RCT</abbr>, 200 mg/day of L-theanine for four weeks improved cognitive function, verbal fluency, and executive function in healthy adults aged 36â€“60. Cognitive function, verbal fluency and executive function scores improved after L-theanine administration. The study's crossover design and methodologies supports their findings that L-theanine can promote mental health in the general population with stress-related cognitive impairments. <cite class="reflink"><a href="#hidese">Hidese</a></cite> 
            </p>
            
            <h4>Effects on Sleep</h4>
            <p>
                Another crossover <abbr title="Randomized Controlled Trial">RCT</abbr> from Japan investigated chronic L-theanine administration on stress-related symptoms and cognitive function in a non-clinical population. 
                
            </p>
            <p>
                Subjects were randomly assigned to L-theanine (200 mg/day) or placebo tablets for 4 weeks. After a 2 week wash-out, the crossover study was continued for 4 weeks. Results showed the L-theanine group experienced shorter sleep latency, reduced sleep disturbances, and decreased reliance on sleep medication. <cite class="reflink"><a href="#kunugi">Kunugi</a></cite> 
            </p>
            
            <h4>Mechanism of Action</h4>
            <p>
                 L-theanine has been found to inhibit the NMDA receptor pathway, thereby preventing excessive glutamate-induced calcium influx and subsequent neuronal damage (Di et al., 2010). Theanine has potential competitively bind to glutamate receptors in the nervous system and may increase GABA levels. <cite class="reflink"><a href="#nathan">Nathan</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                L-theanine is considered very safe, with a recommended dose of 100â€“200 mg taken about 30 minutes before bedtime. An additional daytime dose may enhance mental clarity or counterbalance the stimulating effects of caffeine. Theanine can be taken with GABA for their combined effects on sleep.
            </p>
            <h4>References</h4>
            <ol class="reference-list">
                
                <li id="baba">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080935/"
                    title="Effects of l-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study"
                    target="_blank"
                    >Effects of l-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study</a>, Yoshitake Baba, et al.
                </li>
                
                <li id="hidese">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836118/"
                    title="Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial"
                    target="_blank"
                    >Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial</a>, Shinsuke Hidese, et al.
                </li>
                
                <li id="kunugi">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576271/"
                    title="Effects of Chronic L-theanine on Stress-related Symptoms and Cognitive Function in a Non-clinical Population: A Randomized Controlled Trial"
                    target="_blank"
                    >Effects of Chronic L-theanine on Stress-related Symptoms and Cognitive Function in a Non-clinical Population: A Randomized Controlled Trial</a>, Hiroshi Kunugi, et al.
                </li>
                <li id="nathan">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/17182482/"
                    title="The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent"
                    target="_blank"
                    >The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent</a>, Pradeep J Nathan, et al.
                </li>
                
                <!-- Effects on PD 
                <li id="takeshima">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018574/"
                    title="L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes"
                    target="_blank"
                    >L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes</a>, Mika Takeshima, et al.
                </li>
                <li id="deb">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31145971/"
                    title="Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics"
                    target="_blank"
                    >Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics</a>, Satarupa Deb, et al.
                </li>
                
                <li id="raj">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/34210222/"
                    title="L-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease"
                    target="_blank"
                    >L-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease</a>, Khadga Raj, et al.
                </li>
                
                <li id="shivam-kumar">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/37191688/"
                    title="L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson's disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters"
                    target="_blank"
                    >L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson's disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters</a>, Shivam Kumar, et al.
                </li>
                
                <li id="khoirunnisa">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/36502788/"
                    title="L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/Î²-catenin signaling mediated by the MAPK signaling pathway"
                    target="_blank"
                    >L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/Î²-catenin signaling mediated by the MAPK signaling pathway</a>, Khoirunnisa Rati, et al.
                </li>
                -->
            </ol>
        </section>
        
        <section id="tmg">
            <h3>TMG (Trimethylglycine)</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Anti-inflammatory, DRT Side-Effects, Sleep</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>1-2 g per day, 1g post workout ðŸ‹ï¸, 1g at night ðŸ’¤</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… </td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Somewhat Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>


            <p>
                TMG (trimethylglycine), also known as betaine, is a natural compound in the body and found in various foods. It helps convert homocysteine into methionine, a process that may reduce inflammation linked to PD. <cite class="reflink"><a href="#sleeman">Sleeman</a>, <a href="#murray">Murray</a>, <a href="#bhattacharjee">Bhattacharjee</a></cite>
            </p>   
                     
            <p>
                High homocysteine levels contribute to oxidative stress and inflammation, damaging neurons and blood vessels, including those in the brain.
            </p>    
            <h4>DRT Elevates Homocysteine</h4>
            <p>
                Levodopa metabolism in the liver raises homocysteine levels, potentially worsening neurological and vascular risks in PD. Lowering homocysteine may help mitigate these risks in patients on DRT. <cite class="reflink"><a href="#kocer">Kocer</a></cite>
            </p>    
            
            <h4>TMG or B Vitamins?</h4>
            <p>
                TMG supports methylation alongside B6, B12, and folate by lessening B-vitamin demand, particularly in individuals with high methylation demands, like those on DRT. <cite class="reflink"><a href="#machek">Machek</a></cite>     
            </p>    
             
            <h4>TMG Raises Glutathione</h4>
            <p>
                TMG indirectly supports glutathione synthesis, as methionine produced from TMG can convert to SAMe, a precursor to glutathione, an important antioxidant. <cite class="reflink"><a href="#g-zhao">Zhao</a></cite>
            </p>
              
            <h4>Glycine Support</h4>
            <p>
                When TMG donates a methyl group to homocysteine, a small amount of glycine is released, which helps promote relaxation by acting on NMDA receptors in the brain.
            </p>
            
            
            <h4>Osmotic Balance</h4>
            <p>
            
            </p>
            <p>
                TMG helps cells maintain a healthy balance of water and solutes, potentially protecting neurons from stress. As a stabilizing osmolyte, TMG supports the maintenance of native protein structures, helping to reduce cellular stress and the likelihood of protein misfoldingâ€”a process linked to neurodegenerative diseases like PD. However, these osmolytic effects are not unique to TMG. Other osmolytes, such as taurine, creatine, glycerol, and glycine, contribute to cellular stability in similar ways. By stabilizing proteins and maintaining cellular hydration, osmolytes like these may collectively support brain health by reducing the conditions that lead to protein aggregation and cellular dysfunction. <cite class="reflink"><a href="#knight">Knight &amp; Knight</a>, <a href="#kushwah">Kushwah</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                A split dose of 1g post-exercise and 1g before bed may enhance antioxidant support and improve sleep.
            </p>    
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="sleeman">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6597987/"
                    title="Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinsonâ€™s Disease"
                    target="_blank"
                    >Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinsonâ€™s Disease</a>, Isobel Sleeman, et al.
                </li>
                
                <li id="murray">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31303188/"
                    title="The role of one-carbon metabolism and homocysteine in Parkinson's disease onset, pathology and mechanisms"
                    target="_blank"
                    >The role of one-carbon metabolism and homocysteine in Parkinson's disease onset, pathology and mechanisms</a>, Lauren K Murray and Nafisa M Jadavji.
                </li>
                
                <li id="bhattacharjee">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5600271/"
                    title="Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinsonâ€™s disease"
                    target="_blank"
                    >Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinsonâ€™s disease</a>, Nivedita Bhattacharjee, et al.
                </li>
                
                <li id="kocer">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4967439/"
                    title="Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective?"
                    target="_blank"
                    >Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective?</a>, Bilge Kocer, et al.
                </li>
                
                <li id="machek">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8839982/"
                    title="Human Serum Betaine and Associated Biomarker Concentrations Following a 14 Day Supplemental Betaine Loading Protocol and during a 28 Day Washout Period: A Pilot Investigation"
                    target="_blank"
                    >Human Serum Betaine and Associated Biomarker Concentrations Following a 14 Day Supplemental Betaine Loading Protocol and during a 28 Day Washout Period: A Pilot Investigation</a>, Steven B Machek, et al.
                </li>
                <li id="g-zhao">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5976740/"
                    title="Betaine in Inflammation: Mechanistic Aspects and Applications"
                    target="_blank"
                    >Betaine in Inflammation: Mechanistic Aspects and Applications</a>, Guangfu Zhao, et al.
                </li>
                <li id="knight">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10556504/"
                    title="Making the case for prophylactic use of betaine to promote brain health in young (15â€“24 year old) athletes at risk for concussion"
                    target="_blank"
                    >Making the case for prophylactic use of betaine to promote brain health in young (15â€“24 year old) athletes at risk for concussion</a>, Leena S Knight and Thomas A Knight.
                </li>
                <li id="kushwah">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7022651/"
                    title="Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation"
                    target="_blank"
                    >Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation</a>, Neetu Kushwah, et al.
                </li>
            </ol>
        </section>
        
        <section id="quinones">
            <h3>
                Mitochondrial Quinones (PQQ, CoQ10) and Vitamin K2
            </h3>
            
            <p>
                PQQ and CoQ10 promote mitochondrial biogenesis, improving ATP production and reducing oxidative stress. Their combined supplementation can have synergistic effects, enhancing mitochondrial efficiency, reducing fatigue, and improving overall cellular health. Vitamin K2 supports mitochondrial function to some extent via SIRT1 activation and supports other vital functions such as bone mineralization, gut health, and cardiovascular health.
            </p>
            
            <section id="pqq">
                <h3>Pyrroloquinoline Quinone (PQQ)</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Antifibrillogenic, Anti-aggregant, Anti-ischemic, Mitochondrial, Antioxidant, Anti-inflammatory, Neurorestorative</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>40-200 mg per day ðŸ½ï¸</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âŒ (?)</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Very Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Very Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                <p>
                    Pyrroloquinoline Quinone (PQQ) is a naturally occurring coenzyme manufactured by bacteria, found in plants in tiny amounts, and utilized by mammalian cells as an important nutritional growth factor. PQQ is not produced endogenously in humans.
                </p>

                <p>
                    PQQ activates the signaling pathway involving the transcription factor PGC-1Î± (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), which promotes the formation of new mitochondria. This increases the number and efficiency of mitochondria in cells, improving cellular energy production. <cite class="reflink"><a href="#w-chowanadisai">W. Chowanadisai</a>, <a href="#p-hwang">P. Hwang</a></cite>
                </p>

                <h4>Brain Health</h4>
                <p>
                    Neurologically, PQQ increases blood flow to the cerebral cortex, protects against cell damage, promotes nerve growth factor (NGF) production, and prevents neurodegeneration caused by oxidative stress. These combined effects improve upon cognitive deficits from oxidative damage and senescence, and enhance memory, attention, cognition, learning, and mood. <cite class="reflink"><a href="#k-ohwada">K. Ohwada</a>, <a href="#k-shiojima">K. Shiojima</a>, <a href="#m-tamakoshi">M. Tamakoshi</a>, <a href="#k-ikemoto">K. Ikemoto</a></cite>
                </p>
                
                <h4>Cardiovascular Health</h4>
                <p>
                     By reducing oxidative stress and inflammation, PQQ supports endothelial function and protects against damage to blood vessels. PQQ has been shown to improve LDL levels, probably by the enzyme <abbr title="AMP-activated protein kinase">AMPk</abbr>, which regulates blood lipid levels, and to significantly decrease the levels of plasma C-reactive protein and <abbr title="interleukin 6">IL-6</abbr>. <cite class="reflink"><a href="#c-harris">C. Harris</a>, <a href="#m-nakano">M. Nakano</a>, <a href="#y-huang">Y. Huang</a></cite> 
                </p>
            
                <p>
                    PQQ helps prevent the formation of &alpha;-synuclein fibrils in vitro. However, these antifibrillogenic effects in humans, from supplementation, are unproven and questionable, as PQQ's ability to cross the BBB has not been established. 
                    <cite class="reflink"><a href="#m-kobayashi">M. Kobayashi</a>, <a href="#j-kim">J. Kim</a></cite> 
                </p>
                
                <h4>Blood-Brain Barrier (BBB)</h4>
                <p>
                    PQQ's cognitive and neurological effects could be achieved either through indirect mechanisms, undetermined transport proteins might facilitate the passage of PQQ across the BBB, metabolites that can cross the BBB and exert beneficial effects on brain function, or a combination of things. 
                </p>
                <p> 
                    PQQ's effects do involve enhanced systemic energy metabolism, reduced inflammation, increased antioxidant capacity, stimulation of neurotrophic factors, improved vascular health, and gut-brain axis modulation. These systemic effects create a more favorable environment for brain health, indirectly supporting cognitive function, whether or not PQQ itself crosses the BBB.
                </p>
                
                <h4>Supplementation</h4>
                <p>
                    Although many studies show benefits at 20 or 30 mg, 40 &ndash; 200 mg per day of PQQ is safe. It is fat-soluble and best taken with other fat-soluble supplements and food.
                </p>
                <p>
                    In 2017, the European Food Safety Authority (EFSA) Panel on Dietetic Products determined a No Observed Adverse Effect Level (NOAEL) of 100mg/kg per day for 90 days. For a 50kg woman, this translates to a dose of 5g per day. Other studies have investigated PQQ's benefits and safety using similar dosages.
                </p>
                <p>
                    Given the vast multitude of benefits that occur on the cellular level and the incredibly high safety threshold, a recommended dose of PQQ is 40 &ndash; 200mg per day. There are no known contraindications.  Dose-dependent effects have been observed in rodents with <abbr title="Traumatic Brain Injury">TBI</abbr>. It is recommended to start with a more moderate dose of 40 mg per day and gradually increase. <cite class="reflink"><a href="#l-zhang">L. Zhang</a></cite>
                </p>
                
                <h4>Side Effects</h4>
                <p>
                    Mild headaches and insomnia may be experienced when PQQ is taken at night. Higher doses (e.g., 100-200 mg per day) are well-tolerated and may provide more pronounced effects.
                </p>
                
                <h4>PQQ References</h4>

                <ol class="reference-list">                    
                    <li id="w-chowanadisai">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804159/" 
                            title="Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expressions"
                            target="_blank">Pyrroloquinoline Quinone Stimulates Mitochondrial Biogenesis through cAMP Response Element-binding Protein Phosphorylation and Increased PGC-1Î± Expression</a>, Winyoo Chowanadisai, et al.
                        <p>
                            This in vitro study shows that PQQ enhances mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression.
                        </p>
                    </li>
                    <li id="p-hwang">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31860387/" 
                            title="Effects of Pyrroloquinoline Quinone (PQQ) Supplementation on Aerobic Exercise Performance and Indices of Mitochondrial Biogenesis in Untrained Men"
                            target="_blank">Effects of Pyrroloquinoline Quinone (PQQ) Supplementation on Aerobic Exercise Performance and Indices of Mitochondrial Biogenesis in Untrained Men</a>, Paul S Hwang, et al.
                        <p>
                            This small six week study found PQQ supplementation increases mitochondrial biogenesis by way of significant elevations in PGC-1Î± protein content in previously untrained men, though it did not improve their performance.
                        </p>
                    </li>
                    <li id="k-ohwada">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18231627/" 
                            title="PQQ prevents cognitive deficit in rats"
                            target="_blank">PQQ prevents cognitive deficit caused by oxidative stress in rats</a>, Kei Ohwada, et al.
                        <p>
                            This rodent study indicates that PQQ supplementation markedly improved the memory deficit and can prevent cognitive deficits in rats induced by oxidative stress.
                        </p>
                    </li>
                    <li id="y-shiojima">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34415830/"
                        title="Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study"
                        target="_blank"
                        >Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study</a>, Yoshiaki Shiojima, et al.
                        <p>
                        
                        </p>
                    </li>
                    <li id="m-tamakoshi">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36807425/"
                        title="Pyrroloquinoline quinone disodium salt improves brain function in both younger and older adults"
                        target="_blank"
                        >Pyrroloquinoline quinone disodium salt improves brain function in both younger and older adults</a>, Masanori Tamakoshi, et al.
                        <p>
                             In the logistic regression analysis that included the results of all cognitive tests, the changes due to PQQ intake of 20 mg ED for 12 weeks were observed at 8 and 12 weeks in the young and old groups, respectively.
                        </p>
                    </li>
                    <li id="k-ikemoto">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/38735721/"
                        title="The effects of pyrroloquinoline quinone disodium salt on brain function and physiological processes"
                        target="_blank"
                        >The effects of pyrroloquinoline quinone disodium salt on brain function and physiological processes</a>, Kazuto Ikemoto, et al.
                        <p>
                            PQQ was found to suppress skin moisture loss and increase PGC-1Î± expression. Co-administration of PQQ and coenzyme Q10 further enhanced these effects. 
                        </p>
                    </li>
                    <li id="c-harris">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24231099/"
                        title="Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects"
                        target="_blank"
                        >Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects</a>, Calliandra B Harris, et al.
                        <p>
                        
                        </p>
                    </li>
                    <li id="m-nakano">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26226960/" 
                            title="Effects of Pyrroloquinoline Quinone Disodium Salt Intake on the Serum Cholesterol Levels of Healthy Japanese Adults"
                            target="_blank">PQQ intake effects on serum cholesterol levels</a>, Masahiko Nakano, et al.
                        <p>
                            This study showed the effects of PQQ disodium salt (BioPQQâ„¢) on serum TG and cholesterol levels in humans after 6 and 12 wk of treatment at an oral dosage of 20 mg/d. 
                        </p>
                        <p>
                            PQQ suppressed the LDL-chol level, which is an important finding because a high level of this lipid is a risk factor for various lifestyle-related diseases.
                        </p>
                    </li>
                    <li id="m-kobayashi">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16962995/" 
                            title="Pyrroloquinoline quinone (PQQ) prevents fibril formation of Î±-synuclein"
                            target="_blank">PQQ prevents fibril formation of alpha-synuclein</a>, Masaki Kobayashi, et al.
                        <p>
                            This study demonstrates that PQQ inhibits the fibril formation of alpha-synuclein, which is significant in neurodegenerative diseases.
                        </p>
                    </li>
                    <li id="j-kim">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881056/" 
                            title="The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein"
                            target="_blank">PQQ inhibits amyloid formation and cytotoxicity</a>, Jihoon Kim, et al.
                        <p>
                            This study showed that PQQ dramatically inhibits the fibril formation of C-terminal truncated alpha-synuclein 110119, and 133 as well as the mixtures of full-length alpha-synuclein with these truncated variants. Moreover, PQQ decreases the cytotoxicity of truncated alpha-synuclein.
                        </p>
                    </li>

                    <li id="y-huang">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509087/" 
                            title="P\Biological effects of pyrroloquinoline quinone on liver damage in Bmi-1 knockout mice"
                            target="_blank">PQQ effects on liver damage in Bmi-1 knockout mice</a>, Yuanqing Huang, et al.
                        <p>
                            This study found that a moderate dose of PQQ significantly protected the liver from deleterious effects by inhibiting oxidative stress and participating in DNA damage repair.
                        </p>
                    </li>

                    <li id="q-geng">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329928/"
                        title="Pyrroloquinoline Quinone Prevents Estrogen Deficiency-Induced Osteoporosis by Inhibiting Oxidative Stress and Osteocyte Senescence"
                        target="_blank"
                        >Pyrroloquinoline Quinone Prevents Estrogen Deficiency-Induced Osteoporosis by Inhibiting Oxidative Stress and Osteocyte Senescence</a>, Qinghe Geng, et al.
                        <p>
                        
                        </p>
                    </li>
                    <li id="l-zhang">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303106/"
                        title="The Neuroprotective Effect of Pyrroloquinoline Quinone on Traumatic Brain Injury"
                        target="_blank"
                        >The Neuroprotective Effect of Pyrroloquinoline Quinone on Traumatic Brain Injury</a>, Lili Zhang, et al.
                        <p>
                            This rodent study showed a dose-dependent response of PQQ in rodents with induced TBI from 5â€‰mg/kg to 10 mg/kg per day, injected intraperitoneally. We can extrapolate for <abbr title="Human Equavalent Dose">HED</abbr> by dividing by 12.3, to get the respective human equivalent doses of 0.4 mg / kg, 0.57 mg/ kg, and 0.81 mg/kg. For a 60kg human, the HED dose of 0.81 mg/kg is 48 mg PQQ ED. (See: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804402/#T1">A simple practice guide for dose conversion between animals and human</a> (A. Nair, S. Jacobs)).
                        </p>
                    </li>
                </ol>
            </section>
            <section id="k2">
                <h3>Vitamin K2</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Antioxidant, Anti-inflammatory, Anti-ischemic â€” helps reduce vascular calcification</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>2-5 mg per day (2000-5000 mcg) ðŸ½ï¸</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Very Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                <p>
                    Vitamin K2 supports mitochondrial function by activating sirtuin 1 (SIRT1), a longevity gene that regulates mitochondrial biogenesis and helps manage oxidative stress. However, K2's biggest role is its effects on bone metabolism and the bone-brain axis. <cite class="reflink"><a href="#d-simes">D. Simes</a></cite> 
                </p>
                
                
                <h4>Blood-Brain Barrier</h4>
                <p>
                    Vitamin K2's ability to cross the blood-brain barrier enables it to exert its effects within the central nervous system, including reduced oxidative stress in neurons and reduced neuroinflammation. <cite class="reflink"><a href="#a-popescu">A. Popescu</a></cite>
                </p>
                
                <h4>Bone-Brain Axis</h4>
                <p>
                    Osteocalcin is a protein produced by cells in bones called osteoblasts. Vitamin K2 promotes osteoblastogenesis, the creation of new osteoblasts, which produce osteocalcin. Vitamin K2 also activates osteocalcin (OCN) by <dfn>carboxylating</dfn> it, which allows it to bind calcium to mineralize bones <cite class="reflink"><a href="#m-yamaguchi">M. Yamaguchi</a></cite>.
                </p>
                
                <p>
                    Osteocalcin circulates as a peripheral hormone, crosses the BBB, and promotes spatial learning and memory while preventing anxiety-like behavior. This complex interplay between the bones and the CNS, influencing each otherâ€™s function and behavior, is known as the <dfn>bone-brain axis</dfn>. <cite class="reflink"><a href="#a-obri">A. Obri</a></cite>
                </p>
                
                <h5>Brain Calcification</h5>
                <p>
                    Calcium deposits in the basal ganglia can disrupt normal movement patterns, leading to symptoms such as dystonia, tremors, and unsteady gait. Vitamin K2 supplementation helps address these issues by increasing osteocalcin production and by activating Matrix Gla Protein (MGP), which drives osteoblastogenesis.
                </p>

                <p>
                    Vitamin K2 increases osteocalcin in both its forms, carboxylated and undercarboxylated (ucOCN). Carboxylated osteocalcin moves calcium from the bloodstream into bones, reducing calcification in tissues such as the brain and arteries, promoting neurological function and cerebral blood flow. Serum ucOCN circulates and acts on various tissues, including the brain, and is correlated with better cognitive function <cite class="reflink"><a href="#gu">gu</a></cite>. 
                </p>
                
                <h5>Matrix Gla Protein (MGP)</h5>
                <p>
                    <abbr title="Matrix Gla Protein">MGP</abbr> is a vitamin K-dependent protein synthesized in bone and various mesenchymal cells, including vascular smooth muscle cells and chondrocytes. Vitamin K2 activates MGP by carboxylating it, which can prevent calcification in blood vessels, kidneys, and the brain by helping to direct it to bones <cite class="reflink"><a href="#k-maresz">K. Maresz</a></cite>. These effects are dose-dependent and research has shown that typical microgram doses may not be effective at reducing arterial calcification. <cite class="reflink"><a href="#bjorklund">BjÃ¸rklund</a></cite>
                </p>
                
                <h5>High-Dose K2 Works</h5>
                <p>
                    A randomized, placebo-controlled multicenter study on elderly men with aortic valve calcification found no significant impact of 720 Âµg MK-7 plus vitamin D on calcification progression over two years. 720 Âµg is considered to be a high dose, but was still ineffective <cite class="reflink"><a href="#diederichsen">Diederichsen</a></cite>. Another study demonstrated that a 0.5 mg (500 Âµg) dose of Vitamin K2 significantly reduced undercarboxylated osteocalcin (%ucOC), and a 5 mg dose further enhanced this effect, showing dose-dependent effect, up to 5mg dose, for activation of Vitamin K-dependent proteins like osteocalcin and MGP for reducing calcification <cite class="reflink"><a href="#t-giri">Giri</a></cite>. 
                </p>
                
                <h5>Supplementation</h5>
                <p>
                    Vitamin K2 supplementation is generally safe and well-tolerated, as the body regulates it without toxic effects, even at doses as high as 45 mg per day in women with osteoporosis. Most available supplements, however, contain doses in the microgram range, which may be insufficient to provide the desired health benefits.Â <cite class="reflink"><a href="#t-giri">Giri</a></cite>
                </p>

                <ol class="reference-list">
                     <li id="d-simes">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747195/"
                        title="Vitamin K as a Powerful Micronutrient in Aging and Age-Related Diseases: Pros and Cons from Clinical Studies"
                        target="_blank"
                        >Vitamin K as a Powerful Micronutrient in Aging and Age-Related Diseases: Pros and Cons from Clinical Studies</a>, Dina C. Simes, et al.
                    </li>
                    
                    <li id="a-popescu">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308377/"
                        title="Vitamin K2 Holds Promise for Alzheimerâ€™s Prevention and Treatment"
                        target="_blank"
                        >Vitamin K2 Holds Promise for Alzheimerâ€™s Prevention and Treatment</a>, Alexander Popescu and Monica German.
                    </li>
                    
                    <li id="a-obri">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958904/"
                        title="Osteocalcin in the brain: from embryonic development to age-related decline in cognition"
                        target="_blank"
                        >Osteocalcin in the brain: from embryonic development to age-related decline in cognition</a>, Arnaud Obri, et al.
                    </li>
                    
                    <li id="m-yamaguchi">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21072493/"
                        title="Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-ÎºB activation"
                        target="_blank"
                        >Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-ÎºB activation</a>, Masayoshi Yamaguchi, et al.
                    </li>
                    <li id="k-maresz">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483258/"
                        title="Growing Evidence of a Proven Mechanism Shows Vitamin K2 Can Impact Health Conditions Beyond Bone and Cardiovascular"
                        target="_blank"
                        >Growing Evidence of a Proven Mechanism Shows Vitamin K2 Can Impact Health Conditions Beyond Bone and Cardiovascular</a>, Katarzyna Maresz.
                    </li>

                    <li id="gu">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609217/"
                        title="Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment"
                        target="_blank"
                        >Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment</a>, Peng-Ying Gu, et al.
                    </li>
                    <li id="bjorklund">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30009696/"
                        title="The Role of Matrix Gla Protein (MGP) in Vascular Calcification"
                        target="_blank"
                        >The Role of Matrix Gla Protein (MGP) in Vascular Calcification</a>, Geir BjÃ¸rklund, et al.
                    </li>
                
                    <li id="diederichsen">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047644/"
                        title="Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial"
                        target="_blank"
                        >Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial</a>, Axel C.P. Diederichsen, et al.
                    </li>
                    
                    <li id="t-giri">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30816822/"
                        title="Maximal dose-response of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis"
                        target="_blank"
                        >Maximal dose-response of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis</a>, Tusar K Giri, et al.
                    </li>
                </ol>
            </section>
            
            <section id="ubiquinol">
                <h3>Ubiquinol</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Mitochondrial, Antioxidant</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>400-600mg per day</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âŒ?</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                <p>Humans naturally produce CoQ10, an antioxidant that exists in almost every cell of the body. Ubiquinol is the reduced form of CoQ10 and is absorbed more efficiently by the body than ubiquinone, the oxidized form of CoQ10.
                </p>
                
                <p>
                    Ubiquinol is involved in energy production within the mitochondria. It improves mitochondrial function with exercise, improves cognitive function, and counteracts fatigue. <cite class="reflink"><a href="#s-fukuda">Sanae Fukuda</a></cite>
                </p>
                
                <h4>Mechanism of Action</h4>
                <p>
                    CoQ10 transports electrons in the electron transport chain (ETC) within the mitochondria, which is part of oxidative phosphorylation, to produce <abbr title="adenosine triphosphate">ATP</abbr> for cellular energy. <cite class="reflink"><a href="#m-spindler">M. Spindler</a></cite>
                </p>
                
                <h3>Ubiquinol in Parkinson's Disease</h3>
                <p>
                    In PD, ubiquinol may significantly reduce symptoms during "wearing off" periods (when levodopa's effects fade before the next dose), as reflected in total UPDRS scores, and is safe and well-tolerated. <cite class="reflink"><a href="#a-yoritaka">A. Yoritaka</a></cite>
                </p>
                <p>
                    Previous studies using ubiquinone did not show significant effect in PD patients. However, ubiquinol, the reduced form of CoQ10, has demonstrated efficacy.
                </p>
                   
                <p>
                    Mitochondrial dysfunction accelerates PD progression by increasing oxidative stress, reducing ATP production, and promoting the accumulation of toxic protein aggregates like alpha-synuclein. These aggregates form Lewy bodies, which contribute to further neurodegeneration. <cite class="reflink"><a href="#a-ebrahimi">A. Ebrahimi</a>, <a href="#c-andreani">C. Andreani</a></cite>
                </p>
                <p>
                    Managing mitochondrial dysfunction in PD involves several strategies, and high-dose CoQ10 supplementation, which supports mitochondrial function, is one approach. <cite class="reflink"><a href="#m-spindler">M. Spindler</a></cite>
                </p>
                <p>
                    Multiple system atrophy (MSA) is a progressive neurodegenerative disorder with symptoms similar to PD, including autonomic failure. Decreased ubiquinone levels contribute to this progression. Studies suggest that CoQ10 supplementation may help reduce neuronal apoptosis in MSA patients. <cite class="reflink"><a href="#f-nakamoto">F. Nakamoto</a></cite>
                </p> 

                <h4>Supplementation</h4>
                <p>
                    Ubiquinol has been demonstrated to be superior to ubiquinone. Phytosome Q10 has been shown to provide even greater absorption, but research shows strong safety and efficacy of ubiquinol, making it a reliable option for CoQ10 supplementation. <cite class="reflink"><a href="#p-langsjoen">P. Langsjoen</a>, <a href="#d-mantle">D. Mantle</a>, <a href="#g-petrangolini">G. Petrangolini</a></cite>
                </p>
                <p>
                    In a study published in The Lancet, a patient with advanced Multiple System Atrophy (MSA) showed restored brain oxygen consumption after taking 1200 mg of oral ubiquinol. This finding suggests a potential benefit of high-dose ubiquinol supplementation in MSA patients supports mitochondrial function. <cite class="reflink"><a href="#j-mitsui">J. Mitsui</a></cite>
                </p>
                
                <h4>Products</h4>
                <ul class="product-list">
                    <li>
                        <figure>
                            <img src="img/coq10-pqq.png" alt="Life Extension Super Ubiquinol CoQ10 with PQQ">
                            <figcaption>
                                <p>
                                    <a href="https://www.amazon.com/Life-Extension-Ubiquinol-Softgels-Bottles/dp/B00MOX1IZC/ref=sr_1_5_pp?sr=8-5" target="_blank">Life Extension Super Ubiquinol CoQ10 with PQQ, 30 Softgels. Pack of 2 Bottles</a>
                                </p>
                            </figcaption>
                        </figure>
                    </li>
                    <li>
                        <figure>
                            <img src="img/solary-phytosome-q10.png" alt="CoQ 10 ubiquisome">
                            <figcaption>
                                <p>
                                    <a href="https://www.amazon.com/SOLARAY-CoQ-10-Phytosome-Easy-Digest/dp/B0CD2Z7TFW/ref=sr_1_5?dib=eyJ2IjoiMSJ9.cmtVvwJRdfFnIup8jBAQPfvVyJOLRy8nh2-QFBIp8FRrhaaSERHS7aUruerpkYDNNQLuYcSkt54YPUcPYAm6BK6gTaouilEq7Oba4FdcjHvzQvkLw2K1YeX0pnTSFYvjhwRqOXHnSsl2r0RoMzCilQ.5DYKhoPdVCHt_af3m1ICyUIAviwqKzsCkLSGWbQcUFg&dib_tag=se&keywords=UBIQSOME&qid=1717966723&sr=8-5">SOLARAY CoQ-10 Phytosome</a>
                                </p>
                            </figcaption>
                        </figure>
                    </li>
                </ul>

                <h4>
                    Ubiquinol References:
                </h4>
                
                <ol class="reference-list">
                    <li id="s-fukuda">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27125909/"
                        title="Ubiquinol supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome"
                        target="_blank">Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndromeS</a>, Sanae Fukuda, et al.
                        <p>
                            This RCT showed that supplementation with ubiquinol-10 (150 mg/day) for 12 weeks improved many CFS symptoms.
                        </p>
                    </li>
                    <li id="j-mitsui">
                        <a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00097-4/fulltext"
                        title="High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial"
                        target="_blank">
                        High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial</a>, Jun Mitsui, et al.
                        <p>
                            This multicenter, randomized, double-blind, placebo-controlled, phase 2 trial showed that high-dose ubiquinol was well-tolerated and improved multiple system atrophy, compared with placebo.
                        </p>
                    </li>
                    <li id="a-ebrahimi">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632062/"
                        title="[Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases]"
                        target="_blank"
                        >Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases</a>, Alireza Ebrahimi, et al.
                        <p>
                            Discusses how CoQ10 might protect the nervous system from degeneration and deterioration, mainly due to its antioxidant and energy-regulating role in mitochondria. Specifically, how CoQ10 supplementation can lead to an increment in its levels in the mitochondria.
                        </p>
                    </li>
                    <li id="m-spindler">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785862/"
                        title="Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy"
                        target="_blank"
                        >Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy</a>, Meredith Spindler, et al.
                        <p>
                            Discusses how CoQ10 supplementation may be beneficial for MSA, as for other primary CoQ10 deficiencies
                        </p>
                    </li>
                    <li id="f-nakamoto">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155102/"
                        title="The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy"
                        target="_blank">Coenzyme Q10 insufficiency in patients with multiple-system atrophy</a>, Fumiko Kusunoki Nakamoto, et al.
                        <p>
                            This study shows a causal relationship between neuronal apoptosis and coenzyme Q10 deficiency.
                        </p>
                    </li>
                    <li id="c-andreani">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220380/"
                        title="Combination of Coenzyme Q10 Intake and Moderate Physical Activity Counteracts Mitochondrial Dysfunctions in a SAMP8 Mouse Model"
                        target="_blank">
                        Combination of Coenzyme Q10 Intake and Moderate Physical Activity Counteracts Mitochondrial Dysfunctions in a SAMP8 Mouse Model</a>, C. Andreani, et al.
                        <p>
                            This rodent study shows that ubiquinol supplementation counteracts the deleterious effects of physical exercise-derived ROS improving mitochondrial functionality in an oxidative stress model, such as SAMP8 in the presarcopenia phase
                        </p>
                    </li>
                    <li id="a-yoritaka">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26054881/"
                        title="Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease"
                        target="_blank">
                        Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease</a>, Asako Yoritaka, et al.
                        <p>
                        This  double-blind, placebo-controlled RCT pilot trial showed improvement in symptoms in PD patients.
                        </p>
                    </li>

                    <li id="p-langsjoen">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27128225/"
                        title="Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone"
                        target="_blank">Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone</a>, Peter H Langsjoen, et al.
                        <p>
                            This small study on human volunteers showed both ubiquinol and ubiquinone increased plasma CoQ10, but the increase in CoQ10 /cholesterol ratio was significantly better after ubiquinol than ubiquinone, indicating superior bioavailability. 
                        </p>
                    </li>

                    <li id="d-mantle">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278738/"
                        title="Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism"
                        target="_blank">Bioavailability of Coenzyme Q10</a>, David Mantle, et al. 
                        <p>
                            This study compares the relative bioavailability and efficacy of ubiquinone and ubiquinol forms of CoQ10.
                        </p>
                    </li>
                    <li id="g-petrangolini">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31475897/"
                        title="A New Food-grade Coenzyme Q10 Formulation Improves Bioavailability: Single and Repeated Pharmacokinetic Studies in Healthy Volunteers"
                        target="_blank">Phytosome Q10 Formulation Improves Bioavailability in Healthy Volunteers</a>, Giovanna Petrangolini, et al.
                        <p>
                            This in vitro study shows that coenzyme Q10 phytosome in simulated intestinal fluids results in an improvement in oral absorption of coenzyme Q10 in healthy volunteers, three times more than the coenzyme Q10 according
                        </p>
                    </li>

                </ol>
            </section>
        </section>
        <section id="gg">
            <h3>
                Geranylgeraniol (GG)
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Mitochondrial, Helps DRT Side-Effects, Antioxidant, Anti-inflammatory</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>150 mg per day ðŸ½ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ…</td>
                </tr>

                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…? Probable. GG is 290.48 g/mol. Small lipophilic molecules under 400 Da and forming less than 8 hydrogen bonds easily cross the BBB via lipid-mediated free diffusion.</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
                Geranylgeraniol (GG) is naturally synthesized in the human body via the mevalonate (cholesterol) pathway and can also be extracted from annatto seeds. GG is a precursor of CoQ10, vitamin K2, cholesterol, testosterone, and protein synthesis and modification. GG production declines with age, which can reduce levels of CoQ10, vitamin K2, and testosterone. <cite class="reflink"><a href="#h-j-ho">Ho</a></cite> 
            </p>
            
            <p>
                GG suppresses inflammation by improving the gut microbiome and enhancing glucose response, benefiting both gut health and systemic inflammation. <cite class="reflink"><a href="#e-chung">Chung</a></cite> 
            </p>                     
            
            <h4>Mechanism of Action</h4>
            <p>
                GG converts mevalonic acid (MVA), the precursor for cholesterol, into CoQ10, vitamin K2, and sex hormones, which helps protect mitochondrial function.
            </p>
            
            <p>
                CoQ10 and cholesterol are synthesized endogenously in both the body and brain, but their levels decline due to aging and mitochondrial dysfunction, a major problem in PD. The brain contains around 20% of the bodyâ€™s total cholesterol. GG supplementation may help counteract these deficits by providing the raw material for their synthesis, supporting mitochondrial and neuronal function.
            </p>
            <h5>Cholesterol Turnover</h5>
            <p>
                Cholesterol is essential for synaptogenesis. Studies suggest that higher cholesterol levels are associated with a lower risk of PD, while lower cholesterol may be a risk factor for PD. GG can increase cholesterol turnover in the brain, potentially supporting brain cholesterol levels and neurological function. <cite class="reflink"><a href="#huang">huang</a></cite>
            </p>
            <p>
                A 2006 rodent study demonstrated that GG restored hippocampal long-term potentiation (LTP) levels. The study found that GG, but not cholesterol, increased cholesterol turnover in the brain and activated the mevalonate pathway. The research indicated that continuous production of GG in specific neurons is necessary for <abbr title="long-term potentiation">LTP</abbr> and learning. <cite class="reflink"><a href="#kotti">Kotti</a></cite>
            </p>
            <p>
                Dopamine synthesis requires substantial cellular energy. CoQ10 is a vital energy substrate for brain mitochondria, aiding their function and dopamine production. GG is essential for CoQ10 production, thereby supporting neuronal energy metabolism. <cite class="reflink"><a href="#h-j-ho">Ho</a>, <a href="#b-tan">Tan</a></cite> 
            </p>

            <p>
                While some forms of supplemental CoQ10 may cross the BBB, this remains uncertain. However, GG supplementation supports the body's natural synthesis of CoQ10 and cholesterol, both of which decline with age and mitochondrial dysfunction. Therefore, GG supplementation may help maintain mitochondrial health, support brain energy production, and protect neurons in PD.
            </p>

            <h4>BBB Permeability</h4>
            <p>
                GG, with a molecular weight (MW) of 268.39 g/mol, is likely to cross the BBB, as molecules with an <abbr title="Molecular Weight">MW</abbr> under 400 Da often can. This may offer an advantage over CoQ10, which has a higher <abbr title="Molecular Weight">MW</abbr> of 731 Da and might not cross the BBB (<a href="http://www.chemspider.com/Chemical-Structure.17216048.html"
                >chemspider</a>). 
            </p>

            <h4>Supplementation</h4>
            <p>
                Supplementing geranyl geraniol at 150mg per day is safe, as the body has a natural regulatory mechanism to keep levels from exceeding a healthy range.
            </p>
            
            <h4>Product</h4>

            <ul class="product-list">   
                <li>
                    <a href="https://www.amazon.com/Xtendlife-GG-Pure-Contains-lowering/dp/B0988TVJCH/ref=sr_1_8?sr=8-8">Xtendlife GG Pure - Geranylgeraniol</a>
                </li>
                <li>
                    <figure>
                        <figcaption>
                            <p>
                                <a href="https://www.amazon.com/Xtendlife-Xtend-Quinol-Geranylgeraniol-Supplement-Production/dp/B0CCRMH1W6/ref=sr_1_1?rdc=1&s=hpc&sr=1-1">Xtendlife Xtend-Quinol CoQ10 &amp; GG</a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
            </ul>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="e-chung">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464510/"
                    title="Beneficial effect of dietary geranylgeraniol on glucose homeostasis and bone microstructure in obese mice is associated with suppression of proinflammation and modification of gut microbiome"
                    target="_blank">Beneficial effect of dietary geranylgeraniol on glucose homeostasis and bone microstructure in obese mice is associated with suppression of proinflammation and modification of gut microbiome</a>, Eunhee Chung, et al
                    <p>
                        This rodent study concluded that GG improves glucose homeostasis and bone microstructure in obese mice via suppression of pro-inflammation and modification of microbiome composition.
                    </p>
                </li>
                <li id="huang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420391/#S6"
                    title="Brain cholesterol metabolism and Parkinsonâ€™s disease"
                    target="_blank"
                    >Brain cholesterol metabolism and Parkinsonâ€™s disease</a>, Xuemei Huang,et al.
                </li>
                <li id="kotti">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1450160/"
                    title="Brain cholesterol turnover required for geranylgeraniol production and learning in mice"
                    target="_blank"
                    >Brain cholesterol turnover required for geranylgeraniol production and learning in mice</a>, Tiina J. Kotti, et al.
                </li>
                <li id="b-tan">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/38046949/"
                    title="Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective"
                    target="_blank"
                    >Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective</a>, Barrie Tan, Kok-Yong Chin.
                    <p>
                        CoQ10 supplementation has not been shown to reverse  statin-associated muscle symptoms, therefore, this paper proposes GG for CoQ10 synthesis.
                    </p>
                </li>
                <li id="h-j-ho">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29303051/"
                    title="A novel function of geranylgeraniol in regulating testosterone production"
                    target="_blank"
                    >A novel function of geranylgeraniol in regulating testosterone production</a>
                    <p>
                    </p>
                </li>

            </ol>
        </section>
        
        <section id="nattokinase">
        	<!-- TODO Revisit. Add treatment legend table -->
            <h3>Nattokinase</h3>
            <p>
                Nattokinase is a proteolytic and fibrinolytic enzyme Nattokinase that reduces inflammation.
            </p>
            <p>
                Nattokinase has been shown to degrade amyloid fibrils in mice, which may help to slow down the progression of Parkinsonâ€™s disease.
            </p>
            <p>
                Nattokinase has been shown to promote the non-amyloidogenic processing of AÎ², which may help to reduce the accumulation of amyloid plaques in the brain.
            </p>
        </section>
        
        <section id="dha">
            <h3>
                Docosahexaenoic Acid (DHA)
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Anti-inflammatory, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>2000 â€” 5000 mg ED ðŸ½ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… (50%)</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
                Docosahexaenoic acid (DHA) is an omega-3 fatty acid found in eggs, fish, krill, and algae, and produced in small amounts in humans. DHA is necessary for normal brain function, for cognition, memory, and attention.
            </p>
            
            <p>
                DHA reduces neuroinflammation by mitigating oxidative stress, helping to neutralize <abbr title="Reactive Oxygen Species">ROS</abbr>, and increasing the master antioxidant glutathione. <cite class="reflink"><a href="#h-j-lee">H.J. Lee</a></cite>
            </p>
            
            <h4>DHA in Parkinson's Disease</h4>
            <p>
                Daily DHA supplementation in rodent studies has been shown to protect against core PD symptoms like problems with balance, walking, and dopamine function in brain areas responsible for movement. <cite class="reflink"><a href="#n-m-chitre">N.M. Chitre</a></cite>
            </p>

            <p>
               A 2017 review found that higher doses of DHA were more effective than EPA in increasing the levels of nerve growth factors of <abbr title="Nerve Growth Factor">NGF</abbr> and <abbr title="Brain-derived Neurotrophic Factor">BDNF</abbr> in a dose-dependent response. <cite class="reflink"><a href="#y-p-zhang">Y.P. Zhang</a></cite> 
            </p>

            <p>
                A placebo-controlled trial in adults without cognitive impairments found that supplementing 2g of DHA daily for 6 months led to small increases in <abbr title="cerebrospinal fluid">CSF</abbr> DHA following supplementation, with APOE4 carriers having a lower increase than non-carriers. 
            </p>
            <p>
                The study explained that DHA crosses the BBB through passive diffusion, meaning that high blood levels are required to significantly raise DHA levels in the brain. A 200% increase in blood DHA resulted in only a 28% rise in <abbr title="Cerebrospinal Fluid">CSF</abbr>. <cite class="reflink"><a href="#i-c-arellanes">I.C. Arellanes</a></cite> 
            </p>
            
            <h4>Supplementation</h4>
            <p>
                 Based on the discussed research, DHA can be started at 2 grams per day, and increased gradually. Liquid DHA products may be more effective for those requiring higher doses, but should be kept refrigerated to prevent oxidation. Higher doses of DHA are generally well tolerated, but individual tolerance varies, so splitting doses across meals can help with absorption and reduce the risk of stomach upset.
            </p>

            <h4>DHA Product</h4>
            <figure>
                <img src="img/childrens-dha.jpeg" title="Children's DHA">
                <figcaption>
                    <p>
                    <a href="https://www.amazon.com/gp/product/B004T7DYOO/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B004T7DYOO&amp;linkId=03df93bc6eab5eeabecf94de7e16e7e4"
            target="_blank"
            >Nordic Naturals Children&rsquo;s DHA, Strawberry</a>
                    </p>
                </figcaption>
            </figure>

            <h4>DHA References</h4>
            <ol class="reference-list">

                <li id="h-j-lee">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/25545062/"
                    target="_blank"
                    title="Docosahexaenoic acid prevents paraquat-induced reactive oxygen species production in dopaminergic neurons via enhancement of glutathione homeostasis"
                    >Docosahexaenoic acid prevents paraquat-induced reactive oxygen species production in dopaminergic neurons via enhancement of glutathione homeostasis</a>, Hyoung Jun Lee, et al.
                </li>
                <li id="n-m-chitre">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110909/">
                        Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum
                    </a>, Neha Milind Chitre, et al.
                </li>
                <li id="y-p-zhang">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/28778752/"
                    title="DHA, EPA and their combination at various ratios differently modulated AÎ²25-35-induced neurotoxicity in SH-SY5Y cells"
                    >DHA, EPA, and their combination at various ratios differently modulated AÎ²<sub>25-35</sub>-induced neurotoxicity in SH-SY5Y cells</a>, Yong-Ping Zhang, et al.
                </li>

                <li id="i-c-arellanes">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502665/"
                    title="Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial"
                    target="_blank"
                    >Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial</a>, Isabella C. Arellanes, et al.
                </li>
            </ol>
        </section>
        
        <section id="cholinergics">
            <h3>Cholinergics and Membrane Support</h3>
            
            <p>
                Cholinergics strengthen cell membranes, which can dampen calcium channel overactivation, thereby reducing excitatory states.
            </p>
            <p>
                Cholinergic supplementation has been shown to improve cognitive function, increase physical power output, provide neuroprotection, and improve conditions of neurological disorders. Restoring phosphatidylcholine (PC) to healthy levels has been shown to combat neurological decline and reduce DRT dependence and its associated side effects. <cite class="reflink"><a href="#m-zhou">M. Zhou</a>, <a href="#m-amalric">M. Amalric</a>, <a href="#b-s-baumel">B.S. Baumel</a></cite>
            </p>

            <p>
                Cholinergic supplements support neuronal health by maintaining cell membrane integrity, improving neurotransmitter synthesis, and providing neuroprotection. This helps sustain cognitive function and neuronal survival.
            </p>
            
            <p>
                The cholinergic and dopaminergic systems are interdependent. Cholinergic supplements uridine monophosphate (UMP), CDP-Choline, alpha-GPC, and phosphatidylserine (PS) strengthen the cholinergic system and can help restore balance when DRT is used.
            </p>
            
            <h4>Cholinergic and Dopaminergic Interdependence</h4>
            <p>
                The cholinergic and dopaminergic systems interact and converge in various brain regions, including the basal ganglia and hippocampus, to regulate cognition, movement, and behavior. Disruption of these interactions contributes to various symptoms of PD, including dyskinesia. 
            </p>
            
            <h4>Interactions with DRT</h4>
            <p>
                Supplementation with CDP-choline, UMP, and alpha-GPC reduces the need for DRT and should be considered and monitored under medical supervision. However, the benefits of these supplements extend beyond merely reducing the required dose of DRT. <cite class="reflink"><a href="#r-eberhardt">R. Eberhardt</a></cite>
            </p>
            
            <p>
                Phosphatidylserine (PS) levels are often decreased in idiopathic PD and its supplementation may also alleviate dopamine replacement therapy (DRT) side effects. <cite class="reflink"><a href="#g-zhai">G. Zhai</a></cite>
            </p>


            <h4>Cholinergics Example Stack</h4>
            <p>
                An example cholinergic supplement stack might include UMP and CDP-choline at 250 mg each, twice daily, 500 mg alpha-GPC pre-workout, 200 mg PS after dinner, and 3000 mg DHA daily.
            </p>

            <h4>Phospholipids and Alpha-Synuclein</h4>
            <p>
                Experimental evidence suggests that phospholipids alter the structure and reduce the toxicity of Î±-synuclein oligomers. <cite class="reflink"><a href="#t-dou">T. Dou</a></cite>
            </p>
                        
            <section id="uridine">
                <h3>
                    Uridine Monophosphate (UMP)
                </h3>
                
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Anti-inflammatory, Neuroprotective, Mitochondrial, Helps DRT Side-Effects</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>500mg ED</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>
                
                <p>
                    Uridine is a type of nucleoside, a fundamental component of nucleic acids. Nucleic acids are the building blocks of life and are used for storage and transmission of genetic information.
                </p>
                        
                <h4>How it Works</h4>
                <p>
                    As explained under the section DHA &amp; Uridine, Uridine restores unilateral dopaminergic neurotransmission, transmission from the substantia nigra to the striatum, when that region is impacted by oxidopamine lesions in rodent models. Research shows the best results when uridine is taken with DHA and choline (more on this appears below). <cite class="reflink"><a href="#m-cansev">M. Cansev</a></cite> 
                </p>
                
                <p>
                    UMP supplementation increases CDP-choline levels. As a precursor to brain phospholipids, it supports cell membrane integrity and cognitive functions such as memory and learning. <cite class="reflink"><a href="#n-agarwal">N. Agarwal</a></cite> 
                </p>

                <p>
                    Phospholipids are phosphorus-containing compounds found in the brain involved in the regulation of various signaling pathways, including neurotransmission, synaptic plasticity, energy transfer, and nucleic acid structure.
                </p>
                
                <h4>Uridine with DHA</h4>                
                <p>
                    Phosphatidylcholine (PC), the most abundant phospholipid in the brain, requires three compounds: choline; a pyrimidine such as uridine; and a polyunsaturated fatty acid (PUFA) such as DHA. <q>When all three of the nutrients are provided concurrently, the resulting increase in PC production is greater than the sum of the increases produced by giving each separately.</q> <cite class="reflink"><a href="#r-j-wurtman">R.J. Wurtman</a></cite> 
                </p>
                <p>
                    DHA has been shown to restore dopaminergic neurotransmission loss in PD models, with enhanced effects when combined with UMP. <cite class="reflink"><a href="#m-cansev">M. Cansev</a></cite> 
                </p>
                <p>
                    In a 2006 study conducted by researchers from two universities, Brain <abbr title="Phosphatidylcholine">PC</abbr> rose by 13&ndash;22% with uridine and choline alone, or DHA alone, or by 45% with the combination. Oral administration of uridine or DHA alone was shown to increase synaptic proteins and phospholipids, and in combination, a synergistic effect was noticed. Later research confirmed the cognitive benefits of these effects. <cite class="reflink"><a href="#s-holguin">S. Holguin</a></cite>
                </p>
                
                <h4>Uridine and the BBB</h4>
                <p>
                    UMP is transported across the blood-brain barrier by nucleoside transporters. In the brain, UMP enhances neurite outgrowth and improves synaptic transmission. <cite class="reflink"><a href="#l-wang">L. Wang</a></cite> 
                </p>
                
                <h4>
                    Uridine Monophosphate Product
                </h4>
                <ul class="product-list">
                    <li>
                        <a href="https://www.amazon.com/Monophosphate-Disodium-Supports-Cognitive-Mitochondrial/dp/B01BYY0QY0/ref=sr_1_4_pp?s=hpc&sr=1-4&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B086KMB9YN&amp;linkId=e758783750e802b48ff75aa147f0afa9"
                        target="_blank"
                        >Uridine Monophosphate Powder</a>
                    </li>
                </ul>
                
                <h4>Uridine References</h4>
                <ol class="reference-list">
                    <li id="m-cansev2">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16769123/"
                        title="Uridine and cytidine in the brain: Their transport and utilization"
                        target="_blank"
                        >Uridine and cytidine in the brain: Their transport and utilization</a>, Mehmet Cansev.
                        <p>
                            Uridine and cytidine are transported across the blood-brain barrier by nucleoside transporters. 
                        </p>
                    </li>
                    <li id="l-wang">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16055952/"
                        target="_blank"
                        title="Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats">Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats</a>, Lei Wang
                    </li>
                    <li id="n-agarwal">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020593/"
                        title="Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T"
                        target="_blank"
                        >Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T</a>, Nivedita Agarwal, et al.
                        <p>
                             This small study on 17 healthy males found that daily supplementation with 2g of uridine significantly increased levels of total phosphomonoesters (PME) and phosphatidylethanolamine (PEtn) over one week.
                        </p>
                    </li>

    <!-- Uridine with DHA references -->
                    <li id="r-j-wurtman">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011061//"
                            title="A Nutrient Combination that Can Affect Synapse Formation"
                            target="_blank"
                            >A Nutrient Combination that Can Affect Synapse Formation</a>, Richard J. Wurtman.
                    </li>                    
                    <li id="m-cansev">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592845/"
                        title="Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease"
                        target="_blank"
                        >Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease</a>, Mehmet Cansev, et al.
                    </li>
                    
                    <li id="s-holguin">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478743/"
                        title="Chronic Administration of DHA and UMP Improves the Impaired Memory of Environmentally Impoverished Rats"
                        target="_blank"
                        >Chronic Administration of DHA and UMP Improves the Impaired Memory of Environmentally Impoverished Rats</a>, Sarah Holguin, et al.
                    </li>
                </ol>
            </section>
            
            <section id="citicoline">
                <h3>
                    CDP-Choline (Cytidine 5'-diphosphocholine)
                </h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Neuroprotective, Mitochondrial, Dopaminergic side-effects</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>500mg ED</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ… CDP-Cholineâ€™s metabolites cross the BBB</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                <p>
                    CDP-Choline (cytidine diphosphate-choline, also "Citicoline") is an essential intermediate in the biosynthetic pathway of structural phospholipids, particularly <abbr title="Phosphatidylcholine">PC</abbr>, found in cell membranes through the body, especially the liver and brain. <cite class="reflink"><a href="#jj-secades">J.J. Secades</a></cite>
                </p>
                
                <p>
                    CDP-Choline supports cognitive function, including memory, and offers neuroprotection, potentially slowing age-related cognitive decline and supporting brain health in neurodegenerative diseases. Clinical studies show its benefits for brain health in patients with mild cognitive impairment and other neurological conditions.
                </p>
                <p>
                    CDP-Choline increases brain choline uptake for PC and acetylcholine production, for neuronal membranes and myelin sheaths, membranes that wraps around nerves cells, providing insulation and facilitating the rapid transmission of electrical signals along nerve fibers. 
                </p>
                
                <p>                                     
                    CDP-Choline has several benefits over direct <abbr title="Phosphatidylcholine">PC</abbr> supplementation through its efficient metabolic conversion and broader physiological effects. CDP-Choline is digested into cytidine and choline, which are absorbed into the bloodstream and can then be reassembled into CDP-Choline within cells. Directly supplementing does not achieve the same level of metabolic conversion and physiological effects.  <cite class="reflink"><a href="#u-kansakar">U. Kansakar</a></cite>
                </p>
                
                <p>
                    CDP-Choline's many beneficial effects and supporting evidence are explained by the large role it plays in the body.
                </p>
                <p>
                    In rat brains, citicoline induced sirtuin expression, which was also observed in cultured neurons and lymphocytes, suggesting significant neurovascular protections (either directly or indirectly) via SIRT-1. <cite class="reflink"><a href="#f-oddone">F. Oddone</a></cite>
                </p>
                
                <h4>CDP-Choline and the BBB</h4>
                <p>
                    The breakdown products cytidine and choline cross the BBB and are reassembled to provide a synergistic impact on brain function and cellular health.
                </p>
                
                <h4>CDP-Choline in PD</h4>
                <p>
                    CDP-Choline supplementation can effectively reduce the dosage and consequential side effects of <abbr title="Dopamine Replacement Therapy">DRT</abbr>. <cite class="reflink"><a href="#r-eberhardt">R. Eberhardt</a></cite>
                </p>
                
                <p>
                    Glutamate excitotoxicity is a problem of cellular damage in PD and various other neurodegenerative diseases. This happens when neurons are damaged and killed by the excessive glutamate.  <cite class="reflink"><a href="#f-a-arnold">Arnold</a></cite>
                </p>
                
                <p>     
                    CDP-Choline reduces glutamate excitotoxicity and oxidative stress, increases neurotrophin levels, enhances neurotransmitter release (such as norepinephrine and dopamine), promotes mitochondrial function, and modulates insulin signaling. <cite class="reflink"><a href="#c-mir">C. Mir</a></cite>
                </p>
                
                <p>
                    Neurotrophins BDNF and NT-3, a protein growth factor that belongs to the NGF (Nerve Growth Factor) family of neurotrophins, are reduced in PD. This is problematic, as neurotrophins increase neuronal survival and growth. Their depletion in PD likely contributes to progressive neurodegeneration (PN). CDP-choline increases neurotrophin activity and expression, which is neuroprotective and reported to have noticeable positive effects. <cite class="reflink"><a href="#k-a-jellinger">Jellinger</a>, <a href="#p-arenth">P. Arenth</a></cite>
                </p>
                
                <p>
                 A 2022 review found profound neurological and cognitive benefits from some choline-containing phospholipids (CCPLs), in particular alpha-GPC, and also CDP-choline. They attribute these results to improvement in ischemic conditions, increased synthesis of phospholipids and neurotransmitters, incorporation into the membrane phospholipid structure, and improved mitochondrial metabolism. <cite class="reflink"><a href="#p-roy">P. Roy</a></cite>
                </p>
                
                <h4>Ischemic Mitigation</h4>
                <p>
                     In patients with chronic cerebral ischemia, citicoline improves scores on cognitive rating scales. CDP-choline prevents ischemia-induced tissue accumulation of free fatty acids and reduces infarct volume (direct measurement of the extent of tissue death or necrosis caused by an ischemic stroke), and brain edema, thus resulting in an antiapoptotic effect that is related to the mitochondrial-dependent cell death mechanism. <cite class="reflink"><a href="#jj-secades">J.J. Secades</a></cite>
                </p>
                
                <p>
                    CDP-coline improves axonal transport deficits and supports axon regeneration. Axon regeneration is limited in adults, partly due to the reduced growth potential of mature neurons. <cite class="reflink"><a href="#f-oddone">F. Oddone</a>, <a href="#c-iulia">Iulia</a></cite>
                </p>

                <h5>Uridine and CDP-Choline</h5>
                <p>
                    CDP-Choline aids in the synthesis of <abbr title="Phosphatidylcholine">PC</abbr> and serves as a precursor to choline and uridine in the brain. Uridine, a nucleotide base, can convert to back CDP-choline and vice versa through natural metabolic pathways. 
                </p>
                
                <p>
                    Supplementing with both uridine and CDP-Choline together can significantly benefit brain health and cognitive function, often allowing for lower doses of each. This combination enhances neuroprotection, memory, and learning by boosting acetylcholine production. These synergistic effects are increased with the addition of <abbr title="Docosahexanoic Acid">DHA</abbr>. <cite class="reflink"><a href="#b-s-baumel">B.S. Baumel</a></cite>
                </p>

                <p>
                    Both uridine and CDP-Choline are neuroprotective and independently contribute to the production of PC, which supports acetylcholine synthesis and enhances cell membrane integrity.
                </p>
                <p>
                    Because Uridine increases CDP-choline levels, it is necessary to balance their co-supplemention. Uridine is a precursor to CDP-choline, increasing uridine levels can potentially affect the balance of these two compounds in the body.
                </p>
                
                <p>
                    Uridine and CDP-choline work together to support brain health and cognitive function. CDP-choline helps synthesize phosphatidylcholine (PC) and serves as a precursor to both choline and uridine in the brain. Uridine can convert to CDP-choline and supports RNA synthesis during cell growth and repair. These compounds improve memory, learning, acetylcholine production, and cell membrane stability while providing neuroprotection. UMP, a precursor to uridine, supports dopamine levels and contributes to CDP-choline synthesis, so maintaining balance in their supplementation is important for effective results. <cite class="reflink"><a href="#l-wang">L. Wang</a></cite>
                </p>
                                    
                <h5>CDP-Choline Supplementation</h5>
                <p>
                    A typical dosage of 500 mg CDP-choline per day is safe for most, but tolerance and effects vary based on individual differences or other supplements and medications, requiring dosage adjustments. Excessive supplementation may lead to imbalances, particularly in advanced disease stages.
                </p>
                
                <h5>Anticholinergics âŒ CAUTION</h5>
                <p>
                    Contrary to the dying myth, acetylcholine does not cause the tremors of PD. The drugs <em>given</em> to reduce CDP-choline in PD, such as Trihexyphenidyl and Benztropine, impact neurological function, resulting in confusion, memory issues, hallucinations, dry mouth, blurry vision, and urinary retention problems â€” serious side effects.
                </p>
                
                <p>
                <em>Increasing</em> choline by 1,200 mg of supplemental citicoline improved tremors in PD and allowed patients to halve their L-dopa + decarboxylase inhibitor dose. Uridine increases CDP. It's important to have a healthcare provider that understands and accounts for this as part of a holistic plan.
                </p>
                
                <p>
                    CDP-choline, uridine monophosphate (UMP), and alpha-GPC can augment the effects of DRT due to their neurotransmitter synthesis, particularly acetylcholine, which can interact with dopamine pathways. It is important to balance their supplementation DRT under medical supervision. 
                </p>
                
                <h4>Product</h4>
                <p>
                    <a href="https://www.amazon.com/gp/product/B001ESE21K/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B001ESE21K&amp;linkId=1a2fefa4dbb6e04cc9613e95c02b9867">
                        Healthy Origins Cognizin Citicoline 250 MG, 150 Count
                    </a>
                </p>
                
                <h4><img src="img/cdp-choline.jpeg" alt="Healthy Origins Cognizin Citicoline 250 MG, 150 Count"></h4>
                
                <h4>Citicoline References</h4>

                <ol class="reference-list">
                
                    <li id="jj-secades">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8709678/"
                        title="CDP-choline: pharmacological and clinical review"
                        target="_blank"
                        >CDP-choline: pharmacological and clinical review</a>, J J Secades, G Frontera.
                    </li>
                    
                    <li id="u-kansakar">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025538/"
                        title="Choline supplements: An update"
                        target="_blank"
                        >Choline supplements: An update</a>, Urna Kansakar, et al.
                    </li>
                    
                    <li id="f-oddone">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003774/"
                        title="Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review"
                        target="_blank"
                        >Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review</a>, Francesco Oddone, et al.
                    </li>
                
                    <li id="r-eberhardt">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/2289218/"
                        title="Citicoline in the treatment of Parkinson's disease"
                        target="_blank">Citicoline in the treatment of Parkinson's disease</a>, R Eberhardt, et al.
                    </li>
                    <li id="f-a-arnold">
                        <a href="https://www.mdpi.com/1422-0067/25/11/5587"
                        title="Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration"
                        target="_blank"
                        >Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration</a>, Frederick J. Arnold.
                    </li>

                    <li id="c-mir">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12663935/"
                        title="CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons"
                        target="_blank"
                        >CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons</a>, Cecilia Mir, et al.
                    </li>

                    <li id="p-arenth">
                        <a href="https://www.sciencedirect.com/science/article/abs/pii/S1934148211001766"
                        title="CDP-Choline as a Biological Supplement During Neurorecovery: A Focused Review"
                        target="_blank"
                        >CDP-Choline as a Biological Supplement During Neurorecovery: A Focused Review</a>, Patricia M. Arenth, et al.
                    </li>
                    
                    <li id="k-a-jellinger">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823450/#sec-a.i.g"
                        title="Basic mechanisms of neurodegeneration: Dysfunction of neurotrophins"
                        target="_blank"
                        >Basic mechanisms of neurodegeneration: Dysfunction of neurotrophins</a>, Kurt A Jellinger.
                    </li>
                                        
                    <li id="p-roy">
                        <a 
                        target="_blank"                        href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541750/">Effects of choline containing phospholipids on the neurovascular unit: A review</a>, Proshanta Roy, et al.
                    </li>

                    <li id="c-iulia">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29450391/"
                        >Citicoline - a neuroprotector with proven effects on glaucomatous disease</a>, Chitu Iulia, et al.
                    </li>
                </ol>
            </section>
            <section id="alpha-gpc">
                <h3>Alpha-GPC</h3>
                
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Dopaminergic, Anti-inflammatory, Mitochondrial, Neuroprotective, Neurorestorative</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>300 â€“ 600 mg Pre-WO ðŸ‹ï¸</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ… (via transporters, <abbr title="Choline Transporter">CT</abbr>, <abbr title="High Affinity Choline Transporter">HACT</abbr>, and passive diffusion)</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                
                <p>
                    Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a highly bioavailable, naturally occurring form of choline that is synthesized for dietary supplements.
                </p>
                
                <h4>Benefits</h4>
                <p>
                    Alpha-GPC increases the release of acetylcholine, promotes learning and memory, and counters cognitive impairment. It has been shown to decrease age-dependent structural alterations in the frontal cortex and hippocampus of rats' brains. <cite class="reflink"><a href="#f-amenta">F. Amenta</a></cite> 
                </p>
                
                <p>
                    A review study published in Fronteirs in Cell Neuroscience highlighted some of the amazing benefits of alpha-GPC, considering the most promising molecule for brain disorders characterized by vascular impairment, and called for larger attentively controlled studies. 
                </p>
                
                <p>
                    Citing a rodent model study, they highlighted how administration of Î±-GPC (400 mg/kg) for 7 days countered the increase of stress hormones, reduced hearing loss, and prevented neuronal injury in rats. These neuroprotective effects were due to the increase of choline acetyltransferase (ChAT), reduction of brain neuroinflammation, and enhanced BDNF expression in the hippocampus. 
                </P>
                
                <p>
                    The researchers cited other research showing that Alpha-GPC contributes to anabolic processes responsible for membrane phospholipid and glycerol-lipid synthesis, positively influencing membrane fluidity. <cite class="reflink"><a href="#p-roy-gpc">P. Roy</a></cite> 
                </p>
                
                <h4>Alpha-GPC and Exercise</h4>
                
                <p>
                    A double-blind, placebo-controlled, cross-over design study in 2015 found that 600 mg per day of alpha-GPC increased lower body force production after just 6 days, making a recommendation for speed and power athletes to enhance muscle performance. <cite class="reflink"><a href="#d-bellar">Bellar</a></cite> 
                </p>
                
                <p>
                    Another small, randomized, double-blind, placebo-controlled, crossover study found that alpha-GPC supplementation prevents exercise-induced reductions in choline levels, increases endurance performance, and increases growth hormone secretion. <cite class="reflink"><a href="#a-parker">Parker</a></cite> 
                </p>
                
                <h4>Osmolytic Effects</h4>
                <p>
                    While betaine may provide some general cellular stability that could indirectly aid in preventing misfolding
                </p>
                <h4>Side effects</h4>
                <p>
                    Alpha-GPC may increase the production of Trimethylamine-N-oxide (TMAO) in the gut, which may increase the risk of stroke. A review study published in 2021 found that alpha-GPC usage was associated with a 46% higher risk of stroke. <cite class="reflink"><a href="#g-lee">G. Lee</a></cite> 
                </p>
                                
                <h4>Supplementation</h4>
                <p>
                    Alpha-GPC's rapid uptake leads to sharp increases in acetylcholine, making it an excellent choice 60 min prior to training sessions of maximal power output, as part of a total cholinergic stack. A typical pre-workout dosage is 300 - 600 mg pre-workout.
                </p>
                
                <h4>References</h4>
                <ol class="reference-list">
                
                    <li id="f-amenta">
                        <a href="https://www.sciencedirect.com/science/article/abs/pii/B9780128158548000306/"
                        title="Chapter 30 - Choline-containing phospholipids and treatment of adult-onset dementia disorders"
                        target="_blank"
                        >Chapter 30 - Choline-containing phospholipids and treatment of adult-onset dementia disorders</a>, Francesco Amenta, et al.
                    </li>
                    
                    <li id="p-roy-gpc">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541750/"
                        title="Effects of choline containing phospholipids on the neurovascular unit: A review"
                        target="_blank"
                        >Effects of choline containing phospholipids on the neurovascular unit: A review</a>, Proshanta Roy, et al.
                    </li>
                    
                    <li id="d-bellar">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650143/"
                        title="The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength"
                        target="_blank"
                        >The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength</a>, David Bellar, et al.
                    </li>
                    <li id="a-parker">
                        <a href="https://jissn.biomedcentral.com/articles/10.1186/1550-2783-12-S1-P41"
                        title="The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility"
                        target="_blank"
                        >The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility</a>, Adam G Parker, et al.
                    </li>
                    
                    <li id="g-lee">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613599/"
                        title="Association of L-Î± Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years"
                        target="_blank"
                        >Association of L-Î± Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years</a>, Gyeongsil Lee, et al.
                    </li>
                </ol>
            </section>
            <section id="phosphatidylserine">
                <h3>Phosphatidylserine (PS)</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Dopaminergic, Anti-inflammatory, Mitochondrial, Neuroprotective</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>150mg Post-workout, 150mg ðŸ’¤</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                
                <h4>Benefits</h4>
                <p>
                    Phosphatidylserine (PS) is an essential component of cellular membranes. It helps regulate membrane support, improves signal transduction, inhibits neuroinflammation, provides neuroprotection, and improves cognitive function.
                </p>
                
                <h4>Details and Mechanisms</h4>
                <p>
                    PS binds to various proteins and is involved in many biological processes, including enzyme activation, apoptosis, neurotransmission, and synaptic refinement. Dysregulation of these processes is common in various CNS diseases. <cite class="reflink"><a href="#x-ma">X. Ma</a></cite>
                </p>
                
                <p>
                    In a double-blind study, elderly patients with severe cognitive decline were treated with brain cortex-derived PS (BC-PS) 300 mg/day for 6 months, compared with placebos, BC-PS administration significantly improved the storage, learning, and retrieval abilities of memory in patients. <cite class="reflink"><a href="#x-ma">X. Ma</a></cite>
                </p>
                
                <h4>PS as a Self-emulsifying Drug Delivery System (SEDDS)</h4> 
                <p>
                    SEDDS (Self-Emulsifying Drug Delivery Systems) are formulations designed to improve the oral bioavailability of poorly water-soluble substances. While PS itself is not a SEDDS, taking it with such substances may enhance their absorption and bioavailability. This is because it is both. PS liposomes loaded with astragaloside IV and nestifin-1 were shown to facilitate their penetration of the blood-brain barrier and reduce the expression of Î±-synuclein, making liposomal PS an effective delivery tool for other substances. <cite class="reflink"><a href="#y-kuo">Y. Kuo</a></cite>
                </p>

                <h4>Supplementation â€” Brain-Derived PS (Choric PS)</h4>
                <p>
                     PS promotes relaxation and reduces cortisol, making it a good choice for a post-workout recovery and evening supplementation at about 100 mg - 400 mg once or twice daily. <cite class="reflink"><a href="#m-kingsley">M. Kingsley</a></cite>
                </p>
                
                <h4>References</h4>
                <ol class="reference-list">
                                         
                    <li id="x-ma">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382310/"
                        title="Phosphatidylserine, inflammation, and central nervous system diseases"
                        target="_blank"
                        >Phosphatidylserine, inflammation, and central nervous system diseases</a>, Xiaohua Ma, et al.
                    </li>
                    
                    <li id="m-kingsley">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16869708/"
                        title="Effects of phosphatidylserine supplementation on exercising humans"
                        target="_blank"
                        >Effects of phosphatidylserine supplementation on exercising humans</a>, Michael Kingsley.
                    </li>
                    <li id="y-kuo">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34579880/"
                        title="Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine liposomes conjugated with wheat germ agglutinin and leptin to activate anti-apoptotic pathway and block phosphorylated tau protein expression for Parkinson's disease treatment"
                        target="_blank"
                        >Astragaloside IV- and nesfatin-1-encapsulated phosphatidylserine liposomes conjugated with wheat germ agglutinin and leptin to activate anti-apoptotic pathway and block phosphorylated tau protein expression for Parkinson's disease treatment</a>, Yung-Chih Kuo, et al.
                    </li>

                </ol>
            </section>
            
            
            <h4>Choline References</h4>
            <ol class="reference-list">
            
                <li id="m-zhou">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997672/"
                    title="Effects of different fatty acids composition of phosphatidylcholine on brain function of dementia mice induced by scopolamine"
                    target="_blank"
                    >Effects of different fatty acids composition of phosphatidylcholine on brain function of dementia mice induced by scopolamine</a>, Miao-miao Zhou, et al.
                </li>
                <li id="m-amalric">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340002/"
                    title="Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders"
                    target="_blank"
                    >Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders</a>, Marianne Amalric, et al,
                </li>
                <li id="b-s-baumel">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139993/"
                    title="Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review"
                    target="_blank"
                    >Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review</a>, Barry S. Baumel, et al.
                </li>
                <li id="t-dou">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35904551/"
                    title="Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of Î±-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation"
                    target="_blank"
                    >Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of Î±-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation</a>
                </li>
                <li id="g-zhai">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537766/"
                    title="Serum-Based Lipid Panels for Diagnosis of Idiopathic Parkinsonâ€™s Disease"
                    target="_blank"
                    >Serum-Based Lipid Panels for Diagnosis of Idiopathic Parkinsonâ€™s Disease</a>, Guangju Zhai.

                </li>
            </ol>
        </section>
        
        <section id="magnesium-threonate">
            <h3>
                Magnesium L-Threonate
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>DRT Side-Effects, Anti-inflammatory, Mitochondrial, Neuroprotective, Calcium Dysregulation, BBB and Barrier Dysfunction, Anti-aggregant (GSK3Î² dysregulation)</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>300mg ED/EOD ðŸ’¤</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            <p>
            	Magnesium L-Threonate is a highly bioavailable form of magnesium that, unlike most magnesium supplements, crosses the blood-brain barrier to strongly support brain health and cognitive function. 
            </p>
            
            <p>
                In a 2019 rodent study where magnesium L-Threonate was compared to magnesium sulfate, only the L-Threonate form crossed the blood-brain barrier, where it then inhibited oxidative stress, attenuated motor deficits, and slowed the progression of neurodegeneration. <cite class="reflink"><a href="#y-shen">Y. Shen</a></cite> 
            </p>
            
            <p>
                 A 2022 study from Nanjing Medical University found that MagteinÂ® significantly improved memory and cognition in healthy Chinese adults, with greater benefits in older participants. <cite class="reflink"><a href="#c-zhang">C. Zhang</a></cite> 
            </p>

            <h4>Calcium Regulation</h4>
            <p>
                Magnesium acts as a calcium antagonist in cells, helping to control intracellular calcium levels and reduce excitotoxicity. Excessive mitochondrial calcium, a common problem in PD, damages mitochondria, reducing energy output and contributing to cell death, as dopaminergic neurons are highly sensitive to calcium fluctuations and vulnerable to the excitotoxic damage it causes. <cite class="reflink"><a href="#maier">Maier</a></cite> 
            </p>
            
            <h4>BBB Dysfunction</h4>
            <p>
            	Magnesium also protects the integrity and function of the <abbr title="bloodâ€“brain barrier">BBB</abbr>, necessary for homeostasis, to protect the CNS and maintain healthy neurological function. <cite class="reflink"><a href="#romeo">Romeo</a>, <a href="#daneman">Daneman</a></cite> 
            </p>
            
            <h4>Supplementation</h4>
            <p>
                Magnesium can promote relaxation and improve sleep quality. Therefore, it is recommended to take this supplement in the evening.
            </p>
            
            <h4>Product</h4>
            <figure>
                <img src="img/neuromag.jpeg" alt="neuromag">
                <figcaption>
                <p>
                	<a 
						target="_blank"
						title="Life Extension Neuro-Mag Magnesium L-Threonate"
																href="https://www.amazon.com/gp/product/B07KWM4C5L/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B07KWM4C5L&amp;linkId=8f6f3f54762aeaec83a6e9014c89c8fe"
					>Life Extension Neuro-Mag Magnesium L-Threonate</a>
                </p>
                </figcaption>
            </figure>
            
            <h4>
                References
            </h4>
            
            <ol class="reference-list">
                <li id="y-shen">
                    	<a 
                    href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857673/"
                    title="The treatment with MgT is associated with an increase of Mg in the CSF. MgT, rather than MgSO4, can significantly attenuate MPTP-induced motor deficits and dopamine (DA) neuron loss."
                    target="_blank"
                    >The treatment with MgT is associated with an increase of Mg in the CSF. MgT, rather than MgSO4, can significantly attenuate MPTP-induced motor deficits and dopamine (DA) neuron loss</a>, Yanling Shen, et al.
                </li>

                <li id="c-zhang">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786204/"
                        title="A MagteinÂ®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults"
                        target="_blank"
                        >A MagteinÂ®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults</a>, Chengxiang Zhang, et al.
                </li>
                <li id="maier">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9820677/"
                    title="Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration"
                    target="_blank"
                    >Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration</a>, Jeanette A. M. Maier, et al.
                </li>
                <li id="romeo">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31503002/"
                    title="Magnesium and the blood-brain barrier in vitro: effects on permeability and magnesium transport"
                    target="_blank"
                    >Magnesium and the blood-brain barrier in vitro: effects on permeability and magnesium transport</a>, Valentina Romeo, et al.
                </li>
            	<li id="daneman">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4292164/"
                    title="The Bloodâ€“Brain Barrier"
                    target="_blank"
                    >The Bloodâ€“Brain Barrier</a>, Richard Daneman and Alexandre Prat.
                </li>
            </ol>
        </section>
        
        <section id="vitamin-d">
        	<!-- TODO Revisit. Add treatment legend table -->
            <h3 class="neuroprotective">
                Vitamin D3
            </h3>
            <!--
            Vitamin D3, or cholecalciferol, is a fat-soluble vitamin essential for various bodily functions. It aids in calcium absorption, supporting bone health and helping prevent conditions like osteoporosis. Beyond its role in bone maintenance, Vitamin D3 influences immune function and mood. It is synthesized through sunlight exposure and can also be obtained from diet and supplements. Its potential benefits in neurological health, particularly in conditions like Parkinson's disease, are an area of ongoing research.
            -->
            <p>
                Vitamin D3 stimulates the osteoblasts to produce osteocalcin (OCN). Vitamin K2 converts some of this osteocalcin into its active form, carboxylated OCN. The remaining undercarboxylated OCN (ucOCN) enters the bloodstream and acts as a hormone in various tissues, including the brain. <cite class="reflink"><a href="#c-shan">C. Shan</a></cite>
            </p>
            
            <h4>D3 and Parkinson's Disease</h4>
            <p>
                The Parkinsonâ€™s Disease Research, Education, and Clinical Center at the Portland and Puget Sound Veteran Affairs (VA) Clinics conducted an add-on study to a longitudinal study on neuropsychiatric function in individuals with PD. Researchers found that higher plasma vitamin D levels were associated with improved cognition and mood in PD patients without dementia. <cite class="reflink"><a href="#a-peterson">A. Peterson</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                More is not always better! Too much vitamin D3 can disturb calcium levels. Vitamin D3 levels can be optimized with regular bloodwork and refined supplementation accordingly. 4,000 IU per day is safe. D3 is stored in the body, so a missed dose can be compensated by doubling the intake the next day.
            </p>
            <h3>
                Vitamin D References
            </h3>
            <ol class="reference-list">
                <li id="a-peterson">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966187/">Memory, Mood, and Vitamin D in Persons with Parkinsonâ€™s Disease</a>, Amie L. Peterson, et al.
                </li>
                <li id="c-shan">
                    <a href="https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-019-0444-5"
                    title="Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders"
                    target="_blank"
                    >Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders</a>, Chang Shan, et al.
                </li>
            </ol>
        </section>
        
        <section id="vitamin-b1">
            <h3 class="neuroprotective dopaminergic">
                 Vitamin B-1 (Thiamine)
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Dopaminergic, Anti-inflammatory, Mitochondrial, Neuroprotective, Neurorestorative, Anti-aggregant (GSK3Î² dysregulation)</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>300mg ED ðŸ½ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… (50%)</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>

            
            <p>
                Vitamin B1, also known as thiamine, is an essential vitamin that helps the body turn food into energy by supporting <dfn title="process that converts glucose into usable energy">glycolysis</dfn>, a process necessary for nerve, muscle, and heart health. This is particularly important in PD, where energy production in cells is typically impaired. Deficiencies in thiamine can further disrupt glycolysis, exacerbating energy production issues.
            </p>
            
            <h4>Thiamine and Mitochondrial Function</h4>
            <p>
                Thiamine, in its active form (thiamine pyrophosphate, TPP), serves as a cofactor for several enzymes involved in energy production, from glycolysis to oxidative phosphorylation within the mitochondria. These processes are necessary for meeting the cellular energy demands of neurons, the heart, and other tissues, particularly in conditions like PD, where mitochondrial dysfunction is common.
            </p>
            
            <h4>High-dose Thiamin in PD</h4>
            <p>
                High-dose thiamine has repeatedly been shown to reverse motor and non-motor symptoms in PD. An observational open-label pilot study beginning June 2012, published in the Journal <cite>Alternative and Complementary Medicine</cite> injected patients with 100 mg of thiamine intramuscularly twice a week, without altering patients' existing therapies. Patients were re-evaluated after 1 month and then every 3 months during treatment. This high-dose thiamine was effective in reversing PD motor and non-motor symptoms. The clinical improvement was stable over time in all patients. <cite class="reflink"><a href="#a-constantini">a-constantini</a></cite>
            </p>
            
            <p>
                Researchers hypothesized that thiamine-dependent metabolic processes could cause selective neural damage typically affected by PD which provokes neurodegeneration, and that thiamine could counteract that process, having both restorative and neuroprotective action in PD. 
            </p>
            
            <h4>DJ-1 Genetic Mutations, Thiamine</h4>
            <p>
                Mutations in the DJ-1 gene, also known as PARK7, are confirmed in about 1-2% of early-onset PD cases, but this figure could be higher due to limited genetic screening. The <abbr title="Parkinsonism-Associated Deglycase 1 or Park7">DJ-1</abbr> gene is responsible for thiamine biosynthesis. Since DJ-1 mutations contribute to oxidative stress and mitochondrial dysfunction, patients with these mutations might see greater benefits from therapies that support mitochondrial function, such as high-dose thiamine supplementation. However, this is more related to enhancing mitochondrial health and less about directly addressing DJ-1's function. Genetic testing for DJ-1 mutations may help predict thiamine's usefulness. <cite class="reflink"><a href="#k-luong">k-luong</a></cite>
            </p>
            
            <h4>BBB</h4>
            <p>
                Thiamine has poor bioavailability but can cross the BBB through passive diffusion when its levels in the blood are high.
            </p>
            
            <h4>Supplementation</h4>
            <p>
                High-dose thiamine therapy for PD is not widely recommended by mainstream medical organizations, and long-term safety and efficacy data in humans is lacking. However, some forum users on HealthUnlocked have reported significant benefits from high-dose oral supplementation, with doses up to 1,000 mg per day. Patients should consult with their healthcare providers before initiating high-dose thiamine therapy.
            </p>
            
            <ol class="reference-list">
                <li id="a-constantini">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/26505466/"
                    title="Long-Term Treatment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot Study"
                    target="_blank"
                    >Long-Term Treatment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot Study</a>, A. Costantini, et al.
                    <p>
                        Patients received 100 mg of thiamine, injected intramuscularly twice a week, without any change to personal therapy. All the patients were re-evaluated after 1 month and then every 3 months during treatment. Administration of parenteral high-dose thiamine was effective in reversing PD motor and nonmotor symptoms. 
                    </p>
                </li>
                
                <li id="k-luong">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493530/"
                    title="The Beneficial Role of Thiamine in Parkinson Disease"
                    target="_blank"
                    >The Beneficial Role of Thiamine in Parkinson Disease</a>, Khanh v. q. LÆ°Æ¡ng and Lan T. H. Nguyá»…n.
                    <p>
                         <abbr title="Parkinsonism-Associated Deglycase 1 or Park7">DJ-1</abbr> gene is responsible for such as thiamin biosynthesis. Mutations in the DJ-1 gene can result in a loss of function of the protein. 
                    </p>
                </li>
            </ol>
        </section>
        
        <section id="vitamin-b6">
        
            <h3>
                Vitamin B-6 (Pyridoxine) or P-5-P (Pyridoxal 5-Phosphate)
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>DRT Side Effects, Cognition, Mitochondrial</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>10 - 50 mg</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ… </td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âŒ</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-very">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>    
            <p>
                Vitamin B6, also known as pyridoxine, is used for synthesis of neurotransmitters including dopamine and serotonin, glutamatergic system regulation, and nervous system balance and maintenance.
            </p>
            <p>
                Vitamin B6 is necessary for dopamine biosynthesis and may help reduce the side effects of dopaminergic treatments.
            </p>
            
            <h4>P-5-P (Pyridoxal 5-Phosphate)</h4>
            <p>
                P-5-P (Pyridoxal 5-Phosphate) is the active coenzyme form of vitamin B6, which bypasses the need for liver conversion. While most research focuses on B-6, p-5-p may offer advantages over it. 
            </p>
            
            <h4>Relevance to Parkinson's Disease</h4>
            <p>
                Supplementation of vitamin B-6, along with vitamin B-12 and folic acid, can reduce high homocysteine levels caused by levodopa metabolism, which may help in managing metabolic and clinical complications such as peripheral neuropathy and osteoporosis. <cite class="reflink"><a href="#keun">Keun</a></cite>
            </p>
            
            <h4>Supplementation</h4>
            <p>
                Balanced methylated B-complex formulations generally provide sufficient amounts, from 10 - 50 mg of B-6 or P-5-P. A few such products include <q>Pure Encapsulations B-Complex Plus</q> and <q>Integrative Therapeutics Active B-Complex</q>. Talk to your neurologist about reducing DRT and supplementing with B-6, B-12 and folic acid.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="keun">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8634393/"
                    title="Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review"
                    target="_blank"
                    >Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review</a>, Jikke T Boelens Keun, et al.
                </li>
            </ol>
        </section>
        
        <section id="vitamin-b12">
        	<!-- TODO Revisit. Add treatment legend table -->
            <h3>
                Vitamin B-12 (Cobalamin)
            </h3>
            <h4>How B-12 helps Parkinson's Disease</h4>
            <p>
                Vitamin B-12 reduces <abbr title="Reactive Oxygen Species">ROS</abbr> and improves mitochondrial biogenesis regulator <abbr title="Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha">PGC-1Î±</abbr>.
            </p>
            <p>
                Vitamin B-12 has multiple mechanisms related to <abbr title="Leucine Rich Repeat Kinase 2">LRRK2</abbr> expressions that protect dopaminergic neurons. B-12 inhibits LRRK2 kinase activity. This protects dopaminergic neurons from toxicity induced by LRRK2 and its mutant form, LRRK2-G2019S.
            </p>
            <p>
                Vitamin B-12 prevents LRRK2-G2019S-potentiated &alpha;-synuclein accumulation in dopaminergic neurons.
            </p>
            <ol>
                <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30858560/"
                    title="Vitamin B12 modulates Parkinsonâ€™s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection"
                    target="_blank">Vitamin B12 modulates Parkinsonâ€™s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection</a>
                    <p>
                        Vitamin B-12 protected dopaminergic neurons from toxicity induced by LRRK2 and its mutant form, LRRK2-G2019S. The effect was shown to improve deficits in dopamine transmission in LRRK2-PD mouse models.
                    </p>
                </li>
                 <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854476/"
                    title="Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinsonâ€™s Disease Models by Alleviating Oxidative Stress"
                    target="_blank"
                    >Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinsonâ€™s Disease Models by Alleviating Oxidative Stress</a>
                    <p>
                        This multiple-model study demonstrated that vitamin B-12 significantly ameliorated oxidative stress by reducing ROS and alleviating reductants in a cellular PD model. In vivo, B-12 rescued the movement deficit of C. Elegans in the mouse PD model. Mechanistically, B-12 reduced JNK phosphorylation and improved the mitochondrial biogenesis regulator <abbr title="Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alph">PGC-1Î±</abbr>. 
                    </p>
                </li>
            </ol>
        </section>
        <section id="tocotrienols">
            <h3>
                Tocotrienols and Tocopherols
            </h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Antioxidant, Anti-inflammatory, Mitochondrial, Neuroprotective, <abbr title="ubiquitin proteasome system">UPS</abbr> Dysfunction, BBB Dysfunction</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>150 â€“ 300 IU ED/EOD ðŸ½ï¸</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe</span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-somewhat">
                                <span>Somewhat Effective</span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
            
            <p>
                Vitamin E is a group of eight fat-soluble compounds, comprising four tocopherols and four tocotrienols that offer a spectrum of benefits.
            </p>
            <dl>
                <dt>Tocopherols</dt>
                <dd><strong>Î±-</strong> â€” most common and studied form, antioxidant, immune-enhancing, vascular, and skin effects</dd>
                <dd><strong>Î²-</strong> â€” antioxidant, anti-inflammatory</dd>
                <dd><strong>Î³-</strong> â€” antioxidant, anti-inflammatory, neutralizes <abbr title="Reative Oxygen and Nitrogen Species">RONS</abbr></dd>
                <dd><strong>Î´-</strong> â€” antioxidant, anti-inflammatory, neutralizes <abbr title="Reative Oxygen and Nitrogen Species">RONS</abbr></dd>
                <dt>Tocotrienols</dt>
                <dd><strong>Î±-</strong> â€” strongly neuroprotective, stabilizes cellular membranes</dd>
                <dd><strong>Î²-</strong> â€” antioxidant, anti-inflammatory</dd>
                <dd><strong>Î³-</strong> â€” anti-tumorogenic, antihyperlipidemic</dd>
                <dd><strong>Î´-</strong> â€” anti-cancer, strong antioxidant</dd>
            </dl>
            
            <h4>Full-Spectrum Vitamin E</h4>
            <h5>Tocopherols</h5>
            <p>
                Most vitamin E supplements are only alpha-tocopherol, which has the effect of reducing the body's levels of gamma-tocopherol <cite class="reflink"><a href="#d-wolf">D. Wolf</a></cite>. This is bad because, compared to alpha-tocopherol, gamma-tocopherol and delta-tocopherol can scavenge a wider range of <abbr title="Reative Oxygen and Nitrogen Species">RONS</abbr>  <cite class="reflink"><a href="#c-sen">Sen</a></cite>.
            </p>
            
            <h5>Tocotrienols</h5>
            <p>
                Tocotrienols are neuroprotective, anti-cancer, anti-oxidative, and cholesterol-lowering in ways tocopherols aren't.  <cite class="reflink"><a href="#a-abraham">A. Abraham</a>, <a href="#m-clarke">M. Clarke</a>, <a href="#c-sen">Sen</a></cite>
            </p>
            
            <p> 
                Consuming the full spectrum of all eight natural forms of vitamin E avoids problems with unilateral Î±-tocopherol supplementation and provides maximum synergy and health benefits. <cite class="reflink"><a href="#c-sen">C. Sen</a></cite>
            </p>

            <h4>Neuroprotective Effects</h4>
            
            <p>
                Tocotrienols have been shown to improve learning impairment in elderly subjects. A 2018 double-blind study out of Japan showed that the combination of tocotrienols with astaxanthin improves the composite memory and verbal memory of Japanese adults who feel memory decline. Astaxanthin and vitamin E are anti-oxidative, but tocotrienols are more than that. <cite class="reflink"><a href="#t-sekikawa">T. Sekikawa</a></cite>
            </p>
            
            <p>
                Tocotrienols cross the BBB, exerting neuroprotective effects independent of their antioxidant activity by binding to the estrogen receptor, as shown in multiple studies. <cite class="reflink"><a href="#t-matsura">T. Matsura</a>, <a href="#r-naomi">R. Naomi</a></cite>
           </p>
           
           <p>
               Tocotrienols also reduce BBB permeability by modulating tight junction proteins and reducing oxidative and inflammatory damage to the BBB. This helps maintain its integrity, which is essential for protecting the brain. <cite class="reflink"><a href="n-kaneai">N. Kaneai</a></cite>
           </p>
           
           <p>
                Tocotrienols more effectively inhibit lipid peroxidation compared to tocopherols, due to better incorporation into cell membranes. This action protects mitochondria and reduces oxidative stress. Tocotrienols have been shown to induce apoptosis of cancer cells while protecting neuronal cells from glutamate- and peroxidative-induced death. <cite class="reflink"><a href="#b-aggarwal">B. Aggarwal</a> <a href="#r-c-chiste">R.C. Chiste</a></cite>
            </p>

            <p>
                A 2021 controlled rodent model study showed that Î±- and Î³- tocotrienols improved motor function and neuronal uptake in hippocampal cells, with Î±-tocotrienol demonstrating superior neuroprotective effects and preventing further reduction of dopaminergic neurons. <cite class="reflink"><a href="#m-kumari">M. Kumari</a></cite>
            </p>
            
            <h4>Human Trial Underway</h4>
            <p>
                A large-scale human trial, <a title="Tocotrienols in Parkinson's Disease (PD): A Pilot, Randomised, Placebo-controlled Trial" href="https://clinicaltrials.gov/study/NCT04491383" target="_blank"><q>Tocotrienols in Parkinson's Disease (PD): A Pilot, Randomised, Placebo-controlled Trial</q></a>, was opened on April 2021. This two-year study is designed to compare the effects of 400mg/day tocotrienols vs placebo on neuropsychological conditions using cognitive tests and bloodwork, to evaluate PD biomarkers and for safety monitoring. Tocotrienols are available over the counter, so participation in the trial is not required to use them.
            </p>
            
            <h4>Supplementation and Safety</h4>

            <p>
                Vitamin E is best taken with dietary fat and other fat-soluble supplements.
            </p>
            <p>
                Vitamin E can thin the blood. Individuals taking blood thinners, and those with a history of stroke or brain bleeding should be cautious when taking vitamin E supplements.
            </p>
            <p>
                Light to moderate supplementation consisting of a naturally-sourced, balanced blend of the four tocotrienols and four tocopherols provides benefits while avoiding these risks. Do not exceed the recommended dose. High doses of vitamin E, particularly the synthetic form dl-alpha-tocopherol, are unhelpful to neurodegenerative conditions and are toxic.
            </p>
            
            <h4>
                References
            </h4>
            <ol class="reference-list">
            
                <li id="a-abraham">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29746786/"
                    title="Vitamin E and its anticancer effects"
                    target="_blank"
                    >Vitamin E and its anticancer effects</a>, Annette Abraham, et al.
                </li>
                
                <li id="c-sen">
                    <a href="https://www.sciencedirect.com/science/article/abs/pii/S0024320505012361"
                    title="Tocotrienols: Vitamin E beyond tocopherols"
                    target="_blank"
                    >Tocotrienols: Vitamin E beyond tocopherols</a>, Chandan K. Sen, et al.
                </li>
                <li id="m-clarke">
                    <a href="https://www.sciencedirect.com/science/article/pii/S0002916523292473"
                    title="Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes."
                    target="_blank"
                    >Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes.</a>, M. Clarke, et al.
                    <p> 
                        This <abbr title="Randomized Controlled Trial">RCT</abbr> found that supplementation with alpha-tocopherol (the common form) decreased red blood cell gamma-tocopherol, whereas mixed tocopherols increased both serum alpha-tocopherol and serum and cellular gamma-tocopherol. 
                    </p>
                </li>
                <li id="d-wolf">
                    <a href="https://academic.oup.com/nutritionreviews/article/64/6/295/1830820"
                    title="How an Increased Intake of Alpha-Tocopherol Can Suppress the Bioavailability of Gamma-Tocopherol"
                    target="_blank"
                    >How an Increased Intake of Alpha-Tocopherol Can Suppress the Bioavailability of Gamma-Tocopherol</a>, George Wolf, DPhil.
                </li>
                <li id="t-sekikawa">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705074/"
                    title="Cognitive function improvement with astaxanthin and tocotrienol intake: a randomized, double-blind, placebo-controlled study"
                    target="_blank"
                    >Cognitive function improvement with astaxanthin and tocotrienol intake: a randomized, double-blind, placebo-controlled study</a>, Takahiro Sekikawa, et al.
                </li>
                
                <li id="t-matsura">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/31619646/"
                    >Protective Effect of Tocotrienol on In Vitro and In Vivo Models of Parkinson's Disease</a>, Tatsuya Matsura.
                    <p>
                        This rodent model study demonstrated that tocotrienols bind to the estrogen receptor in vitro, resulting in relieved PD-related symptoms. The result was explained by the observed cellular signalling that led to cytoprotective effects.
                    </p>
                </li>
                
                <li id="r-naomi">
                    <a href="https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2021.754086/full"
                    title="An Interactive Review on the Role of Tocotrienols in the Neurodegenerative Disorders"
                    target="_blank"
                    >An Interactive Review on the Role of Tocotrienols in the Neurodegenerative Disorders</a>, Ruth Naomi, et al.
                </li>
                <li id="n-kaneai">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788404/"
                    title="Tocotrienol improves learning and memory deficit of aged rats"
                    target="_blank"
                    >Tocotrienol improves learning and memory deficit of aged rats</a>, Nozomi Kaneai, et al.
                </li>
                <li id="b-aggarwal">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956867/"
                    title="Tocotrienols, the Vitamin E of the 21st Century: Itâ€™s Potential Against Cancer and Other Chronic Diseases"
                    target="_blank"
                    >Tocotrienols, the Vitamin E of the 21st Century: Itâ€™s Potential Against Cancer and Other Chronic Diseases</a>, Bharat B. Aggarwal, et al.
                </li>
                <li id="r-c-chiste">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/23140681/"
                    title="In vitro scavenging capacity of annatto seed extracts against reactive oxygen and nitrogen species"
                    target="_blank"
                    >In vitro scavenging capacity of annatto seed extracts against reactive oxygen and nitrogen species</a>, Renan Campos ChistÃ©, et al.
                    <p>
                        Annatto seeds contain several carotenoids, terpenoids, tocotrienols and flavonoids, which reduce <abbr title="Reative Oxygen and Nitrogen Species">RONS</abbr>.
                    </p>
                </li>
                <li id="m-kumari">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150907/"
                    title="Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis"
                    target="_blank"
                    >Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis</a>, Mangala Kumari.
                    <p>
                        &ldquo;&hellip;this study revealed that supplementation of Î±- and Î³-T3 was able to ameliorate the motor deficits induced by 6-OHDA and improve the neuronal functions by reducing inflammation, reversing the neuronal degradation, and preventing further reduction of dopaminergic neurons in the SN and striatum (STR) fibre density.&rdquo;
                    </p>
                </li>
            </ol>
            
            <!--
            <h5>
                Product
            </h5>
            <ul class="product-list">
                <li>
                    <figure>
                        <img src="img/tocotrienols.jpeg" alt="mixed tocotrienols">
                        <figcaption>
                            <p>
                                <a href="https://www.amazon.com/Kala-Health-Vitamin-softgels-tocotrienols/dp/B07S52CF4L/ref=pd_ci_mcx_mh_mcx_views_0?pd_rd_i=B07S52CF4L"
                                title="Doctor's Best Tocotrienols contains EVNol SupraBio Full Spectrum Vitamin E Complex"
                target="_blank"
            >Doctor's Best Tocotrienols contains EVNol SupraBio Full Spectrum Vitamin E Complex</a>
                            </p>
                        </figcaption>
                    </figure>
                </li>
                <li>
                    <a href="https://www.amazon.com/gp/product/B00AZQXO3E/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B00AZQXO3E&amp;linkId=3ba360ffd9243d4be9db93ad7adaf534"
                    title="Kala Health Unique Formula with All 8 Tocopherols and Tocotrienols Vitamin Eâ€“ Contains no PAHâ€™s, Heavy Metals, Contaminants or Preservatives - Certified Sustainable - Hair, Scars and Skin"
                    target="_blank"
                >Kala Health Unique Formula with All 8 Tocopherols and Tocotrienols</a>
                </li>
            </ul>
        -->
        </section>
        <section id="nicotinamides">
            <h3>NAD+ and its precursors NMN, NR, and Niacin</h3>

            <h3>Nicotinamide Adenine Dinucleotide (NAD+)</h3>
            <p>
                NAD+ is a coenzyme necessary for mitochondrial health, energy metabolism, DNA repair, and cell signaling. Mitochondrial dysfunction, including reduced NAD+ levels, is a primary pathology of PD requiring thorough attention.
            </p>
            
			<p>
				NAD+ regulates sirtuins, a family of enzymatic proteins that protect cells under stress, reducing inflammatory processes throughout the body and brain, protecting neurons in neurodegenerative diseases like PD, AD, and MS. Mitochondrial sirtuins specifically protect neurons in various PD models. <cite class="reflink"><a href="#l-he">He</a></cite>
			</p>
			
            <p>
                 NAD+ reduces oxidative stress, promoting cellular recovery and improving energy metabolism, neuroprotection, and DNA repair by modulating mitochondrial function. It reduces inflammation through immune modulation, causing macrophages to lower pro-inflammatory cytokines and increase anti-inflammatory cytokines.
            </p>

            <p>
                NAD+ promotes mitophagy, which leads to mitogenesis. Mitophagy, the controlled breakdown of damaged mitochondria, results in new mitochondrial formation, enhancing neuronal survival and reducing reactive oxygen species (ROS). Lower ROS levels reduce oxidative stress and may help prevent Î±-synuclein misfolding and aggregation.
            </p>
            
            <h4>Declining NAD+ Levels</h4>
            <p>
                Declining NAD+ levels contribute to reduced mitochondrial function and impaired cellular energy metabolism in neurons. This increases neurons' susceptibility to oxidative damage and degeneration.
            </p>

            <p>
                Raising NAD levels (through injection, precursor supplementation, and upregulation via exercise) improves mitochondrial function and count in neuronal cells. This explains how it improves neurotransmission, synaptic plasticity, and motor symptoms.
            </p>
            
            <h4>How NAD+ Decline Impacts Brain Health in Aging and PD</h4>
            <p>
	            A 2019 study in Cell Metabolism found that NAD+ decline accelerates cellular aging and predisposes cells to neurodegenerative diseases. Sufficient NAD+ levels support normal autophagy/mitophagy, mitochondrial stress responses, proteasomal degradation (see <a href="#protein-clearance-pathway-dysfunction">Protein Clearance Pathway Dysfunction</a>), and mitochondrial biogenesisâ€”all of which maintain cellular quality and function. Age-increased NAD+ utilization and depletion disrupt these regulatory processes, impairing mitochondrial homeostasis and neuronal function. <cite class="reflink"><a href="#lautrup">Lautrup</a></cite>
			</p>
			<p>
				Mitochondrial dysfunction leads to reduced ATP production and increased reactive oxygen species (ROS), which further damage mitochondria, further impacting its energy production mechanisms, including oxidative phosphorylation (OXPHOS), and the <abbr title="tricarboxylic acid cycle">TCA cycle</abbr>.  This leads to excessive calcium influx which damages mitochondrial membrane potential and damages neurons. Calcium dysregulation in PD worsens mitochondrial dysfunction, further reducing ATP and damaging neurons. (see: <a href="#mitochondrial-calcium-dysregulation">Mitochondrial Calcium Dysregulation</a>).
			</p>
			<p>
				NAD+ depletion compounds these mitochondrial issues, especially by disrupting mitophagy and promoting accumulation of damaged mitochondria. A 2019 study in Cell Metabolism found that NAD+ decline accelerates cellular aging and predisposes cells to neurodegenerative diseases.
			</p>
			<p>
				This research explains how age-associated declines in mitochondrial function accelerates susceptibility to diseases like PD, ALS, and AD, where impaired NAD+-dependent pathways, reduced mitophagy, and increased oxidative stress accelerate neurodegeneration. 
			</p>
            <h4>NAD Precursors</h4>
            <p>
                Supplementation with NAD precursors NMN, NR, and niacin, increases cellular levels of NAD+ (nicotinamide adenine dinucleotide). Among these, NMN is considered the safest and most effective precursor for increasing NAD+ levels, due to its direct conversion pathway.
            </p>

            <p>
                Niacin increases NAD+ levels but through a different metabolic pathway, separate from the more direct conversion of NMN and NR. 
            </p>
            <section id="nmn">
                <h3>Nicotinamide Mononucleotide (NMN)</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Antioxidant, Anti-inflammatory, Mitochondrial, Neuroprotective, Neurorestorative, Anti-aggregant</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>1000mg ED</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Very Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>
                
                <p>
                    NMN is a precursor to NAD+, and supplemental Nicotinamide Mononucleotide (NMN) is directly converted to NAD+, increasing NAD+ levels. <cite class="reflink"><a href="#c-shade">C Shade</a></cite>
                </p>
                
                <h4>NMN and Mental Performance</h4>
                <p>
                    Oral administration of NMN was shown to increase NAD+ levels in rodent brains <cite class="reflink"><a href="#d-i-ingram">D. Ingram</a></cite> and extremely large doses (500 mg/kg) injected over 10 days were shown to cause sustained improvement in cognitive function in rodents, as assessed by the Morris water maze. <cite class="reflink"><a href="#xionan-wang">X. Wang</a></cite>
                </p>
                
                <p>
                    Preclinical studies and some clinical trials have shown promising results regarding the potential benefits of NMN supplementation in Parkinson's disease. <cite class="reflink"><a href="#d-i-ingram">D.I. Ingram</a>, <a href="#x-chen">X. Chen</a></cite> 
                </p>
                
                <h4>NMN and Exercise Performance</h4>
                <p>
                    NMN dose-dependently improves exercise performance. <cite class="reflink"><a href="#b-lao">B. Lao</a></cite>
                </p>
                <p>
                    Long-term NMN supplementation at lower doses has shown increased NAD+ levels, improved insulin sensitivity, enhanced mitochondrial function, anti-aging effects, and cardiovascular health. <cite class="reflink"><a href="#k-f-mills">K.F. Mills</a></cite>
                </p>
                                    
                <h4>Supplementation</h4>
                <p>
                    A typical dose of NMN is about 1g per day. It's safe and effective at much higher levels, as shown in human studies and rodent models. <cite class="reflink"><a href="#l-yi">L. Yi</a></cite>
                </p>                    
                
                <h4>NMN Bulk Powder</h4>
                <p>
                    <a href="https://www.prohealth.com/products/prohealth-nmn-pro-powder-1-kilo-ph537?selling_plan=3992027236">NMN Bulk â€” Prohealth Longevity</a>
                </p>
                <p>
                    ProHealth Longevity is a well-established company that provides GMP compliance and third-party testing for purity and potency.
                </p>
                
                <h4>NMN References</h4>
                <ol class="reference-list">
                
                    <li id="c-shade">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238909/"
                        target="_blank"
                        title="The Science Behind NMNâ€“A Stable, Reliable NAD+Activator and Anti-Aging Molecule">The Science Behind NMNâ€“A Stable, Reliable NAD+Activator and Anti-Aging Molecule</a>, Christopher Shade.
                    </li>
                    
                    <li id="d-i-ingram">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778478/"
                        title="Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain"
                        target="_blank"
                        >Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain</a>, Donald K. Ingram.

                    </li>
                    <li id="xionan-wang">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27130898/"
                        target="_blank"
                        title="Nicotinamide mononucleotide protects against Î²-amyloid oligomer-induced cognitive impairment and neuronal death"
                        >Nicotinamide mononucleotide protects against Î²-amyloid oligomer-induced cognitive impairment and neuronal death</a> by Xiaonan Wang, et al.
                        <p>
                            This rodent study found that large doses (500mg/kg) of NMN injected over 10 days caused sustained improvement in cognitive function as assessed by the Morris water maze.
                        </p>
                    </li>
                    
                    <li id="k-f-mills">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668137/"
                        title="Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice"
                        target="_blank"
                        >Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice</a>, Kathryn F. Mills, et al.
                        <p>
                        
                        </p>
                    </li>
                    <li id="l-yi">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735188/"
                        title="The efficacy and safety of Î²-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial"
                        target="_blank"
                        >The efficacy and safety of Î²-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial</a>, Lin Yi, et al.
                        <p>
                        
                        </p>
                    </li>
                
                    <li id="x-chen">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803565/"
                        >Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment</a>, Xiaohong Chen, et al.              
                        <p>
                            This rodent model study found 250mg/kg and 500mg/kg NMN inhibited cell death at the acute phase of photoreceptor injury, with greater protection at 500 mg/kg.
                        </p>
                    </li>
                    <li id="b-lao">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265078/"
                        target="_blank"
                        title="Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study"
                        >Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study</a>, Bagen Liao, et al.
                        <p>
                            This double-blind <abbr title="randomized controlled trial">RCT</abbr> showed that 6 weeks NMN increased the aerobic capacity of humans during exercise training in groups taking 300mg, 600mg, and 1200mg twice per day.
                        </p>
                    </li>
                </ol>
            </section>
            
            <section id="nr">
                <h3>Nicotinamide Riboside (NR)</h3>
                 <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Antioxidant, Anti-inflammatory, Mitochondrial health promoter, Neuroprotective, Neurorestorative, Anti-aggregant</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>300-500mg ED</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Moderately Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                <p>
                NR is phosphorylated to NMN by the enzyme nicotinamide riboside kinase.
                </p>
                
                <h4>Supplementation</h4>
            
                <p>
                    The recommended dose is 300-500mg ED, taken along with NMN and niacin and occasional NAD+ injections. Oral supplementation of NR at 3000mg daily for 30 days was safe and well-tolerated.
                </p>
                
                <h4>NR References</h4>
                <ol class="reference-list">
                    <li>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29599478/7"
                        title="Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults"
                        target="_blank"
                        >Chronic NR supplementation in older adults</a>
                        <p>
                            This small-scale RCT (Randomized Controlled Clinical Trial) found that chronic oral supplementation with 1000mg of NR daily increased NAD+ levels in healthy middle-aged and older adults. 
                        </p>
                    </li>                   
                    <li>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/38016950/"
                        target="_blank"
                        title="NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease"
                    >NR-SAFE trial</a>, a Phase I clinical trial published in 2023 found that high-dose NR supplementation (3,000 mg/day) was well-tolerated and associated with improved motor symptoms in patients with PD.
                    </li>
                    <li>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35235774/"
                        title="The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinsonâ€™s disease"
                        target="_blank"
                        >NADPARK</a>
                        <p>
                            A phase I clinical trial published in 2022 found that NR supplementation increased whole blood NAD+ levels and expanded the NAD+ metabolome in patients with PD.
                        </p>
                    </li>
                </ol>
            </section>
            
            <section id="niacin">
                <h3>Niacin</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Antioxidant, Anti-inflammatory, Mitochondrial health promoter, Neuroprotective, Neurorestorative, Anti-aggregant</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>100-300mg BID</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-strong">
                                    <span>Moderately Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>
                <p>
                    Niacin increases NAD+ levels through a longer metabolic pathway than that of NMN however, NMN and NR are considered superior due to their more direct conversion pathways and higher efficiency, supported by various studies and research.
                </p>
                
                <h4>Safety</h4>
                <p>
                Niacin causes a flushing at higher doses. This is harmless but may be uncomfortable. 
                </p>

                <h4>Niacin References</h4>
                <ol>
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245760/"
                    >Niacin Enhancement for Parkinsonâ€™s Disease: An Effectiveness Trial</a>
                    </li>
                </ol>
            </section>
            
            <section id="nad-injection">
                <h4>NAD+ Injection &amp; IV Drip</h4>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Antioxidant, Anti-inflammatory, Mitochondrial health promoter, Neuroprotective, Neurorestorative, Anti-aggregant</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>Varies (injections or infusions)</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âŒ</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>

                <p>
                    NAD can be injected intramuscularly, subcutaneously, or intravenously via a drip. It is popular, safe, generally enjoyed, and very well-tolerated. 
                </p>

                <h4>NAD Product</h4>
                <figure>
                    <img src="./img/nad__750mg_30.png" alt="peptide sciences NAD+">
                    <figcaption>
                        <p>
                        <a href="https://www.peptidesciences.com/nadplus-750mg"
                        target="_blank">NAD+ 750mg â€” Peptide Sciences</a> (wait for 15% off sale) Peptide Sciences is the place for peptides. Compared to others, only PS sells lyophilized peptides.
                        </p>
                    </figcaption>
                </figure>
                
                <h4>NAD+ Injection References</h4>
                <ol>
                    <li>
                        <a href="https://www.frontiersin.org/articles/10.3389/fnagi.2019.00257/full"
                        title="A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+"
                        target="_blank">A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+</a>
                    
                        <p>
                            Eleven (Test n = 8, Control n = 3) male participants aged 30&ndash;55 years received 750 mg NAD+ in normal saline over a 6 h period. This resulted in a significant and quick elevation of intracellular NAD+.
                        </p>
                    </li>
                </ol>
            </section>
            
            <h4>NAD+ References</h4>
            <ol class="reference-list">
            	<li id="l-he">
            		<a href="https://pubmed.ncbi.nlm.nih.gov/35220492/"
                    title="Mitochondrial Sirtuins in Parkinson's Disease"
                    target="_blank"
                    >Mitochondrial Sirtuins in Parkinson's Disease</a>, Ling He, et al.
            	</li>

				<li id="lautrup">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6787556/"
                    title="NAD+ in Brain Aging and Neurodegenerative Disorders"
                    target="_blank"
                    >NAD+ in Brain Aging and Neurodegenerative Disorders</a>, Sofie Lautrup, et al.
                </li>
                <li>
                    <a href="https://pubmed.ncbi.nlm.nih.gov/27798264/">NAD+ repletion reverses age-related behavioral and synaptic deficits in mice</a>
                    <p>
                        This study demonstrates supplementation with NAD+ precursors, including NMN, improves mitochondrial function, synaptic plasticity, and cognitive function in aged mice. The findings suggest that NAD+ repletion may have potential therapeutic benefits for age-related neurological disorders.
                    </p>
                </li>
                <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963035/">NAD+ metabolism and its roles in cellular processes during ageing</a>
                    <p>
                        NAD+ metabolism in cellular processes associated with aging and age-related diseases, including neurodegenerative disorders like PD. It highlights the potential therapeutic implications of NAD+ precursors in
                        mitigating age-related declines in cellular function and promoting healthy aging.
                    </p>
                </li>
                <li>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518566/">Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model</a>
                    <p>
                        Although this study focuses on a cardiomyopathy model in Friedrich's ataxia, it provides insights into the potential benefits of NMN supplementation in a disease characterized by mitochondrial dysfunction.
                        The findings suggest that NMN administration improves cardiac function and bioenergetics through SIRT3-mediated mechanisms, highlighting the importance of NAD+ metabolism in mitochondrial health.
                    </p>
                </li>
                <li>
                    <a href="https://www.heraldopenaccess.us/openaccess/intravenous-administration-of-nicotinamide-adenine-dinucleotide-alleviates-tremors-associated-with-parkinson-s-disease-a-case-report"
                    >Intravenous Administration of Nicotinamide Adenine Dinucleotide Alleviates Tremors Associated with Parkinsonâ€™s Disease A Case Repor</a>
                    <p>
                        This single case study used BR+NAD ("Brain Restoration Plus" NAD) comprised of multiple IV infusions of NAD+ over six days, as well as added oral supplementation of Vitamin C, B6, Folate, Selenium, N-acetyl-L-cysteine, N-acetyl-L-tyrosine, and electrolytes. Following Day 6, he received sublingual NAD+ tablets (300mg, twice per day) for 14 days.
                    </p>
                    <p>
                        The patient initially presented with bilateral hand tremors (significantly more pronounced in the right hand), shuffling gate/gait rigidity, and impairments in movements of the hands and fingers
                    <p>
                        Over the six NAD+ the six NAD+ treatment days, the patient showed a significant decline in hand tremors, development of a steady gate, increased sociability, increased cognitive functioning, and improved sleep.
                    </p>
                </li>
            </ol>
        </section>
        
        <section id="bacopa">
            <h3>Bacopa Monnieri (TODO)</h3>            
        </section>
        
        <section id="berberine">
            <h3>Berberine (TODO)</h3>            
        </section>
        
        <section id="gingko">
            <h3>Ginkgo Biloba (TODO)</h3>            
        </section>
        
        <section id="lutein">
            <h3>Lutein (TODO)</h3>            
        </section>            
        
        <section id="zeaxanthin">
            <h3>Zeaxanthin (TODO)</h3>            
        </section>
        
        <section id="blueberry">
            <h3>Blueberry</h3>
            <table class="treatment-legend">
                <tr>
                    <th>Mechanisms</th>
                    <td>Cognition, anti-ischemic, antioxidant, anti-inflammatory, mitochondrial, cognitive</td>
                </tr>
                <tr>
                    <th>Dose</th>
                    <td>100-200 blueberries (or equivalent) per day, plus 50-100 mg pterostilbene per day.</td>
                </tr>
                <tr>
                    <th>ðŸ©¸ðŸ§  BBB</th>
                    <td>âœ…</td>
                </tr>
                <tr>
                    <th>Fat-soluble</th>
                    <td>âœ… â€” pterostilbene, resveratrol, quercetin, and kaempferol are all fat-soluble.</td>
                </tr>
                <tr>
                    <th>Safety</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-strong">
                                <span>Very Safe </span>
                            </div>
                        </div>
                    </td>
                </tr>
                <tr>
                    <th>Efficacy</th>
                    <td>
                        <div class="rating-bar">
                            <div class="indicator indicator-moderate">
                                <span>Moderately Effective </span>
                            </div>
                        </div>
                    </td>
                </tr>
            </table>
        
            <p>
                Blueberries are rich in a variety of bioactive compounds that work together to offer health benefits. These compounds, when consumed from whole blueberries or their extracts, may be more effective than consuming individual components separately.
            </p>

            <h4>Pterostilbene â€” Blueberry's Powerful Polyphenol</h4>
            <p>
                Pterostilbene, a compound in blueberries, protects it against viral, bacterial, and fungal attack and excessive sunlight, similar to resveratrol, another stilbene produced byÂ blueberries and also found in grapes. 
            </p>
            
            <h4>Mechanism of Action</h4>
            <p>
                Pterostilbene exerts its neuroprotective effects by crossing the blood brain barrier, reducing oxidative stress and inflammation, increasing BDNF and neuroplasticity, altering CNS neurotransmitter systems (GABAergic, glutamatergic, and cholinergic), and improving symptoms of anxiety and depression.
            </p>
    
            <p>
                Compared to resveratrol, pterostilbene has been shown to have four times the oral bioavailability, making it much more effective at low doses. <cite class="reflink"><a href="#mccormack">McCormack</a></cite>
            </p>
            
            <h4>Cognitive Effects</h4>
            <p>
                A double-blind <abbr title="randomized controlled trial">RCT</abbr> investigated the effects of dietary blueberry on cognition in adults aged 60-75 years, randomly assigned to receive either 24 g/day of freeze-dried blueberry powder (equivalent to 1 cup of fresh blueberries) or a placebo powder for 90 days, finding that freeze-dried blueberry powder improved verbal memory and executive function. <cite class="reflink"><a href="#miller">miller</a></cite>
            </p>
            
            <h4>Blueberry Juice Plus Exercise</h4>
            <p>
                Exercise combined with polyphenol consumption may impart neuroprotective benefits greater than either treatment alone. 
            </p>
            
            <p>
                A 2022 placebo-controlled rodent study on rats with amphetamine-induced rotational behavior assessed the effects of blueberry juice (BBJ) and exercise (EX) on four groups of rats, with controls for both exercise and blueberry juice (placebo). <abbr title="blueberry juice">BBJ</abbr> alone did not improve rotation in the rats, but <em>exercise</em> alone did, significantly decreasing the number of amphetamine-induced rotations by 42%. However, most impressively, exercise + <abbr title="blueberry juice">BBJ</abbr> improved upon rotational behavior by 80%. <cite class="reflink"><a href="#castro">Catro</a></cite>
            </p>
            
            <h4>Real Blueberry vs. Pterostilbene Intake</h4>
            <p>
                Blueberries contain very small amounts of pterostilbeneâ€”around 99 to 520 ng per gram, meaning vast quantities would need to be consumed approach an effective dosage. For context, a daily dose of 100-250 mg of pterostilbene would require about 300,000 to 1.25 million blueberries, totalling over 40,000 kCal per day â€” an impossible amount.
            </p>
            
            <h4>Whole Blueberry plus Extract Consumption Strategy</h4>
            <p>
                 Blueberries are packed with multiple bioactive compounds (e.g., anthocyanins, resveratrol, flavonoids) that provide synergistic health benefits. However, relying on whole blueberries or concentrated forms like FruitFast to achieve therapeutic pterostilbene levels is impractical for the purposes of targeting effects like cognitive protection or reducing oxidative stress.
            </p>
            
            <p>
                Blueberry extract (e.g., FruitFast) provides a range of bioactive compounds but is low in pterostilbene. A pterostilbene supplement (50-100 mg/day), taken with fats, targets specific neuroprotective and antioxidant effects. Higher pterostilbene doses (>50 mg/day) have been associated with gastrointestinal discomfort and elevated LDL cholesterol, which may require individual testing and dose adjustments.
            </p>
            
            <h4>References</h4>
            <ol class="reference-list">
                <li id="mccormack">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3649683/"
                    title="A Review of Pterostilbene Antioxidant Activity and Disease Modification"
                    target="_blank"
                    >A Review of Pterostilbene Antioxidant Activity and Disease Modification</a>, Denise McCormack and  David McFadden.
                </li>
                
                <li id="miller">
                    <a href="url"
                    title="Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial"
                    target="_blank"
                    >Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial</a>, Marshall G Miller, et al.
                </li>
                
                <li id="castro">
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935512/"
                    title="Blueberry juice augments exercise-induced neuroprotection in a Parkinsonâ€™s disease model through modulation of GDNF levels"
                    target="_blank"
                    >Blueberry juice augments exercise-induced neuroprotection in a Parkinsonâ€™s disease model through modulation of GDNF levels</a>, Sandra L Castro, et al.
                </li>
            </ol>
        </section>      
        <section id="senolytics">
            <h3>Senolytics</h3>
            <p>
                Senolytics are used to selectively induce the death of senescent cells. Senolytic means "senescent cell destruction".
            </p>

            <h4>Senolytics in Parkinson's Disease</h4>
            <p>
                Senolytics inhibit and help degrade &alpha;-synuclein aggregation.
            </p>
            <p>
                In PD, &alpha;-synuclein and especially its mutant forms damage mitochondria, causing a leak of sirtuins from the inner membrane of the mitochondria leading to mitochondrial failure and eventual cell failure.
            </p>
            <p>
                Aggregates of &alpha;-synuclein form Lewy bodies inside the cell and block T-cells from activating the lysosome of non-functioning "zombie" cells.
            </p>
            <p>
                Senolytics help prevent the formation of &alpha;-synuclein aggregates. This has numerous benefits, including neuroprotection, decreased neuroinflammation, improved mitochondrial function, neurogenesis, and autophagy.
            </p>
            <p>
                Senolytics reduce the formation of Lewy bodies and facilitate T-cell activation of the lysosome in senescent cells by preventing obstruction by &alpha;-synuclein.
            </p>

            <section id="urolithin-a" class="mitochondrial senolytic neuroprotective">
                <h3>Urolithin-A</h3>
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td>Antioxidant, Anti-inflammatory, Mitochondrial, Neuroprotective, Neurorestorative, Anti-aggregant</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>1000mg ED</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Safe</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span>Moderately Effective</span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>
                
                <h4>Overview</h4>
                <p>
                    Urolithin-A is a naturally occurring compound produced by gut bacteria through the transformation of polyphenols, such as ellagitannins and ellagic acid, found in small amounts of some foods like wild berries (pomegranates, etc), walnuts, and tea. Urolithin-A supplementation stimulates mitophagy and mitochondrial function in several tissues.
                </p>
                
                <h4>Benefits</h4>
                <p>
                    Urolithin-A-induced mitophagy promotes mitogenesis. This promotes neuronal survival and function, making Urolithin-A strongly neuroprotective. <cite class="reflink"><a href="#p-andreux">P. Andreux</a></cite>
                </p>
                
                <h4>Mitophagy</h4>
                <p>
                    Mitophagy is a cellular process that recycles and removes damaged or unhealthy mitochondria, leading to their replacement with new, healthy mitochondria. 
                </p>
                
                <h5>Urolithin-A and the PINK1-Parkin Pathway</h5>
                
                <p>
                    The PINK1-Parkin pathway is necessary for the removal of damaged mitochondria. In some conditions, including PD, it is impacted. When PINK1 enters healthy mitochondria, the mitochondria remove it. However, when the mitochondria are damaged, PINK1 accumulates on the outer membrane. This signals the recruitment of Parkin to the outer membrane, which marks the damaged mitochondria for recognition by autophagosomes. The autophagosomes engulf the damaged mitochondria and transport them to the cell's lysosome for degradation. This process, known as <dfn>mitophagy</dfn>, signals the cell to initiate  <dfn>mitochondrial biogenesis</dfn>, restoring cellular energy and function.
                </p>
                
                <h4>Mitophagy in Parkinson's Disease</h4>
                <p>
                    In PD, there is an abnormally higher number of damaged mitochondria. These damaged mitochondria accumulate alpha-synuclein and contribute to the formation of Lewy bodies. Inducing mitophagy helps clear these harmful mitochondria and restore cellular energy production. This process protects against dopaminergic neurodegeneration.
                </p>
                
                <p>
                    A 2021 study using a PD-induced rodent model found urolithin-A exerted neuroprotective effects by promoting mitochondrial biogenesis via SIRT1-PGC-1Î± signaling pathway and ameliorated both motor deficits and nigral-striatal dopaminergic neurotoxicity. <cite class="reflink"><a href="#jia-liu">J. Liu</a></cite>
                </p>

                <p>
                    A 2019 rodent study out of Guangzhou, China found Urolithin-A, in a mouse model of AD, significantly improved spatial learning and memory, protected neurons from death, reduced neuroinflammation, and triggered neurogenesis. <cite class="reflink"><a href="#z-gong">Z. Gong</a></cite>
                </p>
                <p>
                    A 2023 review study found Urolithin-A was neuroprotective, protected against brain injuries, improved mitophagy and overall mitochondrial functions of the nerve cells, inhibited monoamine oxidase, and reduced cognitive decline. <cite class="reflink"><a href="#o-wojciechowska">O. Wojciechowska</a></cite>
                </p>
                
                <h4>Product</h4>
                <figure>
                    <img src="img/urolithin-a-activity.png"
                    class="block-image">
                
                    <figcaption>
                        <p>
                            Urolithin-A benefits include reduced neuroinflammation, reduced &alpha;-synuclein aggregation, decreased apoptosis, protection of dopaminergic neurons, improved mitochondrial function, and improved motor and cognitive function.
                        </p>
                        <p>
                            <cite>Urolithin A in Health and Diseases: Prospects for Parkinsonâ€™s Disease Management</cite>, O. Wojciechowska, et al.
                        </p>
                    </figcaption>
                </figure>
                
                <h4>Exercise Performance</h4>
                <p>
                    A 2022 <abbr title="randomized controlled trial">RCT</abbr> found Urolithin-A improved muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. <cite class="reflink"><a href="#a-singh">A. Singh</a></cite>
                </p>
                Mice were gavage-fed with vehicle or taurine (500 or 1000 mg per kg body weight) daily for 10â€“12 month and culled at the age of 24 months for terminal assays
                <p>
                    Another <abbr title="randomized controlled trial">RCT</abbr> in 2022 found Urolithin-A conferred a significant improvement in muscle endurance and reduced <abbr title="C-Reactive Protein">CRP</abbr>. <cite class="reflink"><a href="#s-liu">S. Liu</a></cite>
                </p>
                
                <h4>Supplementation</h4>
                
                <p>
                    1000mg per day of Urolithin-A is safe and well-tolerated in humans.
                </p>
                
                <p>
                    Urolithin-A is fat-soluble and can cross the BBB. Taking with food or other fat-soluble vitamins may improve absorption. 
                </p>
                
                <h4>Food Sources</h4>
                    Pomegranates contain ellagitannins, convertible to urolithin A by gut bacteria in 30% to 50% of people. Optimistically, eating 1 pomegranate might yield a negligible 2 milligrams of Urolithin-A â€” <em>not enough</em>!             
                
                <h4>Side Effects</h4>
                <p>
                    Potential unknown side effects might include gastric upset or potential interactions with certain medications that also undergo hepatic metabolism.  Taking with food may help.
                </p>

                <h4>References</h4>
                <ol class="reference-list">
                    <li id="p-andreux">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32694802/"
                        title="The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
"
                        target="_blank"
                        >The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans</a>, PÃ©nÃ©lope A Andreux, et al.
                        <p>
                            This clinical trial found Urolithin-A induces a molecular signature of improved mitochondrial and cellular health following regular oral consumption in humans.
                        </p>
                    </li>

                    <li id="jia-liu">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34905594/"
                        title="Urolithin-A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1Î± signaling pathway"
                        target="_blank"
                        >Urolithin-A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1Î± signaling pathway</a>, Jia Liu, et al.
                        <p>
                            This rodent study demonstrated Urolithin-A's neuroprotective effects, promoting mitochondrial biogenesis via SIRT1-PGC-1Î± signaling.
                        </p>
                    </li>
                    
                    <li id="z-gong">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417212/"
                        title="Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice"
                        target="_blank"
                        >Urolithin-A attenuates memory impairment and neuroinflammation</a>, Zhuo Gong, et al.
                        <p>
                             Urolithin-A significantly improved spatial learning and memory, protected neurons from death, reduced neuroinflammation, and triggered neurogenesis.
                        </p>
                    </li>
                    
                    <li id="o-wojciechowska">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376282/"
                        title="Urolithin-A in Health and Diseases: Prospects for Parkinsonâ€™s Disease Management"
                        target="_blank"
                        >Urolithin-A in Health and Diseases: Prospects for Parkinsonâ€™s Disease Management</a>, Olga Wojciechowska and MaÅ‚gorzata Kujawska.
                        <p>
                            This review study found Urolithin-A reduced cognitive decline, increased mitochondrial quality and content, and protected against neurodegeneration.
                        </p>
                    </li>
                    
                    <li id="a-singh">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133463/" title="Urolithin-A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults"
                        target="_blank"
                        >Urolithin-A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults</a>, Anurag Singh, et al.
                        <p>
                            This randomized, placebo-controlled trial in middle-aged adults found Urolithin-A improved muscle strength, exercise performance, inflammation, and biomarkers of mitochondrial health.
                        </p>
                    </li>
                    <li id="s-liu">
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777576/"
                            title="Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults"
                            target="_blank"
                            >Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults</a>, Sophia Liu, et al.
                        <p>
                            Ceramides and plasma CRP were significantly lower in the Urolithin A group compared to the placebo group. (Ceramides are sphingolipids used in cellular signaling, membrane integrity, and cellular stress response. Elevated ceramides indicate inflammation and metabolic disorder.)
                        </p>
                    </li>
                </ol>
            </section>

            <section id="resveratrol">
                <h4>
                    Resveratrol (TODO)
                </h4>            

                <p>
                    Resveratrol has displayed potent neuroprotective efficacy in several PD animal models.
                </p>
                <h5>
                    How it works:
                </h5>
                <p>
                    Resveratrol inhibits &alpha;-synuclein aggregation and cytotoxicity, lowering the levels of total &alpha;-synuclein and oligomers, and reducing neuroinflammation and oxidative stress in a dose-dependent manner.
                </p>
                <h5>
                    Product:
                </h5>
                <p>
                    <a
                        href="https://www.amazon.com/gp/product/B00IM21FBG/ref=as_li_tl?ie=UTF8&amp;tag=garrettsmit02-20&amp;camp=1789&amp;creative=9325&amp;linkCode=as2&amp;creativeASIN=B00IM21FBG&amp;linkId=ec9df367e733c718d4c8ac89e53e5bdf"
                        target="_blank"
                    >Purity Labs Organic Trans-Resveratrol 1,500MG Enhanced with Quercetin</a>
                </p>
                <img src="img/trans-resveratrol.jpeg" alt="trans-resveratrol">
                <p>
                    Purity Labs Trans-Resveratrol is a high dose, 2 pills per day formula. It might be better to take just one
                </p>
                
                <h4>Resveratrol References</h4>
                <ol>
                    <li>
                        <a href="https://scienceofparkinsons.com/tag/resveratrol/"
                        target="_blank"
                        >Brain. On. Fire | The Science of Parkinson&rsquo;s.
                        </a>
                        (this article covers other published research on compounds with inhibitory activities on components of the NLRP3 inflammasome pathway, including EGCG, Curcumin, Sulforaphane, and Quercetin)
                    </li>

                    <li>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33967780/"
                        target="_blank"
                        >Resveratrol in Rodent Models of Parkinson's Disease: A Systematic Review of Experimental Studies
                        </a>
                    </li>
                </ol>
            </section>
            <section id="fisetin">
                <h3>Fisetin (TODO)</h3>
                <p>
                    Fisetin is a fat-soluble polyphenol capable of crossing the BBB. Fisetin is found in many fruits and vegetables, such as strawberries, apples, persimmons, onions, and cucumbers.
                </p>
                <h4>Fisetin References</h4>
                <ol>
                    <li>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34199487/">Small Molecule Fisetin Modulates Alpha-Synuclein Aggregation</a>
                    </li>
                    <li>
                        Fisetin <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527824/">helps to maintain glutathione (GSH) levels</a>.</li>
                    <li>
                        <a href="https://link.springer.com/article/10.1007/s11626-013-9681-6">Fisetin reduces ROS production</a>
                    </li>
                </ol>
            </section>
            
            <section id="quercetin">
                <h3>Quercetin</h3>
				<table class="treatment-legend">
					<tr>
						<th>Mechanisms:</th>
						<td>Antioxidant, Anti-inflammatory, Mitochondrial, BBB and Barrier Dysfunction</td>
					</tr>
					<tr>
						<th>Dose:</th>
						<td>30mg of Isoquercetin or 1000mg quercetin per day</td>
					</tr>
					<tr>
						<th>Fat-soluble:</th>
						<td>âœ…</td>
					</tr>
					<tr>
						<th>ðŸ©¸ðŸ§  BBB:</th>
						<td>âœ… â€”Â crosses BBB and reduces BBB permeability</td>
					</tr>
					<tr>
						<th>Safety:</th>
						<td>
							<div class="rating-bar">
								<div class="indicator indicator-strong">
									<span>Very Safe</span>
								</div>
							</div>
						</td>
					</tr>
					<tr>
						<th>Efficacy:</th>
						<td>
							<div class="rating-bar">
								<div class="indicator indicator-somewhat">
									<span>Somewhat Effective</span>
								</div>
							</div>
						</td>
					</tr>
				</table>

                <p>
                    Quercetin is a fat-soluble flavonoid naturally found in many plant foods like fruits and vegetables, especially apples, onions, and capers.
                </p>
                
                <p>
                	Quercetin has demonstrated neuroprotection in Parkinson's and other neurodegenerative brain disorders such as Alzheimer's, Huntington's, <abbr title="multiple sclerosis">MS</abbr>, and <abbr title="amyotrophic lateral sclerosis">ALS</abbr>. <cite class="reflink"><a href="#islam">Islam</a></cite>
                </p>
                
                <h4>Neurodegenerative Disease Effects</h4>                
				<p>
	                A 2023 review highlighted quercetin's cognitive benefits in preclinical studies. Mechanisms included decreased neuroinflammation and oxidative stress, improved mitochondrial function and neurotransmitter signaling, and enhanced neurogenesis via <abbr title="Brain-Derived Neurotrophic Factor">BDNF</abbr> and <abbr title="Nerve Growth Factor">NGF</abbr>, and gene expression markers like <abbr title="Cyclic AMP Response Element-Binding Protein">CREB</abbr> and <abbr title="early growth response 1">EGR-1</abbr>, all relevant to PD. <cite class="reflink"><a href="#chiang">Chiang</a>, <a href="#x-w-zhang">Zhang</a></cite>
				</p>
                		
                <h4>Effects on Alpha-Synuclein</h4>
                <p>
                    A 2023 editorial published in Current Neuropharmacology revealed multiple studies including a lab study where oral administration of quercetin reduced Î±-synuclein clumpingâ€”a hallmark of PDâ€”and protected dopamine-producing neurons from oxidative damage. <cite class="reflink"><a href="#das">Das</a></cite>
                </p>
				
				<h5>Ischemic Stroke â€” BBB and Other Effects</h5>
				<p>
					A 2022 meta analysis and systematic review found that quercetin promotes neurogenesis and reduces BBB permeabilityâ€”both relevant to PD due to its antioxidant and anti-inflammatory effects. <cite class="reflink"><a href="#guo">guo</a></cite>
				</p>
				
				<!--
				In PD, Quercetin inhibits Î±-synuclein aggregation, protects mitochondria, and modulates various cell-signaling pathways to promote neuronal survival and function. 
				-->
            	
				<h4>Calcium-Regulating Effects</h4>
				<p>
            		Quercetin has been found to inhibit calcium release from the endoplasmic reticulum (ER) in response to <abbr title="endoplasmic reticulum">ER</abbr> stress, and may help maintain calcium homeostasis by reducing excessive calcium release. <cite class="reflink"><a href="#el-horany">El-Horany</a></cite>
            	</p>

                <!-- TODO
            	<p>
					It has been shown to modulate calcium channels, including voltage-gated calcium channels (VGCCs) and store-operated calcium channels (SOCCs). This modulation may help regulate calcium influx and efflux, contributing to overall calcium homeostasis.
				</p>
				-->
				<p>
					A highly-cited 2020 review found quercetin improves bone mineralization by stimulating the vitamin D receptor. This implies an uptake of calcium into bone, resulting in less extracellular calcium, which means less potential for excess intracellular calcium. This offers a potential benefit, given the known problems of <a href="#calcium-dysregulation">calcium dysregulation</a> and excess intracellular calcium in PD. The dose used in most of the reviewed rodent studies was 50mg/kg BW. For humans, that would roughly equate to 4mg/kg/day, so a 70kg human would need about 500mg per day. <cite class="reflink"><a href="#s-wong">Wong</a></cite>
				</p>
	                
                <h4>Quercetin vs Isoquercetin</h4>
            	<p>
            		Isoquercetin, with up to 40x higher absorption, offers greater therapeutic potential, making it a preferred option for supplementation. <cite class="reflink"><a href="#islam">Islam</a></cite>
            	</p>
                <h4>Supplementation</h4>
                <p>
                	A daily dose of 30 mg Isoquercetin or 1000 mg quercetin, taken with food, is well-tolerated and supports calcium regulation and neuroprotection.
                </p>
                <h4>Quercetin References</h4>
                <ol class="reference-list">
                
                	<li id="islam">
						<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8248808/"
						title="Neuropharmacological Effects of Quercetin: A Literature-Based Review"
						target="_blank">Neuropharmacological Effects of Quercetin: A Literature-Based Review</a>, Md Shahazul Islam, et al.
					</li>
                    <li id="chiang">
                        <a 
							target="_blank"                        	
							title="The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms"
            	href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094159/">The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms</a>, Ming-Chang Chiang, et al.
                    </li>
                    <li id="x-w-zhang">
						<a 
							target="_blank"                        								href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7014205/"
						title="Quercetin in Animal Models of Alzheimerâ€™s Disease: A Systematic Review of Preclinical Studies"
						target="_blank"
						>Quercetin in Animal Models of Alzheimerâ€™s Disease: A Systematic Review of Preclinical Studies</a>, Xiao-Wen Zhang, et al.
                    </li>
                    <li id="das">
						<a 
							target="_blank"
							href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10472805/"
						title="Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinsonâ€™s Disease"
						target="_blank"
						>Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinsonâ€™s Disease</a>, Sabya Sachi Das, et al.
                    </li>
					<li id="guo">
						<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8896934/"
						title="Effect and Mechanisms of Quercetin for Experimental Focal Cerebral Ischemia: A Systematic Review and Meta-Analysis"
						target="_blank"
						>Effect and Mechanisms of Quercetin for Experimental Focal Cerebral Ischemia: A Systematic Review and Meta-Analysis</a>, Chao Guo, et al.
					</li>

                    <li id="s-sharma">
                        <a 
							target="_blank"                        	
                        	href="https://pubmed.ncbi.nlm.nih.gov/31654381/"
                        >Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats</a>, Shakshi Sharma, et al.
                        <p>
                            This preclinical study conducted on rats found the combination of quercetin and piperine provided substantial neuroprotection in the rat model of Parkinson's disease, suggesting potential for therapeutic use.
                        </p>
                    </li>
                    <li id="el-horany">
						<a 
							target="_blank"                        	
						href="https://onlinelibrary.wiley.com/doi/abs/10.1002/jbt.21821"
						title="Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease)"
						target="_blank"
						>Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease)</a>, Hemat E. El-Horany, et al.
					</li>
					<li id="s-wong">
						<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7503351/"
						title="Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence"
						target="_blank"
						>Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence</a>, S. Wong, et al.
					</li>
                </ol>
            </section>
            
            <section id="sulforaphane">
                <h3>Sulforaphane</h3>
                
                <table class="treatment-legend">
                    <tr>
                        <th>Mechanisms</th>
                        <td><strong>Antioxidant</strong> â€” induces Nrf2, <strong>Anti-inflammatory</strong> (via Nrf2 pathway activation), <strong>Antifibrillogenic</strong>, <strong>Anti-aggregant</strong>, <strong>Mitochondrial</strong> â€” mitogenesis and mitophagy, <strong>BBB and Barrier Dysfunction</strong>Â â€” reduces oxidative and inflammatory damage to BBB endothelial cells, <strong>Anti-ischemic</strong> â€” boosts endothelial function and NOâ‚‚ vasodilation, <strong>Cognitive</strong> â€” boosts synaptic plasticity, <strong>Senolytic</strong> â€” boosts <abbr title="ubiquitin proteasome system">UPS</abbr> and <abbr title="autophagy-lysosomal pathway">ALP</abbr>, <strong>Gastrointestinal</strong> â€” lowers gut inflammation and helps microbiome, <strong>Sleep</strong> â€” lowers oxidative stress.</td>
                    </tr>
                    <tr>
                        <th>Dose</th>
                        <td>50mg daily</td>
                    </tr>
                    <tr>
                        <th>ðŸ©¸ðŸ§  BBB</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Fat-soluble</th>
                        <td>âœ…</td>
                    </tr>
                    <tr>
                        <th>Safety</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span> </span>
                                </div>
                            </div>
                        </td>
                    </tr>
                    <tr>
                        <th>Efficacy</th>
                        <td>
                            <div class="rating-bar">
                                <div class="indicator indicator-moderate">
                                    <span> </span>
                                </div>
                            </div>
                        </td>
                    </tr>
                </table>
                
                <p>
                	Sulforaphane is a naturally occurring organosulfur compound found in cruciferous vegetables, especially broccoli sprouts. It has been shown to increase glutathione, the master antioxidant, in humans. It improves neurogenic pathways, activating anti-inflammatory microglia, leading to increased <abbr title="Brain-Derived Neurotrophic Factor">BDNF</abbr>. It has been shown to improve cognitive function in <abbr title="Traumatic Brain Injury">TBI</abbr> animal models, and its effects on PD are currently being studied in a phase II clinical trial, <a href="https://connect.careboxhealth.com/en-US/trial/listing/492695" target="_blank">A 6-month Study to Evaluate Sulforaphane Effects in PD Patients</a>. <cite class="reflink"><a href="#sedlak">Sedlak</a></cite>
                </p>
                
                <h4>Effects on Cognition and Mood</h4>
                <p>
                	In a 2022 double-blinded RCT published in <cite>Frontiers in Aging Neuroscience</cite>, 144 older adults were randomly assigned to take sulforaphane or placebo for 2 weeks. Researchers measured several cognitive functions, mood states, and biomarkers before and after the intervention period. The sulforaphane group showed significant improvement in processing speed and a decrease in negative mood compared to the placebo group. <cite class="reflink"><a href="#nouchi">Nouchi</a></cite>
                </p>
                <ol class="reference-list">
                
                	<li id="sedlak">
						<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5981770/"
						title="Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study"
						target="_blank"
						>Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study</a>, Thomas W Sedlak, et al.
					</li>
					<li id="nouchi">
						<a href="https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2022.929628/full"
						title="Effects of sulforaphane intake on processing speed and negative moods in healthy older adults: Evidence from a randomized controlled trial"
						target="_blank"
						>Effects of sulforaphane intake on processing speed and negative moods in healthy older adults: Evidence from a randomized controlled trial</a>, Rui Nouchi, et al.
					</li>
				</ol>
            </section>
            <section id="apigenin">
                <h3>Apigenin (TODO)</h3>
            </section>
            <section id="trehalose">
                <h3>Trehalose (TODO)</h3>
            </section>            
            
            <section id="piperlongum">
                <h3>Piperlongumin (TODO)</h3>
                <p>
                    Piper longum, also known as Long Pepper or Indian Long Pepper is used as a spice and seasoning with a flavor similar to, but sweeter and less pungent than, black pepper (Piper nigrum). Piperlongumine has been identified as a novel senolytic agent that selectively kills senescent cells over non-senescent cells.
                </p>
                
                <p>
                    Piperlongumine induces apoptosis in senescent cells without requiring the induction of reactive oxygen species (ROS).
                </p>
                
                <h4>References</h4>
                <ol class="reference-list">
                    <li id="yinyin-wang">
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5191878/"
                        title="Discovery of piperlongumine as a potential novel lead for the development of senolytic agents"
                        target="_blank"
                        >Discovery of piperlongumine as a potential novel lead for the development of senolytic agents</a>, Yingying Wang, et al.
                    </li>
                    <li id="x-zhang">
                    <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6052462/"
                        title="Oxidation resistance 1 is a novel senolytic target"
                        target="_blank"
                        >Oxidation resistance 1 is a novel senolytic target</a>, Xin Zhang, et al.
                    </li>
                    <li id="go">
                        <a href="https://www.spandidos-publications.com/10.3892/ijmm.2018.3782"
                        title="Piperlongumine decreases cognitive impairment and improves hippocampal function in aged mice"
                        target="_blank"
                        >Piperlongumine decreases cognitive impairment and improves hippocampal function in aged mice</a>, Jun Go, et al.
                    </li>
                    
                    <li id="hassan">
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9462063/"
                        title="Senolytics in the treatment of diabetic retinopathy"
                        target="_blank"
                        >Senolytics in the treatment of diabetic retinopathy</a>, Jannah Waled Hassan and Ashay D Bhatwadekar.
                    </li>
                    <li id="w-li">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31077707/"
                        title="Emerging senolytic agents derived from natural products"
                        target="_blank"
                        >Emerging senolytic agents derived from natural products</a>, Wen Li, et al.
                    </li>

                </ol>
            </section>
            
            <section id="theaflavin">
                <h4>Theaflavin (TODO)</h4>
                <p>
                    Theaflavin, from black tea, is senolytic.
                </p>
            </section>
        </section>
    </section>

    <section id="summary">
        <h2>Summary</h2>
        <p>
            By applying the principles of volition, self-ownership, informed decision-making, and critical thinking, and by directly examining evidence, this guide has challenged conventional approaches to Parkinson's Disease. It has highlighted the limitations of pharmaceutical interests and institutional biases, and has aimed to foster a clear understanding of effective treatments and their underlying mechanisms.
        </p>
        <p>
            With comprehensive coverage of disease etiology, diagnostic methods, and evidence-based interventionsâ€”including medications, advanced therapies, dietary strategies, and supplementationâ€”the guide has equipped the reader to critically evaluate and manage their condition. By distinguishing between evidence and misinformation, the reader is now prepared to take proactive, independent steps in navigating the complexities of Parkinsonâ€™s Disease effectively.
        </p>
    </section>

    <footer id="copyright">
        <p>&copy; 2024 Garrett Smith. All rights reserved.</p>
    </footer>    
</body>
</html>
